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ABSTRACT 
 
The Use of COD, TOC, Fluorescence, and Absorbance Spectroscopy to Estimate 
Biochemical Oxygen Demand in Wastewater  
 
By 
Evelyn Christian  
 
Dr. Daniel Gerrity, Examination Committee Co-Chair 
Assistant Professor of Environmental Engineering  
University of Nevada, Las Vegas 
 
Dr. Jacimaria Batista, Examination Committee Co-Chair 
Professor of Environmental Engineering 
University of Nevada, Las Vegas 
 
All wastewater treatment facilities must obtain a National Pollution Discharge 
Elimination System (NPDES) permit, which regulates the quality of water that is 
discharged.  Common to all NPDES permits is a limit on organic matter, as determined 
by the five-day biochemical oxygen demand (BOD5) test.  More rapid methods, such as 
chemical oxygen demand (COD), total organic carbon (TOC), fluorescence, and 
absorbance spectroscopy are also capable of quantifying organic matter. Previous studies 
indicate it is possible to develop correlations between these parameters.  This study 
explored the correlations using influent, primary clarifier effluent, and finished effluent 
samples from an operational wastewater treatment plant located in Nevada.  It was 
concluded that COD could be used to estimate BOD5 for influent, primary clarifier 
effluent, and finished effluent.  TOC could be used as a surrogate for finished effluent, 
but it was not suitable for influent or primary clarifier effluent.  The relationship 
developed for fluorescence and BOD5 was nonlinear, presumably due to inner filter effect 
(IFE) interference.  Power functions were developed for region I of the excitation 
emission matrix (EEM) and peak T (excitation=275 nm, emission=340 nm) that could be 
used to estimate BOD5 for finished effluent and primary clarifier effluent, but they were 
poor estimators for plant influent.  Comparison of removal efficiencies indicated that 
TOC and fulvic-like fluorescence peaks increased in the primary clarifier, presumably 
due to the return of centrate that is sent back to the primary clarifier.  The fluorescence 
removals indicated that over 80% of protein-like (typically associated with BOD5) 
fluorescence was removed during treatment and approximately half of humic- and fulvic-
like fluorescence was removed during treatment.  Quality control experiments indicated 
that holding the samples overnight biased the test results low, which was more 
pronounced when samples were held with headspace. Degradation likely occurs due to 
the biological consumption of organic matter that is occurring within the sample during 
the holding time.  	    
	   iv	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 CHAPTER	  1	  	  	  	   	  
PROBLEM STATEMENT AND OBJECTIVES 	  
 In accordance with the United States (US) Clean Water Act (CWA), wastewater 
treatment plants must obtain a National Pollution Discharge Elimination System 
(NPDES) permit to discharge treated domestic wastewater into a receiving water body 
(EPA, 2014).  In Nevada, NPDES permits are issued and enforced by the Nevada 
Division of Environmental Protection (NDEP) (NDEP, 2014).  Common to all NPDES 
permits for treated domestic wastewater is a limit on the biochemical oxygen demand 
(BOD) of the treated wastewater, as determined by the five-day BOD test (BOD5).    
 BOD is a surrogate parameter used to determine the content of biodegradable 
organic matter present in water.  In the BOD test, the depletion of dissolved oxygen 
utilized by bacteria as they consume the organic matter is measured. Therefore, the BOD5 
test indirectly quantifies the biodegradable organic matter based on the level of oxygen 
depletion over the 5-day test period (Standard Methods, 2005).  The presence of BOD in 
wastewater discharge can impact receiving waters because the water body cannot absorb 
oxygen from the atmosphere as quickly as the bacteria are utilizing it, which leads to an 
oxygen deficit in the water that can potentially cause the deaths of aquatic organisms.   
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 As implied by the subscript in its name, the BOD5 test takes five days to 
complete, which is a major drawback.  A treatment facility that experiences operational 
problems may unintentionally discharge polluted water for up to five days before plant 
staff become aware of the issue. The long time needed to complete the BOD test also 
delays adjustments by plant staff during operational upsets.  
 Although the BOD5 test is a Standard Method approved by the EPA to quantify 
organic discharge from wastewater treatment, it has become desirable to seek alternative 
test procedures to quantify organic matter more quickly than five days (40CFR136, 
2012).  Alternative test methods, such as chemical oxygen demand (COD), total organic 
carbon (TOC), fluorescence, and absorbance can potentially be used as a more direct 
measure of the organic content of waters.  Each method offers distinct advantages and 
limitations based on the manner in which the organic matter is quantified.  The results 
from all four of the aforementioned tests can be obtained within minutes or hours or even 
with on-line TOC, fluorescence, or absorbance instruments.  Currently, the only approved 
analytical method to measure the organic content of treated wastewater is the BOD test.  
However, some treatment facilities in Nevada have started using TOC measurements to 
estimate the BOD5 of both raw influent wastewater and the effluent discharged to 
receiving waters (Drury, 2014).  In these instances, upon establishing a correlation 
between BOD5 and TOC, the plants run TOC daily, convert the TOC to BOD5, and then 
report the BOD5 value to the to comply with permit requirements.   
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1.1 Objectives and Hypothesis 	  
This study explores the relationships between various organic matter 
quantification and characterization methods using samples collected from an operating 
wastewater treatment facility located in Nevada.  
1. The primary objective of this research was to develop relationships between BOD5 
and alternate test methods that quantify organic matter.  Literature review indicates 
that COD, TOC, fluorescence, and absorbance can be used to predict BOD5 in 
wastewater samples.  It was hypothesized that independent correlations can be 
made for BOD5 to COD, BOD5 to TOC, BOD5 to fluorescence, and BOD5 to 
absorbance. The basis for the hypothesis is that all of the methods quantify the 
organic matter in water, albeit by targeting different organic matter components.  
The BOD5 method indirectly quantifies the biodegradable organic matter based on 
the amount of oxygen depleted during an incubation period, the COD method 
quantifies the organic matter that can be chemically oxidized, and the TOC method 
quantifies the organic carbon that can be mineralized to carbon dioxide (Standard 
Methods, 2005).  Fluorescence quantifies organic matter that contains fluorophores, 
which have unique fluorescence properties that make it possible to identify them in 
water.  Fluorophores are not characteristic of all organic molecules so fluorescence 
is only linked to a portion of the overall organic matter in an environmental water 
sample.  The amount of fluorescence is assumed to be proportionate to the organic 
matter contained in the sample (Locowicz, 1999).  Absorbance is a measure of how 
much incident light is absorbed by a sample.  Specifically, chromophore molecules 
in the water sample will absorb light at unique wavelengths, and this absorbance is 
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proportionate to the chromophore concentration according to Beer’s Law.  The 
amount of light absorbed is assumed to be proportionate to the concentration of 
organic matter (Locowicz, 1999).   2.	   The second objective of this research was to determine how sample collection, 
holding times, and storage techniques impact the results of the methods currently 
used to measure organic content in wastewater. It is well known that the BOD5 test 
should be performed as quickly as possible, because biological degradation can 
occur in the sample with time, which will bias the test results low.  It was 
hypothesized that the TOC, BOD5, COD, fluorescence, and absorbance would be 
significantly affected by sampling methodology.  The basis for the hypothesis is 
that the organic matter will be consumed by microorganisms during the holding 
time.   
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CHAPTER 2 
 
LITERATURE REVIEW 
Part A: Permits, Organics, and BOD 
2.1 Permits 
2.1.1 NPDES Permits 
 The United States (US) Environmental Protection Agency (EPA) was given the 
ability to control pollution in 1972 through the Clean Water Act (CWA) (33 U.S.C. §1251 et 
seq., 2002).  Specifically, section 402 of the CWA allowed the EPA to develop and 
implement the National Pollutant Discharge Elimination System (NPDES) program.  In some 
cases, the EPA issues permits directly, but the EPA has also granted certain states the ability 
to issue permits (EPA, 2014). 
Entities or persons who wish to discharge water or wastewater into a receiving body 
of water must first obtain a NPDES permit that restricts the quality of the effluent by 
establishing minimum water quality standards.  Restrictions are placed on a number of water 
quality characteristics including, but not limited to, total suspended solids (TSS), biochemical 
oxygen demand (BOD), fecal coliforms, ammonia, and nitrogen.  Permits can vary 
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depending on the municipality or entity that has obtained a permit; one can contact the EPA 
or appropriate issuing state to request copies of NPDES permits. 
 The EPA has given the Nevada Division of Environmental Protection (NDEP) the 
authority to issue NPDES permits in Nevada, with the exception of tribal lands (EPA, 2014).  
NDEP is a broad organization that regulates many environmental laws including air quality, 
greenhouse gas emissions, and water quality.  The subdivision of the NDEP that is 
responsible for regulating water quality is the Bureau of Water Pollution Control (BWPC).  
The purpose of the BWPC is to protect all water sources by permitting discharges to surface 
water, groundwater, and underground injection wells (NDEP, 2014). 
Samples collected in this research were collected from an operational WWTP in 
Nevada.  At the time of this writing, the NPDES limited the 30-day average uninhibited 
BOD5 to 30 mg/L and the 7-day average limit was limited to 45 mg/L.  The influent 
uninhibited BOD5 must be monitored and reported, but influent water quality is not directly 
regulated. For both the influent and effluent samples, daily composite samples are required 
for permit compliance.  The uninhibited BOD5 and total TSS must be calculated monthly and 
demonstrate that the 30-day average percentage removal is at least 85%. The uninhibited 
BOD5 test means the test accounts for oxygen demand due to the presence of both organics 
and ammonium in the wastewater. 
NDEP has allowed the Nevada plant to use an alternate test procedure, specifically 
TOC, to estimate their BOD5 for plant influent and for treated effluent.  TOC at plant influent 
and treated effluent are converted to a BOD5 equivalent, and this number is reported to 
NDEP.   
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2.1.2 Alternate Test Procedures for NPDES Permit Compliance 
 The Clean Water Alternate Test Procedure (ATP) is a program offered by the EPA 
that allows persons or entities with NPDES permits to apply for permission to use alternate 
test methods in lieu of the method required by their permit. This allows WWTPs greater 
flexibility to modify their current methods to overcome matrix interference and also to 
explore alternate test procedures in lieu of their current methods.  
Alternate test procedures are addressed in section 40 CFR Part 136 of the Code of 
Federal Regulations.  A person or agency with an NPDES permit can apply for an ATP by 
submitting an application or letter to the Regional Administrator through the Director of the 
State agency that issued the NPDES permit.  The application or letter should provide the 
identity of the person applying for the permit and the permit number, identify the pollutant, 
provide justification as to why test procedures identified in CFR Table I were not used, and 
provide information on the proposed alternate test procedure.  The code specifies that the 
procedure should include a detailed description of the alternate test and also include 
references to published studies that support that applicability of the procedure.   
The applicant sends the application or letter to the Regional Administrator, which is 
then forwarded to the Director of the State who has the final approval of any alternate test 
procedure application.  The Director of the State will review the information and then 
forward their recommendation to the Regional Administrator within 30 days of receipt.   
The applicant sends the application or letter to the Regional Administrator, which is 
then forwarded to the Director of the State who has the final approval of any alternate test 
procedure application.  The Director of the State will review the information and then 
forward their recommendation to the Regional Administrator within 30 days of receipt.  If 
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the Director of the State recommends denial of the application based on technical and 
scientific reasons, then the Regional Administrator must deny the application.  The Regional 
Administrator has 90 days from the time the application is received to contact and inform the 
applicant as to whether the application has been approved or denied.  The Regional 
Administrator may request more information or provide technical and scientific 
recommendations.  The Regional Administrator must forward all approved and denied 
applications to the Director of the Analytical Methods Staff in Washington, DC.   
  The CFR does not directly address the minimum testing requirements when 
submitting an application.  It would appear that the applicant, Director of the State, and 
Regional Administrator make technical judgments based on the goals of the alternate test 
procedures. This allows the applicant some leeway based on available resources and the 
water matrix in question.   
2.2 Organic Compounds 
2.2.1 Organic Compounds and Their Presence in Wastewater 
 Organic compounds are composed of carbon (C), hydrogen (H), oxygen (O), and 
nitrogen (N) (Tchobanoglous et al., 2003; Crittenden et al., 2012). Certain compounds such 
as carbon monoxide, carbon dioxide, carbonate, bicarbonate, and cyanide are also composed 
of C, H, O, and N, but these behave as inorganic compounds and they are classified as such 
(Crittenden et al., 2012).  Organic compounds have strong carbon-carbon bonds, whereas 
inorganic compounds do not (Crittenden et al., 2012).  Organic matter in wastewater 
typically consists of proteins (40 to 60%), carbohydrates (25 to 50%), and oils and fats (8 to 
12%), but it can also contain urea (from urine) and synthetic organic compounds 
(Tchobanoglous et al., 2003). 
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 Treated wastewater effluent will typically contain organic compounds that are 
classified as naturally occurring, anthropogenic, or as soluble microbial products.  These 
three classes are collectively referred to as effluent organic matter (EfOM) when referring to 
treated wastewater effluent (Shon et al., 2007).  Naturally occurring organics come from 
nature (e.g., humic and fulvic acids), whereas anthropogenic organic matter comes from 
human activities; both of these will be present in WWTP influent.  Soluble microbial 
products are created during biological treatment process at the WWTP; these are typically 
not present in the influent, but they are present in the effluent (Barker and Stuckey, 1999).  
Natural organic matter (NOM) is found in natural water bodies and is composed of 
the secretions and excretions of living organisms such as algae and fish. Terrestrial sources 
can also contribute to NOM in the water when vegetation and other debris are washed into 
the water source and decompose.  When a natural water body is used as a drinking water 
source, NOM is particularly important because the chlorine used in the disinfection process 
will convert the humic substances in NOM to certain disinfection byproducts, such as 
trihalomethanes, which are harmful to human health (Crittenden et al., 2012).  
 Anthropogenic organic matter originates from human activities and includes a myriad 
of compounds, including synthetic organic compounds used for industrial purposes, 
pesticides, herbicides, and other contaminants of emerging concern.  Contaminants of 
emerging concern are contaminants that have recently been identified and are being 
investigated to understand how they impact human health and the environment. Many of 
these compounds are not yet regulated by the EPA and may never be regulated by the EPA if 
they do not pose a significant risk to human or environmental health.  These contaminants are 
only partially removed by drinking water and wastewater treatment processes, and it is often 
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cost prohibitive to test and/or treat specifically for these contaminants.  This category 
includes medications (e.g., antibiotics, antidepressants, antacids), industrial and household 
wastes (fragrances, antioxidants, pesticides, insecticides, detergents, fire retardants), and 
steroid hormones (cholesterol, mestranol, estrone, estradiol, ethinylestradiol, progesterone, 
testosterone) (Tchobanoglous et al., 2003). Contaminants of emerging concern are a current 
topic of interest with extensive literature exploring their impacts (Baker et al., 2014; 
Houtman et al., 2014; Jarvis et al., 2014; Taylor and Senac, 2014; Wu et al., 2014).   
 Soluble microbial products (SMPs) are primarily created during the biological 
treatment process within a wastewater treatment plant.  In a review by Barker and Stuckey 
(1999), they found that the definition of SMPs was ambiguous among the literature, but the 
generally accepted definition is “ the pool of organic compounds that result from substrate 
metabolism (usually with biomass growth) and biomass decay.”  SMPs associated with 
substrate metabolism and biomass growth are categorized as utilization associated products 
(UAP), whereas SMPs associated with biomass decay are categorized as biomass associated 
product (BAP).  UAP is proportional to the rate of substrate utilization and BAP is 
proportional to the concentration of biomass (Barker and Stuckey, 1999).   
 Organic compounds can be classified as either particulate organic carbon (POC) or 
dissolved organic carbon (DOC).  POC, such as bacteria, algae, and protozoa, are compounds 
greater than 0.45 µm.  DOC is smaller than 0.45 µm and can be classified as either 
hydrophobic (humic, fulvic, alkyl monocarboxylic, dicarboxylic), transphilic (hydroxyl, 
sugar acids, sulfonic acid), or hydrophilic (polysaccharide, alkyl alcohol, amide, alkyl amine, 
amino acids) (Shon et al., 2007).  DOC can also be classified as biodegradable or recalcitrant.  
Biodegradable refers to the labile organic matter that is easily broken down by 
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microorganisms. Recalcitrant matter is very small compared with other DOM (<0.1 nm) and 
is resistant to biodegradation (Shon et al., 2007; Lu and Speitel, 1991) 
2.2.2 Organic Compounds Removal in Activated Sludge Systems 
 Biodegradable organic matter can be removed successfully using activated sludge 
systems.  Conventional wastewater treatment trains typically consist of primary clarifiers 
followed by an activated sludge system with aeration basins and secondary clarifiers (Figure 
2.1).  The primary clarifier is used for initial sedimentation, the aeration basin is used for 
biological treatment, and the secondary clarifier is used for secondary sedimentation and 
biomass collection.  The solids settled from the clarifiers are called sludge.  The sludge from 
the secondary clarifier has high concentrations of microbes; therefore, a portion of the sludge 
is sent back to the aeration basin to ‘seed’ the biological treatment process. 
 
 
Figure 2.1: Schematic of an activated sludge system. 
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It is estimated that 25 to 40% of the biodegradable organic matter and 50 to 70% of 
the TSS can be removed in the primary clarifier without chemical addition (i.e., coagulants 
such as alum or ferric chloride), but this can be increased to 50 to 80% removal of organics 
and 80 to 90% removal of TSS with chemical addition (Tchobanoglous et al., 2003).   
The purpose of the aeration basin is primarily to remove biodegradable organic 
matter, but ammonia, nitrates, and phosphorous can also be removed depending on the 
configuration.  The design of the aeration basin can vary based on the treatment facility, but 
the aeration basin is typically divided into zones that either have dissolved oxygen (aerobic) 
or do not have dissolved oxygen (anoxic).  In anoxic zones, dissolved oxygen is generally 
unavailable, which causes microbes to use nitrate as an electron acceptor (i.e., conversion of 
nitrate to nitrogen gas).  In the aerobic zones, pure oxygen or compressed air is injected into 
the water to increase the efficiency of biodegradation, and oxygen is used as the electron 
acceptor (i.e., conversion of organic molecules to carbon dioxide).  The specific number of 
zones will depend on the design, but each zone is designed to promote specific 
microorganism growth (Tchobanoglous et al., 2003).  It should be noted that the competition 
of the microorganisms varies depending on the environmental conditions (e.g., seasonal 
differences); therefore, their activity can change throughout the year (Esener et al., 1981).   
Biodegradable organic matter is primarily removed in the aerobic zones.  In the first 
aerobic zone, return activated sludge (RAS) with high concentrations of microorganisms, 
particularly bacteria, is pumped in.  These microorganisms utilize organic matter, air, 
ammonia, and phosphate to produce simple byproducts.  One of the principal byproducts is 
biomass, but other byproducts such as carbon dioxide, water, and SMPs are also generated. 
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In the aeration basins, it is assumed that organic nitrogen is converted to ammonia 
(Tchobanoglous et al., 2003).  Assuming the appropriate bacteria are present, the ammonia is 
then converted to nitrite and then nitrate via the nitrification process.  When the nitrate-
containing RAS is recycled to the head of the activated sludge process (i.e., the anoxic 
zones), denitrification, or the conversion of nitrate to nitrogen gas, will occur.  The presence 
of specific bacteria facilitates the transformations during nitrification and denitrification.  
Additional bacteria are capable of converting nitrogen directly to gaseous nitrogen in the 
aeration basins as well (Tchobanoglous et al., 2003).  
Phosphorous removal can be achieved in advanced biological treatment plants using 
various combinations of activated sludge, chemical addition, sedimentation, and filtration.  
Certain bacteria in the aeration basin are capable of the uptake and storage of inorganic 
phosphorous.  In the aeration basin, these bacteria grow and increase their storage capacity.  
This biomass is then settled in the secondary clarifier.  Phosphorous can be further removed 
by adding chemical coagulants, which will chemically transform the soluble orthophosphate 
into a precipitate, which can be removed from the water by filtration (Tchobanoglous et al., 
2003). 
Following the aeration basin, water is sent through a secondary clarifier, which is 
similar to the primary clarifier, but the water is allowed to settle for a longer period of time. 
The SMPs that were created in the aeration basin in addition to recalcitrant organic matter 
that could not be removed in the aeration basin will be present in the secondary clarifier 
effluent.  
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2.2.3 Characterization of Organics in the WWTP 
Based on the prior discussion, it is clear that influent water consists of NOM and 
anthropogenic organic matter, and only a portion of the overall organic matter is 
biodegradable.  During the treatment process, much of the biodegradable organic matter is 
removed, but residuals and recalcitrant organic matter remain.  SMPs are also created in the 
biological treatment process; therefore, SMPs will be present in the effluent water, but 
generally not in the influent water.  Effluent water can thus be characterized as the sum of the 
residual biodegradable organic matter, recalcitrant NOM, recalcitrant anthropogenic matter, 
and SMPs.  
2.3 Biochemical Oxygen Demand 
2.3.1 BOD5 and Biodegradable Organics 
 Biodegradable organic matter is quantified using the BOD test.  There are different 
approved methods for the BOD test, but the most common is the 5-day BOD test, also 
referred to as BOD5.  In this specific method, a sample is prepared and incubated for five 
days.  The change in oxygen is quantified and expressed in mg/L.  The BOD5 test directly 
measures the oxygen demand of the sample, which is used as a surrogate to quantify the 
biodegradable organic matter in the sample.  BOD5 and biodegradable organics are assumed 
to be proportional; therefore, increases in BOD5 are associated with higher biodegradable 
organic content.  Ideally, the BOD5 method would only measure the carbonaceous demand 
(i.e., the demand from biodegradable organic matter).  In practice, interference can occur due 
to reduced forms of ammonia (nitrogenous demand) and inorganic matter (iron and sulfur 
compounds).  
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2.3.2 Why is BOD5 a 5-day test? 
 As mentioned, BOD5 is the most common of the BOD methods, but a common 
question is why five days was selected as the test period.  The common belief is that the five 
day test period was based on a report by the Royal Commission on Sewage Disposal in the 
United Kingdom (UK), which concluded that the maximum time it took water to travel 
through British rivers to the open sea was five days, and the maximum temperature of the 
water in the river was 18.3°C.  The incubation period has remained at 5 days, but the 
incubation temperature has been rounded up to 20°C (Royal Commission on Sewage 
Disposal, 1915; Delzer and McKenzie, 2003)  
Indeed, it is true that the UK published a report in 1915 that established the five-day 
incubation period, but it is not a reasonable explanation as to why this is still a standard in the 
20th century.  The incubation period is still true today for two important reasons.  First, 
approximately 60-70% of the organics are degraded within the first five days.  
Approximately 95% of the organics will be consumed around day 20 of incubation, and it 
will slowly continue to degrade thereafter. The second reason is that nitrifying bacteria are 
slow to reproduce, and they will not become active until five to eight days after the start of 
the incubation test.  It therefore seems unnecessary to continue the test after five days when it 
is approximately known what percentage of organics will degrade and also because 
nitrogenous demand will become an issue after five days (Tchobanoglous et al., 2003; Siwiec 
et al., 2011; Riffat, 2012). 
2.3.3 Importance of BOD5 
 BOD5 is one of the parameters used to size a wastewater treatment plant when it is 
being designed. After a WWTP is built, the BOD influent waste loadings can be compared to 
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the effluent waste loadings to determine the removal efficiency of the treatment plant. 
Treatment plants that use activated sludge processes can benefit from knowing the BOD5 
because it will aid them in determining the oxygen required to stabilize the organic matter.  
As mentioned, the BOD test is a direct measurement of the oxygen demand of the 
water, but it is also a surrogate test for the organic compounds present in the water. The 
amount of organic matter in the water can be used as an indicator of the degree of pollution 
of the water.  The discharge of organic compounds into receiving waters can impact the 
ecological system and cause distress or death to different aquatic species.  When organic 
compounds are introduced, the native microorganisms will utilize the oxygen naturally 
present in the water to metabolize the organics.  If the water body cannot absorb oxygen from 
the atmosphere faster than the microorganisms are utilizing the oxygen within the water 
body, then there will be an oxygen deficit in the water.  Lack of sufficient oxygen can lead to 
fish kills. 
2.3.4 Limitations to the BOD5 test 
The BOD5 test is a relatively straightforward test procedure, but it has some major 
limitations.  The most obvious drawback to the five-day BOD test is that it takes five days to 
obtain the results of the test.  By the time the results are obtained, the water has completed 
the treatment process and if treatment is not adequate, polluted water may be unintentionally 
discharged into receiving waters.   
An additional limitation to the test is that it only measures biodegradable organics 
(Tchobanoglous et al., 2003).  As such, the BOD test is not a reliable indicator of 
nonbiodegradable organic matter, which can also be harmful to the environment.   
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The BOD test can be limited by certain industries and toxic wastes, thus pretreatment 
may be necessary (Tchobanoglous et al., 2003).  For instance, paper mills use hydrogen 
peroxide as a bleaching process so it is necessary to quench the peroxide (a disinfectant) 
prior to conducting the BOD test (Standard Methods, 2005).  It is important for the 
laboratory analyst to have a thorough understanding of the wastewater influent, and the 
possible pollutants, contaminants, and toxic wastes that may be added by nearby industries 
and commercial activities.   
Part B: Test Procedures for Organic Content Determination in Water 
 
 BOD5 is important to wastewater treatment plants for many reasons such as treatment 
plant adjustments, permit compliance, and to protect the environment, but the time that it 
takes to obtain the test results is a major limitation.  As such, it has become desirable to 
explore alternate test methods that produce results much faster, usually within a matter of 
hours as opposed to days.  Alternate test methods can be used for faster response to treatment 
plant adjustments. Additionally, it may be possible for WWTPs to get approval for alternate 
test methods to estimate their BOD5.   
The Standard Methods for the Examination of Water and Wastewater 21st Edition 
(commonly referred to as Standard Methods, 2005) has approved several methods for the 
determination of aggregate organic constituents; these methods are discussed in Standard 
Methods Part 5000.  The three approved standard methods that are included in this research 
include Biochemical Oxygen Demand (BOD), Chemical Oxygen Demand (COD), and Total 
Organic Carbon (TOC) analysis.  An alternate method for determining organic compounds is 
fluorescence, but this is not an approved Standard Method.  Each of these methods quantifies 
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organic material in different ways, but the literature has shown that each can be correlated 
with BOD5.   
 The following discussion provides information on the five methods (BOD5, COD, 
TOC, fluorescence, and absorbance) such as the background, selection of a method, 
interferences, and sample preservation. A side-by-side comparison of each of the methods is 
then provided to show the advantages and disadvantages of each method and how each 
quantifies organic matter.  
2.4 Biochemical Oxygen Demand  
2.4.1 BOD Principle 
 BOD is an empirical test that measures the oxygen requirements of the water during a 
specified incubation period.  During the incubation period microorganisms consume the 
biodegradable organic matter in the sample. The oxygen utilized is affected by the pH and 
temperature of the water; therefore, the Standard Methods specifies that the pH of the water 
should be between 6 and 8.  The BOD results can be used to directly determine the oxygen 
requirements of the water, but the results are also used as a surrogate to determine how much 
biodegradable organic matter is present in the water (Standard Methods, 2005). 
 During the incubation period, the sample undergoes three distinct processes: 
oxidation, synthesis, and endogenous respiration.  Energy is obtained by oxidizing the waste 
(oxidation); the energy is then used during the oxidation process and for the production of 
cell tissue (synthesis).  Once the energy is exhausted from the organic matter, the cells begin 
to consume themselves (endogenous respiration).  The chemical processes are described 
below.  The term “COHNS” represents the organic waste, which is composed of carbon, 
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oxygen, hydrogen, nitrogen, and sulfur.  The new cell tissue is represented by C5H7NO2 
(Tchobanoglous et al., 2003). 
Oxidation: 𝐶𝑂𝐻𝑁𝑆 + 𝑂! + 𝑏𝑎𝑐𝑡𝑒𝑟𝑖𝑎 → 𝐶𝑂! + 𝐻!0+ 𝑁𝐻! + 𝑜𝑡ℎ𝑒𝑟  𝑒𝑛𝑑  𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑠 + 𝑒𝑛𝑒𝑟𝑔𝑦 
Synthesis: 𝐶𝑂𝐻𝑁𝑆 + 𝑂! + 𝑏𝑎𝑐𝑡𝑒𝑟𝑖𝑎 + 𝑒𝑛𝑒𝑟𝑔𝑦 → 𝐶!𝐻!𝑁𝑂! 
Endogenous respiration: 𝐶!𝐻!𝑁𝑂! + 5𝑂! →   5𝐶𝑂! + 2𝐻!0+ 𝑁𝐻!   
2.4.2 Selection of a BOD Method 
There are three approved Standard Methods for determining BOD: the five-day BOD 
test (BOD5), the ultimate BOD test (BODU), and the respirometric method.  The most 
common method is the five-day BOD test, which is commonly referred to as BOD5; the 
subscript is a reference to the incubation time frame.  This is the required method for the 
NPDES permit; therefore, this is the method adopted for this research.   
Modifications to the BOD5 test can be made to parameters such as the incubation 
period, the incubation temperature, dilution, and seeding to provide similar conditions to 
receiving waters, which is useful when evaluating potential environmental effects.  As 
mentioned, a five-day incubation period at 20°C is the most common test parameter, but a 
seven-day incubation period (i.e., BOD7) may be useful for working schedules, where results 
cannot be read on the weekends.  The ultimate BOD (BODU, UBOD, or Method 5210C) test 
is conducted over an incubation period (20°C) period of 30 to 60 days, and possibly longer. 
This method is similar to BOD5, with some modifications, but the purpose of this method is 
to determine the oxygen required to degrade all of the organic matter.  The respirometric 
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method directly and continuously measures the oxygen uptake of the microorganisms during 
the incubation period.  The method has use for assessing how chemicals degrade over time 
and the effects of toxic wastes on oxygen uptake (Standard Methods, 2005).   
2.4.3 Interferences 
Samples that contain chlorine, toxic substances, or hydrogen peroxide can interfere 
with the BOD analysis; therefore, these samples require either pretreatment or a special study 
(Standard Methods, 2005).  Samples used in this research were purely domestic wastewater, 
so special considerations were not necessary. 
When inhibitors are not used, the oxygen demand is the sum of the carbonaceous 
demand, the nitrogenous demand, and the demand from inorganic matter such as sulfides and 
ferrous iron.  The carbonaceous demand is the oxygen demand of biodegradable organic 
matter in the water, and it is the BOD value that is typically desired.  Inorganic matter can 
affect the results of the BOD test, but there are not inhibitors available or adjustments that 
can be made to the results to account for inorganic demand (Standard Methods, 2005). 
Nitrogenous demand is the oxygen consumed when oxidizing reduced forms of 
nitrogen, such as ammonia.  The types of microorganisms in the water will affect how and if 
reduced forms of nitrogen will be oxidized. If nitrogenous oxidation will occur in the water, 
then inhibitors can be used to prevent oxidation (Tchobanoglous et al., 2003; Standard 
Methods, 2005).   
 When nitrogenous inhibitors are not used, then both the carbonaceous and 
nitrogenous demands are included in the BOD results.  Methods are available that estimate 
the theoretical nitrogen demand, which can be subtracted from the test results to obtain the 
carbonaceous demand (Tchobanoglous et al., 2003; Standard Methods, 2005).  This method 
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is not recommended by the Standard Methods (2005) because it is subject to error and it is 
cumbersome. The use of inhibitors is more direct and reliable; therefore, the Standard 
Methods recommends using inhibitors when the carbonaceous demand is desired.  NPDES 
permits typically specify that the total BOD5 be reported; therefore, nitrogenous inhibitors 
were not used for this research and the procedure does not reflect their use. 
2.4.4 Sample Handling and Preservation 
 The Standard Methods (2005) specifies that samples that cannot immediately be 
analyzed should be stored at 4 ± 1°C for up to 24 hours following the end of the 24 hour 
composite period or up to 48 hours after a grab sample.   
2.4.5 Sample Pretreatment 
 Samples temperature should be 20 ± 3°C with a pH between 6 and 8 before analysis.  
If necessary, the pH of the sample should be adjusted to 7.0 to 7.2 using either sulfuric acid 
or sodium hydroxide. Ideally, samples should be collected ahead of chlorination; if chlorine 
is present then the sample must be dechlorinated (Standard Methods, 2005).  Sample 
temperature and chlorine residuals were checked in this research.  
2.4.6 Quality Assurance/ Quality Control 
 The Standard Methods (2005) outlines four quality controls for the BOD5 method: a) 
samples must meet oxygen depletion requirements (referred to as qualified samples), b) seed 
controls, c) a glucose glutamic acid check and d) a dilution water blank.  Qualified samples 
are used to verify that the microorganisms are effectively uptaking the oxygen. The GGA 
sample is used to verify the seed source is adequate and it is used as a benchmark for the 
precision and accuracy of the test.  The dilution water blank is used to verify the dilution 
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water is free from contaminants (organics and/or microorganisms) and to verify the 
cleanliness of the glassware.  The following discussion provides additional information 
regarding each of these quality controls.  A calculation flowchart addressing each of these 
controls is provided in Chapter 3 to guide the analyst with validation of their test results.   
2.4.7 Qualified Samples (BOD5) 
 Samples must meet two requirements in order for them to be qualified 1) the sample 
must deplete a minimum of 2 mg/L of oxygen during the incubation period and 2) the sample 
must have a minimum residual dissolved oxygen (DO) reading of 1 mg/L.   
 The minimum depletion requirement is a minimum tolerance to ensure that the results 
are valid. A minimum 1 mg/L residual DO is required to ensure that there was enough 
oxygen available during the incubation period. Since the DO is only being recorded at the 
beginning and end of the incubation period, there is no way of knowing when the oxygen 
was depleted.  It is assumed that if there were more oxygen present, then the microorganisms 
would have continued oxidizing the biodegradable organic matter.  When all dilutions have a 
residual DO of ≤ 1 mg/L, the results are reported as “greater than.” 
2.4.8 Dilution Water Source and Control 
The Standard Methods (2005) specifies that the dilution water cannot exert an oxygen 
demand, because it will bias the results.  Specifically, dilution water should not deplete more 
than 0.20 mg/L of dissolved oxygen during the five-day incubation period, but it is preferable 
that depletion is limited to under 0.10 mg/L.  
 The Standard Methods (2005) allows flexibility for the dilution water source, as long 
as it does not exceed the minimum depletion requirements.  Deionized water often contains 
organics and microorganisms that can bias the test results high; therefore, traditional 
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laboratory deionized water is not always a suitable dilution water source and additional water 
treatment may be necessary (Standard Methods, 2005).  Treated tap water was used as 
dilution water in this research, as described in Chapter 3.   
 Reagents are added to the dilution water to stabilize the pH and provide the necessary 
nutrients for the microorganisms.  The Standard Methods (2005) provides a detailed 
description of how to prepare the reagents.  Alternatively, prepared buffer pillow packs 
containing the reagents are commercially available from companies such as Hach (Loveland, 
CO).  Prior to use, the dilution water should be at 20 ± 3°C.  The water should have a 
minimum initial DO of 7.5 mg/L to ensure there is enough oxygen available.  In addition, the 
initial DO should be below 9.0 mg/L to prevent supersaturated water from degassing during 
the incubation period, which can bias the results high. If an aerator is used, it should be free 
from contaminants (Standard Methods, 2005).   
2.4.9 Seed Source 
 Seed is a concentrated population of microorganisms.  The seed source can either 
come from within the wastewater treatment process or it can be purchased commercially.  
The seed sample strength is determined by the GGA sample, but it should generally be 
between 0.6 and 1 mg/L (Standard Methods, 2005).  The GGA sample will be discussed in 
further detail in the next section.  The supernatant from settled domestic wastewater is a 
viable seed source, and preferable because the microorganisms are acclimated to the sample 
matrix (Standard Methods, 2005).  If the seed source is too strong it may be helpful to let the 
sample sit at room temperature for some time, or store the sample overnight at 4 ± 1°C. 
Alternatively, the supernatant from a settled primary clarifier influent may be used (Standard 
Methods, 2005).  Commercial seed sources are also available, but they are not ideal because 
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the microorganisms may not be acclimated to the sample matrix and also there can be 
variability in the manufacturing process that can cause issues with GGA controls.   
2.4.10 Glucose Glutamic Check  (GGA) 
 The GGA is a solution made of 150 mg of glucose and 150 mg of glutamic acid 
dissolved in 1-liter of distilled water (Standard Methods, 2005).  Glucose is a simple sugar 
that is easily oxidized and glutamic acid is an amino acid that stabilizes the sample results.  
The GGA can be prepared before use, or commercial GGA standards (Hach, Loveland, CO) 
are available that can be stored at 4°C or lower.   
 GGA samples are prepared by adding 6 mL of GGA per 300 mL BOD bottle, and 
then the sample is seeded with the same volume of seed that is added to the seeded samples.  
The seed should result in a final GGA BOD5 of 198±30.5 mg/L (Standard Methods, 2005).  
The seed strength should be adjusted to meet the GGA BOD5 requirement.  Judgment should 
be used to determine if an alternate sample site or adjusting the seed volume is more 
appropriate to change the seed strength.   
 Once the seed strength consistently meets the GGA requirements, the method for 
collecting the seed and seed volume should remain the same for future testing.  If seeded 
samples are not meeting the qualified sample criteria, then the volume of sample (not seed) 
should be adjusted accordingly.   
2.4.11 Seed Controls 
 A minimum of three seed control blanks with different dilutions should be prepared 
with each BOD5 setup.  The seed control samples are used to determine the seed strength 
either by the ratio method or by the slope method.  For the ratio method, the seed strength is 
ratio of the oxygen depletion to the volume of seed.  For the slope method, the seed strength 
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is determined by the slope of the plotted data where x=volume and y=DO uptake.  The y-axis 
intersection represents the demand of the dilution water, which should be less than 0.2 mg/L 
(Standard Methods, 2005).   
 It should be noted that seed controls might also contain organic matter.  Any oxygen 
demand associated with this organic matter is inherently included in the seed strength 
calculation.  The oxygen demand of the seeded sample is corrected for in the final BOD5 
calculation; therefore, if there is organic matter in the seed source it is corrected for as well. 
2.4.12 Sample Preparation 
 Samples can either be seeded or unseeded.  Samples, such as treated effluent, do not 
have sufficient microorganisms to deplete enough oxygen to meet the minimum qualified 
criteria requirements; therefore, it is necessary to seed these samples.  Influent samples 
impacted by certain industries may also require seeding.  For instance, hydrogen peroxide is 
used as a bleaching agent in paper mills, but peroxide is also a disinfectant that will kill the 
influent microbe population, thus influent samples may need to be seeded.  The volume of 
seed is determined based on the GGA requirements.  If the seeded samples are not meeting 
the qualified sample criteria, then the sample volume should be adjusted accordingly.   
 The volume of sample added to the BOD bottle will depend on the oxygen demands 
of the sample.  Samples with a high BOD5 will require less sample, and samples with a low 
BOD5 will require more sample (and possibly seeding).  Ideally, one would want to add 
enough sample volume such that 50% of the oxygen is depleted. There are several resources 
available that suggest how to dilute the sample (Delzer and McKenzie, 2003; Standard 
Methods, 2005).  
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2.4.13 BOD Calculations  
 Equation 2.1 is used to calculate the BOD5.  The seed strength is determined based on 
the average strength of the seed controls, as determined in section 2.4.10. 
    DO!"#$#%& − DO!"#$% − Seed  Strength ∗ Volume  seedVolume  of  SampleVolume  of  BOD  bottle = BOD!                                            Eqn. 2.1 
2.4.14 Interpretation of the BOD5 Results 
 As previously mentioned, BOD5 is a measure of the oxygen demand of the water, 
which is used as a surrogate for biodegradable organic matter; the oxygen demand is 
assumed to be proportionate to the biodegradable organic matter.  Table 2.1 is a summary of 
the pollutants in the sample (either microorganisms or organic matter) and how this impacts 
the BOD5 results.  Table 2.2 shows some common issues encountered during the BOD5 test 
and possible solutions.  
  The amount of oxygen that the microorganisms deplete is what is measured during 
the BOD5 test.  If there is not a presence of microorganisms, the organic matter will not have 
an impact on the oxygen demand, and the BOD5 cannot be measured.  If there are 
microorganisms present, but no biodegradable organic matter, the bacteria will still consume 
oxygen proportionate to their population; this is represented by the seed samples.  Ideally, 
dilution water will not have microorganisms or organic material; therefore, there will not be a 
BOD5 result. Some samples (e.g., plant influent and primary clarifier effluent), naturally 
will contain both organics and microorganisms, therefore seeding is not necessary to obtain a 
BOD5 result.  Samples such as effluent typically have limited microorganisms and organics; 
therefore, they must be seeded with microorganisms to utilize the organics (if they are 
present) and provide a useful BOD5 result (i.e., qualified sample).   
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Table 2.1 Interpretation of the BOD5 Results for Each of the BOD Samples Adapted from 
Standard Methods (2005) 
Sample Expected sample pollutants 
Expected 
outcome 
BOD5 
result? Interpretation 
Blank 
No Organics + 
No 
microorganisms  
Will not 
deplete 
oxygen 
No 
Good quality dilution water will not 
exert a demand.  If demand occurs 
it could indicate presence of 
microorganisms.   
Seed No organics + Microorganisms 
Will 
deplete 
oxygen 
Yes 
This is the oxygen demand 
attributed to the microorganisms.  
The seed sample could contain 
organics, but these are not 
important.  All oxygen demand 
(including its organic matter) is 
corrected for in seeded samples.   
Influent 
and 
Primary 
Clarifier 
Effluent  
Organics + 
Microorganisms 
Will 
deplete 
oxygen  
Yes 
Sufficient microorganisms are 
naturally present.  These will 
oxidize the organics and exert an 
oxygen demand. 
Advanced 
treatment 
Effluent 
(unseeded) 
Organics + None 
or small 
population of 
microorganisms 
Will not 
deplete 
oxygen  
No 
Organic matter cannot change the 
oxygen demand.  The sample must 
be seeded to obtain a BOD5 result.   
Advanced 
treatment 
Effluent 
(seeded) 
Organics + Seed 
(microorganisms) 
Will 
deplete 
oxygen  
Yes 
The added presence of 
microorganisms will consume the 
organic matter, and give a BOD5 
result.  The oxygen demand from 
the seed is corrected for in the 
calculations, so the results represent 
the demand of the effluent sample.   
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Table 2.2 Common Issues Encountered in the BOD5 Test Adapted Standard Methods (2005) 
 
Issue Possible reasons Possible solutions 
Initial dilution water DO reading is 
below 7.5 mg/L  
Check temperature (too 
warm) 
Adjust the temperature.  If the problem persists, consider 
using an aerator. 
Initial dilution water DO reading is 
above 9 mg/L  
Check temperature (too 
cold) 
Adjust the temperature.  Let the water degas for a period-
of-time.  
Dilution water depletes more the 
0.2 mg/L  
Water source has 
microorganisms or 
glassware is dirty 
Check the water source.  Consider an alternate source or 
further water treatment.  If the water source is reliable, 
check the cleaning procedure.   
Sample does not deplete 2 mg/L  
Not enough sample 
volume was added or 
seeding may be 
necessary 
If this occasionally occurs with the smallest sample 
volume, then adjustments may not be necessary.  If this 
occurs on a regular basis and with all samples try the 
following: Increase the sample volumes.  Also, verify that 
the sample has sufficient microbes to oxidize the organics.  
If not, consider seeding the sample.   
Final DO reading is less than 1 
mg/L for unseeded samples Too much sample 
If this occasionally occurs with the largest sample volume, 
then adjustments may not be necessary.  If this occurs 
often to multiple sample dilutions, then decrease the 
sample volume. 
Final DO reading is less than 1 
mg/L for seeded samples Too much sample 
See comments for the unseeded sample.  If the seed is 
meeting the GGA requirements, then DO NOT adjust the 
seed volume.  Decrease the sample volume.   
Seed is too weak Seed is not strong enough 
Try an alternate seed source.  If the seed source is reliable, 
check the accuracy of pipettor. 
Seed is too strong Seed is too strong Let the sample settle longer.  If this does not work, try a more treated seed source such as primary effluent. 
GGA falls below acceptable range Seed may be too weak See issue "seed is too weak" 
GGA Is above acceptable range Seed may be too strong or glassware is dirty 
See issue "seed is too strong."  If the dilution blank also 
fails, check the cleanliness of the glassware.   
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2.5 Chemical Oxygen Demand 
2.5.1 COD Principle 
 The COD method determines both the inorganic and organic oxygen demand of water 
based on the quantity of oxidant (expressed in oxygen equivalence) that is oxidized within a 
specified time frame (Standard Methods, 2005). The Standard Methods (2005) specifies that 
dichromate (Cr2O72-) be used as the oxidant because of its unique chemical properties.  The 
following chemical equation shows that the dichromate ion is reduced to the chromate ion 
(Cr3+) during the oxidation process (Tchobanoglous et al., 2003).   
𝐶!𝐻!𝑂!𝑁! + 𝑑𝐶𝑟!𝑂!!! + 8𝑑 + 𝑐 𝐻! → 𝑛𝐶𝑂! + 𝑎 + 8𝑑 − 3𝑐2 𝐻!𝑂 + 𝑐𝑁𝐻!! + 2𝑑𝐶𝑟!! 𝑤ℎ𝑒𝑟𝑒  𝑑 = 2𝑛3 + 𝑎6 − 𝑏3 − 𝑐2 
 
Digestion time, reagent strength, and aliquot COD concentration can affect the extent 
of oxidation in the sample.  During the COD test, hazardous waste such as mercury, 
hexavalent chromium, sulfuric acid, silvers, and acids are generated (Standard Methods, 
2005).  
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Table 2.3: Comparison of COD Methods Adapted from Standard Methods (2005) 
 
COD Method Selection 
 Open Reflux Method (Method 
5220B) 
Closed Reflux Titrimetric 
Method (Method 5220C) 
Closed Reflux 
Colorimetric Method 
(Method 5220D) 
U
se
 
Use Method 5220B.4a for 
sample with COD >50 mg 
O2/L. Use Method 5220B.4b 
for sample with COD from 5 
to 50 mg O2/L. 
Use Method 5220C.4 for 
samples with COD from 
40 to 400 mg O2/L. 
 
Greater concentrations 
can be determined by 
dilution. 
Use Method 5220D.4 
for samples with 
COD>50 mg O2/L. 
 
Greater concentrations 
can be determined by 
dilution. 
A
dv
an
ta
ge
s 
Useful for several types of 
water.  More accurate and 
representative then Method 
5220C and 5220D. 
Produces less hazardous 
waste and it is more 
economical then 5220B.  
Premeasured reagents in 
ampules and cultured 
tubes are commercially 
available. 
Produces less 
hazardous waste and it 
is more economical 
then 5220B.  
Premeasured reagents 
in ampules and cultured 
tubes are commercially 
available. 
D
is
ad
va
nt
ag
es
 
Produces more hazardous 
waste then 5220C and 5220D. 
 
Method 5220B requires a 
blender and reflux apparatus, 
which can occupy considerable 
lab space. 
 
Procedure 5220B4.b is highly 
sensitive to organic matter on 
the glassware. 
Less accurate and less 
representative than 
5220B. 
 
Requires more 
homogenous samples to 
reproduce results. 
Less accurate and less 
representative than 
5220B. 
 
Requires more 
homogenous samples 
to reproduce results. 
 
Light absorbing 
interferents must be 
removed from the 
sample. 
Pr
in
ci
pl
e 
The aliquot is boiled with a 
mixture of potassium 
dichromate and sulfuric acid, 
which chemically oxidize the 
organic matter.  After a 2-hr 
digestion period ferrous 
ammonium sulfate is used to 
titrate the remaining potassium 
dichromate, from which the 
quantity of oxidizable material 
can be calculated in oxygen 
equivalence. 
See Principle for Method 
5220B 
See Principle for 
Method 5220B. 
 
This method uses light 
absorption to determine 
oxygen demand.  The 
dichromate ion absorbs 
light in the 400-nm 
region and the chromic 
ion absorbs light in the 
600-nm region. 
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2.5.2 Selection of a COD Method 
 Table 2.3 compares the uses, advantages, and disadvantages of the three types of 
COD tests.  The closed reflux methods are more common than the open reflux method 
because they are economical, require less equipment space, and produce less hazardous 
waste.  The caveat is that the closed reflux methods are also less accurate and less 
representative then the open reflux method (Standard Methods, 2005).  The closed reflux 
colorimetric method was chosen for this research (Method 5220D).   
2.5.3 Principle for the COD Closed Reflux Colorimetric Method 
As previously discussed, the COD method determines the oxygen demand by 
reducing the dichromate ion to the chromic ion through oxidation.  Each of these ions has a 
unique color and a unique absorption.  Dichromate absorbs light in the 400-nm region and 
chromic absorbs light in the 600-nm region (Standard Methods, 2005).  For this test, light 
absorbance is used to determine how much COD is oxidized by the dichromate ion, therefore 
it is crucial that the sample is free from light-absorbing interferents or compensated for in the 
testing methods. 
 Hach (Loveland, CO) is company that manufactures laboratory equipment and 
chemistries that can be used for water and wastewater analysis.  They have chemistries to 
determine the concentrations of contaminants such as ammonia, phosphorus, COD, and many 
others.   
For the COD test, there are different reagent ampules available to accommodate 
different COD sample concentrations.  These fall into four categories: ultra low range (0 to 
50 mg/L), low range (0 to 150 mg/L), high range (0 to 1,500 mg/L) and high range plus (0 to 
15,000 mg/L).  
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2.5.4 Principle for the Hach Method 
The Hach COD chemistry used in this research is based on the dichromate reactor 
digestion method.  Hach provides ampules that contain premeasured reagents.  A specified 
volume of sample (2 mL) is added to the Hach ampule, and then it is incubated at 150 °C for 
2 hours to allow the sample to digest.  When the sample has cooled to room temperature, a 
spectrophotometer is used to measure the COD using the colorimetric method.  
Potassium dichromate is the reagent in the ampule, which oxidizes the organic matter 
during the digestion period.  The chromium ion is transformed from a hexavalent to a 
trivalent state during the digestion period.  The ion absorbs light at different wavelengths, 
dependent on the concentration of COD in the sample.  Additional reagents in the ampule 
include mercuric sulfate to eliminate chloride interference and silver is used as a catalyst 
(Hach, 1999).  
The spectrophotometer is programmed using potassium hydrogen phthalate (KHP) at 
different concentrations to develop a concentration curve (Hach, 1999; Standard Methods, 
2005).  There are different methods programmed in the Hach spectrophotometers for each of 
the Hach COD concentration chemistries; each chemistry has its own wavelength and 
calibration curve (e.g., the low range COD chemistry has a unique wavelength and 
calibration curve programmed into the spectrophotometer).  When the sample is put into the 
spectrophotometer, the amount of light absorbed by the sample at a predetermined 
wavelength is converted to an equivalent COD measurement based on the calibration curve.   
The Standard Methods and the Hach method provide instructions for creating KHP 
standards to verify the equipment is working correctly (Hach, 1999; Standard Methods, 
2005).  The KHP control should be made from a different stock than the KHP used to 
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calibrate the spectrophotometer so that it can serve as an independent control to validate 
analytical technique and to verify the equipment is holding its calibration (Standard Methods, 
2005).   
2.5.5 Interferences 
The COD test is effective at oxidizing 95-100% of the organic compounds, but 
certain volatile organic compounds may resist oxidation.  A silver sulfate catalyst can be 
used to oxidize straight-chain aliphatic compounds more effectively.  Chloride ion, bromide, 
iodide, and other similar ions inhibit the oxidation of the dichromate ion.  The chemical 
reaction between chloride and dichromate results in halogen and the chromic ion, which will 
error the oxygen demand on the high side.  The interference due to chloride can be overcome 
in waters where the concentration is less than 2,000 mg/L by adding mercury sulfate 
(HgSO4) prior to refluxing the sample; if the chloride concentration is greater than 2,000 
mg/L, then alternate COD testing techniques specific to saline water must be used.  
Ammonia and its derivatives are not oxidized in the COD method.  Nitrite interference is 
usually negligible, but significant interference can be eliminated with sulfamic acid.  
Inorganics compounds (e.g., ferrous iron, sulfide, manganous manganese, etc.) are also 
oxidized during the test procedure.  Suspended matter and color absorbing compounds will 
impact the results by interfering with the amount of light absorbed; if this occurs, then it may 
be possible to determine the COD based on the titrimetric method (Standard Methods, 2005). 
2.5.6 Sample Collection and Preservation  
 It is preferable that the sample is collected in a glass bottle to minimize interference.  
Samples that are unstable should be tested immediately.  If the sample cannot be analyzed 
immediately, then the sample can be preserved by acidification to pH≤2 using sulfuric acid 
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(H2SO4.) and stored at 4°C±2°C for up to 28 days (EPA, 1999; Standard Methods, 2005).  
Samples with suspended solids should be blended before analysis to homogenize the sample 
2.5.7 Quality Control/Quality Assurance 
 Standard Methods (2005) recommends that samples be collected in a glass bottle.  In 
the event that the concentration of COD is high, preliminary dilutions can be made to reduce 
the error associated with small volume size. 
 A potassium hydrogen phthalate control should be prepared from a different stock 
solution used to make the spectrophotometer calibration curve.  This control sample can be 
used to validate analytical technique, identify potential contamination, and to verify the 
calibration curve is valid, and ensure the digester and spectrophotometer equipment are 
working properly.   
2.5.8 Disposal of Hazardous Waste 
 Mercury, silver, and chromium reagents are used in the analysis, which are 
considered hazardous waste.  As such, the samples need to be disposed of accordingly to 
local regulations.  
2.6 Total Organic Carbon 
2.6.1 TOC Principle 
The total organic carbon (TOC) method is a more direct way to quantify the organic 
compounds in water or wastewater.  In TOC analysis, organically bound carbon is converted 
to carbon dioxide (CO2), which is directly measured. Each of the methods breaks down the 
organic molecules in slightly different ways.  High temperature methods use catalysts and 
oxygen, whereas lower temperature methods use ultraviolet irradiation or chemical oxidants.  
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The CO2 can be quantified using an infrared analyzer, a colorimetric titrator, or by separating 
the CO2 from the liquid with a membrane (Standard Methods, 2005). 
 
Table 2.4: Fractions of Total Carbon 
Name	   Definition*	  
Inorganic	  carbon	   Carbonate,	  bicarbonate,	  and	  dissolved	  CO2	  
Total	  organic	  carbon	  (TOC)	   Carbon	  atoms	  covalently	  bonded	  in	  organic	  
molecules	  
Dissolved	  organic	  carbon	  
(DOC)	  
The	  fraction	  of	  TOC	  that	  passes	  through	  a	  
0.45μm	  filter	  
Suspended	  organic	  carbon	   The	  fraction	  of	  TOC	  that	  is	  retained	  on	  a	  
0.45μm	  filter	  
Purgeable	  organic	  carbon	  (aka	  
volatile	  organic	  carbon)	  
The	  fraction	  of	  TOC	  that	  is	  removed	  from	  an	  
aqueous	  solution	  by	  gas	  stripping	  	  
Nonpurgeable	  organic	  carbon	   The	  fraction	  of	  TOC	  that	  is	  not	  removed	  from	  
an	  aqueous	  solution	  by	  gas	  stripping	  
*Adapted	  from	  the	  Standards	  Methods	  (2005)	  
 
Fractions of the total carbon can be determined as well; Table 2.4 summarizes the 
different fractions and their definitions.  Inorganic interference can skew the results because 
it may be greater than the TOC fraction; interference can be eliminated by acidifying the 
sample to ≤pH 2 to convert the carbonate and bicarbonate to CO2.  The carbonate CO2 can 
then be removed by volatilization by purging the sample with purified gas or vacuum 
degassing.  The purging process will also remove purgeable organic compounds (Standard 
Methods, 2005). 
2.6.2 Method Selection 
 There are three approved Standard Methods to determine TOC.  The high temperature 
method uses high temperatures to combust the organic matter into CO2, which can be 
measured with a nondispersive infrared analyzer or through colorimetric titration.  This 
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method is best for samples that have TOC > 1mg/L.  The persulfate method utilizes 
persulfate to oxidize the organic matter to CO2 and it is capable of determining TOC 
concentration < 1mg/L as well as higher concentrations.  The wet oxidation method is 
slightly different than the persulfate method, but it also uses persulfate to oxidize organic 
matter.  This method is more sensitive at determining the concentration of TOC < 1mg/L 
(Standard Methods, 2005). 
Based on historical TOC data, the concentration in the treated WWTP effluent is always 
above 1 mg/L.  Given the levels of TOC (>1 mg/L) of wastewater in this research, the 
purgeable organic carbon was determined with the high temperature combustion method.   
2.6.3 Interferences  
As previously discussed, inorganic compounds can be greater than the total organic 
carbon.  This interference can be eliminated by acidifying the sample to less than 2 pH to 
convert the inorganics to CO2, and then volatizing the sample to remove the CO2.  Volatile 
organic substances are removed during this process as well.  Misrepresentative samples can 
be analyzed due to particulate occlusion when the particles do not enter the needle used for 
injection.  Filters used to determine DOC can either adsorb or desorb carbon material, 
resulting in either a higher or lower DOC value; analysis of a blank will help identify if 
filters are contributing to the DOC.  Finally, contaminated or dirty glassware, containers, and 
tubing will impact the final TOC results (Standard Methods, 2005).   
2.6.4 Sample Preservation and Storage 
Samples can be preserved by acidification to a pH less than 2 and stored at 4°C with 
minimal exposure to light and the atmosphere.  The acidification will also eliminate the 
inorganic carbon-containing compounds, so this should be taken into consideration (Standard 
  37 
Methods, 2005).  The Standard Methods specifies that samples should be collected and 
stored in in glass bottles that are protected from sunlight and sealed with TFE-backed septa.   
2.6.5 Quality Control/Quality Assurance 
 The instrument detection limit should be determined based on part 1000 section 1030 
of the Standard Methods.  A control should be prepared from a source of material separate 
from the calibration standards and at a concentration similar to the samples being tested to 
verify the equipment is operating correctly and there are no sources of contamination 
(Standard Methods, 2005).   
2.7 Fluorescence and Absorbance Method  
 At the time of this writing, fluorescence spectroscopy was not an approved Standard 
Method for quantifying organic matter in water or wastewater (Standard Methods, 2005).  
Despite this, fluorescence is a method that can be used to identify organic matter (Henderson 
et al., 2009; Vasel and Praet, 2002; Baker and Inverarity, 2004). The most similar method in 
the Standard Methods is the Ultraviolet (UV) Absorption Method (Method 5910 B), which 
has some similarity to fluorescence, but they are not the same.  
 Fluorescence spectroscopy is a method that that can be used to identify analytes based 
on their molecular properties.  Certain molecules have a molecular component called 
fluorophores that will absorb energy and reemit energy at unique wavelength.  These 
molecules are sometimes generally referred to as fluorophores, but it is important to realize 
that fluorophore is a characteristic of certain molecules and that not all molecules have this 
characteristic.  As a consequence, some molecules cannot be identified using fluorescence 
(Sauer et al., 2011; Lakowicz, 2011).   
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 Chromophores are molecules that absorb energy, but they do not reemit energy.  
These are distinctly different from fluorophores that absorb light and emit fluorescence 
(Lakowicz, 2011).  Therefore, chromophores are responsible for the absorbance 
characteristics of a sample and fluorophores are responsible for the fluorescence 
characteristics of a sample.  It is possible for a sample to have chromophores and be void of 
fluorophores thus exhibiting absorbance properties, but not fluorescence.  
2.7.1 Fluorescence Theory 
 Molecules are typically in a ground state.  When a fluorophore molecule absorbs 
energy at a specific wavelength, it is no longer in its ground state.  The molecule will excite 
and will undergo different states to relax back to its ground state.   
Ground State à Higher Vibrational State à Lower Vibrational State àGround State 
 Once a molecule absorbs energy it excites into a higher vibrational state and then 
relaxes into a lower vibrational state.  A molecule will transition from the lower vibrational 
state to the relaxed state via several mechanisms, but the one that is the most important to this 
research is fluorescence.  The molecule will release energy in the form of fluorescence at a 
unique wavelength to relax from its excited state back to its ground state (Sauer et al., 2011; 
Lakowicz, 2011). 
2.7.2 Spectrofluorometer 
Figure 2.2 is a typical spectrofluorometer, such as the Horiba AquaLog ® (Edison, 
NJ) equipment used for this research.  This type of equipment can quantify both the 
absorbance and fluorescence properties of the sample.  A lamp is used as the energy source 
to excite the molecules in the sample.  The light passes through a mirror, which is used to 
focus the light into the monochromator.  Internal components in the monochromator are used 
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to adjust the wavelength of the light being sent through the sample and also to minimize light 
scattering. The reference detector is used to check the wavelength being sent through the 
sample and make internal adjustments to the monochromator if necessary.  Two detectors 
measure the wavelengths after the light is passed through the sample.  The intensity detector 
measures the light that passes through the sample, which is used to determine absorbance.  
The fluorescence detector is perpendicular to the lamp; this measures the fluorescence 
emitted by the fluorophore molecules in the sample (Horiba Scientific, 2012).   
 
 
Figure 2.2: Schematic of a typical spectrofluorometer arrangement adapted from Horiba 
Scientific (2012). 
 
The incident light that is sent through the sample is called the excitation wavelength 
when referring to fluorescence and it is called the incident wavelength when referring to 
absorbance; this is the wavelength that the reference detector measures.  The light captured 
by the fluorescence detector is the emission wavelength; this is the fluorescence energy 
emitted by the fluorophores. Because absorbance and fluorescence are independent of one 
another, the emission wavelength will never be used to describe absorbance properties.  
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Spectrofluorometers are capable of analyzing the fluorescence of a sample across a 
range of excitation and emission wavelengths.  An excitation-emission matrix (EEM) is 
commonly developed for a sample, which captures the fluorescence at a range of paired 
excitation and emission wavelengths.  The results are reported on a 3D plot or a contour plot 
and are typically represented as (emission, excitation, fluorescence intensity) (Zhou et al., 
2013; Henderson et al., 2009). 
 The spectrofluorometer equipment will typically have a user interface so that the user 
can adjust the settings (Lakowicz, 2001; Horiba Scientific, 2012). The user can set an 
excitation range and determine the increments that they want to use, as well as the emission 
wavelength increments that they desire.  Another spectrofluorometer setting is the integration 
time.  Longer integration times will reduce the signal to noise ratio (S/N). The signal is the 
fluorescence intensity corresponding to the relevant emission wavelength and the noise is the 
background illumination (Ahmad and Reynolds, 1999). Noise is reduced proportionate to the 
square root of the lamp pulses (i.e., 60 pulses per second).  Longer integration times will 
increase the number of lamp pulses, and thus decrease the S/N ratio (Ahmad and Reynolds, 
1999; University of Washington, 1999).  Consider the integration times for 1 second to 5 
seconds (Table 2.5).  It becomes clear that after 3 seconds the impact of longer integration 
times plateaus; therefore, it becomes unreasonable to use integration times that exceed 3 
seconds (University of Washington, 1999).  Longer integration times will decrease the S/N 
ratio, but it will also increase the amount of time that it takes to analyze a sample; therefore, 
the minimum integration time should be chosen such that it meets the S/N ratio requirements 
(Ahmad and Reynolds, 1999). 
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Table 2.5: Integration Times and the Impact on S/N for Fluorescence Spectroscopy 
Integration 
time 𝐍𝐨𝐢𝐬𝐞 = 𝟔𝟎  𝐩𝐮𝐥𝐬𝐞𝐬𝐬𝐞𝐜 ∗ 𝐈𝐧𝐭  𝐭𝐢𝐦𝐞  (𝐬𝐞𝐜) 1/Noise  (e.g., S/N) 
1s 7.75 0.13 
2s 10.95 0.09 
3s 13.42 0.07 
4s 15.49 0.06 
5s 17.32 0.06 
 
2.7.3 Interferences 
 Quenching interference is a broad term used to describe any process that will bias the 
fluorescence results low.  Increases in sample temperature and pH can quench the 
fluorescence of the sample (Henderson et al., 2009; Hudson et al., 2007).  Specifically, when 
the pH and temperature fall outside of the ranges of 3 – 7 and 10 – 80°C, the results of the 
fluorescence can be impacted (Ahmad and Reynolds, 1999).  Temperature can change the 
mechanisms (e.g., fluorescence) that molecules use to transition from an excited to a relaxed 
state (Henderson et al., 2009).  The pH impacts the molecular orbits and shape, and also 
changes the competition between the metal ions and hydrogen ion (Henderson et al., 2009). 
An interference known as the inner filter effect (IFE) can occur in samples with high 
absorbance.  When light passes through the sample, it is disproportionately absorbed on the 
front face of the sample and inhibits the amount of light sent through the remainder of the 
sample, which will quench the fluorescence.  The sample will also reabsorb some of the 
fluorescence light.  This type of interference can be overcome by diluting the sample 
(Lakowicz, 2011; Henderson et al., 2009; Hudson et al., 2007).   
Raman and Rayleigh interference are caused by stray and scattered light that occurs 
during analysis (Lakowicz, 2011). Spectrophotometers typically have built in functions that 
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can correct for Rayleigh and IFE interference.  The user can normalize the samples to Raman 
peaks or Raman peak areas.  The Raman peak should be identified based on observed peaks 
in the sample (Yu et al., 2014).   
 Inorganic compounds (e.g., ferrous iron, iron, nitrite, nitrate, and bromide), oxidants, 
and reducing agents (e.g., ozone, chlorate, chloramines, and thiosulfate) will absorb light, 
thus interfering with the absorbance of a sample (Standard Methods, 2005).  Chlorination and 
ozonation have also been found to interfere with fluorescence (Henderson et al., 2009). 
Different metal ions may interfere with fluorescence, but the results were variable in the 
literature; however, copper and aluminum are the most likely ions to cause quenching and 
impact the relationship of BOD5 to fluorescence (Henderson et al., 2009; Reynolds and 
Ahmad, 1995).  
2.7.4 Sample Preservation  
 Fluorescence is not yet an approved method for the quantification of organic matter in 
water and wastewater.  It would be prudent to follow sample perseveration techniques 
outlined for the other methods.  The sample should be refrigerated and stored in containers 
that will minimize light interference and the storage time should be limited to 24 hours after 
the composite period and 48 hours after a grab sample (Standard Methods, 2005).  
2.7.5 Quality Control/Quality Assurance 
At the time of this writing, there were not any standardized quality controls for 
fluorescence.  Literature suggests that quinine sulfate may be a potential fluorophore to use 
as a quality control (Chen et al., 2003; Fletcher, 1969; Drobnik and Yeargers, 1966).   
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2.7.6 How Organics Are Quantified With Fluorescence 
 The organic matter quantified in this research is limited to dissolved organic matter 
(DOM), because samples were filtered prior to analysis to prevent light scattering 
interference.  There are multiple ways to identify dissolved organic compounds based on the 
results of the spectrophotometer.   
1) EEM peaks – these correspond to fluorescent peaks at their respective excitation and 
emission wavelengths.  Organic matter that fluoresces is called fluorescent dissolved organic 
matter (FDOM) (Zhou et al., 2013).   
2) EEM ratios – a ratio between two points on the EEM graph. 
3) Regions – the EEM graph can be broken into regions and the fluorescence is determined 
based on the integrated area of that region.   
EEM peaks can be identified on the graph by the level of fluorescence.  Peaks can be 
associated with several compounds including humic acids, fulvic acids, and tyrosine (Chen et 
al., 2003).  Peaks are referred to as protein-like, fulvic-like, and humic-like because it is 
difficult to identify specific fluorophores (Hudson et al., 2007). 
Protein and carbohydrates contribute significantly to the organic matter in wastewater 
(Tchobanoglous et al., 2003).  Three aromatic fluorophore molecules are common to 
proteins: phenylalanine, tyrosine, and tryptophan; their respective excitation and emission 
wavelengths are summarized in Table 2.6.  Carbohydrates do not fluoresce; therefore, it is 
not possible to identify them using an EEM (Lakowicz, 2011).  Coble et al. (1996) identified 
the peaks A, C, and T (Table 2.6) using seawater.  Nam and Amy (2008) reported that the 
first maxima humic peaks occur near the excitation/emission wavelengths 280 nm/450 nm, 
which is consistent with the A and C peaks reported by Coble et al. (1996).  Second maxima 
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humic peaks occur near 340 nm excitation and 420 nm emission wavelengths; second 
maxima humic peaks were chosen to be 342 nm and 436 nm for this research and labeled as 
humic (Nam and Amy, 2008).   
The second method of quantification is with EEM peak ratios. One such peak is the 
fluorescence index (FI), which was defined by McKnight et al. (2001).  The FI is defined as 
the ratio of the fluorescence at the excitation/emission wavelengths of 370nm/450nm to 
370nm/500nm. The researchers concluded that the FI was higher (1.7 to 2.0) for microbial 
organics and lower (1.3 to 1.4) for terrestrial organics.  
 Fluorescence regional integration (FRI) was first introduced by Chen et al. (2003) as 
a means to simplify the interpretation of the EEM graphs.  This technique breaks the EEM 
graph into unique regions and integrates the area under the spectra; the results are reported as 
arbitrary fluorescence units (AFU).  Figure 2.3 is an adapted version of their defined regions 
and Table 2.7 summarizes the organics present in each region.  Modified regions were 
adopted for this research, as shown in Figure 2.4.  
 Other methods for interpreting the EEMs include principal component analysis, 
partial least squares regression, principal factor analysis, and parallel factor analysis 
(PARAFAC), generalized rank annihilation models, Tucker models, multiway PLS, and 
multivariate curve resolution (Henderson et al., 2009).  A review of each of these methods is 
outside of the scope of this project.  The methods chosen for this research were based on 
successful approaches in the literature that were able to relate BOD5 and fluorescence.  
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Table 2.6: Fluorescence EEM Peaks Associated With Organics 
 
 
Peak 
 
Excitation (nm)/ 
Emission (nm) 
As defined in the 
literature 
 
Ex. (nm)/ 
Em. (nm) 
Adopted 
for this 
research 
 
 
Description 
 
 
Reference 
Proteins Phenylalanine 260/282 
Tyrosine 275/304 
Tryptophan 295/353 
280/331 The three 
mentioned 
fluorophores are 
molecules are 
characteristic of 
proteins.  
Lakowicz 
(2011) 
Humic 340/420 342/436 Humic  Nam and Amy 
(2008) 
A 260/380-460 260/450 Humic-like Coble et al. 
(1996) 
C 350/420-480 330/450 Humic-like Coble et al. 
(1996) 
T 275/340 275/340 Tryptophan-like, 
protein-like 
Coble et al. 
(1996) 
 
 
 
Figure 2.3: Fluorescence EEM regions defined by Chen et al. (2003).   
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Table 2.7: Fluorescence EEM Peaks for Each Region adapted from Chen et al. (2003) 
Region Quantification EEM Peaks 
Region I Aromatic proteins I Tyrosine 
Region II Aromatic proteins II BOD5 
Region III Fulvic-acid-like Hydrophobic acid & fulvic acid 
Region IV Soluble-microbial-byproduct-like 
Tyrosine, protein-like, 
and tryptophan 
Region V Humic-acid-like 
Marine humic acids, 
hydrophobic acids, 
humic-like acids, model 
humic, acid polymers, 
hydrophobic acids 
 
 
 
Figure 2.4: Fluorescence EEM regions and peaks that were adopted for this research.   
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2.7.7 Fluorescence Reporting Units 
 Fluorescence is unitless and it is reported as “arbitrary fluorescence units” (AFU) or 
“fluorescence units” (FU). Some researchers may also prefer to normalize their fluorescence 
results to quinine sulfate and report their results as quinine sulfate units (QSU) or quinine 
sulfate equivalent (QSE).  All results in this report are given in AFU. 
 Fluorescence is reported with the excitation and emission wavelengths.  The 
excitation wavelength refers to the energy that is sent through the sample, and the emission 
wavelength is the energy that is reemitted from the samples through fluorescence.  The 
excitation wavelength will always be less than the emission wavelength.  
2.7.8 How Fluorescence Can Be Used  
 Fluorescence can be used to identify organics based on their unique characteristics, 
such as humic-like, fulvic-like, or protein-like, which is a major advantage over alternate 
organic quantification methods such as COD, TOC, and BOD5 (Chen et al., 2003; Coble et 
al., 1996; Nam and Amy, 2008; Hudson et al., 2007).  Fluorescence has been used to 
characterize a variety of water sources, some of which include groundwater, wastewater, 
drinking water, river water, and reclaimed water (Albrektiene et al., 2012; Vasel and Praet, 
2002; Park et al., 2010; Bridgeman et al., 2011, Baker and Inverarity, 2004; Laws et al., 
2011).  
It has been discussed that the characteristics of wastewater changes as treatment 
progresses.  Specifically, biodegradable organic matter is removed and SMPs are formed.  
Fluorescence can be used in a number of ways to quantify the changes. The EEM peak T 
(tryptophan-like compounds) will decrease in a WWTP as treatment progresses, which can 
be associated with BOD5 removal (Hudson et al., 2007; Henderson et al., 2009).  All 
  48 
fluorescence will decrease as a result of filtration (Henderson et al., 2009).  The change in 
SMPs and biodegradable can be further quantified with the fluorescence index.  The findings 
of McKnight et al. (2001) were that the fluorescence index was greater for water with 
microbial contaminants (SMPs) and less for terrestrial contaminant.  It would be reasonable 
to assume that a higher FI will be observed in the effluent due to the formation of SMPs in 
the biological treatment, and a lower FI will be observed in the influent.   
Furthermore, anthropogenic compounds can be identified using fluorescence (Laws et 
al., 2011).  WWTPs are designed to remove biodegradable organic matter, but fluorescence 
can be used to quantify the oxidization of anthropogenic organics during the treatment 
process.  This is beneficial for treatment plants that are designed for water reuse.  In a closed 
loop water reuse system, organics that are not removed in the treatment processes will 
inevitably increase in concentration and thus increase the loadings on the treatment facilities.   
2.7.9 How Organics Are Quantified With Absorbance 
The absorbance of a sample is independent of the fluorescence properties; therefore, 
it is possible for a sample to absorb light in the absence of fluorophores. Specifically, 
molecules that absorb light are chromophores; it is possible for a sample to have 
chromophores and lack fluorophores (Hudson et al., 2007).  Absorbance is related to the 
amount of light that is transmitted through the sample. Equation 2.2 shows the relationship 
between the light intensity that enters the sample (I0) and the light that passes through the 
sample (IT).  The amount of absorbance (A) is directly related to the path length (d) that the 
light follows, the molar absorptivity (𝜖), and the concentration in the sample, as described by 
Beer’s Law (Sauer et al., 2011).   
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 The spectrophotometer gives the absorbance property of the entire sample (Equation 
2.3).  Absorbance alone cannot identify the particular contaminants in the sample.  Without 
information regarding the contaminants and their relative contribution in the sample, it is not 
possible to determine their respective concentrations.  The absorbance results can give a 
relative understanding of the concentration of contaminants in the sample, and therefore be 
used as surrogate for the degree of contamination in the sample.  The absorbance of the 
sample is assumed to be proportionate to the organic matter in the sample.  Single incident 
wavelengths can arbitrarily be chosen to determine the absorbance properties of a sample, but 
they must be used consistently because the absorbance will change at different wavelengths.  
Absorbance is typically reported in cm-1 at a specific incident wavelength.   
2.8 Comparison of the Methods 
 Table 2.8 provides a comparison of each of the methods, including the advantages 
and disadvantages.  It is clear that each method quantifies organic matter differently; 
therefore, the results of the methods are not interchangeable.  It is possible, however, to 
develop relationships between each of the methods.  A clear understanding of how each 
method quantifies organic matter and the removal of organic matter in the WWTP is crucial 
to interpreting relationships between the methods.   
Organic matter that is easily biodegradable is quantified in the BOD5 method.  The 
potassium dichromate used in the COD test will oxidize biodegradable matter and inorganics, 
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as well as recalcitrant matter; therefore, the results of the COD test will always be higher 
than the results of the BOD5 test.  The absorbance of a sample is assumed to be proportionate 
to the organic concentration of the sample, based on the presence of chromophores.   
 The TOC test measures the total organic carbon based on the amount of carbon that is 
converted to CO2.  The type of organic matter quantified can vary depending on how the 
analyst chooses to perform the test. For instance, dissolved organic carbon and suspended 
organic carbon can be determined by filtering the sample. Alternatively, a sample can be 
analyzed to determine both organic and inorganic (bicarbonate and carbonate).  Inorganic 
interference due to the carbonates can be eliminated when the sample is acidified and 
sparged, but some organics may be purged during this process that can cause a low bias in 
the TOC results.   
Fluorescence quantifies the dissolved organic matter (DOM) based on its molecular 
properties.  This test has the distinct advantage over the methods because it can discretely 
identify the organics present.  This can be used to identify recalcitrant and SMPs in the 
effluent water.  Fluorescent DOM (FDOM) can be identified as peaks in the EEM, which can 
include humic-like acids, fulvic-like acids, and proteins (mostly in the form of the amino acid 
tryptophan, which is a building block for proteins).  Sometimes it is useful to consider a 
range of excitation-emission wavelengths; in this case, the EEM can be broken into regions. 
Reynolds and Ahmad (1997) have also shown that biodegradable organics and 
nonbiodegradable organics can be distinguished from one another, which makes it more 
comparable to the BOD5 test. 
The fate of organic matter in the treatment system is important to the relationships 
between the methods.  Particularly, biodegradable organic matter is easily removed during 
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biological treatment and recalcitrant organic matter can build up in the process.  SMPs are 
created during the treatment process as well.  The BOD5 and fluorescence methods can 
quantify biodegradable organic matter in the sample.  The TOC, COD, and fluorescence will 
quantify the recalcitrant and SMPs in the effluent samples, whereas BOD5 method will not.  
Fluorescence is the only method that can differentiate between biodegradable and 
nonbiodegradable organics, humic-like acids, fulvic-like acids, and proteins.   
The fact that each of these methods quantifies different types of organic matter is 
particularly important. The organic matrix evolves as treatment progresses, specifically labile 
organic matter will decompose, but the recalcitrant matter will remain. Thus, the BOD5 will 
decrease at a different rate than the TOC and COD as treatment progresses, which will 
impact the ratios between these methods.  The ratios will be discussed in further detail later 
in the thesis.   
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Table 2.8: Comparison of TOC, BOD5, TOC, and Fluorescence Methodologies 
  BOD5 COD TOC Fluorescence 
O
rg
an
ic
s 
Biodegradable organics  Organics Total organic carbon Dissolved organic matter (DOM)  
In
te
rf
er
en
ce
 Inorganics (sulfur and 
iron) and nitrogenous 
demand (unless it is 
inhibited) 
Inorganics are prone to 
chemical oxidation 
Inorganics can bias results 
high, unless they are acidified 
and sparged prior to TOC 
analysis.  Some of the organics 
may be lost during this process. 
Inorganics and chemical 
reducing compounds can 
absorb light 
A
dv
an
ta
ge
s 
ü Mimics the biological 
process of the 
treatment plant  
ü Approved by the 
Standard Methods 
Method  
ü Required by NPDES 
permits 
ü Quick and easy to perform 
ü Hach equipment is 
available that nearly anyone 
(non lab personal) can be 
trained to use.  
ü Some labs already have the 
spectrophotometer that they 
use for other purposes  
ü Effective at oxidizing 95-
100% of the organic 
compounds  
ü Fractions of TOC can be 
determined  
ü Some TOC analyzers can 
also determine total 
Nitrogen (TN) while 
running the TOC test  
ü Inorganic interference can 
be eliminated 
ü Can uniquely identify 
organics based on their 
fluorescence properties 
ü Can distinguish between 
NOM, SMPs, and 
anthropogenic organic 
matter  
ü Can distinguish between 
biodegradable and 
nonbiodegradable 
D
is
ad
va
nt
ag
es
 
§ 5-days to obtain 
results 
§ Sensitive to organic 
and bacterial 
contamination 
§ Cannot reanalyze 
sample if test fails 
§ Labor intensive 
§ Chemicals used in test are 
hazardous waste  
§ Unrepresentative samples 
(e.g., particulate) can 
impact the quality of results   
§ Potassium dichromate will 
also oxidize inorganic 
compounds 
§ Sensitive to organic 
contamination 
§ Injection points can get 
clogged 
§ Expensive equipment 
§ Not an approved 
Standard Method  
§ Does not have a 
standardized control 
§ Some organics do not 
fluoresce (e.g., 
carbohydrates) 
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Part C: Existing Literature on Alternative Correlations 
2.9 Existing BOD5 and COD Correlations 
 Several studies have concluded that BOD5 and COD can be correlated for different 
water sources (Table 2.9), but samples with minimal organic pollution (e.g., BOD5 <3 mg/L) 
may be more difficult to correlate (Aziz and Tebbutt, 1979; Jin et al., 2009).  This is likely 
due to the reporting limits of the BOD5 method, although the authors did not conclude this.  
A report by Esener et al. (1981) concluded that the ratio between BOD and COD is reliant on 
the efficiency of the microbial growth, and that microbial growth is a function of 
environmental conditions.  Both microbes and environmental conditions will vary among 
water sources; therefore, the correlations may not be consistent among water sources, as 
suggested by the literature.  
A study by Rowe (1968) compared the relationship between synthetic sewage and 
influent domestic sewage from a WWTP in Louisiana; he concluded that both had strong 
linear relationships that could be used to estimate BOD5 within 5%, but correlations were 
different because the synthetic water responded better to biodegradation compared with the 
sewage from the WWTP.  The samples were diluted to three concentrations to create the 
correlations.  The correlation equations are reported in Table 2.9.  
 A study conducted by Jin et al. (2009) explored the relationship BOD5 and COD in 
coastal seawaters.  This study was particularly interesting because the BOD5 was not 
determined using the traditional Standard Method, but instead using a “BOD fast 
measurement system” that estimated the BOD5 results within thirty minutes.  The system 
consisted of a BOD sensor film that was composed of a dissolved oxygen membrane and 
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aerobic bacteria.  An LED light emits light at 495 nm that excites the BOD sensor film, 
which will emit fluorescence at 580 nm for detection.  The depletion of dissolved oxygen in 
the water is quantified using an oxygen sensor. This type of monitoring system may be of 
interest to WWTPs as an alternate test procedure for determining their BOD5.  The results of 
the study showed that a significant relationship exists for polluted (i.e., BOD5 > 3 mg/L) 
brackish water (r = 0.983), but relatively clean coastal water (i.e., BOD5 < 3 mg/L) did not 
have a significant relationship. 
Domestic wastewater was collected and treated with a continuous flow activated 
sludge plant (i.e., primary clarifier àaeration basin à secondary clarifier) in the research 
conducted by Aziz and Tebbutt (1979). A statistically significant linear relationship was 
established for settled influent, but they concluded that a relationship could not be established 
for treated secondary clarifier effluent, as shown in Table 2.9. The COD/BOD5 ratio was 
approximately 2.412 in the influent and decreased to 1.438 in the secondary clarifier effluent, 
due to biological treatments.  The ratio is somewhat higher compared with other literature 
that reported a ratio of 1.1 to 2.4 and 1.85 for influent samples (Dazae, 1974; Eckenfelder 
and Ford, 1970) 
 The conclusions of Dubber and Gray (2010) were that settled domestic wastewater 
influent correlated well, but the effluent samples did not have a significant relationship based 
on samples collected from 11 WWTPs in Ireland. Their influent model was similar to 
Ademoroti’s (1986) generic model.  They concluded that their effluent samples did not 
correlate well because the ratio of BOD to COD varied too much among the WWTPs, which 
was expected due to the different treatment efficiencies.
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Table 2.9: Existing BOD5 and COD Correlations 
 
BOD-COD Conclusion r Statistically significant Source Reference 
BOD5=0.46*(COD) - 20 NR Yes Domestic WW Harahan, LA Rowe (1968) 
BOD5=1.03*(COD) - 58 NR Yes Synthetic WW Rowe (1968) 
COD=3.54*(BOD5) + 2.38 r=0.98 Yes 
Brackish coastal seawater BOD5 > 
3mg/L Jin et al. (2009) 
NR r=0.34 No Brackish coastal seawater BOD5 < 3mg/L Jin et al. (2009) 
BOD5=0.413*(COD) + 1.22 r2=0.75 Yes Settled domestic WW  Aziz and Tebbutt (1979) 
NR NR No Domestic WW secondary treatment Aziz and Tebbutt (1979) 
BOD5=0.4259*(COD) + 50.99 NR Yes WWTP Tehran, Iran Abyaneh (2014) 
BOD5=0.589*(COD) – 11.3 r2=0.98 Yes 
Settled domestic WW 11 WWTPs in 
Ireland Dubber and Gray (2010) 
NR r2=0.49 No Final effluent WW from 11 WWTPs in Ireland Dubber and Gray (2010) 
COD=1.64*(BOD5) + 11.36 NR Yes Domestic influent WW Ademoroti (1986) 
COD=1.27*(BOD5) - 134.5 r=0.96 Yes Sewage Wagh and Shrivastava (2007) 
COD=0.87*(BOD5) - 3.99 r=0.96 Yes Groundwater Wagh and Shrivastava (2007) 
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2.10 Existing BOD5 and TOC Correlations 
 There are inconsistencies in the literature regarding the ability to correlate BOD5 and 
TOC among a variety of water sources.  Some of the literature suggests that the relationship 
between BOD5 and TOC is insignificant, while others suggest that correlations exist, as 
summarized in Table 2.10.   
 Viraraghavan (1976) reported that the relationship between TOC and BOD5 was 
insignificant for raw sewage, septic tank effluent, and polluted groundwater.  Aziz and 
Tebbutt (1979) found a weak relationship for domestic wastewater.  Relationships between 
TOC and BOD5 did not have a significant relationship for surface water collected from 
different water sources in Minnesota (Maier and McConnell, 1974).  Dubber and Gray 
(2010) reported insignificant relationships between TOC and BOD5 for eleven wastewater 
treatment plant effluents, which was likely due to variations in the treatment processes and 
due to the buildup of recalcitrant matter during biological treatment.  
 There have been many successful correlations made between BOD5 and TOC.  For 
instance, Schaffer et al. (1965) developed a relationship for the combined sample points of 
influent, primary effluent, and secondary effluent.  Dubber and Gray (2010) concluded that a 
significant model for settled domestic influent existed for samples collected from 11 WWTPs 
in Ireland.  It should be noted that Dubber and Gray (2010) also concluded that the collective 
effluent samples from the 11 WWTPs could not be correlated well because of the variability 
in the treatment processes.   
 Ostendorf and Byrd (1969) did not report a linear equation, but they concluded that 
the relationship between TOC and BOD5 was significant at a 95% confidence interval for 
effluent at a paper mill plant. The work of Emery et al. (1971) concluded that TOC and 
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BOD5 relationships were significant for water samples collected from the Cherokee 
Reservoir in Tennessee.   
 Chandler et al. (1976) successfully developed relationships for BOD5 and TOC for 
six WWTPs in Massachusetts for both influent and effluent water.  Five of the plants were 
grouped together because they discharge into the same receiving water, but the treatment 
trains were not all the same.  The treatment train of one of the plants consisted of an extended 
aeration facility without primary clarification, one of the plants used conventional activated 
sludge system followed by an a nitrifying activated sludge system, and the other three plants 
were trickling filter facilities.  Despite the differences in treatment efficiencies, the 
researchers were able to develop models for both inhibited and uninhibited BOD5 for the 
combined treatment plant effluent.  This is contradictory to Dubber and Gray (2010), who 
concluded effluent could not be correlated with different combined effluents due to treatment 
efficiencies.  A correlation for the sixth treatment plant (conventional activated sludge) was 
developed independently; decent correlations were developed for both raw influent and 
secondary effluent.  
 It was found that the BOD5/TOC ratio was approximately 2.0 for the raw wastewater 
and decreased to 0.53 for the secondary effluent for the combined treatment plants. The ratios 
for the conventional activated sludge plants varied between 0.67 and 2.53 for the influent and 
varied between 0.22 and 0.78 for the effluent water (Chandler et al., 1976).  Other literature 
have reported ratios from 1.3 to 1.9 and 1.35 to 2.62 for influent wastewaters (Ford, 1968; 
Eckenfelder, 1970) 
 Santa Cruz Wastewater Treatment Facility currently uses TOC to estimate BOD5 for 
their NPDES permit reporting.  The plant uses an exponential relationship to estimate their 
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influent BOD5 loadings and a linear relationship to estimate their effluent BOD5.  Several 
data points collected over a year showed that the ratio for influent ranged (TOC/BOD5) from 
0.31 to 0.58 for the influent, indicating little variability (Babatola and Xu, 2010).  Indeed, 
other wastewater plants such as Clark County Water Reclamation District and Inland Empire 
Utilities Agency also use TOC to estimate their BOD5 (Drury, 2014).   
  Constable and McBean (1979) explored the use of different statistical models to relate 
BOD5 and TOC.  Specifically, they used more complex models that account for errors to 
determine if they were more suitable than the traditional linear model. It was shown that the 
traditional linear model had the highest correlation coefficient, so more complex models 
were not necessary.  The correlation coefficient for primary influent and primary effluent was 
0.901 and 0.743, respectively, showing significant relationships for both samples.  It was 
shown that the model behaved well for the sampling period in which it was derived, but the 
model performed poorly during different sampling periods.   
 The literature indicates that some studies were able to correlate TOC to BOD5, but 
others were not.  It can be speculated that the differences in the methodologies or the 
difference in water matrices could have contributed to poor correlations.  The unsuccessful 
studies should not overshadow the successful correlations by other researchers. The fact that 
three operating WWTPs are currently allowed to use TOC to estimate BOD5 is encouraging 
considering the potential time and cost savings associated with such change.  
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Table 2.10: Existing BOD5 and TOC Correlations 
BOD-TOC Conclusion r Statistically Significant Source Reference 
BOD5=0.031*(TOC)+554 r=0.02 No Raw sewage Viraraghavan (1976) 
BOD5=1.27*(TOC)+87 r=0.395 No Septic tank effluent Viraraghavan (1976) BOD5=1.20*(TOC)+48 r=0.34 No Polluted groundwater Viraraghavan (1976) 
NR NR No Influent domestic wastewater Aziz and Tebbutt (1979) 
NR r=0.24 No Surface Water MN Maier and McConnell (1974) 
BOD5=1.875*(TOC)-11.6 r2=0.94 Yes Domestic WW combined at 3 sites Schaffer et al. (1965) 
BOD5=1.68*(TOC)+23.7 r2=0.96 Yes Settled domestic WW 11 WWTPs Dubber and Gray (2010) 
NR r2=0.33 No Final effluent WW from 11 WWTPs Dubber and Gray (2010) 
BOD5=1.507*(TOC)-55.43 r=0.90 Yes Primary influent from WWTP Constable and McBean (1979) 
BOD5=1.336*(TOC)+2.544 r=0.74 Yes Primary effluent from WWTP Constable and McBean (1979) 
TOC=0.479*(BOD)0.98 r2=0.82 Yes 
Primary influent from 
WWTP Babatola and Xu (2010) 
TOC=9.052*(BOD)-0.9409 r2=0.93 Yes Effluent from WWTP Babatola and Xu (2010) 
NR NR Yes Effluent of a paper mill plant Ostendorf and Byrd (1969) 
BOD5 uninhibited =0.64*(TOC)+19.6 r=0.71 Yes Effluent of 5 WWTPs Chandler et al. (1976) 
BOD5 inhibited=0.84*(TOC)-1.9 r=0.81 Yes Effluent of 5 WWTPs Chandler et al. (1976) 
BOD5=0.84*(TOC)+86.15 r=0.79 Yes Raw influent of 1 WWTP Chandler et al. (1976) 
BOD5=0.57*(TOC)-0.58 r=0.76 Yes Secondary effluent of 1 WWTP Chandler et al. (1976) 
BOD5=0.0708*(TOC)+0.2470 r=0.69 Yes Reservoir Emery et al. (1971) 
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2.11 Existing BOD5 and Absorbance and Fluorescence Correlations 
Absorbance is typically reported at 254 nm wavelengths, but other wavelengths can 
be adopted to reduce interference (Standard Methods, 2005).  Studies have shown that 
absorbance can be successfully correlated at BOD5 at several different wavelengths including 
250 nm, 254 nm, 260 nm 280 nm, and 650 nm (Comber et al., 1996; Wu et al., 2006; 
Chevakidagarn, 2007; Natarja et al., 2006; Michail and Idelvoitch, 1981).  Investigation of 
fluorescence has been gaining attention over absorbance because it has the potential to be 
used for real time monitoring and it can be used to identify organics based on their 
fluorescent properties (Reynolds and Ahmad, 1997; Ahmad and Reynolds, 1999; Reynolds, 
2002; Hudson et al., 2007).   
In the 1990s, Ahmad and Reynolds began to explore fluorescence as a way to identify 
organic compounds in wastewater and relate it to BOD5.  When their research began, 
fluorescence was not a novel technique for organic quantification, but it was a novel 
technique for organic quantification in wastewater (Reynolds and Ahmad, 1995).  These 
researchers have made significant contributions to the characterization of organic matter in 
wastewater through the use of fluorescence.  This literature review begins with the work of 
Ahmad and Reynolds and progresses to current studies that have used fluorescence to 
characterize organic matter in wastewater and as a predictor for BOD5.   
A preliminary study (Ahmad and Reynolds 1995) was conducted using 24-hour 
composite wastewater samples from three wastewater treatment plants.  It was shown that the 
amino acids tryptophan, lignin, and humic were highly fluorescent.  Two major peaks 
occurred near 280 nm and 390 nm that correspond with biodegradable and humic substances, 
respectively.  A comparison between the influent and the effluent samples showed a decrease 
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in fluorescence that ranged from 50 to 85%.  The samples were filtered with 0.45-µm filters 
to determine the impact of suspended solids on the fluorescence.  It was concluded that 
filtering did not impact the peak associated with the biodegradable matter, but the humic 
peak was substantially reduced.   
The researchers expanded their work by exploring the relationship between inhibited 
BOD5 and absorbance/fluorescence using real time monitoring (Reynolds and Ahmad, 1997).  
To simulate in situ monitoring effect, samples were magnetically stirred during the 
fluorescence analysis to simulate turbidity.  Samples were collected from three WWTPs that 
were from a) industrial and domestic origins, b) industrial origins, and c) domestic origins.  It 
was observed that significant linear relationships exist between absorbance at 254 nm and 
fluorescence intensity (excitation=280 nm, emission= 340 nm).  The absorbance and 
fluorescence peaks occurred in the same location for each of the sample sites, but the 
magnitude of the peaks differed.  Table 2.11 summarizes the ratios determined in this study, 
which indicate that the ratio decreases as treatment progresses; this is expected because 
BOD5 is removed during the treatment process and it is consistent with the findings reported 
in the COD and TOC literature reviews.  A comparison between influent and effluent 
samples indicated that there was a reduction in fluorescence across the entire matrix.   
Ahmad and Reynolds (1999) concluded that biodegradable organic matter occurs near 
emission bands at 350 nm and nonbiodegradable organic matter occurs near emission bands 
at 440 nm.  It was observed that the fluorescence decreased nearly 90% near the 350 nm 
emission band after wastewater treatment, which is indicative of biodegradable organic 
removal.  Furthermore, there was approximately 60% reduction after treatment near the 440 
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nm emission band, which is indicative of nonbiodegradable organic matter that was not 
easily removed during the treatment process.   
  
Table 2.11: BOD5 ratios for Absorbance and Fluorescence adapted from Reynolds 
and Ahmad (1997) 
 
Source Water type BOD5/Abs λex=254 nm 
BOD5 / Fl 
λex=340 nm 
BOD5 / Fl 
λex=450 nm 
Domestic + 
Industrial 
Raw settled WW 162.11 8.23 22.56 
Treated effluent 16.84 1.15 1.14 
Industrial  Raw settled WW 113.28 6.94 21.74 Treated effluents 30.19 1.84 2.34 
Domestic Raw settled WW 129.11 8.85 23.32 
Treated effluent 16.51 1.04 1.97 
 
Reynolds (2002) compared synthetic and wastewater samples; the wastewater 
samples were grab samples from a treatment facility in England.  It was shown that BOD5 
could be correlated to fluorescence intensities for both sample types, but the synthetic 
samples correlated better than the wastewater samples (Table 2.12).  Furthermore, the 
wastewater fluorescence intensities were up to five times higher compared with the synthetic 
samples.   
Table 2.12 summarizes the work of Ahmad and Reynolds.  The fluorescence 
intensities (reported in AFU) were normalized to their respective Raman peaks at a specific 
emission/excitation wavelength.  Fluorescence intensity in the 1997 study was reported at 
excitation and emission wavelengths of 280 nm and 340 nm, respectively.  The emission 
wavelength was reduced from 280 nm to 248 in the subsequent 1999 study, but all other 
parameters remained the same.  Relationships for the study conducted in 2002 show that 
synthetic sewage and actual sewage have similar slopes.  
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Table 2.12: Early BOD5 and Fluorescence Relationships 
 
BOD-Fluorescence Conclusion Sig. Source Reference 
Biodegradable OM fluoresces at λex 280 nm - WW Ahmad and Reynolds (1995) 
Humic OM fluoresces at λex 390 nm - WW Ahmad and Reynolds (1995) 
Eqn NR Abs λ254 =f(BOD5) r2=0.97 Industrial and domestic WW Reynolds and Ahmad (1997) 
Eqn NR Abs λ254 =f(BOD5) r2=0.95 Industrial WW Reynolds and Ahmad (1997) 
Eqn NR Abs λ254 =f(BOD5) r2=0.87 Domestic WW Reynolds and Ahmad (1997) 
Eqn NR AFU = f(BOD5) [Ex=280 nm, Em=340 nm] r2=0.93 Industrial and domestic WW Reynolds and Ahmad (1997) 
Eqn NR AFU = f(BOD5) [Ex=280 nm, Em=340 nm] r2=0.94 Industrial WW Reynolds and Ahmad (1997) 
Eqn NR AFU = f(BOD5) [Ex=280 nm, Em=340 nm] r2=0.89 Domestic WW Reynolds and Ahmad (1997) 
Eqn NR AFU = f(BOD5) [Ex=248 nm, Em=340 nm] r2=0.97 Domestic WW Reynolds and Ahmad (1999) 
Biodegradable OM fluoresces at em. bands near 340 nm -­‐	   Domestic WW Reynolds and Ahmad (1999) 
Nonbiodegradable OM fluoresces at em. bands near 440 
nm -­‐	   Domestic WW Reynolds and Ahmad (1999) 
AFU = 0.073(BOD5) + 0.0061 [Ex=280 nm, Em=350 nm] r2=0.89 
Synthetic WW (Total 
relative normalized fl. from 
300 to 540 nm) 
Reynolds (2002) 
AFU = 0.070(BOD5) +1.606e-4 [Ex=280 nm, Em=350 
nm] r
2=0.79 
 WW (Total relative 
normalized fl. from 300 to 
540 nm) 
Reynolds (2002) 
AFU = 0.024(BOD5) + 0.002 [Ex=280 nm, Em=350 nm] r2=0.98 
Synthetic WW (Relative 
normalized fl. at 350 nm) Reynolds (2002) 
AFU = 0.025(BOD5) +6.05e-4 [Ex=280 nm, Em=350 nm] r2=0.93 
WW (Relative normalized 
fl. at 350 nm) Reynolds (2002) 
Biodegradable OM fluoresces at Ex=280 nm Em =350 
nm -­‐	   WW Reynolds (2002) 
Nonbiodegradable OM fluoresces at Ex=280 nm Em 
=440 nm -­‐	   WW Reynolds (2002) 
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A study (Baker and Invarartity, 2004) of sixty-two sites along a river impacted with 
sewage discharge concluded that BOD5 correlated well (r=0.85) to tryptophan-like peaks at 
220 nm excitation and 350 nm emission wavelengths.  Furthermore, the relationship between 
BOD5 and humic and fulvic peaks were found to be statistically significant (r=NR).  It was 
found that BOD5 can be predicted as a function of tyrosine-like fluorescence and fulvic 
fluorescence.  An examination of the data revealed that some of the sample sites were 
considered outliers because their pollution loads were different from the other sites.  When 
these outlier sample sites were excluded from the dataset, the relationship changed and 
became a function of tryptophan and fulvic fluorescence.  The implications of this are that 
BOD5 can be related to fluorescence parameters, but the relationship is most likely site 
specific due to the water matrix. 
Chevakidagarn (2007) studied the relationship between BOD5 and fluorescence in 
industrial wastewaters (i.e., Para rubber and seafood industries).  They found the correlations 
to be variable and concluded that BOD5 would be better correlated as a function of COD and 
fluorescence to obtain more consistent results.   
A study by Hur et al. (2008) conducted on a river that was impacted with sewage 
discharge concluded that BOD5 could be correlated to absorbance at 254 nm, and three EEM 
peaks.  Three sample sites were included in the study that included sample sites both 
upstream and downstream from the plant.  It was shown that the strongest correlations were 
developed when the sites were combined.  The peaks could still be correlated for the 
upstream and downstream sites individually, but the relationship was weaker than when they 
were combined.  Table 2.13 summarizes the correlations; fluorescence was normalized to the 
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Raman peak.  Peak I corresponds to a 280-300 nm wavelength at Δλ=30 nm and peak A 
corresponds to a 285 nm wavelength at Δλ=60 nm. 
 
Table 2.13: BOD5 and Fluorescence Correlations adapted from Hur et al. (2008) 
  
Sample point Peak I Peak A UV254 
All 3 sample 
points BOD5=2.79x – 2.03 BOD5=6.52x + 2.93 BOD5=0.004x + 0.03 
Upstream of 
WWTP BOD5=1.67x + 1.80 BOD5=6.77x + 1.80 BOD5=0.001x + 0.16 
Downstream of 
WWTP BOD5=2.73x – 0.84 BOD5=6.21x + 8.20 BOD5=0.003x + 0.04 
 
Hudson et al. (2008) conducted a study that included 469 sample sites that included 
industrial effluent, surface waters, and pollution sites.  Corrections to the unfiltered samples 
were not made in the fluorescence analysis.  The correlations were strongest for the 
combined sample sites and weakened when surface water and effluent were considered 
independently, which is consistent with the finding of Hur et al. (2008).  The authors 
segregated the tryptophan peak into T1 (excitation=280 nm and emission=350 nm) and T2 
(excitation=225-237 nm and emission=340 – 380 nm).  It was determined that T1 had a 
higher correlation than T2, but they were both significant.  The fluorescence associated with 
peak T1 is believed to be related to microbial activity either because of the bioavailable 
substrate available or because it is the result of SMPs.  Their conclusions were that BOD5 
correlated well with fluorescence at an excitation of 280 nm and an emission of 350 nm, 
which was consistent with the findings of the aforementioned studies (Reynolds and Ahmad, 
1997; Ahmad and Reynolds, 1999; Baker and Invararity, 2004).   
An investigation of domestic wastewater was conducted using grab samples collected 
via manholes in a sewage system (Hur et al., 2010).  It was observed that BOD5 could be 
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estimated by 0.397*PLF+11.2.  A protein-like fluorescence (PLF) occurred between 250 and 
300 nm, with corresponding BOD5 values ranged from 5.2 to 208 mg/L.  A similar PLF peak 
occurred in domestic sewage influent samples collected from six wastewater treatment plants 
(Lai et al., 2011).  Tryptophan can be categorized as protein-like fluorescence; therefore, this 
study is consistent with previously mentioned studies.  Lai et al. (2011) observed that the 
PLF was reduced in effluent matter, indicative of biodegradable organic removal during the 
biological treatment at the wastewater facility.   
An early study (Comber et al., 1996) suggested that fluorescence could not be 
successfully correlated to BOD5 in sewage effluents and rivers.  That particular study was 
conducted at a fixed emission wavelength of 430 nm and two excitation wavelengths at 250 
nm and 350 nm.  Several studies have since contradicted these finding, with the general 
conclusion that BOD5 can be related to fluorescence at specific excitation/emission (i.e., 280 
nm and 350 nm) wavelengths associated with tryptophan (Reynolds and Ahmad, 1997; 
Ahmad and Reynolds, 1999; Baker and Invararity, 2004).  It can thus be concluded that 
relationships cannot be developed at arbitrary points on the EEM graph.   
All of the literature discussed until this point has reported peaks based on known 
protein, humic, and fulvic-like peaks (e.g., T peak, A peak, etc.) that were visually observed 
(Stedmon et al., 2003; Hur and Cho, 2012).  Stedmon et al. (2003) introduced the idea of 
using parallel factor analysis (PARAFAC) to characterize organic matter in surface water.  
This method is preferred because it mathematically interprets the multiple EEM data points, 
rather than by human interpretation.  Data are decomposed into trilinear components (i.e., 
three linear components that represent fluorescence, excitation, and emission wavelengths).  
The components are analyzed using statistical algorithms, which identify significant 
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components (e.g., EEM peaks associated with fluorescence of fluorophores). The reader is 
referred to Bro (1997), Stedmon et at. (2003), and Stedmon and Bro (2008) for more 
information regarding the principles of the PARAFAC model, which include a tutorial and a 
specific application to EEM fluorescence. 
A PARAFAC model was used to identify EEM peak components in surface water 
samples collected over three days.  Four of the components were related to previously 
identified humic-like peaks and one of the peaks was related to a tryptophan peak (Stedmon 
et al., 2003).  Stedmon and Markager (2005) expanded on this research by collecting surface 
water samples for a year and then creating a new PARAFAC model.  Eight components were 
identified in this research.  Four components had terrestrial origins, two components had 
anthropogenic origins, and two components had protein-like fractions.  Both of these studies 
showed that PARAFAC models are capable of discretely identify EEM peaks associated with 
organics from different origins. 
Several studies have followed that utilize PARAFAC for water characterization, 
water quality monitoring throughout the wastewater treatment plant, and as a means to 
determine removal efficiency (Miettinen et al., 2004; Wang et al., 2007; Singh et al., 2009; 
Yu et al., 2010; Yu et al., 2013; Cohen et al., 2014; Li et al., 2014).  Very few studies have 
implemented PARAFAC modeling to estimate BOD5.   
Hur and Cho (2012) used PARAFAC analysis to identify components in an urban 
river that is the receiving body for a wastewater treatment plant.  Sample were collected from 
eight locations along the river (BOD5< 25 mg/L) and filtered prior to analysis.  Sites that 
were close to the treatment plant had the highest BOD5 concentrations, which were reduced 
at sampling points downstream.  The authors visually identified three peaks on the EEM.  A 
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tryptophan-like peak (Ex=275 nm, Em=340 nm) was most prominent in sample sites near the 
treatment plant.  Peak A (Ex=250 nm, Em=400-450 nm) and Peak C (Ex=330-340 nm, 
Em=350-400 nm) were observed in all of the samples. Each of these peaks increased as 
organic pollution increased.  The PARAFAC model identified three components, which were 
consistent with the authors visual observations.  The components were identified as C1 
(Ex=250 nm, Em=405 nm), C2 (Ex=250 and 350 nm, Em=450 nm), and C3 (Ex=275 nm, 
Em=340 nm).  BOD5 could be correlated well to all three components, as well as absorbance 
at 220 nm and 254 nm.  The authors did not consider regression analysis with multiple 
components to estimate BOD5.   
A study (Yang et al., 2014) of 22 wastewater treatment plants in Korea concluded that 
PARAFAC models can be used to identify EEM peaks and estimate BOD5.  Humic-like, 
fulvic-like, and protein-like peaks were identified in the PARAFAC model.  The protein-like 
peak was the best parameter to estimate BOD5.  The correlation model was strengthened 
when suspended solids were included in the stepwise regression.  The study also concluded 
that protein-like organic matter is most readily removed in wastewater treatment plants, 
followed by fulvic-like organic matter.  Humic-like organic matter accumulated during the 
biological process, thus causing an increase to the humic fluorescence peaks.  
 This literature review on fluorescence has shown that BOD5 correlates well with 
protein-like peaks that are associated with tryptophan fluorescence.  Traditionally, peaks 
have been identified visually, but the use of PARAFAC modeling has been proven to be a 
useful tool that can identify these peaks through statistical algorithms.  Several studies have 
investigated the use of PARAFAC to characterize water quality, but only two studies were 
identified that used PARAFAC modeling to estimate BOD5.  The PARAFAC models were 
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used to identify humic-like, fulvic-like, and protein-like peaks in the EEM, which is 
consistent with visual observations previously made.  The protein-like peaks were shown to 
correlate well to BOD5, which was consistent with previous literature. The consistency 
between the visualization of peaks and those found by statistical algorithms may suggest that 
PARAFAC analysis is not always necessary.  It can be a useful tool when precision is 
needed, but visual observations may be sufficient.  Furthermore, PARAFAC can be a useful 
tool to identify peaks that are not visually obvious.  For the purposes of this research 
PARAFAC modeling was not used, because the literature has suggested that BOD5 correlates 
well to specific excitation and emission wavelengths.     
Alternate analytical methods, such as fluorescence regional integration (FRI), capture 
a range of excitation emission wavelengths that are associated with fluorescence peaks.  FRI 
is useful because it combines several peaks into a single value.  The advantage is that it is 
less information to process (e.g., five regions versus thousands of peaks).  It is important to 
realize that FRI represents fluorescence that is integrated over an area of excitation/emission 
wavelengths, whereas PARAFAC and visual observation identify fluorescence at specific 
excitation/emission wavelengths.  As such, these methods are not interchangeable, but rather 
represent the fluorescence peaks in different ways (i.e., at a single point or across a specified 
area).   
There is a deficit in the literature regarding the use of FRI and BOD5.  The idea was 
first introduced in 2003, but no studies were identified that used the regions as estimators for 
BOD5.  Chen et al. (2003) proposed that the EEM could be broken intro five regions 
represented by humic-like acids, fulvic-like acids, soluble-microbial-product-like, aromatic 
(tyrosine), and aromatics (BOD5).  The region proposed by Chen et al. (2003) were modified 
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for this research to better represent the observed peaks of the samples.  Region I of this 
research is associated with protein-like fluorescence.  Based on the previous literature that 
correlated BOD5 to protein-like fluorescence, it is hypothesized that BOD5 can be correlated 
to the FRI region associated with protein-like fluorescence (i.e., region I).  This hypothesis 
will be explored in this research. 
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Chapter 3 
METHODOLOGY 
Part A: Sample Collection 
3.1 Sample Source, Collection, and Labeling 
Samples used in this research were collected from an operating wastewater treatment 
plant (WWTP) located in Las Vegas, Nevada; the treatment train is depicted in Figure 3.1.  
The primary industry is tourism and the wastewater treated is purely domestic; there are no 
known industries contributing toxic wastes or hydrogen peroxide, which could interfere with 
the BOD5 method. The treatment plants discharge into the Las Vegas Wash, which 
eventually flows into Lake Mead, which is the primary drinking water source for the entire 
Las Vegas Valley. 
The three sample sites chosen for this research were the plant influent, primary 
clarifier effluent (hereafter referred to as “CABI”) and finished effluent (referred to as 
effluent),  (Figure 3.1).  
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Figure 3.1: Schematic diagram of the wastewater treatment facility used as sample source for this research showing the three sample 
points used.  
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 Samples were collected on Tuesdays, Wednesdays, Thursdays and Fridays from the 
middle of June 2014 through the end of September 2014 (Table 3.1 and Table 3.2). They 
were collected over a 24-hour period using a refrigerated compositor (Hach, Loveland, CO) 
and stored at 4 ± 1°C.  During the composite period, the samples were collected in a 5-liter 
polyethylene cubitainer. Influent and effluent samples were composited proportional to flow.  
CABI samples were composited with time using a set volume aliquot.  Generally, the 
composite samples were collected from approximately 7AM to 7AM.  Sample labeling 
throughout this research refers to the date at the end of the composite time.  If a sample was 
collected from 7AM July 1st to 7AM July 2nd, then the sample was labeled as July 2nd.   
3.2   Sample Handling 
 Immediately following the composite period, the samples were transported in ice 
coolers to the onsite laboratory facility.  The samples were immediately divided into their 
respective containers (Table 3.3) upon arriving at the laboratory.  TOC samples were 
transferred to a 125 mL polypropylene bottle and preserved with hydrochloric acid at pH=2. 
TOC analysis was typically conducted the same day that the sample was collected; otherwise, 
the sample was analyzed the following day.  Samples can be preserved for the COD test by 
acidification, but this was not done at any point during data collection because samples were 
analyzed within five hours.   
 When BOD5 analysis was conducted the same day, approximately 500 mL of influent 
sample was transferred to a single amber glassware container.  Similarly, approximately 500 
mL of CABI sample was transferred to a single amber glassware container.  The sample was 
analyzed for the COD, BOD5, and fluorescence the same day as collection. Approximately 
300 mL of effluent sample was transferred to an amber glassware container; this sample was 
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used for COD and fluorescence analysis.  Approximately 1-liter of effluent sample was 
transferred to a polyethylene cubitainer and used for BOD5 analysis.   
When BOD5 analysis was conducted the following day, samples were transferred into 
two separate containers, one sample was used for BOD5 analysis the following day and the 
other sample was used for COD and fluorescence analysis.  Approximately 250 mL of 
influent sample was refrigerated overnight and used for BOD5 analysis the following day.  
Approximately 250 mL of influent sample was transferred into a separate amber glassware 
container and analyzed for COD and fluorescence the same day as collection.  CABI samples 
were handled the same way as influent samples.  Approximately 300 mL of effluent sample 
was transferred to an amber glassware container and analyzed for COD and fluorescence the 
same day that the sample was collected.  Approximately 1-liter of effluent sample was 
transferred to a polyethylene cubitainer, refrigerated, and analyzed the following day for 
BOD5.  
When samples could not be analyzed immediately, they were refrigerated at 4 ± 1°C 
until analysis could be conducted.  Table 3.3 summarizes the time frame within which that 
analysis typically occurred.  All samples and reagents were brought to room temperature 
prior to analysis, including water samples, standards, dilution water, and sample seeds.  
The amber glassware (BOD5, COD, and fluorescence) and polypropylene containers 
(TOC) used to store the samples were cleaned by thoroughly rinsing with hot water a 
minimum of six times, and then it was given three rinses using deionized water.  The bottles 
were stored upside down with their lid off. 
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Table 3.1: Collection Dates for Correlation Data and BOD5 Group Holding Time Data 
Correlation Samples a, b Comparative Samples a, b 
BOD5 samples analyzed the same day 
(Samples used for correlation and for 
the BOD5 grouped holding time 
comparison) 
BOD5 samples held overnight and 
analyzed the following day 
(Samples used for BOD5 grouped 
holding time comparison) 
6/25/14 6/24/14 
6/27/14 6/26/14 
7/2/14 7/1/14 
7/3/14 7/8/14 
7/9/14 7/10/14 
7/11/14 7/15/14 
7/16/14 7/17/14 
7/18/14 7/22/14 
7/23/14 7/24/14 
7/25/14 7/29/14 
7/30/14 7/31/14 
8/1/14 8/5/14 
8/6/14 8/7/14 
8/8/14 8/12/14 
8/13/14 8/14/14 
8/15/14 8/19/14 
8/20/14 8/21/14 
8/22/14 8/26/14 
8/27/14 8/28/14 
8/29/14 9/2/14 
9/3/14 9/4/14 
9/5/14 - 
9/9/14 - 
9/11/14 - 
9/16/14 - 
aCOD, fluorescence, and absorbance were analyzed the same day 
bTOC was typically analyzed the same day (else the following day)
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Table 3.2: Summary of Sample Holding Times for BOD, TOC, COD, and Fluorescence Analysis 
Sample schedule for holding tests 
Date 
Holding test  
Samples were analyzed 
the same day, 
refrigerated overnight, 
and then reanalyzed 
the following day 
Comments 
Test conducted on sample 
Included in 
correlation? BOD COD TOC Fluorescence 
9/9/14 Day 1 BOD Day 2 GGA failed, 
so trial omitted 
✓ ✓ ✓ ✓ ✓ 
9/10/14 Day 2 BOD ✓ ✕ ✕ ✕ ✕ 
9/11/14 Day 1 BOD Trial A BOD hold 
test 
✓ ✓ ✓ ✓ ✓ 
9/12/14 Day 2 BOD ✓ ✕ ✕ ✕ ✕ 
9/16/14 Day 1 BOD Trial B BOD hold 
test 
✓ ✓ ✓ ✓ ✓ 
9/17/14 Day 2 BOD ✓ ✕ ✕ ✕ ✕ 
9/30/14 Day 1 COD Trial A COD hold 
test 
✕ ✓ ✕ ✕ ✕ 
10/1/14 Day 2 COD ✕ ✓ ✕ ✕ ✕ 
10/1/14 Day 1 COD Trial B COD hold 
test 
✕ ✓ ✕ ✕ ✕ 
10/2/14 Day 2 COD ✕ ✓ ✕ ✕ ✕ 
10/6/14 Day 1 Fluorescence Trial A fluorescence 
hold test 
✕ ✕ ✕ ✓ ✕ 
10/7/14 Day 2 Fluorescence ✕ ✕ ✕ ✓ ✕ 
10/8/14 Day 1 Fluorescence Trial B fluorescence 
hold test 
✕ ✕ ✕ ✓ ✕ 
10/9/14 Day 2 Fluorescence ✕ ✕ ✕ ✓ ✕ 	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Table 3.3: Summary of Sample Handling Techniques for TOC, COD, BOD5, and Fluorescence Analysis of Wastewater Samples 	  
Test Method Storage 
Container  
Typical time frame 
that analysis was 
completed 
Chemical 
preservation 
available  
Additional test information 
TOC 125 mL 
polypropylene 
container for all 
samples 
Typically the same day 
sample received, else 
the next day.    
Yes Samples were immediately 
preserved with HCl once they 
were received in the lab.    
COD Amber glassware 
for all samples. 
Same day, usually 
between 9AM and 12 
PM 
Yes Samples were not chemically 
preserved for this research.   
BOD Amber glassware 
for influent and 
CABI samples. 
Polyethylene 
cubitainer for 
effluent.   
The BOD analysis was 
typically performed 
between 10 AM and 2 
PM 
No Samples were analyzed either 
the same day or the following 
day, as summarized in Table 
3.1.   
Fluorescence Amber glassware 
for all samples. 
Same day, usually 
between 12 PM and 
4PM 
No Sample analyzed the same day 
it was collected. 
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3.3 Sample Holding Schedule  
Correlation data:  
 The sampling dates for the correlation data are summarized in Table 3.1 and Table 
3.2.  Samples that were analyzed the same day for BOD5, COD, and fluorescence as 
collection were included in the correlation analysis.  Effluent BOD5 samples that were held 
overnight were also included in the correlation data, because they were shown not to be 
statistically different than the samples analyzed the same day.  These results are presented 
and discussed in the Chapter 4 Results.  All TOC data was included in the correlation, 
regardless of the analysis timeframe because the samples were preserved.   
BOD5 grouped data: 
 Two groups of BOD5 data were collected during the summer.  The first group of data 
were collected and analyzed the same day they were collected.  These are labeled in Table 
3.1 as the correlation data. The second group of data, labeled as the comparative data in 
Table 3.1, is independent of the first group.  Samples used for comparison were collected and 
then refrigerated with headspace overnight.  A BOD5 analysis was performed on the samples 
the day following collection. 
Holding test data: 
 Samples were collected and analyzed the same day that they were collected.  The 
same samples were held overnight and then reanalyzed the following day.  The results of the 
first day were compared with the results obtained the following day to determine if they were 
statistically different from one another.  Holding tests were conducted on samples for BOD5, 
COD, and fluorescence, as summarized in Table 3.2.  	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3.4 Sample Replicates 
  The BOD replicate schedule is shown is Table 3.4.  It was not possible to have 
multiple dilutions of the effluent sample due to the sample volume required to conduct the 
analysis.   
 
Table 3.4: BOD Sample Replicate Schedule 
BOD sample replicate schedule 
Tuesday 
3 Influent dilutions + 2 replicates of middle dilution 
3 CABI dilutions 
2 to 3 Effluent dilutions 
Wednesday  
3 Influent dilutions 
3 CABI dilutions + 2 replicates of middle dilution 
2 to 3 Effluent dilutions 
Thursday 
3 Influent dilutions + 2 replicates of middle dilution 
3 CABI dilutions 
2 to 3 Effluent dilutions 
Friday 
3 Influent dilutions 
3 CABI dilutions + 2 replicates of middle dilution 
2 to 3 Effluent dilutions 
 
 For the COD test, either the CABI or effluent sample was tested in triplicate each 
analysis day, based on a rotation schedule.  The influent sample was always tested in 
triplicate due to the high standard deviation that was observed with this sample.    
 One sample site (influent, CABI, or effluent) was analyzed in triplicate each day the 
fluorescence test was performed, based on a rotation schedule.   
 Samples for the TOC test were not analyzed in triplicate, but several other QA/QC 
controls were implemented in the analysis, as discussed in later in this thesis under the TOC 
methodology.   
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Part B: Methods 
3.5 BOD5 Methodology 
(Adapted from the Standard Methods (2005)) 
 The BOD5 was determined by diluting the sample and incubating it for five-days.  
The BOD5 is calculated based on the initial and final dissolved oxygen readings.  Seed blank 
samples, glucose glutamic acid (GGA) samples, and dilution water blank samples were also 
prepared with each analysis to validate the test results.  For more information regarding 
background of this method, the importance of the additional samples, and a discussion on the 
interpretations of the results, refer to Chapter 2 Literature Review.   
Wheaton (Millville, NJ) 300 mL glass BOD bottles with glass pennyhead stoppers 
were used for this research.  Polyethylene BOD bottle caps were used to prevent evaporation 
during the incubation period.   
The dissolved oxygen (DO) reading was performed using an LDO (luminescent 
dissolved oxygen) probe.  The specific probe used for this research was the YSI Pro O DO 
probe (Yellow Springs, OH).  When not in use, the probe was stored in a BOD bottle to 
prevent it from becoming damaged.  Daily probe calibration was not necessary (as per the 
instruction manual).  If alternate probe technologies are used, such as a membrane electrode 
probe, then daily calibration may be necessary to eliminate drift (Standard Methods, 2005).   
3.5.1 Quality Control/Quality Assurance 
The dilution water blank was used to ensure that the water being used in the test 
procedure was free from, microorgansisms, organics and metals that can interfere with test 
procedure and also to verify the cleanliness of the incubation bottles. Glucose glutamic acid 
(GGA) was used to ensure the seed was effective and ensure proper technique.  
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Samples that met the minimum depletion requirements were reported and were 
verified to be within 30% of one another were reported.  As discussed in the Chapter 2 
literature review, samples must have a residual dissolved oxygen above 1 mg/L to ensure 
there was enough oxygen available during the incubation period.  Additionally, the samples 
had to deplete a minimum of 2 mg/L to ensure that the results were meaningful. 
3.5.2 Sample Preservation 
 When samples could not be analyzed immediately, they were stored at 4 ± 1°C.   
3.5.3 Interferences 
 Nitrogenous demand can interfere with the test, unless an inhibitor is used. 
Uninhibited BOD5 is required on the NPDES permit; therefore, inhibitors were not used in 
this research.  As discussed in the literature review, uninhibited BOD5 is the sum of the 
carbonaceous (demand from biodegradable organic matter) and the nitrogenous demand 
(demand from ammonium).  Iron and sulfur compounds can also interfere with the test, but 
inhibitors or corrections are not available to adjust for these.  Additional interferences can 
occur due to dirty glassware, poor dilution water, inadequate seed source, and poor 
technique.    
3.5.4 Dilution Water Source 
 Treated tap water, using a pre-filter, a carbon filter, an RO system, and a polishing 
treatment, was used for dilution water for this study, as illustrated in Figure 3.2.  Raw tap 
water has a chlorine residual, and it contains organics and bacteria that will interfere with the 
BOD5 test.  The carbon tank and pre-filter carbon filtration remove chlorine and provide 
preliminary filtration.  After the pretreatment, the water goes through an Elix 70 (Darmstadt, 
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Germany) reverse osmosis (RO) process that produces water quality that has <10 cfu/mL of 
bacteria, >99.9% silicate removal, and >5 MΩ-cm resistivity.  After the water leaves the RO 
system, it goes through two ion exchange columns that further reduce the ion concentration, 
resulting in water that has a resistivity of approximately 18.2 MΩ-cm.   
 The water is then sent into a large storage tank fitted with ultraviolet (UV) 
disinfection and recirculating pipes designed to keep the water flowing until it is ready to use.  
The UV prevents bacteria regrowth, and the flow of water prevents water from becoming 
stagnant.  
Before the water is used as a dilution water source for the BOD5 test, it is passed 
through a polishing water treatment system (Milli-Q Advantage A10 water purification 
system, Darmstadt, Germany).  The system consists of four cartridges: the first is an 
activated carbon filter, the second and third contain deionizing ion-exchange resins, and the 
fourth is a cartridge containing ion exchange designed to remove organic compounds.  The 
water spigot in this system contains a 0.22-µm membrane filter to further remove 
microorganisms before it is dispensed.    
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Figure 3.2: BOD dilution water treatment system. 	  
3.5.5 Dilution Water Preparation   
 The dilution water was collected in a 10-liter polyethylene jug and placed into the 
BOD incubator overnight.  The water jug was removed from the incubator the following day, 
and a premixed Hach (Loveland, CO) BOD nutrient buffer pillow was added. The buffer 
pillows are composed of ammonium chloride, calcium chloride, ferric chloride, potassium 
phosphate monobasic, demineralized water, sodium phosphate dibasic, magnesium sulfate, 
and potassium phosphate dibasic.  The buffer pillow was added to the dilution water, and 
then the jug was shook for several minutes to thoroughly mix the buffer pillow into the 
water.   
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 Two dilution water blanks were incubated for five days to verify that the water did 
not consume more than 0.2 mg/L of dissolved oxygen, as per Standard Methods (2005) 
requirements.  In cases where the dilution water consumed more than 0.2 mg/L of oxygen, 
the data were reported, but it was not included in the statistical analysis.   
3.5.6 Glucose Glutamic Acid 
 A commercially available glucose glutamic acid (GGA) manufactured by North 
Central Laboratory (Birnamwood, WI) was used for this research. The GGA standard is 
designed for a BOD5 of 198 ± 30.5 mg/L, as per Standard Methods (2005) specifications.  
The GGA is used to control the strength of the seed and as a quality control to ensure the 
cleanliness of the glassware and analytical technique.   
As per the manufacturer’s directions, the GGA sample was prepared with 6 mL of the 
GGA standard and seeded in a 300 mL BOD bottle.  The volume of seed added was the 
equivalent to the volume of seed used for the samples. 
The GGA standard was refrigerated between uses at 4 ± 1°C.  Prior to the BOD test, 
the GGA standard was brought to room temperature. 
3.5.7 Seed Preparation 
The sample seed was prepared with primary influent from the WWTP.  The primary 
seed sample was refrigerated at 4 ± 1°C overnight.  The supernatant was poured off the 
following day and used as the seed source.  The seed was brought to room temperature prior 
to the BOD test.   
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3.5.8 Sample Pretreatment 
According to the Standard Methods (2005), the pH should be adjusted using sulfuric 
acid or sodium hydroxide to values between 6-8.  For this research, the pH was verified on 
the day of the BOD test.  Each sample fell within this range, so pH adjustments were not 
necessary.   
 Chlorine is not added during the treatment process; therefore, a residual is not 
expected in any of the samples.  Potassium iodide was used to verify that chlorine was not 
present in the sample.    
 Influent wastewater to this particular WWTP does not contain any toxic metals or 
hydrogen peroxide; therefore, adjustments were not necessary to accommodate these 
interferences.   
3.5.9 Cleaning Procedure 
The dilution water jug was cleaned with three hot water rinses and then three 
deionized water rinses immediately before it was filled with dilution water.     
All containers used for seed or sample storage were rinsed with a minimum of six hot 
water rinses and then three deionized water rinses.  Volumetric containers were rinsed with 
hot tap water after each use.    
BOD bottles, bottle stoppers, and plastic covers were cleaned using a commercial 
dishwasher (Miele, Auborn Hills, MI) with a disinfection cycle.  Dishwasher detergent 
(Miele, Auborn Hills, MI) was added to the dishwasher as well.  After the dishwasher cycle, 
the bottle stoppers were rinsed with deionized water.  Each BOD bottle was rinsed with 
deionized water three times, and then the stoppers and plastic caps were immediately placed 
on the bottle to prevent contamination. 
	  	   86	  
The DO and pH probes were rinsed with deionized water prior to taking the reading.   
3.5.10 Standard Operating Procedure for the BOD5 test 
Preparation the day immediately preceding the BOD test 
1) A polyethylene jug was filled with approximately 7 liters of dilution water.  The dilution 
water was stored in the incubator (20 ± 1°C) overnight with the lid lightly screwed on to 
allow the water to degas.   
2) The sample seed was prepared by obtaining a sample of primary influent.  The influent 
sample was stored in the refrigerator overnight at 4 ± 1°C.  
Preparation the day of the BOD test 
1) All of the samples were brought to room temperature.   
2) The GGA was removed from the refrigerator and brought to room temperature.   
3) The seed source was prepared.  The primary influent sample was removed from the 
refrigerator and the supernatant was poured off the sample into a separate container. The 
supernatant was brought to room temperature and used as the seed source.   
4) The dilution water was prepared.  The Hach buffer pillow was thoroughly mixed before 
adding it to the dilution water. The dilution water was removed from incubator and the 
Hach nutrient buffer pillow was added.  The dilution water was mixed for approximately 2 
to 3 minutes to ensure the pillow was thoroughly mixed also to release excess dissolved 
oxygen.   
 Note: The dilution water should be at 20 ± 3°C and the initial dissolved oxygen reading of 
the dilution water should be between 7.5 and 9 mg/L.  Adjustments to the temperature 
were made when necessary.   
5) Calibration of the DO probe and pH probe were verified and adjusted when necessary.   
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BOD test procedure      
 The test procedure is outlined in Figure 3.3 and the sample/seed volumes used in this 
research are given in Table 3.5.  The effluent volumes were occasionally modified due to 
limited sample availability; the seed sample remained at 2 mL throughout the data collection.  
The influent and CABI sample dilutions were not modified.  The actual sample volumes used 
during the experiment are appropriately labeled in the data sheets.    
 
Table 3.5: BOD5 Sample Volumes for GGA, Seeds, Influent, CABI, and Effluent 
Sample Sample Volume Seed volume Dilution Water 
Blank duplicate A & B 0 mL 0 mL 
Fill to middle of 
bottleneck of 300 
mL BOD bottle 
 
GGA duplicate A & B 6 mL 2 mL 
Seed dilution 1 0 mL 3 mL 
Seed dilution 2 0 mL 5 mL 
Seed dilution 3 0 mL 7 mL 
Seed dilution 4 0 mL 10 mL 
Influent dilution 1 2 mL 0 mL 
Influent dilution 2 3 mL 0 mL 
Influent dilution 3 5 mL 0 mL 
CABI dilution 1 3 mL 0 mL 
CABI dilution 2 5 mL 0 mL 
CABI dilution 3 10 mL 0 mL 
Effluent dilution 1 100 mL 2 mL 
Effluent dilution 2 150 mL 2 mL 
Effluent dilution 3 200 mL 2 mL 
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Figure 3.3: Flowchart for the BOD5 test setup.  Table 3.5 provides the sample and seed 
volumes used in this experiment.  Refer to the important guidance section for additional 
information on sample preparation. 	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Important Guidance for the BOD Test Procedure 
 The following tips were implemented during sample preparation to improve the 
quality of the test results by minimizing errors associated with elapsed time, air bubbles, and 
overall poor technique.   
ü One sample bottle was prepared at a time.  The initial DO reading was taken 
immediately, and then the bottle was placed in the incubator right away.  After the bottle 
was placed in the incubator, then the next sample was prepared.  This was repeated until 
all of the samples were prepared and placed in the incubator.   
ü After the incubation period, BOD bottles were removed in the same order that they were 
prepared.  One bottle was removed and the final DO reading was taken.  This was 
repeated until all of the final readings were recorded.   
ü The BOD bottles were filled to the top with dilution water.  There is not an exact 
specified volume of water that should be added to the BOD bottle; the rule of thumb 
adopted in this research was to fill the bottle up to the middle of the bottleneck.  This 
gives some room for the DO probe to be inserted, but the bottle was full enough to 
prevent air bubbles from being trapped.   
ü BOD bottles were filled with dilution water in a way that avoided entraining air.  Bottles 
were slowly filled and the dilution water was poured such that it flowed down the inside 
of the bottle.     
ü Entrapment of air bubbles was avoided during DO readings and also after the bottle 
stopper was placed into the bottle.   
ü The DO probe was rinsed prior to each reading to prevent cross contamination. 
ü The bottle stopper was placed gently to avoid displacing additional sample.  
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Figure 3.1: Flowchart of the BOD5 calculation procedure adapted from Standard Methods (2005). 
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3.5.11 Calculation Procedure 
 Figure 3.4 provides a flowchart for the calculation procedure.  
Definition of “Qualified Samples” 
 Samples that met the minimum qualification criteria, as defined by the Standard 
Methods (2005), were used in this research.  Qualified samples are samples that deplete a 
minimum of 2 mg/L and have a final dissolved oxygen reading greater than 1 mg/L.  Refer to 
the Literature Review for additional information regarding qualified samples.   
Sample Check:   
            DOFinal ≥ 1 mg/L                                                          Eqn. 3.1 
  DO!"#$#%& − DO!"#$% ≥ 2!"!                                                                                                                                                               Eqn. 3.2 
 
1) It was verified that the dilution water did not deplete more than 0.20 mg/L.  If the water 
has a demand greater than 0.20 mg/L, then the BOD results cannot be used because the 
water is exerting a demand and can cause inaccurate results (Standard Methods, 2005). 
Dilution Water Check:   
 DO!"#$#%& − DO!"#$% ≤ 0.20!"!                                                                                                                                                   Eqn. 3.3 
2) The average seed strength of the qualified samples was calculated using the ratio method. 
It was also verified that the largest and smallest seed strengths were within 30% of one 
another.   
      DO!"#$#%& − DO!"#$%Volume  of  seed = Seed  strength   mgLmL                                                                                       Eqn. 3.4 
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3) The BOD5 of the GGA was calculated and verified to be 198±30.5 mg/L.  The average 
seed strength calculated in Step 2 was used for the seed strength.  If the GGA did not meet 
the criteria, then seeded samples were not reported.  
  DO!"#$#%& − DO!"#$% − Seed  Strength ∗ Volume  seedVolume  of  GGAVolume  of  BOD  bottle = BOD!                        Eqn. 3.5 
4) The BOD5 of the qualified samples was calculated and averaged.  The highest and lowest 
BOD5 values were verified to be within 30% of one another.   
                                        DO!"#$#%& − DO!"#$% − Seed  Strength ∗ Volume  seedVolume  of  sampleVolume  of  BOD  bottle = BOD!                            Eqn. 3.6 
Notice that the unseeded samples do not have a volume of seed added; the unseeded BOD5 
equation can be reduced to:  
   DO!"#$#%& − DO!"#$%   Volume  of  sampleVolume  of  BOD  bottle = BOD!   Unseeded  sample                                                             Eqn. 3.7 
 
3.6 COD Methodology 
 (Adapted from the Hach Wastewater and Biosolids Analysis Manual) 
 The COD method was performed using Hach (Loveland, CO) chemistries.  The Hach 
method was adapted from the Standard Method’s closed reflux colorimetric method. The 
principles of both the closed reflux method and the Hach method are provided in the Chapter 
2 literature review.   
Specifically the low range COD chemistry (0 – 150 mg/L) was used for plant effluent 
and the high range COD chemistry (0 – 1,500 mg/L) was used for plant influent and CABI.  
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These test chemistries were determined based on preliminary COD testing using different 
COD range kits.   
3.6.1 Quality Control/Quality Assurance 
A 500 mg/L COD standard was prepared to check the accuracy of the test.  The 
standard was prepared by dissolving 0.425 g of dried potassium hydrogen phthalate (KHP) in 
1,000 mL of deionized water, as per Hach instructions.  KHP is used to develop the 
calibration curves of the spectrophotometer; therefore, it is also used as the standard control 
to verify the equipment is operating correctly.   
A standard control ampule was prepared with each batch of samples and verified to 
be between 90 – 110% of the true value.  The 500 mg/L standard was used with the high 
range COD test.  The prepared 500 mg/L standard was diluted to 50 mg/L to check the 
accuracy of the low range COD test.  Both of the standards were stored in the refrigerator at 
4 ± 1°C between uses.   
New blank samples were prepared approximately once a week or after pipettor 
calibration adjustments were made; the blank was stored in the dark.  The calibration of the 
pipettor was periodically verified using an analytical balance.   
3.6.2 Sample Preservation 
 Samples can be preserved by acidification to pH ≤ 2 and stored up to 28 days.  During 
this research, samples were not preserved.  This includes samples that were held overnight 
for the holding time test.   
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3.6.3 Sample Interferences 
 Interference related to chloride, bromide, iodide, and other contaminants was 
discussed in Chapter 2 literature review.  Additional interference can happen when the acid 
etches the COD vials, which will affect the spectrophotometer readings; this is overcome by 
rinsing the sample with deionized water and drying it prior to digesting the sample.  Skewed 
test results can occur in samples with large particulate content.  The Hach method specifies to 
blend the sample prior to testing, but this step was omitted because it is not the common 
practice at the laboratory facility at the WWTP studied.  Pipettors with small openings can 
occlude particulate, so a wide mouthed pipettor tip for influent and CABI samples was used 
in this research.   
3.6.4 Standard Operating Procedure for the COD test  
1) All of the samples and control standards were bought to room temperature. 
2) The Hach DRB200 digestion block was preheated to 150°C.   
3) Samples were homogenized by thoroughly mixing the sample (note: samples were not 
blended).    
4) A volume of 2 mL (based on Hach directions) of sample was pipetted into the appropriate 
Hach ampule. The vial lid was closed tightly and inverted several times to mix the 
contents of the vial.  
  Note: The high range Hach method was used for the influent and CABI samples.  
  Note: The low range Hach method was used for the effluent samples.   
Note: A blank and control vial were prepared for each Hach range used.   
5) The vial was rinsed with deionized water and dried to prevent acid etching on the vial 
during the digestion period.   
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6) The vials were placed into the Hach DRB200 digestion block, the shield was closed, and 
the samples were digested for 2 hours.   
7) After the samples cooled, the vials were removed from the digester, inverted several times, 
placed into a rack, and stored in a dark drawer until they reached room temperature.  The 
samples were stored in a dark drawer to avoid light interference.    
8) After the samples reached room temperature, the COD was measured with the Hach 
DR2700 spectrophotometer (Program 430 for the low range COD test and Program 435 
for the high range COD test). Each of the vials was wiped (Kimtech, Roswell, GA) to 
remove fingerprints, smudges, etc.  The instrument was zeroed with the appropriate blank 
vial, and then the COD reading of each of the samples (including the controls) was taken 
using the spectrophotometer.    
3.7 TOC Methodology  
(Adapted from the Standard Methods) 
 The high temperature combustion method was used to convert the organics to CO2, 
and a non-dispersive infrared (NDIR) gas analyzer measured the CO2.  A Shimadzu TOC-V 
Auto Analyzer with TNM-1 (Honshu, Japan) with a 50 µL volume injector was used to 
determine the nonpurgeable organic carbon (NPOC) in the range of 1 – 50 mg/L; greater 
concentrations were determined by dilution.  The sample was acidified, homogenized, 
sparged and diluted (if necessary) to remove the carbonates and bicarbonates from the 
sample.  The sample was then sent through a combustion tube with a platinum catalyst and 
heated to 680°C to combust the samples and covert the organic matter to CO2.  The sample 
then flowed (150 mL/min) through a dehumidifier, a halogen scrubber, and then to the 
NDIR, which measured the CO2 with a detection signal.  The TOC – Control V Software 
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interprets the peak area of the NDIR detection signal to a final NDOC value that the user can 
understand.   
3.7.1 Quality Control/Quality Assurance 
 The 0.06% hydrochloric acid solution used to prepare the controls was prepared by 
diluting 10 mL of 6N hydrochloric acid into reagent water in a 1-liter volumetric flask.  The 
reagent water is the same water that was used for the BOD dilution water source.  The 0.06% 
HCl reagent was prepared daily.   
Equipment Calibration 
The equipment was calibrated every three months, when significant changes were 
made, or when calibration samples failed.  A linear curve that was not forced through the 
origin was used.  The correlation coefficient had to be ≥ 0.995; the equipment is capable of a 
correlation coefficient up to 0.9999.  The validity of the calibration curve was based on the 
correlation coefficient (≥ 0.995), the Y intercept (it should not be too far from the origin or 
results may be biased), the quality control standards (initial calibration sample and 
continuing calibration verification sample), and by visual inspection.  The TOC standard 
solution was prepared by dissolving 2.128 grams of potassium hydrogen phthalate into the 
0.06% HCl reagent in a 1-liter volumetric flask. The TOC standard was diluted in 0.06% HCl 
to the following TOC concentrations: 1.0 mg/L, 2.5 mg/L, 5.0 mg/L, 10.0 mg/L, 25.0 mg/L, 
and 50 mg/L.  The calibration curve was developed using a minimum of five standard 
dilutions and a blank to determine the quantitation range.   
 The initial calibration verification (ICV) sample was analyzed after the initial 
calibration and at the beginning of the day. This sample had to be within 10% of the true 
value for the results to be valid.  If issues occurred, the equipment was recalibrated.  The ICV 
	  	   97	  
was prepared with a different stock source than the one used for the calibration; the standard 
was prepared by dissolving 2.128 grams of anhydrous potassium hydrogen phthalate into the 
0.06% HCl reagent in a 1-liter volumetric flask on a weekly basis.   
 The initial calibration blank (ICB) was analyzed immediately following the ICV 
sample.  This sample had to be below the minimum detectable limit for the results to be 
valid.  The ICB is an aliquot of reagent water that was used to verify the equipment was free 
from contamination after the equipment was calibrated.   
Controls 
A lab fortified blank (LFB) was analyzed every 20 or fewer samples.  The TOC 
standard was diluted to the desired concentration (20 mg/L) with the 0.06% HCl reagent to 
be used as the TOC spike.  The LFB sample was prepared by diluting the TOC spike with 
reagent water.  The LFB sample was valid if it had a recovery within 10% of its true value.     
 A method blank was prepared and analyzed after each LFB.  This sample was an 
aliquot of reagent water and treated the same as a sample including being exposed to all 
glassware, equipment, solvents, reagents, internal standards, and surrogates used with other 
standards.  The sample was valid if it was less than the reporting limit.   
Continuing Calibration Controls 
 A continuing calibration verification (CCV) sample was analyzed between each 
group of 10 injecting samples.  This standard was prepared by diluting the TOC stock 
standard with 0.06% HCl to the midpoint of the calibration curve.  This sample had to be 
within 10% of the true value to verify that the equipment was maintaining its calibration.   
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 A continuing calibration blank (CCB) was analyzed after the CCV sample to verify 
that the equipment was not contaminated.  This sample was reagent water and the results 
were valid if the results were less than the reporting limit.   
Matrix Spike Sample 
A matrix spike sample was analyzed every 20 or less field samples.  The TOC 
standard was diluted to the desired concentration (20 mg/L) with the 0.06% HCl reagent to 
be used as the TOC spike.  A matrix spike sample was prepared by spiking a field sample 
with the TOC spike.  The concentration of the TOC spike was determined in a separate 
aliquot.  The matrix spike sample was then corrected for the known amount of TOC spike.  
The spiked sample should have a recovery within 20% for the results to be valid.  This 
process was repeated for every sample matrix.  The purpose of this control is to determine if 
the sample matrix is contributing bias to the results.   
3.7.2 Interferences 
Contamination in the glassware, reagents, reagent water, and other items can impact 
the TOC results.  The reagent water used in this analysis was the same source water that was 
used as the dilution water for the BOD5 test.  Samples that have large particulate (>0.45-µm) 
can clog and damage the instruments and flow system; samples were filtered through a 1.2-
micron filter to minimize this interference.  Halogens can cause interference as well; a 
halogen scrubber was used to prevent this interference.  Interference due to inorganic 
(carbonate and bicarbonate) compounds was minimized by acidifying the sample and 
sparging.  It should be noted that this process could potentially remove some of the purgeable 
organic compounds and bias the results low.   
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3.7.3 Sample Preservation 
The samples were collected in a clear polyethylene container during the composite 
period, and then transferred to a clear 125 mL polypropylene container and acidified with 
hydrochloric acid (HCl).  
3.7.4 Standard Operating Procedure for the TOC analysis 
Sample preparation  
1) The sample was filtered through a 1.2-micron filter.   
2) The pH of the sample was adjusted using HCl drops until the pH was below 2.   
3) The sample was then homogenized by inverting the sample several times.    
4) When it was necessary, the homogenized sample was diluted with the 0.06% HCl reagent.  
Dilution is necessary for final TOC values greater than the upper limit of the calibration 
curve (i.e. 50 mg/L).   
Sample analysis 
The proper method (either TOC and high level total nitrogen or TOC and low level 
nitrogen) was chosen.  The samples were analyzed in in the following order using the TOC 
analyzer.  The TOC software provided the results, given in mg/L.   
a) Initial calibration verification (ICV) 
b) Initial calibration blank (ICB) 
c) Laboratory fortified blank (LFB) 
d) Method Blank (MB) 
e) Reporting limiting standard (RL) 
f) 9 injecting samples + matrix sample  
g) Continuing calibration verification (CCV) 
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h) Continuing calibration blank (CCB) 
i) Up to 10 injecting samples 
j) CCV  
k) CCB  
l) Repeat steps i) through k) until all samples have been analyzed.  
3.8 Fluorescence Methodology  
 The fluorescence test was conducted using a Horiba AquaLog® (Edison, NJ) 
spectrofluorometer and calculations were executed in Matlab.  The instrument was warmed 
up for at least 20 minutes to allow the xenon lamp to stabilize prior to use.  The settings 
provided in the standard operating procedure reflect the input settings to the Horiba software. 
The software provided with the equipment automatically subtracts the blanks from the 
samples, and it is capable of making the inner filter effect corrections and the Rayleigh 
corrections.   
 The corrected data were exported from the Horiba software and imported into 
MatLab to perform the calculations; the calculation procedure is discussed after the standard 
operating procedure.   
 Samples were filtered using 0.7-micron glass microfiber GF/F syringe filters with 
polypropylene housing (Whatman, Pittsburg, PA).  A 10-mm path length Spectrosil® 
rectangular quartz cell (Starna Cells, Inc., Atascadero, CA) was used in the fluorometer.   
3.8.1 Quality Control/Quality Assurance   
Samples were transferred to amber glassware to minimize light interference.  The 
equipment was given a minimum of 20 minutes to allow the lamp to warm up.  New blank 
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and Raman samples were analyzed each day of analysis.  Approximately 20 mL of sample 
was purged through the syringe filters to minimize leaching interference.   
It was observed that when new gloves were used, the variance between the triplicate 
samples was reduced.  Therefore, it was necessary to change gloves between every sample to 
prevent cross contamination from other samples, clothing, and the lab area.   
3.8.2 Interferences 
Filters can either adsorb or desorb organic materials into the sample, which will affect the 
results; a minimum of 20 mL of sample was purged and disposed of to minimize leaching 
interference.  The lamp used in the equipment can become aged and also impact the results; 
the manufacturer offers recommendations on the frequency required to change the bulbs.  
The cuvettes were visually inspected prior to each use to verify that there was no damage, 
such as chips or scratches that could impact the analysis.  Suspended materials can impact the 
test results by either scattering or absorbing light; samples were filtered prior to analysis to 
minimize interference.  Changing gloves prior to each sample analysis reduced interference 
from cross contamination.  Light scattering and reabsorbance can occur during the test 
procedure, as discussed in the Literature Review; Raman, inner filter effect, and Rayleigh 
corrections were performed during the analysis to minimize the interference.   
3.8.3 Standard Operating Procedure for the Fluorescence Test 
1) The fluorometer turned on for at least 20 minutes to allow the xenon lamp to stabilize 
before analysis was conducted.    
2) All samples were brought to room temperature.   
3) Three Raman measurements were performed on the same sample.   
 a) The cuvette was rinsed with deionized water three times. 
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 b) The cuvette was filled with deionized water and wiped with a Kimtech (Roswell, GA) 
to removed fingerprints, smudges, etc. 
 c) Three Raman measurements were taken at a 350 nm excitation wavelength, using the 
settings in Table 3.6.   
 
Table 3.6: Fluorescence Raman Settings 
Raman settings 
Integration  3 seconds 
Accumulations 1 
Excitation wavelength park 350 nm 
Excitation wavelength increment  0.82 nm (2 pixels) 
CCD gain speed Medium 
 
4) A blank sample was analyzed for each analysis event. 
 a) The sample that was used for the Raman measurements was also used for the blank 
measurement.   
 b) The blank measurement was taken with the settings that are summarized in Table 3.7.  
 
Table 3.7: Fluorescence Settings for Blank, Influent, CABI, and Effluent Samples 
Sample settings 
Integration  3 seconds 
Accumulations 1 
Excitation range 
High = 470 nm 
Low= 240 nm 
Increments = 1 nm 
Excitation wavelength increment  0.82 nm (2 pixels) 
CCD gain speed Medium 
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5) Each of the samples was prepared for fluorescence analysis.      
a) The sample was homogenized by inverting the sample several times, and then a 50 mL 
aliquot was drawn with a syringe.   
b) A 0.7-micron filter was placed onto the syringe.   
c) Approximately 20 mL of sample was purged through the filter and disposed of to 
minimize organic leaching from the filter.   
6) Each of the samples was analyzed for fluorescence.     
 a) The cuvette was rinsed three times with deionized water. 
 b) The cuvette was then rinsed three times with the filtered sample.     
 c) The cuvette was filled with filtered sample.     
 d) The fluorescence of the sample was determined using the settings that are summarized 
in Table 3.7.  
7) Sample corrections were performed using the AquaLog® software.   
Note: The Horiba AquaLog® software corrects for blanks, dark offsets, emission 
corrections, and excitation corrections automatically.   
a) An inner filter effect (IFE) correction was made to each sample. 
b) A Rayleigh correction with an offset of 10 nm in each direction was made to each 
sample.   
3.8.4 Fluorescence Calculations 
 Matlab was used to perform Raman corrections and fluorescence regional integration 
(FRI) based on techniques that were introduced by Chen et al. (2003).  The fluorescence data 
was normalized to the average of three Raman peaks areas at a 350 nm excitation wavelength 
to allow for direct comparisons with data from other instruments or laboratories.     
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 Figure 3.5 illustrates the EEM regions that were adopted for this research.  The units 
for the regions are reported in arbitrary fluorescence units (AFU).  A series of calculations 
were performed to determine the fluorescence of each region.  The projected area is 
calculated with the excitation and emission axis.   
Fractional  projected  area   =    Projected  area  of  region  (nm!)All  projected  region  areas (nm!)                               Eqn. 3.8 MF! =    (Fractional  projected  area)!!                                                                                                                                    Eqn. 3.9     Φ!"#$%& = Fluorescence  in  region                                                                                                                              Eqn. 3.10 Total  fluorescence  of  region   AFU = MF!Φ!"#$%&                                                                                                        Eqn. 3.11 Total  fluorescence   AFU = MF!Φ!"#$%&                                                                                                         Eqn. 3.12 
 
 
Figure 3.5: EEM regions defined for this research.   
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Part C: Calculation Methodology 
3.9 Correlations 
3.9.1 Data Pairing Methods 
Bivariate data can be paired either based on their means or the data can be paired 
based on the replicate samples (Mutulsky and Christpoulos, 2003).  BOD5 data and COD data 
were collected in uneven replicates.  The BOD5 replicates were paired with the average of the 
COD replicates for their respective sample days. Similarly, fluorescence data were collected 
in uneven replicates.  The average fluorescence was paired with the each BOD5 replicate.  
BOD5 data were collected in replicates, but the TOC data were not. The BOD5 replicates 
were paired with the actual TOC value.   
3.9.2 Correlations 
 All correlations data were analyzed in R statistical software (R Core Team, 2013).  
Least square regression was used to independently correlate BOD5 to several parameters 
including COD, TOC, absorbance, fluorescence at specific excitation/emission wavelengths, 
and fluorescence of integrated regions.  The data were correlated using linear regression and 
the correlation coefficient was used to determine the goodness of fit.  The assumed normality 
of the data was checked using the Shapiro-Wilk test.  It was determined that none of the data 
were normally distributed.   
 Due to the violations of the normality assumption, robust linear and nonlinear 
regressions were implemented.  Robust regression methods use an iterative reweighted least 
squares method to estimate the model.  These models are not as susceptible to outliers and 
heteroscedastic data.  Heteroscedasticity refers to the horizontal spread of data. Ideally, the 
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scatterplot of the residual versus fitted value plot will not have heteroscedastic trends or 
curves; rather, the scatterplot should be random and show no pattern (Navidi, 2011).  The 
pseudo correlation coefficient was determined by creating a linear model between the true 
BOD5 value and the fitted BOD5 value of the model.   
 When multiple models were developed, they were compared based on the pseudo 
correlation coefficient, the residual standard error of the model, and the visual observation of 
the fit of the data.  Robust linear models were fitted using the “rlm” function and nonlinear 
regression lines were fitted using the “nlrob” function in R statistical software.  
3.10 Removal Efficiency  
 The removal efficiency was calculated for the primary clarifier, biological treatment 
(i.e., the aeration basin), and the overall treatment train.  The three removal efficiency 
datasets were treated independent from one another.  Bootstrapping was used to create a 
dataset of 1,000 random bootstrapped samples, which were chosen with replacement from 
the original dataset.  The mean and standard deviations of the bootstrap samples were used to 
construct the 95% confidence interval.   
 
Removal  efficiency = Input− OutputInput x100%                                                                                    Eqn. 3.13 
Removal  primary  clarifier = Influent− CABIInfluent x100%                                                      Eqn. 3.14 
Removal  aeration  basin = CABI− EffluentCABI x100%                                                              Eqn. 3.15 Removal  enitre  treatment  plant = Influent− EffluentInfluent x100%                    Eqn. 3.16 
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 95%  CI = X± 1.96 ∗ SD                                                                                                                                                                  Eqn. 3.17 
Method Development 
3.11 Two-Sample t-tests For Holding Tests 
 R statistical software (R Core Team, 2013) was used to conduct the t-test, which was 
used to compare the means of the samples for the holding tests.  The test was conducted at a 
95% confidence interval, and it was assumed that the samples had unequal variance and that 
the samples were normally distributed.  The null hypothesis was that the means were the 
same, and the alternate hypothesis was that the means differed.  When the null hypothesis 
was rejected, it could be interpreted that the means were different and thus holding time had 
an effect.  When the null hypothesis was not rejected, it was interpreted that it was plausible 
that the means were the same.  Notice that it is only possible to say that it is plausible that the 
means are the same, but it is not the same as saying that it is true that the means are the same.   
3.12 Fluorescence Integration Times 
The fluorescence integration times were compared using the two-sample t-test 
discussed in the previous section.  The normalized standard deviations were also used to 
compare the results of the integration times.  The normalized standard deviation was 
calculated by dividing the standard deviation by the mean.  
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CHAPTER 4 
 
RESULTS 
4.1 Important Terminology 
 The removal of organics with an activated sludge system was discussed in Chapter 2 
Literature Review, and a schematic of the treatment train was presented in Chapter 3 
Methodology.  This section is intended to clarify the terminology used throughout this 
chapter.  As shown in Figure 3.1 (Methodology Chapter), the treatment process is primary 
clarifier à aeration basin à secondary clarifier à tertiary treatment (filtration/disinfection) 
à treated effluent.  
 The terms influent, raw sewage, and sewage refers to the wastewater that is entering 
the wastewater treatment plant (WWTP).  The terms primary effluent and CABI are used 
interchangeably to describe the water that is leaving the primary clarifier and entering the 
aeration basin.  Secondary effluent refers to the water that is leaving the secondary clarifier.  
The terms effluent and treated effluent are used to describe the water that has passed through 
the entire treatment train and is being discharged into the environment.   
 Sludge refers to the settled solids from both of the clarifiers.  The sludge is sent to 
solids handling, where the liquid is removed from the solids.  The liquid, referred to as 
centrate, is sent back to the primary clarifiers. The centrate is highly concentrated with 
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organic matter and suspended solids.  The return of centrate to the primary clarifier causes an 
increase in organic matter loading in the primary clarifier (Tchobanoglous et al., 2003).  
Part A: Correlation Results  
4.2 Correlations Developed with Sample Site as an Independent Variable 
The following discussion includes correlations that were developed as a function of the 
alternate test procedure (Eqn. 4.1), as well as correlations that were developed as a function 
of the alternate test procedure and the sample site (Eqn. 4.2).  Eqn. 4.1 is straightforward and 
easily interpreted.  Eqn. 4.2 is unique to this research; this section is intended to clarify how 
the model was developed and explain how the subsequent regression models were derived 
for each sample site. BOD! =   β! Alternate  Method +   β!                                                                                                                                                            Eqn. 4.1   BOD! =   β! Alternate  Method +   β! Sample  Site! …+ β! Sample  Site!                 Eqn. 4.2 
 Consider a generic model developed with the independent variables COD, influent, 
CABI, and effluent (Eqn. 4.3).  In the actual model, one of the independent variables will 
become a coefficient; the CABI sample site typically became the coefficient in this research 
(Eqn. 4.4), but this may not always be the case.   BOD! =   β!(COD)+   β! Influent + β! CABI + β! Effluent                                                                   Eqn. 4.3 BOD! =   β!(COD)+   β! Influent + β! + β! Effluent                                                                                               Eqn. 4.4 
 BOD5 (mg/L) is estimated by entering the value for COD (mg/L), entering the value 1 
(unitless) for the sample site which COD is known, and entering the value 0 for all other 
sample sites.  For example, influent BOD5 can be estimated from Eqn. 4.4 as shown in Eqn. 
4.4a; the reduced form of the equation is shown in Eqn 4.4b.   
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Influent  BOD! =   β!(COD)+   β! 1 + β! + β! 0                                                                                                       Eqn. 4.4a Influent  BOD! =   β!(COD)+   (β! + β!)                                                                                                                                            Eqn. 4.4b 
Similarly, effluent BOD5 can be determined from Eqn. 4.4, as shown in Eqn. 4.4c and 
Eqn. 4.4d.  CABI BOD5 is determined from Eqn. 4.4 by entering 0 for influent and effluent 
(Eqn. 4.4e and Eqn. 4.4f).   Effluent  BOD! =   β!(COD)+   β! 0 + β! + β! 1                                                                                                       Eqn. 4.4c Effluent  BOD! =   β!(COD)+   (β! + β!)                                                                                                                                          Eqn. 4.4d CABI  BOD! = β!(COD)+   β! 0 + β! + β! 0                                                                                                                     Eqn. 4.4e CABI  BOD! = β!(COD)+ β!                                                                                                                                                                                        Eqn. 4.4f 
The regression model is valid for the range of COD values which the model was 
developed, based on the specific sample site.  Another limitation to this type of model is that 
the slope is the same for each of the sample sites considered in the model, but the intercept is 
different.  The literature has shown that biodegradable organic matter is selectively removed 
during the treatment process, which will cause the ratio of BOD5 to other methods to change 
as treatment progresses.  This type of regression model assumes that the ratio is the same 
(i.e., the same slope) throughout the treatment process.   
Despite these limitations, the models were developed and they are discussed 
throughout this chapter.  Models were developed that considered influent and CABI sample 
sites, as well as influent, CABI, and effluent sample sites.  These models were developed to 
determine if considering sample site as an independent variable resulted in a better-fit model, 
compared with a regression model that considered the data at these sample sites, but did not 
consider sample site as an independent variable in the model (i.e., Eqn. 4.1).     
 111 
4.3 BOD5 and COD Correlations 
 Figure 4.1 is a plot of the COD and BOD5 data that were used for the correlations; 
Figure 4.2 and Figure 4.3 summarize the regression models developed for the data, and Table 
4.1 summarizes the regression equations represented in the figures.  It is clear that the values 
obtained are clustered by sampling location.  Figure 4.1 shows that the influent data points 
tend to be more spread out, and then they become more tightly clustered as treatment 
progresses.  The quality of the plant influent is uncontrolled, but the quality of the water as 
treatment progresses becomes more consistent, because treatment is engineered to generate a 
certain organic removal level.   
Correlation coefficients were determined for each of the sample sites individually, for 
CABI and influent, and for all three of the sample sites combined, as summarized in Table 
4.1.  Due to the clustering of data, linear correlations were poor for influent (r2= 0.03) and 
CABI (r2= 0.15), but effluent correlated well when it was considered independently (r2= 
0.77).  When influent and CABI are combined, the correlation coefficient (r2= 0.73) is 
respectable, and it further increases when effluent is included in the correlation (r2=0.92).   
Initially, the data were analyzed using a traditional least squares model, which 
assumes that the data are normally distributed.  The Shapiro-Wilk test for normality indicated 
that the data violated this assumption, so a robust regression analysis was used that does not 
assume that the data are normally distributed.  From Table 4.1, one can see that the residual 
square errors were reduced when the robust regression was used in lieu of the least squares 
regression, with the exception of effluent, which slightly increased.  The r2 value reported for 
the robust models were determined by plotting the actual BOD5 value to the (robust) fitted 
BOD5 value.  
  
112 
 
Figure 4.1: Plot of BOD5 and COD data points used in correlation for influent, CABI, and effluent sample sites. 
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Figure 4.2: Regression lines for BOD5 and COD correlations that were developed with influent and CABI sample sites as an 
independent variable (Table 4.1 Eqn. III).  The model can be broken into two regression lines that represent influent (Table 4.1 Eqn. 
IIIa) and CABI (Table 4.1 Eqn. IIIb).     
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Figure 4.3: Regression lines for BOD5 and COD correlations; the models do not consider sample site as an independent variable.  The 
regression model that was developed using influent and CABI data (Table 4.2 Eqn. II) is represented by the red line on the graph.  The 
model that considers influent, CABI, and effluent data (Table 4.1 Eqn. IV) is represented by the orange line.  A visual comparison of 
the two trend lines indicates that the models are similar with respect to influent and CABI data.  The effluent regression model (Table 
4.1 Eqn. I) was developed independent of influent and CABI.    
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Table 4.1: Summary of BOD5 and COD Correlations for Influent, CABI, and Effluent Samples 
Reference 
Equation  
Sample 
site(s) 
included 
in 
correlation 
 
r2 
Least 
squares 
Shapiro-
Wilk 
normality 
test p value 
(p<0.05 
indicates 
non normal) 
Least 
squares 
residual 
standard 
error 
Robust linear model 
Robust 
model 
residual 
standard 
error 
r2 
Robust 
- Influent 0.03 - - -  - - 
- CABI 0.15 - - -  - - 
Eqn. I Effluent 0.77 0.0241 1.713 
3BOD5 = 0.49*COD-7.78 
(Graph shown in Figure 4.3) 1.931 0.77 
Eqn. II Influent + CABI 0.73 1.01E-08 55.75 
4BOD5 = 0.52*COD + 5.09 
(Graph shown in Figure 4.3) 41.17 0.73 
Eqn. III 
1Influent + 
CABI  - - - 
BOD5 = 0.18*COD + (119.84* 
Influent) + 136.01 35.87 0.76 
Eqn. IIIa 
Eqn. IIIb 
Derived equations from Eqn. III 
(Graph shown in Figure 4.2)  
BOD5 Influent = 0.18*COD + 255.85 
BOD5 CABI=0.18*COD + 136.01 
- - 
Eqn. IV 
Influent + 
CABI + 
Effluent 
0.92 2.73E-16 44.98 BOD5 = 0.55*COD  - 7.79 (Graph shown in Figure 4.3) 20.16 0.92 
Eqn. V 
2Influent + 
CABI + 
Effluent 
- - - 
BOD5 = 0.20*COD + 
(110.87*Influent)  -  (127.73* 
Effluent) + 129.02 
16.21 0.93 
Eqn. Va 
Eqn. Vb 
Eqn. Vc 
Derived equations from Eqn. V 
 (Graph not shown) 
BOD5 Influent = 0.20*COD + 239.89 
BOD5 CABI = 0.20*COD + 129.02 
BOD5 Effluent = 0.20*COD + 1.29 
- - 
1Influent and CABI sample sites were considered as independent variables in the regression model 
2Influent, CABI, and effluent sample sites were considered as independent variables in the regression model 
3Final recommendation for best fit regression model for effluent 
4Final recommendation for best fit regression model for influent and CABI 
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Table 4.2: Results for COD to BOD5 Ratios for Influent, CABI, and Effluent Samples 
COD/BOD5 Ratio Influent CABI Effluent 
Minimum  1.12 1.33 2.37 
Average ± SD1 1.88 ± 0.37 1.93 ± 0.27 4.77 ± 1.57 
Maximum 2.83 2.76 8.67 
1Standard deviation 
 
One model was developed that considered COD, influent, and CABI as components 
in the model, and another model was developed that considered COD, influent, CABI, and 
effluent as components in the model.  These models had similar slopes and intercepts; the 
model that was developed as a function of influent and CABI was plotted, (Figure 4.2) but 
the other model was not.  Although the models are similar, the correlation coefficient of the 
model that considers all three of the sample sites (r2 = 0.93) is higher than the model that only 
considers influent and CABI (r2 = 0.76).  It appears that effluent is increasing the correlation 
coefficient, which can mislead someone into believing that this model is a better fit for 
influent and CABI, even though the regression models are similar in terms of slope and 
coefficients.  Figure 4.2 shows that the models that include sample site as part of the 
regression model are decent indicators of BOD5 for CABI, but they underestimate influent 
BOD5.  As such, this model is not ideal. 
Models were also created that only consider COD as the independent variable; they 
did not consider sample site as part of the regression equation.  One of the models considers 
influent and CABI sample sites together (r2 = 0.73) and the other considers influent, CABI, 
and effluent sample sites together (r2 =0.92).  Both of the regression models are plotted in 
Figure 4.3.  From the figure, it is clear that both of the models are quite similar for influent 
and CABI.  The model that considers all three of the sample sites has a higher correlation 
coefficient and lower residual square error, which can be attributed to the effluent sample 
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being considered as part of the regression equation.  Despite the better statistical parameters 
associated with model, all three sample sites should not be considered as part of the model, 
primarily due to the changing ratio that occurs as treatment progresses.  Table 4.2 shows that 
the average ratio between influent (1.88±0.37) and CABI (1.93±0.27) is nearly the same, but 
the ratio increases after biological treatment (4.77±1.57).  Because the ratios are similar for 
influent and CABI, it indicates that the relationship is linear between the two sample sites 
and they can be combined.  Furthermore, effluent correlates well when it is considered 
independent of the other sites (Table 4.1 and Figure 4.3), so it is not necessary to combine the 
sample site to strengthen the correlation.   
Table 4.2 shows that the ratio between COD and BOD5 increases as treatment 
progresses.  Colloidal organic matter is removed during primary treatment, and dissolved 
biodegradable organic matter is removed in the aeration basins. Recall that the BOD5 test 
quantifies the portion of biodegradable organic matter that microorganisms consume during 
the five-day incubation period, but the COD test quantifies all of the biodegradable organic 
matter as well as some inorganics and recalcitrant organic matter.  As such, the COD and 
BOD5 will decrease at different rates through the train because conventional wastewater 
treatment, specifically the activated sludge process, selectively removes the biodegradable 
fraction.  The influent ratio ranged from 1.33 to 2.76 (average=1.93), which is consistent 
with the findings of other researchers that reported influent ratios of 2.412 (Aziz and Tebbutt, 
1979), 1.1 to 2.4 (Dazae, 1974), 1.85 (Eckenfelder and Ford, 1970) and 1.25 to 3.33 
(Tchobanoglous et al., 2003).  The ratio at CABI ranged from 1.33 to 2.76 (average=1.93), 
which is also consistent with previous literature that reported a ratio of 1.412 (Aziz and 
Tebbutt, 1979) and 1.67 to 2.5 (Tchobanoglous et al., 2003).  The ratio for treated effluent 
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was between 2.27 and 8.67 (average=4.77).  The most similar ratio identified in the literature 
for effluent was a range of 3.33 to 10 for COD to carbonaceous BOD (i.e., the BOD demand 
due to biodegradable organic matter) (Tchobanoglous et al., 2003), which is consistent with 
this research.  Although nitrifying inhibitors (i.e., demand due to ammonia) were not used in 
this research, it is assumed that the BOD during the first five days can be attributed to 
carbonaceous demand because nitrifying bacteria are not yet active; therefore, the ratios of 
this research can be compared with the ratios reported by Tchobanoglous et al. (2003).   
The literature focused primarily on correlations developed for specific sample sites.  
Several researchers were able to correlate BOD with COD in influent wastewater (Rowe, 
1968; Aziz and Tebbutt, 1979; Dubber and Gray, 2010; Abyaneh, 2014), which was 
inconsistent with the findings of this research (when influent was considered independently), 
presumably due to the variability of COD and BOD5 influent data that was observed. 
It was possible to develop linear regression models for treated effluent in this 
research, which was consistent with the research of Jin et al. (2009), but inconsistent with 
other literature (Aziz and Tebbutt, 1979; Jin et al., 2009 Dubber and Gray, 2010).  Jin et al. 
(2009) were able to correlate polluted seawater (BOD5> 3mg/L), but they were not able to 
correlate relatively clean seawater (BOD5< 3mg/L); the researchers were unable to conclude 
why there was a difference in the relationships, although it may be attributed to the detection 
limits of the BOD5 test.  Dubber and Gray (2010) were unable to correlate the treated effluent 
of 11 combined WWTPs, which they attributed to the variability in treatments processes and 
the differing operational conditions.  
The regression models developed in this research indicate that BOD5 can be correlated 
to COD, which is consistent with the literature.  Also consistent with the literature is the 
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change in ratios observed as treatment progressed.  The changes in ratios are an important 
indicator that correlations are better when made at site-specific locations, rather than across 
the entire treatment train, which is consistent with the conclusions of Aziz and Tebbutt 
(1979).  Influent and CABI had similar ratios in this research, but the ratio drastically 
changes after aeration basin treatment.  It can be concluded that the influent and CABI model 
is the best surrogate for influent and CABI samples because they have similar ratios, and the 
independent effluent model is the best surrogate for the effluent samples.  The linear model 
that combined the sample sites had the best correlation coefficient, but it is not recommended 
due to the ratio change from CABI to effluent.   
4.4 BOD5 and TOC Correlation 
 The data for the BOD5 and TOC correlations were not normally distributed; therefore, 
robust regression was performed to develop the models, similar to the COD models 
developed in the previous section.  Figure 4.4 summarizes the data, Figure 4.5 summarizes 
the regression lines, and Table 4.3 summarizes the models and their respective correlation 
coefficients.  It is clear that influent and CABI do not correlate well when they are 
considered individually.  When influent and CABI are combined, the correlation coefficient 
(r2=0.11) is still insignificant; therefore, it is not a good model.  Finished effluent (r2=0.87) 
correlates well when it is considered independently.  When all three of the sample sites are 
combined (r2=0.75), it appears that the effluent sample data are significantly contributing to 
the improved correlation.  As shown in Figure 4.5, the model overestimates BOD5 for CABI 
samples and underestimates the BOD5 for influent samples.  
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Figure 4.4: Plot of BOD5 and TOC data points used in correlation for influent, CABI, and effluent sample sites.   
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Figure 4.5: Plot of BOD5 and TOC regression models for influent, CABI, and effluent sample sites.  The influent, CABI, and effluent 
model (Table 4.3 Eqn. II) considered that data points at each of these samples sites, but sample site was not considered an independent 
variable in the model.   From the graph, the model underestimates influent and overestimates CABI BOD5.  The effluent regression 
model was developed considering only the effluent data points (Table 4.3 Eqn. I) and appears to be a good estimator for effluent 
BOD5.   
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Table 4.3: Summary of BOD5 and TOC Correlations for Influent, CABI, and Effluent Sample Sites 
Reference 
Equation 
Sample 
site(s) 
included 
in 
correlation 
 
r2 
Least 
squares 
Shapiro 
Wilks 
normality 
test p value 
(p<0.05 
indicates 
non normal) 
Least 
squares 
residual 
standard 
error 
Robust model 
Robust 
model 
residual 
standard 
error 
r2 
Robust 
- Influent 0.06 - - -  - - 
- CABI 0.03 - -  - - - 
 
Eqn. I Effluent 0.87 5.90E-08 1.237 
2BOD5 = 2.25*TOC - 12.07 
(Graph shown in Fig 4.5) 0.8721 0.87 
- Influent + CABI 0.11 - - - - - 
Eqn. II 
Influent + 
CABI + 
Effluent 
0.75 2.85E-15 79.54 BOD5 = 4.41*TOC - 31.71 (Graph shown in Fig 4.5) 27.92 0.75 
Eqn. III 
1Influent + 
CABI + 
Effluent 
- - - 
BOD5= -1.11*TOC + (193.75 
*Influent)  - (258.93*Effluent) 
+275.45 
(Graph not shown) 
42.82 0.93 
1Influent, CABI, and effluent sample sites were considered as an independent variable in the regression model 
2Final recommendation for best fit regression model for effluent 
No final recommendations for best fit regression model influent or CABI 
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A model was also developed that considered all three of the sample sites as 
independent variables in the regression model.  The model is shown in Table 4.3 (Eqn. III), 
but it was not plotted.  The slope of the model is -1.11, which indicates that BOD5 is 
decreasing when TOC is increasing. This is inconsistent with the physical relationship 
between TOC and BOD5; therefore, this is not a practical model.   
Viraghaven (1976) and Aziz and Tebbutt (1979) reported insignificant correlations 
for domestic wastewater influent samples, which is consistent with the findings in this 
research. Despite these findings, other researchers have successfully developed influent 
correlations (Chandler et al., 1976; Constable and McBean, 1979; Dubber and Gray, 2010).  
Dubber and Gray (2010) developed their correlations using influent samples from eleven 
WWTPs in Ireland that received wastewater from domestic and industrial sources.  Chandler 
et al. (1976) developed a correlation for domestic wastewater influent from five municipal 
WWTPs combined and a correlation for the domestic wastewater influent from a single 
municipal WWTP.  These two studies are notably different from this research because 
influent from one treatment facility was used in this research.  The data collected in this 
study was clustered, which is indicative of consistent influent wastewater and a reliable 
treatment process.  It may be possible that the success of the other researchers was because 
they were able to create a larger spread of data (i.e., no clustering) by collecting samples 
form a series of WWTPs and thus they could develop site-specific correlations.  This type of 
correlation may not be reasonable though, because the treatment efficiencies of the WWTPSs 
can differ, thus creating differences in the ratios among the different facilities, which will 
lead to different linear regressions for each of the treatment plants.  Constable and McBean 
(1979) developed their regression model using domestic wastewater influent collected over a 
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two-day sampling period from a single WWTP, but they also concluded that the model did 
not adequately predict BOD5 outside of the sampling period for which the model was 
developed; therefore, the model was of little practical use.   
Despite the failures of the influent and CABI correlations, effluent proved to correlate 
rather well in this research.  This is consistent with the findings of Chandler et al. (1976) who 
were able to correlate effluent for one WWTP and a combination of five WWTPs, but 
inconsistent to the findings of Dubber and Gray (2010) who could not develop correlations 
for eleven combined WWTP effluents.  Constable and McBean (1979) developed a 
statistically significant effluent regression model, but the model was not useful because it 
could not predict BOD5 outside of the sampling period for which the model was developed; 
this is consistent with their conclusions made for their influent regression model.   
Interestingly, Schaffer et al. (1965) were able to correlate BOD5 to TOC by 
combining influent, secondary effluent (CABI), and effluent samples sites for domestic 
wastewater collected from a WWTP similar to this research.  A similar model was developed 
in this research, but it was not a good predictor.  Their sampling techniques were different 
from the methods adopted in this research, most notably the sampling period, which may be 
attributed to the inconsistencies in the results of the studies.  Schaffer et al. (1965) collected 
grab samples by hand every 15 minutes over an eight-hour composite period for four 
consecutive days.  The samples were refrigerated overnight and then analyzed the following 
day. Samples collected in this research were mechanically sampled proportional to flow and 
analyzed the day that they were collected over a period of four months.  The short sampling 
duration of Schaffer et al. (1965) is major limitation to their work, particularly because large 
variations cannot be observed in such a short time frame.  Possibly, these researchers may 
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not have developed significant correlations had the sampling campaign been extended over 
several months.    
 
Table 4.4:  Results for BOD5 to TOC Ratios for Influent, CABI, and Effluent Sample Sites 
BOD5/TOC ratio Influent CABI Effluent 
Minimum  3.19 2.22 0.44 
Average ± SD1 5.82 ± 1.54  3.40 ± 0.51 0.84 ± 0.26 
Maximum 9.46 4.78 1.76 
1Standard deviation 
 
Table 4.4 summarizes the ratios between BOD5 and TOC found in this research.  
Reported ratios of BOD5/TOC have been 1.44 (Aziz and Tebbutt, 1979), 2.0 (Chandler et al., 
1976), and 1.2 to 2.0 (Tchobanoglous et al., 2003) for domestic wastewater influent.  The 
BOD5/TOC ratio of influent in this research ranged from 3.19 to 9.46, with an average ratio 
of 5.82±1.54, indicating a higher influent biodegradable organic content than what has been 
reported in the literature.  The range of BOD5 values (216 to 611 mg/L) observed in this 
research were much higher than those reported by Aziz and Tebbutt (1979), which ranged 
from 136 to 231 mg/L.  The TOC values in this research ranged from 54 to 90 mg/L, which 
was less than the TOC values reported by Aziz and Tebbutt (1979), which ranged from 95 to 
163 mg/L.  The ratio reported by Viraraghavan (1976) was based on the stoichiometric 
relationship, not actual wastewater samples, and the ratio range reported by Tchobanoglous 
et al. (2003) was based on values from various municipal wastewater treatment facilities.  
The discrepancies between the BOD5/TOC of this research and the stoichiometric ratio are 
unclear.  Figure 4.4 shows that the relationship between BOD5 and TOC is highly variable 
for the influent, which could be an indication that TOC and BOD5 become less related as 
BOD5 increases.  Indeed, both of these methods quantify different types of organic matter.  It 
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may be possible that as the BOD5 increases, the TOC analysis does not quantify the increased 
biodegradable organic matter, particularly if the increase in organics is associated with the 
volatile organics removed during the acidification/sparging process in the TOC analysis.   
This would also explain why there is a difference in the ratios between this research and Aziz 
and Tebbutt (1979). 
The ratio of CABI decreases relative to the influent sample.  The average ratio 
reported in this research (3.40±0.51) was higher than the range (0.8 to 1.2) reported by 
Tchobanoglous et al. (2003), but the relative change in the ratio from influent to CABI was 
similar (i.e., the ratio decreases by approximately the same percentage).  The decrease in the 
BOD5/TOC ratio from influent to CABI is impacted by two things.  First, organic matter is 
selectively removed from the primary clarifier, which will change the ratio.  Second, the 
WWTP in this research has a return flow of centrate into the primary clarifier, which 
increases the organic loading and suspended solids.  The characterization of BOD5 and TOC 
of centrate is unknown; however, it is known that TOC has a negative removal in the primary 
clarifier, whereas BOD5 does not have a negative removal (this will be discussed later in the 
thesis).  Based on this information it can be concluded that organics are removed by primary 
clarification, but organics also increase due to the return flow of centrate.  A mass balance of 
the primary clarifier and information regarding the characterization of the return flows would 
be necessary to fully understand the impacts on the BOD5/TOC ratio.  The data collected in 
this research show that the ratio decreases, which is indicative that either biodegradable 
organic matter is removed during primary sedimentation, TOC is increased during primary 
sedimentation due to return flows, or a combination of both.  It is believed that both 
mechanisms are occurring and contributing to the change in the ratio.   
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The average ratio between BOD5/TOC in the effluent (0.84±0.26) decreased from 
CABI (3.40±0.51), and it is significantly less than the influent ratio (5.82±1.54).  Aziz and 
Tebbutt (1979), Dubber and Gray (2010), Ford (1968), Tchobanoglous et al. (2003) also 
reported that the BOD5/TOC ratio decreased from primary influent to treated effluent.  The 
decrease in the ratio is attributed to the removal of biodegradable organic matter and the 
accumulation of recalcitrant organic matter (Aziz and Tebbutt, 1979; Dubber and Gray, 
2010). 
The data and ratios suggest that the ratio between TOC and BOD5 is changing as 
treatment progresses.  This conclusion is important because it signifies that correlations 
should be developed independently at each sample site (Chandler et al., 1976; Aziz and 
Tebbutt, 1979; Dubber and Gray, 2010).  Most of the literature attempted to correlate data 
using a linear model.  Babatola and Xu (2010) used a power function to fit their model, 
which may be a better approach when trying to combine several sample sites, due to the 
change in ratio. The data in this research was fitted using a linear model when all of the 
sample sites are combined, but it is not a good predictor for CABI or influent BOD5.  
Nonlinear regression models were also explored in this research, but these did not provide a 
good fit for the data; therefore, they were not reported. The linear model developed for 
effluent was the only correlation that could be developed between TOC and BOD5.  This 
model appears to be a good predictor, and may be useful for permit compliance.  
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4.5 BOD5 and Fluorescence Results 
Figure 4.6 illustrates the regions and peaks that were adopted for this research.  These 
were presented and discussed previously in the literature review, but the figure is provided 
here to provide clarification for the following discussion.  Figures 4.7 to 4.15 are the results 
of BOD5 and each of the fluorescence parameters (i.e., total, region I, region II, region III, 
protein peak, humic peak, peak A, peak C, and peak T).  Table 4.5 summarizes the non-
robust linear correlation coefficients for each of the parameters, and Figure 4.16 provides a 
ranking of the correlation coefficients.   
 
 
Figure 4.6: Fluorescence regions and peaks adapted for this research.   
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Figure 4.7: Results of BOD5 and total fluorescence for influent, CABI, and effluent. 
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Figure 4.8: Results of BOD5 and region I fluorescence influent, CABI, and effluent.   
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Figure 4.9: Results of BOD5 and region II fluorescence for influent, CABI, and effluent. 
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Figure 4.10: Results of BOD5 and region III fluorescence influent, CABI, and effluent. 
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Figure 4.11: Results of BOD5 and protein peak fluorescence influent, CABI, and effluent.   
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Figure 4.12: Results of BOD5 and humic peak fluorescence influent, CABI, and effluent.   
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Figure 4.13: Results of BOD5 and peak A fluorescence for influent, CABI, and effluent.   
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Figure 4.14: Results of BOD5 and peak C fluorescence for influent, CABI, and effluent.   
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Figure 4.15: Results of BOD5 and peak T fluorescence for influent, CABI, and effluent.   
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Table 4.5: Correlation Coefficients for Non-robust Linear Models for Each of the 
Fluorescence Parameters and Regions for Each Sample Site 
BOD~	   Influent	   CABI	   Effluent	  
Influent	  +	  
CABI	  
Influent	  +	  CABI	  +	  
Effluent	  
Total	   0.0139	   0.0069	   0.1111	   0.2953	   0.7915	  
Region	  I	   0.0132	   0.0113	   0.0758	   0.3208	   0.7971	  
Region	  II	   0.0072	   0.0016	   0.1354	   0.0608	   0.7303	  
Region	  III	   0.0354	   0.0002	   0.068	   0.5331	   0.8618	  
Proteins	   0.0118	   0.0209	   0.0262	   0.4314	   0.8261	  
Humic	   0.0014	   0.0015	   0.0655	   0.6489	   0.8946	  
Peak	  A	   0.0019	   0.0097	   0.0492	   0.0355	   0.7128	  
Peak	  C	   0.0642	   0.0015	   0.092	   0.5699	   0.8764	  
Peak	  T	   0.0068	   0.0144	   0.0192	   0.4322	   0.8234	  
 
 
 
Figure 4.16: Ranking of the correlation coefficients for each of the fluorescence parameters 
and regions in descending order. 
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4.5.1 Observed Fluorescence IFE and the Impact on the Results 
Figures 4.7 to 4.15 indicate that the trend is not linear; therefore, nonlinear 
regressions were used to correlate BOD5 to the fluorescence regions. The literature suggested 
that the relationship between BOD5 and fluorescence data were linear, which is contradictory 
to the results obtained in this research.  There are two possible explanations for the result 
deviations.  The first explanation is that the fluorometer reached the maximum fluorescence 
detection limit.  Inspection of the raw uncorrected fluorescence data indicated that the data 
were not likely surpassing the detector limit; therefore, this was determined an unlikely 
cause.  The second explanation for the nonlinear trend in data is due to inner filter effects 
(IFE).  As discussed in the literature review, IFE occurs in samples that have high 
fluorescence and it is characteristic of samples that have high absorbance.  The excitation 
wavelength is absorbed primarily on the front face of the sample, which inhibits the energy 
from penetrating through to the remainder of the sample.  The result is that the energy is 
disproportionally absorbed and the sample absorbs some of the fluorescence, which 
ultimately quenches the fluorescence (i.e., the observed fluorescence is lower than the true 
fluorescence).   
IFE can be reduced by using equipment corrections, diluting the sample, or by 
normalizing the sample to an absorbance wavelength (Henderson et al., 2009).  The Horiba 
AquaLog® software was used to make IFE corrections on all samples.  Normalizing the 
fluorescence data to the absorbance at 254 nm did not change the trend of the fluorescence 
graphs (i.e., they were still nonlinear); since the absorbance correction only changed the 
magnitude of the graph and not the trend of the graph, it was determined to be an 
unnecessary step for correlation.  Several researchers diluted their samples to minimize IFE; 
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samples were diluted such that the absorbance at a particular wavelength (most commonly 
254 nm) did not exceed a predetermined absorbance value (e.g., 0.05 cm-1, 0.10 cm-1, or 0.30 
cm-1) (Hur et al., 2010; Hur et al., 2012; Zhou et al., 2013; Yang et al., 2014).  Samples were 
not diluted for this research, and the observed absorbance at influent and CABI were 
typically higher than the maximum absorbance criteria mentioned in the literature.  The 
influent and CABI absorbance values obtained in this research were consistent with values 
reported by Tchobanoglous et al. (2003), which ranged from 0.30 to 0.55 cm-1 for primary 
wastewater and 0.15 to 0.30 cm-1 for secondary wastewater.  It was concluded that 
fluorescence of influent and CABI was presumably quenched due to IFE.  In addition, it is 
likely that other researchers will encounter the same issue because the absorbance of a typical 
characteristic of wastewater is often related to IFE interference.   
The literature suggests that correlating the data with uncorrected IFE may be an 
alternative to implementing IFE corrections, such as normalizing the data to absorbance 
values or dilution (Henderson et al., 2009).  The adopted approach of this study was to 
correct for IFE through equipment corrections only, and not by dilution or normalization to 
absorbance.  One of the primary reasons this approach was chosen is because diluting the 
sample is not practical for in situ fluorescence monitoring.  Interpretation and use of these 
models should take into account that fluorescence was being quenched due to IFE.  
4.5.2 BOD5 and Fluorescence Linear Correlation Coefficients 
Table 4.5 summarizes the correlation coefficients for each of the parameters, based on 
non-robust linear correlations.  Similar to the previous findings of this research, independent 
correlations at each sample site were not significant. The correlation coefficients for the three 
combined sample sites suggest that linear models are a good fit.  An interesting observation 
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can be made when the correlation coefficients are organized in descending order, as shown in 
Figure 4.16.  The correlation coefficients show consistency in their grouping based on 
regions and the peaks within the region.  The humic peak and peak C are contained within 
region III, and each of these are ranked in the top three for correlation coefficients.  The next 
group of coefficients are peak T and the protein peak, which are contained within region I.  
The fulvic-like region and peak A have the lowest correlation coefficients. 
4.5.3 BOD5 and Fluorescence Correlation Approach 
Figure 4.16 and the literature review were used to determine which peaks and regions 
should be explored as possible surrogates for the BOD5 test.  The linear correlation 
coefficients indicate that the humic-like peak appears to be the best linear fit.  This peak was 
chosen as well as region III, which contains the humic-like peak.  Several studies have 
suggested that BOD5 was most related to tryptophan-like peaks (peak T), which are near 280 
nm excitation wavelengths and 340 nm emission wavelengths (Reynolds and Ahmad, 1997; 
Ahmad and Reynolds, 1999; Baker and Invararity, 2004; Hudson et al., 2008; Hur et al., 
2008; Hur et al., 2010; Yang et al., 2014).  The T peak adopted in this research was at a 275 
nm excitation wavelength and a 340 nm emission wavelength.  
 As previously mentioned, the relationship between BOD5 and each of the 
fluorescence parameters do not appear to have a linear relationship based on the graphs, but 
the correlation coefficients suggest that linear relationships exist.  Robust linear and robust 
nonlinear regression models were explored for each of the chosen fluorescence parameters 
(region I, region III, peak T, and the humic-like peak), as summarized in the following 
equations.  
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BOD  ! =   β! ∗ Parameter +   β  !                                                                                                                                                                                      Eqn. 4.5 BOD  ! =   β! ∗ Parameter +   β  ! ∗ Influent + β  ! ∗ CABI +β  ! ∗ Effluent               Eqn. 4.6 BOD  ! =   β! ∗ (Parameter)!!                                                                                                                                                                                                       Eqn. 4.7 BOD  ! =   β! ∗ Parameter !! + 𝛽!                                                                                                                                                                                  Eqn. 4.8 BOD  ! =   β! ∗ e!!∗(!"#"$%&%#)                                                                                                                                                                                                    Eqn. 4.9 BOD  ! =   β! ∗ e!!∗ !"#"$%&%# + 𝛽!                                                                                                                                                                            Eqn. 4.10 
 
Eqn. 4.5 represents the linear regression model that was developed considering the 
data from all three of the sample sites (i.e., influent, CABI, and effluent).  Eqn. 4.6 represents 
the linear regression model that considers each of the sample sites as independent variables in 
the model.   
 Eqn. 4.7 through Eqn. 4.10 represent the nonlinear regression models that were 
developed.  Eqn. 4.7 and Eqn. 4.8 represent the power model and the power model with a 
constant, respectively.  Eqn. 4.9 and Eqn. 4.10 represent the exponential model and the 
exponential model with a constant, respectively.   
 Each of these models were developed and compared using the correlation coefficient, 
the residual standard error, and by visually comparing the goodness of fit.   
4.5.4 BOD5 and Humic Peak Correlations 
 The results of the robust linear and nonlinear regressions are shown in Figures 4.17 
and 4.18, respectively.  The regression lines, pseudo correlation coefficients (i.e., the 
correlation coefficient of the true BOD5 plotted against the fitted BOD5 value), and the 
residual standard errors are summarized in Table 4.6.  
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The linear functions had lower residual standard errors when compared with the 
nonlinear functions, indicating that they were a better fit.  Two linear functions were 
developed: one that estimated the BOD5 as a function of the humic fluorescence and another 
that estimated BOD5 as a function of the humic fluorescence and the sample sites.  When the 
sample sites are considered as part of the function, then independent equations can be 
developed for each of the sample sites, as shown in Figure 4.17 and summarized in Table 4.6 
Eqn. IIa, IIb, and IIc.  The figure shows that the independent equations estimate effluent 
BOD5 fairly well, but it is not a good fit for CABI or influent.  On the other hand, the linear 
equation that does not include sample sites appears to be a better fit for CABI and influent, 
but not for effluent.  
As mentioned, the nonlinear functions were subpar to the linear models in terms of 
the residual standard error. Figure 4.18 indicates that the power and exponential functions 
overestimate effluent BOD5 and underestimate both CABI and influent BOD5.  The 
exponential and power models have nearly identical trend lines, as shown in Figure 4.18.  
Both of these models are poor estimators for effluent BOD5, but they appear to be reasonable 
estimators for CABI and influent BOD5.   
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Figure 4.17: Linear regression fits between BOD5 and humic peak fluorescence for influent, CABI, and effluent samples. The influent, 
CABI, and effluent regression lines (Table 4.6 Eqn II) that were developed with sample site are not good indicators for CABI or 
influent.  The regression model that was developed with data from each sample site (Table 4.6 Eqn. I), but did not consider sample site 
as an independent variable, appears to estimate influent and CABI, but it is not a good fit for effluent.    
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Figure 4.18: Nonlinear regression fits between BOD5 and humic peak fluorescence for influent, CABI, and effluent samples.  The 
power and exponential models (Table 4.6 Eqn. III and Eqn. V, respectively) are poor estimators for each of the sample sites.  The 
power and exponential models with constants (Table 4.6 Eqn. IV and Eqn. VI, respectively) are poor estimators for effluent BOD5, but 
they both appear to be reasonable estimators for CABI and influent BOD5.    
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Table 4.6: Linear and Nonlinear Regression Fits for Humic Peak Fluorescence 
 
Humic Peak Regression Models 
Reference 
Equation Generic Model Regression Model r
2 
Residual 
Standard 
Error 
Eqn. I Eqn. 4.5 – Linear model BOD5= 227.68*Humic-277.76 0.89 28.86 
Eqn. II Eqn. 4.6 – Linear model (sample site independent variable) 
BOD5= 14.65*Humic + 166.75*Influent - 
187.34*Effluent + 176.22 0.93 13.59 
Eqn. IIa Influent BOD5= 14.65*Humic + 342.97 - - 
Eqn. IIb CABI BOD5= 14.65*Humic + 176.22 - - 
Eqn. IIc Effluent BOD5= 14.65*Humic - 11.12 - - 
Eqn. III Eqn. 4.7 – Power model BOD5 = 29.70*(Humic) 2.39 0.85 64.81 
Eqn. IV Eqn. 4.8 – Power model with a constant BOD5 = 297.28*(Humic) 
0.85 - 353.35 0.90 31.97 
Eqn. V Eqn. 4.9 – Exponential model  BOD5 = 19.96*e (Humic)*1.00 0.75 90.80 
Eqn. VI 
Eqn. 4.10 – Exponential model 
with constant Eqn. 4.10 with a 
constant  
BOD5 = 2903*e (Humic)*-0.094 + 2585 0.90 32.09 
No final recommendations for a best fit regression model influent, CABI, or effluent 
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4.5.5 BOD5 and Region III Correlations 
The results of the robust linear and nonlinear regressions are shown in Figures 4.19 
and 4.20, respectively.  The regression lines, pseudo correlation coefficients, and the residual 
standard errors are summarized in Table 4.7.  Similar to the humic peak fluorescence 
findings, the models have high correlation coefficients, but the graph of the models indicate 
that they are not necessarily a good fit.  The model with the lowest residual standard error 
was the linear model with sample sites included as a function of the model.  Figure 4.19 
indicates that this is not a good fit for CABI or influent, but it fits the effluent data fairly 
well.  When the model is considered, the slope is negative; in other words, as fluorescence 
increases, the BOD5 decreases.  
Each of the nonlinear models (Figure 4.20) indicates that they are reasonable 
estimators for influent and CABI BOD5, but they are poor estimators for effluent BOD5.  The 
exponential and power models without constants overestimate effluent BOD5.  The 
exponential and power models with constants are a poor fit for the effluent data.  
It can be concluded that neither the linear or nonlinear models are a good fit for 
effluent BOD5, but the nonlinear models can be used to estimate CABI and influent BOD5.  
None of the models can be used for permit compliance; therefore, region III fluorescence is 
not recommended as an alternate test procedure. 
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Figure 4.19: Linear regression fits between BOD5 and region III fluorescence for influent, CABI, and effluent samples. The influent, 
CABI, and effluent regression lines (Table 4.7 Eqn. II) that were developed with sample site are not good indicators for CABI or 
influent.  The regression model that was developed with data from each sample site (Table 4.7 Eqn. I), but did not consider sample site 
as an independent variable, appears to estimate influent, but it overestimates both effluent and CABI.   
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Figure 4.20: Nonlinear regression fits between BOD5 and region III fluorescence for influent, CABI, and effluent samples.  All four of 
the models appear to be poor estimators for effluent BOD5, but they each appear to be reasonable estimators for CABI and influent 
BOD5.    
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Table 4.7: Linear and Nonlinear Regression Fits for Region III Fluorescence 
 
Region III Regression Models 
Reference 
Equation Generic Model Regression Model r
2 
Residual 
Standard 
Error 
Eqn. I Eqn. 4.5 – Linear model BOD5= 0.0337*Region III-271.46 0.86 30.89 
Eqn. II Eqn. 4.6 – Linear model (sample site independent variable) 
BOD5= -0.0006*Region III + 179.82* 
Influent - 204.18*Effluent + 216.76 0.92 14.21 
Eqn. IIa Influent BOD5= -0.0006*Region III + 396.58 - - 
Eqn. IIb CABI BOD5= -0.0006*Region III + 216.76 - - 
Eqn. IIc Effluent BOD5= -0.0006*Region III + 12.58 - - 
Eqn. III Eqn. 4.7 – Power model BOD5 = (3.99x10-7) *Region III3.045 0.83 40.63 
Eqn. IV Eqn. 4.8 – Power model with a constant BOD5 = (1.50x10-6) *Region III1.99-84.7 0.86 24.53 
Eqn. V Eqn. 4.9 – Exponential model  BOD5 = 10.50*e (Region III)*0.000195 0.79 65.86 
Eqn. VI Eqn. 4.10 – Exponential model with constant  BOD5 =207.2*e (Region III)*0.00006854  - 355.6 0.86 25.00 
No final recommendations for a best fit regression model influent, CABI, or effluent 
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4.5.6 BOD5 and Peak T Correlations 
 Several studies (Reynolds and Ahmad, 1997; Reynolds 2002; Baker and Invararity, 
2004; Hudson et al., 2008; Hur et al., 2010; Lai et al., 2011; Yang et al., 2014) concluded that 
BOD5 correlated well with protein-like peaks near an excitation wavelength of 280 nm and 
an emission wavelength of 340 nm.  The peak chosen for this research was at an excitation 
wavelength of 275 nm and an emission wavelength of 340 nm, which is similar to the 
literature.   
 Similar to the previous fluorescence approaches, linear, power, and exponential 
models were developed to describe the relationship between BOD5 and peak T fluorescence 
(Figure 4.21, Figure 4.22, and Table 4.8).  The linear regression model that was developed 
independent of the sample sites is not a good fit for effluent and it underestimates influent 
BOD5. The linear model that considers the sample site as an independent variable in the 
regression model does not appear to be a good fit either. The slope of the equation is 
negative, which indicates that the fluorescence decreases as the BOD5 increases.   
 The nonlinear exponential model is the worst fit followed by the exponential model 
with a constant.  Figure 4.22 and the reported correlation coefficients indicate that the power 
function and the exponential function with a constant are nearly identical.  The power model 
with a constant has a slightly lower residual standard error so it may be preferred. 
 The results of the peak T correlation indicate the linear model is not a best fit, which 
is inconsistent with the literature (Reynolds and Ahmad, 1997; Reynolds 2002; Baker and 
Invararity, 2004; Hudson et al., 2008; Hur et al., 2010; Lai et al., 2011;Yang et al., 2014).  
The power function with a constant appears to be a good surrogate to estimate BOD5 for 
effluent and CABI samples, although it will likely underestimate the BOD5 of influent.   
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Figure 4.21: Linear regression fits between BOD5 and peak T fluorescence for influent, CABI, and effluent samples.  The regression 
model that was developed with sample site as an independent variable (Table 4.8 Eqn. II) is a poor fit for the data.  The linear 
regression model that did not consider sample site as an independent variable (Table 4.8 Eqn. I) is a poor estimator for influent and 
effluent BOD5.   
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Figure 4.22: Nonlinear regression fits between BOD5 and peak T fluorescence for influent, CABI, and effluent samples. The 
exponential model (Table 4.8 Eqn. V) is a poor estimator for effluent BOD5.  Each of the other models (Table 4.8 Eqn. III, Eqn. IV, 
and Eqn. VI) appears to be a reasonable fit for effluent and CABI, but they each underestimate influent BOD5.   
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Table 4.8: Linear and Nonlinear Regression Fits for Peak T Fluorescence 
 
Peak T Regression Models 
Reference 
Equation Generic Model Regression Model r
2 
Residual 
Standard 
Error 
Eqn. I Eqn. 4.5 – Linear model BOD5= 42.02*T-36.09 0.82 29.42 
Eqn. II Eqn. 4.6 – Linear model (sample site independent variable) 
BOD5= -1.06*T + 179.59*Influent 
- 205.97*Effluent + 214.58 0.92 14.24 
Eqn. IIa Influent BOD5= -1.06*T + 394.07 - - 
Eqn. IIb CABI BOD5= -1.06*T + 214.48 - - 
Eqn. IIc Effluent BOD5= -1.06*T + 8.51 - - 
Eqn. III Eqn. 4.7 – Power model BOD5 = (7.85) *T1.78 0.84 23.19 
Eqn. IV Eqn. 4.8 – Power model with a constant 1BOD5 = (7.95) *T1.77- 0.36 0.84 23.06 
Eqn. V Eqn. 4.9 – Exponential model  BOD5 = 26.05*e(T)*0.31 0.80 45.66 
Eqn. VI Eqn. 4.10 – Exponential model with constant  BOD5 =143.25*e(T)*0.149 - 158.39 0.84 24.46 
1Final recommendation for effluent and CABI  
No final recommendations are given for influent 
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4.5.7 BOD5 and Region I Correlations 
 Region I was chosen as a fluorescence correlation parameter because it contains the 
protein-like fluorescence peaks (i.e., peak T) most associated with BOD5 as reported in the 
literature.  Figure 4.23, Figure 4.24, and Table 4.9 show the results of the linear and 
nonlinear robust correlations that were developed.  Similar to the findings of the peak T 
correlations, linear correlations do not appear to adequately describe the data (Figure 4.23).   
 The nonlinear exponential model is the worst fit; it overestimates effluent and 
underestimates influent BOD5.  Each of the other three nonlinear models has a similar trend 
line.  They each appear to be reasonable estimators for effluent and CABI BOD5, but they 
underestimate influent BOD5.  These conclusions are similar to the finding of the peak T 
regression models.  A comparison of the statistical parameters (Table 4.9) indicates that the 
correlation coefficients of the three models are similar.  The power model has the lowest 
residual standard error; therefore, it can be concluded that this is the better of the three 
models.  The power model can be used to estimate effluent and CABI BOD5.  None of the 
models adequately estimated influent BOD5, so peak T fluorescence is not recommended as 
an estimator for influent.    
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Figure 4.23: Linear regression fits between BOD5 and peak T fluorescence for influent, CABI, and effluent samples.  The regression 
model that was developed with sample site as an independent variable (Table 4.9 Eqn. II) is a poor fit for the data.  The linear 
regression model that did not consider sample site as an independent variable (Table 4.9 Eqn. I) is a poor fit for effluent, it 
overestimates CABI, and it underestimates influent BOD5.   
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Figure 4.24: Nonlinear regression fits between BOD5 and peak T fluorescence for influent, CABI, and effluent samples. The 
exponential model (Table 4.9 Eqn. V) is a poor estimator for effluent BOD5.  Each of the other models (Table 4.9 Eqn. III, Eqn. IV, 
and Eqn. VI) appears to be a reasonable fit for effluent and CABI, but they each underestimate influent BOD5.   
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Table 4.9: Linear and Nonlinear Regression Fits for Region I Fluorescence 
 
Region I Regression Models 
Reference 
Equation Generic Model Regression Model r
2 
Residual 
Standard 
Error 
Eqn. I Eqn. 4.5 – Linear model BOD5= 0.0042*Region I-55.64 0.80 33.79 
Eqn. II Eqn. 4.6 – Linear model (sample site independent variable) 
BOD5= 0*Region I + 178.25*Influent 
- 202.03*Effluent + 210.00 0.93 14.16 
Eqn. IIa Influent BOD5= 0*Region I + 388.25 - - 
Eqn. IIb CABI BOD5= 0*Region I + 210.00 - - 
Eqn. IIc Effluent BOD5= 0*Region I + 7.97 - - 
Eqn. III Eqn. 4.7 – Power model 1BOD5 = (7.41x10-8) *Region I1.95 0.81 22.22 
Eqn. IV Eqn. 4.8 – Power model with a constant 
BOD5 = (2.28x10-7) *Region I1.856  
–  4.79 0.81 25.42 
Eqn. V Eqn. 4.9 – Exponential model  BOD5 = 21.28*e (Region I)*0.0003198 0.77 44.56 
Eqn. VI Eqn. 4.10 – Exponential model with constant  BOD5 =129.6*e (Region I)*0.00001511 - 154 0.80 26.11 
1Final recommendation for effluent and CABI  
No final recommendations are given for influent 
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4.5.8 Fluorescence Correlation Discussion  
Four parameters were considered for the fluorescence correlation: the humic peak, 
region III, peak T, and region I.  It can be concluded that the humic peak and region III are 
not the best surrogates for BOD5 because they do not quantify biodegradable organic matter 
(Chen et al., 2003).  Peaks near an excitation wavelength of 280 nm and an emission 
wavelength 340 nm are better surrogates for BOD5 because they are indicators of labile 
organic matter that is removed during the treatment process (Hudson et al., 2007).   
The best fit models for region I and peak T (ex = 275 nm and em = 340 nm) were the 
power function and the power function with a constant, respectively.  Both of the models had 
similar correlation coefficients (peak T = 0.84 and region I = 0.81) and residual square errors 
(peak T = 23.06 and region I = 22.22).  Similar statistical parameters were expected because 
the region represents the enclosed peaks.  If the regions were defined appropriately to only 
include the protein like fluorescence, then it is reasonable that the region and the enclosed 
peaks should have similar statistical results. The results of peak T and region I fluorescence 
support this hypothesis.  The use of a peak T fluorescence may be preferred to region I 
fluorescence because it takes more time to obtain the results of region fluorescence.  
Specifically, region fluorescence is the integrated area of several individual peaks.  
Therefore, the analyst must determine the fluorescence of multiple peaks to determine the 
region fluorescence; this is opposed to peak fluorescence, which only requires the analyst to 
determine the fluorescence at a specific point on the EEM graph. 
The power function developed in this research is contradictory to previous studies 
that developed linear correlations, but the nonlinear trend can most likely be attributed to the 
observed IFE that was occurring in CABI and influent samples.  Although it is not possible 
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to conclude with certainty, the literature suggests the model would have exhibited linear 
characteristics if the samples were diluted prior to fluorescence analysis.   
An interesting trend emerged when the sample sites were considered as an 
independent variable in the linear model functions.  The slope of region I (0) and region III (-
0.0006) were nearly 0, whereas the slope of peak T (-1.06) was negative.  It appears that the 
effluent sample sites are significantly contributing to the slope of the model, which is similar 
to the conclusions made in the TOC and COD correlations when sample site was not 
considered as an independent variable in the regression equation.  The results were that the 
model was not a good predictor for either CABI or influent.  As previously discussed, the 
ratios change as treatment progresses, indicating that independent correlations for sample 
sites should be developed or nonlinear regression models should be explored.   Therefore, it 
can be concluded that the regression models that consider sample site are not an adequate 
representation of the physical relationship between BOD5 and the alternate methods.  
4.6 BOD5 and Absorbance Correlations 
 The chosen wavelengths to correlate for this research were at 254 nm and 340 nm.  
Figure 4.25 and Figure 4.26 summarize the data used for the correlation for 254 nm 
absorbance and 340 nm absorbance, respectively.  The first was chosen because it is the most 
common wavelength that absorbance is reported at (Tchobanoglous et al., 2003), and the 
latter was chosen because it falls in middle of the fluorescence spectrum.  Several 
wavelengths have been successfully correlated based on linear regression (Comber et al., 
1996; Wu et al., 2006; Chevakidagarn, 2006; Natarja et al., 2006; Michail and Idelvoitch, 
1981).  Nonlinear trends were observed in the absorbance data (Figure 4.25 and Figure 4.26), 
similar to the trends of the fluorescence data, which is contradictory to the literature.   
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4.6.1 BOD5 and Absorbance at 254 nm Correlation 
 The linear trends are shown in Figure 4.27.  From the figure, it is clear that the basic 
linear regression model is a poor estimator for each sample site and the linear model that 
considers each sample site as an independent variable is not a better indicator either.  In fact, 
the regression line (Table 4.10) indicates that the slope is negative. Neither of the linear 
regression models are good predictors.  
 From Figure 4.28, the power and exponential functions without constants are poor fits 
for the effluent data.  Their counterparts with constants appear to be the better fits, but the 
power function with a constant is slightly better due to the smaller residual standard error.  
Both of these models appear to overestimate CABI and underestimate influent BOD5.  It can 
be concluded that absorbance at 254 nm is not a good estimator for BOD5.   
4.6.2 BOD5 and Absorbance at 340 nm Correlation 
 The results for the 340 nm absorbance correlations are summarized in Figure 4.29, 
4.30, and Table 4.11.  Both of the linear models are poor estimators for each of the sample 
sites. Figure 4.30 indicates that each of the nonlinear models are poor fits for the data as well.  
The power model passes through effluent, but is underestimates CABI and influent.  The 
exponential model overestimates effluent and underestimates influent, but it appears to 
estimate CABI fairly well.  The power and exponential models with constants are poor 
estimators for effluent, they overestimate CABI, and they underestimate influent.  It can be 
concluded that the absorbance at 340 nm is a poor estimator for BOD5. 
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4.6.3 Absorbance Correlation Discussion  
 A feasible correlation between absorbance and BOD5 could not be found in this 
research, which is contradictory to other studies that have found strong relationships 
(Comber et al., 1996; Wu et al., 2006; Chevakidagarn, 2006; Natarja et al., 2006; Michail and 
Idelvoitch, 1981). Comber et al. (1996) concluded that the relationship between BOD5 and 
absorbance weakened when samples were filtered, which may explain the weak correlation.  
Furthermore, absorbance is a measure of how much light passes through a sample, which in 
an indirect measurement of the organic matter.  It can thus be concluded that absorbance is a 
poor surrogate for BOD5 because of the method itself and because strong correlations could 
not be established. 
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Figure 4.25: BOD5 and absorbance data for absorbance at 254 nm.
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Figure 4.26: BOD5 and absorbance data for absorbance at 340 nm.
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Figure 4.27: Linear regression fits for absorbance at 254 nm.  The regression model that considers sample site as an independent 
variable (Table 4.10 Eqn. II) is a poor estimator for each of the samples sites.  The linear model that does not consider sample site as 
an independent variable (Table 4.10 Eqn. I) is a poor fit for effluent, it overestimates CABI, and it underestimates influent BOD5.  
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Figure 4.28: Nonlinear regression fits for absorbance at 254 nm.  The power and exponential models (Table 4.10 Eqn. III and Eqn. V) 
overestimate effluent and CABI BOD5, and they underestimate influent BOD5.  The models with constants (Table 4.10 Eqn. IV and 
Eqn. VI) overestimate CABI and they underestimate influent BOD5.   
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Table 4.10: Absorbance at 254 nm Linear and Nonlinear Regression Models 
 
Absorbance at 254 nm Regression Models 
Reference 
Equation Generic Model Regression Model r
2 
Residual 
Standard 
Error 
Eqn. I Eqn. 4.5 – Linear model BOD5= 1457.67*Abs - 155.07 0.77 31.93 
Eqn. II Eqn. 4.6 – Linear model (sample site independent variable) 
BOD5= -377.88*Abs + 188.28*Influent 
- 261.763*Effluent + 310.79 0.93 13.18 
Eqn. IIa Influent BOD5= -377.88*Abs + 499.07 - - 
Eqn. IIb CABI BOD5= -377.88*Abs + 310.79 - - 
Eqn. IIc Effluent BOD5= -377.88*Abs - 49.03  - - 
Eqn. III Eqn. 4.7 – Power model BOD5 = (8533) *Abs2.80 0.76 26.14 
Eqn. IV Eqn. 4.8 – Power model with a constant BOD5 = (4090) *Abs2.11 - 31.64 0.77 22.07 
Eqn. V Eqn. 4.9 – Exponential model  BOD5 = 9.73*e (Abs)*11.34 0.73 44.02 
Eqn. VI Eqn. 4.10 – Exponential model with constant  BOD5 =120.41*e (Abs)*4.63 - 193.20 0.77 22.33 
No final recommendations are given for influent, CABI, or effluent 
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Figure 4.29: Linear regression fits for absorbance at 340 nm.  The regression model that considers sample site as an independent 
variable (Table 4.11 Eqn. II) is a poor estimator for each of the sample sites.  The linear model that does not consider sample site as an 
independent variable (Table 4.11 Eqn. I) is a poor fit for effluent, it overestimates CABI, and it underestimates influent BOD5.   
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Figure 4.30: Nonlinear regression fits for absorbance at 340 nm.  The power model (Table 4.11 Eqn. III) grossly underestimates the 
CABI and influent BOD5.  The exponential model (Table 4.11 Eqn. V) overestimates effluent and underestimates influent BOD5.  The 
exponential and power models with a constant (Table 4.11 Eqn. IV and VI) are poor fits for effluent, they overestimate CABI, and the 
underestimate influent BOD5.   
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Table 4.11: Absorbance at 340 nm Linear and Nonlinear Regression Models 
 
Absorbance at 340 nm Regression Models 
Reference 
Equation Generic Model Regression Model r
2 
Residual 
Standard 
Error 
Eqn. I Eqn. 4.5 – Linear model BOD5= 7094*Abs - 211 0.78 31.72 
Eqn. II Eqn. 4.6 – Linear model (sample site independent variable) 
BOD5= -1124*Abs + 189.94*Influent - 
234.56*Effluent + 276.80 0.92 14.35 
Eqn. IIa Influent BOD5= -1124*Abs + 466.74 - - 
Eqn. IIb CABI BOD5= -1124*Abs + 276.80 - - 
Eqn. IIc Effluent BOD5= -1124*Abs + 42.24 - - 
Eqn. III Eqn. 4.7 – Power model BOD5 = (19550) *Abs2.46 0.73 50.23 
Eqn. IV Eqn. 4.8 – Power model with a constant BOD5 = (7641) *Abs1.04 - 199.61 0.78 31.23 
Eqn. V Eqn. 4.9 – Exponential model  BOD5 = 17.66*e (Abs)*39.14 0.66 76.89 
Eqn. VI Eqn. 4.10 – Exponential model with constant  BOD5 =-8871*e (Abs)*0.835 - 8652 0.78 32.25 
No final recommendations are given for influent, CABI, or effluent 
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4.7 Final Recommendations for Alternate Test Procedures to Estimate BOD5 
Several surrogates were considered as alternatives to BOD5, including COD, TOC, 
fluorescence, and absorbance. COD correlated well for all sample sites, TOC correlated well 
for effluent, and protein-like fluorescence correlated well for effluent and CABI, but not for 
influent.  Absorbance and fluorescence that is not related to protein-like fluorescence, 
specifically humic-like and region III, did not correlate well and they are not recommended 
as a surrogates for BOD5.   
COD can be used to estimate BOD5 for each sample site.  Eqn. 4.11 (r2=0.77) and Eqn. 
4.12 (r2=0.73) summarize the final models to estimate effluent and to estimate CABI or 
influent BOD5.  Eqn. 4.13 is valid for both influent and CABI, because the sample sites had 
similar ratios. 
 Effluent  BOD! = 0.49 ∗ COD− 7.78                                                                                                                                                    Eqn. 4.12 CABI  or  Influent  BOD! = 0.52 ∗ COD+ 5.09                                                                                                                    Eqn. 4.13 
 TOC can be used to estimate BOD5 of effluent, but it was not a good surrogate for 
influent or CABI.  Eqn. 4.14 (r2=0.87) summarizes the final model that can be used to 
estimate the BOD5 of effluent. Effluent  BOD! = 2.25 ∗ TOC− 12.07                                                                                                                                                Eqn. 4.14 
Peak T and region I fluorescence can be used as a surrogate for BOD5 for effluent and 
CABI, but use of these models would underestimate influent BOD5.  Eqn. 4.15 (r2=0.84) and 
4.16 (r2=0.81) summarize the models.  Both of these models are similar in terms of statistics, 
but peak T fluorescence can be obtained more quickly, so it is recommended.   CABI  or  Effluent  BOD! = 7.95 ∗ (peak  T  fl. )!.!! − 0.36                                                                              Eqn. 4.15 CABI  or  Effluent  BOD! = 7.41x10!! ∗ region  I  fl. !.!"                                                                      Eqn. 4.16 
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A sensitivity analysis was conducted on each of the five recommended models to 
determine if the sample size was sufficient.  Specifically, the sample size of each dataset was 
reduced to determine if the regression model and/or the correlation coefficients changed.  A 
new dataset was created by randomly selecting 90% of data points from the original dataset 
and a new regression model was generated from new dataset.  This process was repeated 
1,000 times and the mean coefficients of the model and the mean correlation coefficients 
were determined, which were then compared with the models reported in the results. It was 
concluded that reducing the number of data points by 10% had minor impacts (i.e., they did 
not change by more than 5%) on the regression models and the correlation coefficients.  
Therefore, it can be concluded that a sufficient number of data points were used to generate 
each of the final recommended regression models.   
4.8 Implications for WWTPs and their NPDES Permits 
 Wastewater treatment plants should consider available resources (e.g., TOC 
equipment, COD equipment, etc.) and their ultimate goals (e.g., NPDES alternate test 
procedure, in situ monitoring, process control) to determine which of these methods is the 
most practical for their plant.  For instance, COD and BOD5 had a good correlation for 
effluent, CABI, and influent.  Many plants have Hach spectrophotometers at their facility, 
which can be used to complete the analysis, and the test is straightforward and easy to 
perform/interpret.  This option may be beneficial for both process control and permit 
compliance.  The TOC method was a good surrogate for effluent BOD5; therefore, it may be 
a good option for permit compliance, but not necessarily process control.  Fluorescence is not 
an approved Standard Method (2005); therefore, it is unlikely that it can currently be used as 
an alternate test procedure for NPDES permit compliance.  Despite this fact, several studies 
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have shown that fluorescence can be used as a surrogate to BOD5 and as a means to 
characterize the wastewater.  It may be possible in the near future for the EPA to recognize 
fluorescence as a method for wastewater organic quantification, and thus treatment plants can 
use fluorescence as an alternate test method. In the meantime, treatment plants can use 
fluorescence to characterize their wastewater and potentially collect data for anticipated EPA 
changes that could allow them to use the method in lieu of BOD5.   
The models developed in this research are specific to the treatment facility where the 
samples were collected, but some of the generalized findings and conclusions can be used for 
other WWTPs.  This research, along with the findings of previous studies, have concluded 
that correlation models are site specific due to the changing ratio as treatment progresses.  
This change in ratio is due to the selective removal of organics in the treatment process, and 
the fact that each alternate test procedure quantifies different types of organic matter.  
Furthermore, the correlation models are WWTP specific because each treatment facility 
operates at different efficiencies.  The wastewater characteristics and the ratios can vary 
depending on the treatment facility efficiency, as well as the quality of wastewater influent 
(e.g., domestic versus industrial wastewater).  Based on this logic, it can be further concluded 
that changes or additions to unit processes within the WWTP can potentially impact the 
correlation.  Specifically, if a unit process selectively removes organic matter, it will change 
the BOD5 ratio both at that point in the treatment process and downstream.  
This research used samples collected from a single WWTP to develop correlations, 
which is highly recommended to other facilities.  Clustering of data was observed at each 
sample site; the clusters of influent data were more spread and became tightly clustered as 
treatment progressed.  This was expected, because influent wastewater is uncontrolled, but 
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the quality of wastewater is controlled as treatment progresses because the WWTP is 
engineered to remove organic matter.  This type of data clustering is not ideal for developing 
site-specific correlations, but it is indicative of a treatment facility that is operating 
consistently.  Combining samples collected from multiple treatment facilities is not preferred 
due to the difference in influent quality and difference in BOD5 ratios among treatment 
plants, but this approach may lead to site-specific correlations.  Data collected from multiple 
facilities will not be clustered due to the different influent wastewater characteristics and the 
different organic removal efficiencies, thus making it possible to develop site-specific 
correlations.  Despite the potential positive results of this approach, combining samples 
collected from multiple sites is not recommended because the physical relationship and 
organic removal among multiple facilities is not identical.     
 WWTPs looking into alternate test procedures should consider the impacts of the 
testing methodology as well.  In this research, samples were not diluted for the fluorescence 
testing to mimic in situ monitoring.  This choice led to IFE, which quenched the fluorescence 
results, and may have caused the nonlinear relationships.  In the TOC analysis, samples were 
acidified and sparged, which may have removed some of the organic matter and biased the 
results low.  Although these are systematic errors, it is important to understand the impacts of 
the test procedure on the organic quantification.  Slight changes to test procedure can impact 
the test results, which can lead to changes in the correlation model.   
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Part B: Removal Efficiency  
4.9 Removal Efficiency of BOD5, COD, TOC, and Absorbance 
 The removal efficiency of BOD5, TOC, COD, and absorbance in the primary clarifier, 
biological treatment (i.e., the aeration basin), and the entire treatment plant was determined. 
The removal equations are summarized below.  The removal for each sample day was 
calculated; only samples that were analyzed the same day as collection were included in the 
removal efficiency calculations.  R statistical software was used to bootstrap 1,000 samples 
from the original dataset.  The average and standard deviation of the bootstrap samples were 
used to construct a 95% confidence interval of the removal efficiency.   
 
Removal  of  primary  clarifier = Influent− CABIInfluent   x100%                                                          Eqn. 4.17 Removal  of  biological  treatment = CABI− EffluentCABI   x100%                                            Eqn. 4.18 
Removal  of  treatment  plant = Influent− EffluentInfluent   x100%                                                  Eqn. 4.19 
 
The removal efficiencies of each method are summarized in Table 4.12 and Figures 
4.31 to 4.36 summarize the boxplots for each removal. The n value given in Table 4.12 
represents the original number of data points, but as mentioned 1,000 bootstrap samples were 
created from the original dataset.  The boxplots were plotted based on the original dataset.   
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Table 4.12: Removal Efficiency of BOD5, COD, TOC, and Absorbance 
 
    Primary Biological Treatment Entire Plant 
Method n Mean 
95% 
Confidence 
interval (±) 
Mean  
95% 
Confidence 
interval (±) 
Mean  
95% 
Confidence 
interval (±) 
BOD5 21 48.15 4.75 96.26 0.84 98.13 0.36 
COD 36 44.93 1.99 91.76 0.68 95.52 0.34 
TOC 50 9.15 3.28 85.37 0.79 86.82 0.70 
Absorbance 
254 nm 21 8.27 2.42 61.08 1.05 64.29 1.12 
Absorbance 
340 nm 21 14.99 4.59 52.60 2.08 59.60 2.93 
 
 
Figure 4.34 is a boxplot of the TOC removal, based on historical TOC data. The 
following discussion will address how it is related to the current data and its relevance.  
Unfortunately, historical data were not available for the other methods to make similar 
comparisons.  
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Figure 4.31: Boxplot of the BOD5 removals of the primary clarifier, biological treatment, and the entire treatment process.   
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Figure 4.32: Boxplot of the COD removals of the primary clarifier, biological treatment, and the entire treatment process.   
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Figure 4.33: Boxplot of the TOC removals of the primary clarifier, biological treatment, and the entire treatment process.   
-2
0
-1
0
0
10
20
30
TOC Removal of Primary Clarifier
P
er
ce
nt
 re
m
ov
al
70
75
80
85
90
95
10
0
 TOC Removal of Aeration Basin
P
er
ce
nt
 re
m
ov
al
70
75
80
85
90
95
10
0
 TOC Removal of the Entire Treatment Train
P
er
ce
nt
 re
m
ov
al
   
180 
 
Figure 4.34: Boxplot of the historical TOC removals of the primary clarifier, biological treatment, and the entire treatment process. 
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Figure 4.35: Boxplot of the absorbance at 254 nm removals of the primary clarifier, biological treatment, and the entire treatment 
process.  .   
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Figure 4.36: Boxplot of the absorbance at 340 nm removals of the primary clarifier, biological treatment, and the entire treatment 
process.  
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 The results indicate that approximately 48% of BOD5 is removed in the primary 
clarifiers, 96% of BOD5 entering the biological treatment is removed, and 98% of BOD5 is 
removed during the entire process.  Tchobanoglous et al. (2003) reported that between 50 and 
80% of colloidal biodegradable organic matter are removed in the primary clarifier when 
chemical precipitates are used, which is consistent with the findings of this research albeit on 
the lower end of this range.  As expected, biological treatment, using activated sludge, is 
extremely effective at removing biodegradable organic matter.  The removal of the treatment 
plant indicates that the facility is removing nearly all of the biodegradable organic matter that 
enters the plant. The plant’s NPDES permit specifies that the 30-day average removal of TSS 
and BOD5 must be a minimum of 85%. Figure 4.31 shows that the wastewater treatment 
removed over 96% of the BOD5 during data collection for this research.   
 The results of COD removal (Table 4.12 and Figure 4.32) are similar to the removals 
observed for BOD5, except that the COD removals are slightly less than the BOD5 values. 
COD quantifies the organic matter based on the organics that are oxidized using potassium 
dichromate, which can also include some inorganic matter and non-biodegradable organic 
matter. Inorganics are not readily biodegradable; therefore, they are not readily removed 
during biological treatment.  The BOD5 test does not quantify these inorganics or non-
biodegradable organics, so the method will not reflect their lack of removal, whereas the 
COD test will.  Furthermore, the chemicals used in the COD test are capable of oxidizing 
more biodegradable organic matter than the microorganisms used in the BOD5 test.  The 
effect is that observed COD removals will be slightly less than the observed BOD5 removals.  
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 The average TOC removal in the primary clarifier was quite low, and Figure 4.33 
indicates that there were actually increases in TOC in the primary clarifier.  The mean 
removals for the biological treatment and the entire treatment plant are similar.  
Historical TOC data that were collected from 2010 to 2014 were statistically analyzed 
to determine the TOC removal efficiencies.  The removal efficiency was calculated for each 
data point (n=1,642) and 1,000 bootstrap samples were used to calculate the mean, standard 
deviation, and confidence intervals.  The boxplot of the historical data are shown in Figure 
4.34.  The average TOC removal of the primary clarifier was determined to be 8.03±0.94%, 
the average removal of biological treatment was 88.58±0.15%, and the removal of the entire 
plant was 89.78±0.11%.  The historical means are similar to the means calculated for this 
research (9.15±2.38%, 85.37±0.79%, and 86.82±0.70%).  A comparison between the current 
and historical boxplots (Figure 4.33 and Figure 4.34) indicates that the current data did not 
capture the large variations that can occur in primary removal efficiencies.  Specifically, the 
historical data indicate that the removal varied from -100% to +90% (Figure 4.34), but the 
removals observed in this research ranged from -20% to +30%.  This is further support that 
longer sampling periods are necessary to develop adequate correlations.   
A mass balance of the primary clarifier is necessary to understand the organic loading 
and why TOC sometimes increased.  Organics are input into the primary clarifier through 
influent wastewater and through return streams, which include the centrate return (Figure 
3.1), as well as thickened sludge overflow and supernatant from the anaerobic digestion of 
the primary and secondary sludge.  Organics either leave the system through primary sludge 
or they are sent to the aeration basin for biological treatment.  Tchobanoglous et al. (2003) 
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provides an excellent mass balance schematic and example of how to calculate the BOD5 and 
TSS in the system for a secondary treatment facility.   
Primary clarifiers are designed to remove particulate, suspended, and colloidal 
organic matter, which leave the primary clarifier as sludge.  Particulate and suspended 
organic matter is removed by sedimentation and colloidal organic matter can be removed 
with coagulants.  Colloidal organic matter repels one another at a molecular level; coagulants 
overcome the molecular repulsion so that the colloidal matter can be brought together into 
large flocs that can be removed through sedimentation, which leave the primary clarifier in 
the form of sludge (Tchobanoglous et al., 2003).  In addition, colloidal organic matter is 
dissolved into the water during primary treatment, and thus becomes soluble organic matter, 
which is then sent to the aeration basin.  The soluble organic matter is quantified at CABI 
with the TOC test, but it may not be quantified at influent; the result is an apparent increase 
in TOC between the two sample sites.  This is because the organics are particulate at influent 
and may not be quantified in the influent TOC analysis due to needle occlusion and/or coarse 
filtration involved in the analysis of the sample.  
The more critical reason for the increase in organic loading can be related to the 
return flows from sludge handling.  The sludge from the secondary clarifier is thickened and 
blended with primary sludge.  Some of the overflow from this process is sent to the primary 
clarifier, which has a typical BOD5 value of 250 mg/L, but it can range from 6 to 400 mg/L.  
The sludge is then sent through an anaerobic digester, which separates the sludge into 
supernatant and biosolids.  The supernatant from this process is returned back to the primary 
clarifier and can have a typical BOD5 value of 1,000 mg/L, but it can range from 500 to 
5,000 mg/L.  The biosolids are sent to solids dewatering, where the liquid centrate is 
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removed from the solids.  The centrate is returned to the primary clarifier and can have BOD5 
values that range from 100 to 2,000 mg/L, with an average value of 1,000 mg/L 
(Tchobanoglous et al., 2003).   
Clearly, the return streams have a significant impact on the BOD5 loading in the 
primary clarifier, even if the return flow is a small fraction of the total flow.  A formal mass 
balance that considered actual flow rates and the characteristics of the influent, sludge, and 
effluent would need to be conducted to fully understand the impact of the return flows.  This 
type of data was not collected in this research and it is not within the objectives of this thesis.  
Regardless, return flows clearly impact the treatment process and should be researched.  
Specifically, the characterization of return flows (i.e., TOC, BOD5, COD, and fluorescence) 
would be extremely beneficial to plant operators. They could better understand if the sludge 
returned is being adequately treated or if it is building up with the system. In other words, 
research should be conducted to determine if the sludge characterized by biodegradable or 
recalcitrant organic matter.  This type of information could help WWTP designers determine 
if side stream treatment is more appropriate rather than sending the water back to the primary 
clarifier for biological treatment, particularly if the return flows are not predominantly 
characterized by biodegradable organic matter.  Additionally, chemicals are often added to 
the WWTP flow to target the return flows, which are a small percentage of the total flow.  It 
is possible that side stream treatment would be more cost effective, particularly in terms of 
chemical additives, and result in a better quality effluent because the side stream organics 
would be targeted.   
A literature review did not produce any articles where researchers have characterized 
sludge by their TOC and fluorescence characteristics, and this type of analysis was not 
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conducted in this research.  As mentioned, this type of information would be invaluable.  In 
fact, the results of this research indicate that BOD5 had an overall positive removal, but it 
was on the lower end of the range indicated by Tchobanoglous et al. (2003), which may 
indicate an influx in biodegradable organic matter.  In other words, the true removal of 
biodegradable organic matter is possibly higher than the observed 48%, but the observed 
removal is dampened due to an increase in BOD5 caused by the return flow.  Both the 
historical removal and current removal of TOC had rather large variability and indicated that 
the TOC increased, presumably due to the return stream.  It should be mentioned that the 
removal of BOD5 was always positive is this research, which may indicate that the return 
stream is predominantly characterized by TOC and to a lesser extent biodegradable organic 
matter (i.e., COD and BOD5).  It also supports that fact that BOD5 and TOC do not quantify 
the same type of organic matter.   
 The removal of organics related to absorbance at 254 nm was approximately 8% in 
the primary clarifier and just over 60% for biological treatment and the entire plant.  The 
removal in the primary clarifier increased in some instances.  These results are similar to the 
observations made for the TOC data.  As mentioned, the return flows increase the organics in 
the primary clarifier.  Likely, the absorbance at 254 nm is quantifying these organics, 
whereas BOD5 and COD do not.  
 The mean removals of absorbance at 340 nm were slightly higher than the removal at 
254 nm and negative removals were not observed in the primary clarifier.  Despite this 
observation, negative removals may be observed during longer data collection periods.  This 
is believed because the TOC variations were large for data collected from 2010 to 2014, 
which were not captured in this research.   
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4.10 Removal Efficiency of Fluorescence 
 The removals of the peaks and regions are shown in Table 4.13.  The fluorescence 
EEM graphs for influent, CABI, and effluent are shown in Figure 4.37, Figure 4.38, and 
Figure 4.39, respectively.  The fluorescence scale (0 to 10 AFU) for influent and CABI are 
the same, so that one can visually see how the sample changes during treatment in the 
primary clarifier. The fluorescence of effluent is much smaller, so the fluorescence scale (0 to 
2 AFU) was changed accordingly.   
 
Table 4.13: Removal Efficiency of Fluorescence of the Primary Clarifier, Biological 
Treatment, and the Entire Treatment Process for Each Region and Peak  
 
    Primary Biological Treatment Entire Plant 
Fluorescence 
parameter 
(ex/em) –  
Region  
n Mean 
95% 
Confidence 
interval (±) 
Mean 
95% 
Confidence 
interval (±) 
Mean 
95% 
Confidence 
interval (±) 
Total  39 10.09 1.3 67.83 0.86 70.96 0.65 
Region I 39 12.03 1.48 80.26 0.78 82.66 0.62 
Region II 39 3.10 1.35 54.20 1.03 55.73 0.89 
Region III 39 18.24 1.14 45.01 0.9 55.07 0.69 
Protein peak 
(280/331) –
Region I 
39 17.19 1.54 84.74 0.98 87.41 0.73 
Humic peak 
(342/436) – 
Region III 
39 27.73 1.23 40.79 1.05 57.02 0.71 
Peak A 
(260/450) – 
Region II  
39 2.18 1.41 46.6 0.81 47.78 0.86 
Peak C 
(330/450) – 
Region III  
39 24.3 1.35 48.76 0.92 61.28 0.68 
Peak T 
(275/340) – 
Region I 
39 16.45 1.34 85.59 0.81 87.98 0.63 
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Figure 4.37: Fluorescence EEM graph of influent sample analyzed on 7/17/2014.   
 
Figure 4.38: Fluorescence EEM graph of CABI sample analyzed on 7/17/2014.   
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Figure 4.39: Fluorescence EEM graph of effluent sample analyzed on 7/17/2014.   
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Figure 4.40: Boxplot of total fluorescence removals of the primary clarifier, biological treatment, and the entire treatment process.  
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Figure 4.41:  Boxplot of region I fluorescence removals of the primary clarifier, biological treatment, and the entire treatment process.   
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Figure 4.42: Boxplot of region II fluorescence removals of the primary clarifier, biological treatment, and the entire treatment process.   
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Figure 4.43: Boxplot of region III fluorescence removals of the primary clarifier, biological treatment, and the entire treatment 
process.   
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Figure 4.44: Boxplot of protein peak fluorescence removals of the primary clarifier, biological treatment, and the entire treatment 
process.   
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Figure 4.45: Boxplot of humic peak fluorescence removals of the primary clarifier, biological treatment, and the entire treatment 
process.   
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Figure 4.46: Boxplot of peak A fluorescence removals of the primary clarifier, biological treatment, and the entire treatment process.   
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Figure 4.47: Boxplot of peak C fluorescence removals of the primary clarifier, biological treatment, and the entire treatment process.   
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Figure 4.48: Boxplot of peak T fluorescence removals of the primary clarifier, biological treatment, and the entire treatment process.  
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 Table 4.13 summarizes the means and confidence intervals for each of the 
fluorescence parameters.  The region that the peak is associated with is noted in the table for 
clarity. 
 Some of the total fluorescence was removed during primary clarification 
(mean=10%), but the majority of the total fluorescence was removed during biological 
treatment in the aeration basin (mean basin = 68% and mean plant=71%).  The boxplots 
(Figure 4.38) indicate that up to 75% of the total fluorescence was removed during treatment.  
A better understanding of the organics removed can be determined by assessing each region 
and the peaks contained within that region.   
 Region I is the region most related to BOD5 and protein-like fluorescence; it contains 
peak T and the protein peak defined in this research.  The mean removals for the primary 
clarifier, biological treatment, and the plant were similar for the protein peak (17%, 85%, and 
87%), T peak (16%, 86%, and 88%), and region I (12%, 80%, and 83%, respectively). 
Figures 4.35 and 4.36 indicate that the fluorescence peak in region I was the most dominant 
for influent and CABI, but the fluorescence decreased after primary clarification, which was 
consistent with BOD5 removal observations.  This is expected because domestic wastewater 
contains 40-60% proteins, which are readily removed during the treatment process 
(Tchobanoglous et al., 2003).  Region I and the associated peaks had the highest removal 
efficiency for both biological treatment and the entire plant compared with the other 
parameters.  Figure 4.37 indicates that protein-like (region I) fluorescence is less dominant 
than fulvic-like (region II) or humic-like (region III) fluorescence.  This further supports the 
literature, which has concluded that up to 90% of the fluorescence associated with region I 
and the peaks is removed during the wastewater treatment process and that these peaks are 
  201 
most related to the wastewater treatment process (Hudson et al., 2007; Henderson et al., 
2009). 
 Region II is associated with fulvic-like fluorescence and contains peak A.  There does 
not appear to be a significant change in fulvic-like fluorescence during primary clarification 
(Figure 4.37 and 4.38), which is consistent with the mean removal values determined for 
peak A (2%) and region II (3%).  Observation of the boxplots (Figure 4.40 and Figure 4.44) 
indicated that the fluorescence associated with this region increased (i.e., the removal is 
negative) during primary clarification. None of the other peaks or regions (with the exception 
of total region) had negative removals.  This is an important observation because it may 
indicate a link between TOC and absorbance to fulvic-like organic compounds, both of 
which also had negative removals that were also observed in the primary clarifier.  It may 
also be an indicator that fulvic-like compounds are likely characteristic of the return flows.  
Park et al. (2010) suggested that humic and fulvic-like materials may be byproducts of the 
biological process, which could be characteristic of the secondary clarifier sludge returned to 
the primary clarifier.  Approximately 50% of the fulvic-like fluorescence is removed during 
the entire treatment process.    
 Region III is associated with humic-like fluorescence and it contains the humic-like 
peak and peak C.  The observed fluorescence was less than region I, but greater than the 
fluorescence observed in region II.  The primary clarifier was most efficient at removing 
humic peak fluorescence (28%), peak C fluorescence (24%), and region III fluorescence 
(18%), compared with the other peaks and regions.  Approximately 45% of the remaining 
humic-like fluorescence was removed during biological treatment, resulting in total 
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fluorescence removals of 57%, 61%, and 55% for the humic peak, peak C, and region III, 
respectively.   
 It can be concluded that the primary clarifier removes humic-like fluorescence 
followed by protein-like fluorescence, but it does not remove fulvic-like fluorescence.  In 
fact, fulvic-like fluorescence increased in the primary clarifier presumably due to the return 
flows associated with sludge treatment.  Biological treatment is the most effective at 
removing protein-like fluorescence, and to a lesser degree it removes humic and fulvic-like 
fluorescence.  The resulting effluent has very little protein-like fluorescence, but it is 
characterized by humic and fulvic-like fluorescence, which is consistent with Hudson et al. 
(2008), Henderson et al. (2009), and Yang et al. (2014).  The decreases observed in the peaks 
and regions were consistent with Ahmad and Reynolds (1995) and Reynolds (2002), who 
concluded that peaks near excitation wavelengths of 280 nm (e.g., region I, peak T, and 
protein peak) were associated with biodegradable matter and peaks near excitation 
wavelength of 350 nm (e.g., region III and the humic peak) were associated with 
nonbiodegradable organic matter.   
4.11 Relationship Between the Removal Efficiencies and Correlations 
The strongest correlation was developed for BOD5 and COD.  A comparison of the 
removal efficiencies indicates that they had the most similar removal efficiencies for the 
primary clarifier, biological treatment, and the entire treatment plant.  This further supports 
the conclusion that COD is a good surrogate for BOD5 for the domestic wastewater used in 
this research. 
TOC was related to effluent BOD5, but it did not relate well to the influent or CABI 
samples. The TOC removal in the primary clarifier (9%) was far less than the BOD5 removal 
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(49%) indicating that TOC and BOD5 should not be related for this portion of treatment.  
TOC removal for biological treatment (85%), was slightly less than the removal observed for 
BOD5 (96%).  The similar removals observed during biological treatment may explain why 
effluent correlated better than the rest of the treatment process.  A comparison between TOC 
removals and fulvic-like fluorescence removals indicate that they both increased in the 
primary clarifier, which may be an indicator that they are related to one another.    
The absorbance correlations indicated that the relationship was nonlinear and weak for 
BOD5 at both 254 nm and 340 nm.  The removal efficiencies indicate that absorbance is not 
readily removed in the primary clarifier and 60% is removed during the entire treatment 
process.  Recall that absorbance is a measure of how much light passes through a sample, 
based on the presence of chromophores.  Therefore, it is not a direct indicator of 
biodegradable organic matter.  It can be concluded that absorbance is not a good surrogate 
for BOD5 or biodegradable organic matter.  However, the removal efficiencies suggest that it 
may be a good indicator for total fluorescence, region II fluorescence, and/or region III 
fluorescence.   
BOD5 was compared to the humic-like peak and region III.  It was concluded that these 
fluorescence parameters were not good surrogates for BOD5 because they are not associated 
with labile organic matter.  The removal efficiencies observed in this research show that less 
than 60% of humic-like fluorescence is removed during treatment, which supports the fact 
that it is not labile.  This can be extended to fulvic-like peaks and region II as well. 
It was concluded that region I and peak T were the best fluorescence parameters to 
correlate to BOD5 because they are the most related to biodegradable organic matter.  The 
removal efficiencies show that region I, peak T, and the protein peak had similar removal 
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efficiencies (<20%) in the primary clarifier, but they were much less than the observed BOD5 
removal (49%).  On the other hand, the average removal efficiencies of biological treatment 
(80-86%) and the entire treatment train (83-88%) were more similar to the observed BOD5 
removal (96% and 98%, respectively).  It is not known why there is a stark difference in 
removal efficiencies between fluorescence and BOD5 in the primary clarifier, but it may be 
due to either IFE quenching and/or the centrate return. If IFE were not occurring in the 
sample, then the observed influent and CABI fluorescence would have been higher.  The 
change in fluorescence would have been different, which could have potentially increased the 
removal efficiency making it more comparable to BOD5.  The other reason may be due to the 
return streams that increase the organic loading in the primary clarifier.  It is possible that 
some of the organic matter is fluorescent but not necessarily biodegradable. The impact 
would be an increase in fluorescence in region I, peak T, and protein peak in the primary 
clarifier, which would make the apparent removal seem less than it truly is. 
Part C: Method Development 
4.12 Interpretation of the t-test Results 
 T-tests were used to compare datasets for the holding time tests and for the 
integration time comparison.  The null hypothesis of the t-test was that the means were equal 
and the alternate hypothesis was that the means were not equal.  When the p value of the t-
test is greater the 0.05, then one accepts the null hypothesis as being plausible.  When p is 
less than 0.05, then null hypothesis is rejected and one accepts that the means are different. It 
is important to clarify that the t-test does not definitively say the means are equal, only that it 
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is plausible that they are equal.  The term “plausible” is used when the null hypothesis is 
accepted, rather that erroneously saying that the means are equal. 
4.13 Grouped BOD5 Data Holding Test 
 Samples were collected and analyzed for BOD5 in two groups.  One group was 
analyzed the same day it was collected and the other group of samples was stored overnight 
with headspace and analyzed the day after collection. The overnight samples were not tested 
the same day as collected and have no relation to the first group of samples; the two groups 
were sampled and analyzed independent of one another.  The results are presented in Figures 
4.49, 4.50, and 4.51.  Notice that the x-axis is labeled index, this is because the data were 
randomly plotted and they are not paired with anything.  The purpose of these plots was to 
illustrate the relative BOD5 values with one another for data collected and analyzed over a 
period-of-time.   
Figure 4.49 demonstrates that influent samples that were analyzed the same day had 
consistently higher BOD5 results compared with samples that were analyzed the following 
day and the two-sample t-test (p < 2.2e-16) shows that the mean values between the groups 
are different.  Figure 4.50 indicates that CABI samples also had higher BOD5 when they 
were analyzed the same day, although the discrepancy is not as pronounced compared with 
the influent.  Furthermore, the two-sample t-test indicated the sample groups were 
statistically different (p=3.53e-7).  Figure 4.51 shows that the effluent data were clustered on 
top of one another and most likely holding time did not impact the results.  A two sample t-
test indicated that the p=0.699, so it is plausible that the sample groups were the same.   
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The results indicate that holding the samples with a headspace overnight impacted 
BOD5 analysis of influent and CABI samples, but did not have a significant effect on effluent 
samples.  
 
 
Figure 4.49: Holding tests results for influent grouped BOD5 data.  
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Figure 4.50: Holding tests results for CABI grouped BOD5 data.  
 
Figure 4.51: Holding tests results for effluent grouped BOD5 data.  
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4.14 Holding Tests 
4.14.1 BOD5 Holding Test 
 In the previous section, two groups of BOD5 data were compared.  One group of 
samples was analyzed the same day and the other group was analyzed the following day, but 
the samples were not related to one another.  It was shown that influent and CABI 
systematically differ from one another, but effluent samples were plausibly similar. This 
section takes these results a step further to investigate how an individual sample result 
changes overnight when it is held overnight a) with headspace and b) without headspace.   
 Samples (influent, CABI, and effluent) were collected and analyzed the same day.  
The samples were then refrigerated overnight and reanalyzed the following day.  The influent 
sample was refrigerated overnight in two amber bottles, one that had headspace and another 
that did not have headspace.  The CABI sample was stored in an amber bottle with 
headspace.  The effluent sample was refrigerated overnight in a polyethylene cubitainer with 
headspace.  The results from the initial BOD5 analysis were directly compared with the 
sample counterpart analyzed the following day using the two-sample t-test.  Two trials were 
conducted to determine if there was consistency among the variations. 
Table 4.14 summarizes the mean and the standard deviations of the datasets.  It is 
clear that there was a downward trend of BOD5 between the results from day 1 and the 
results from day 2, which was consistent with the observations made in the grouped BOD5 
data.  The standard deviation and the t-test results are not reported for effluent in trial A 
because only two sample dilutions were valid.   
It is unsurprising that the observed BOD5 of samples held overnight is less than the 
BOD5 samples analyzed the same day that they were collected.  BOD is a first order reaction, 
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modeled by BODt=BODU(1-e-kt), where k values typically range from 0.12 to 0.23 day-1.  
The k value is the reaction rate of BOD and it increases as the fraction of soluble organic 
matter increases, but it is also temperature dependent (Tchobanoglous et al., 2003).  If a k 
value of 0.23 d-1 at 20°C is considered, then it can be approximated that 21% of the ultimate 
BOD is consumed during the first day, 68% is consumed by the fifth day, and 75% by the 
sixth day during incubation.  The reaction rate will be less under refrigerated conditions 
(4°C), because the k value will be lower due to the colder temperature.  In other words, when 
the sample is refrigerated overnight the k value is small and reaction rate is slower, but the k 
value will increase under incubation temperatures and increase the reaction rate.  In addition, 
some of the colloidal organic matter may be dissolved into the sample and become soluble, 
which will increase the k value and bias the BOD5 results high.  This is because bacteria are 
able to oxidize soluble organic matter easier than particulate or colloidal organic matter.   
The results in Table 4.15 indicate that influent and CABI samples that were held with 
headspace overnight significantly degraded.  The influent sample that was held without 
headspace in trial B was statistically different than the initial sample, but the results from trial 
A indicate that the means were plausibly the same.  
Influent and CABI samples have high microbe populations and concentrations of 
organic matter.  Microbes are consuming organics, despite refrigeration, during the holding 
time because there is oxygen present (i.e., there is a headspace).  This process is the same 
mechanism upon which the BOD5 test is based.  The headspace in the sample increases the 
amount of oxygen available (as opposed to samples stored without headspace), which further 
encourages microbial activity.  Effluent water has fewer microbes present and most of the 
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biodegradable BOD has already been used; therefore, the presence of oxygen via the 
headspace does not impact the measurement much.   
 
Table 4.14: Summary Statistics of the BOD5 Holding Test Trials for Influent, CABI, and 
Effluent 
  Trial A Trial B 
Sample Sample day 
Mean 
(mg/L) SD n 
Mean 
(mg/L) SD n 
Influent 
Day 1  327 3 4 236 16 4 
Day 2 without headspace 307 13 4 277 21 4 
Day 2 with headspace 226 12 4 188 7 4 
 
CABI Day 1 228 18 4 185 16 4 
Day 2 165 8 4 159 7 4 
 
Effluent Day 1 3.95 N/A 2 4.92 0.17 3 
Day 2 3.58 N/A 2 4.67 0.38 3 
 
 
Table 4.15: Summary of the t-test Results of the BOD5 Holding Test Trials for Influent, 
CABI, and Effluent 
BOD	  t-­‐test	  p	  value	  
Sample	   Test	   Trial	  A	   Trial	  B	  
Influent	   Day	  1	  vs	  Day	  2	  full	   0.0589	   0.0239	  
Day	  1	  vs	  Day	  2	  partial	   0.0003	   0.0043	  
	  CABI	   Day	  1	  vs	  Day	  2	  full	   0.0025	   0.0008	  
	  Effluent	   Day	  1	  vs	  Day	  2	  partial	   N/A	   0.3706	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4.14.2 COD Holding Test 
 The COD holding test was conducted similar to the BOD5 holding test.  Samples 
(influent, CABI, and effluent) were collected and analyzed the same day.  The samples were 
then refrigerated overnight.  Influent and CABI samples were stored both with and without 
headspace in amber glassware.  The effluent samples were stored overnight with headspace.   
Table 4.16 summarizes the means and standard deviations from the two trials 
conducted.  The results indicate the samples held overnight without headspace were similar 
to the samples analyzed the same day.  Samples that were stored with headspace deteriorated 
more quickly, and thus had smaller COD values than the initial analysis.   
 The t-test (Table 4.17) indicates that it is plausible that the means of the first day 
were the same as samples held overnight without headspace for both influent and CABI.  
Influent and CABI samples held with headspace had similar means in trial A and different 
means in trial B.  Similar to the BOD5 test, the effluent sample means were not statistically 
different.   
These results indicate that sample degradation is accelerated when samples are held 
overnight with headspace.  The degree of degradation can vary based on the sample and 
likely the amount of headspace (e.g., more headspace means more degradation), thus creating 
variability in whether or not the degradation significantly changes the quality of the sample.  
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Table 4.16: Summary Statistics of the COD Holding Test Trials for Influent, CABI, and 
Effluent Samples 
	  	   Trial	  A	   Trial	  B	  
Sample	   Sample	  day	  
Mean	  
(mg/L)	   SD	   n	  
Mean	  
(mg/L)	   SD	   n	  
Influent	  
Day	  1	  	   691	   22	   3	   683	   14	   3	  
Day	  2	  with	  headspace	   669	   10	   3	   668	   26	   3	  
Day	  2	  without	  headspace	   617	   5	   3	   663	   32	   3	  
	  	   	  	  
CABI	  
Day	  1	  	   396	   8	   3	   467	   1	   3	  
Day	  2	  with	  headspace	   389	   5	   3	   494	   22	   3	  
Day	  2	  without	  headspace	   373	   3	   3	   473	   26	   3	  
	  	  
Effluent	   Day	  1	   32	   2	   3	   30	   2	   3	  
Day	  2	   31	   1	   3	   32	   1	   3	  
 
 
Table 4.17: Results of the t-test for the COD Holding Test for Influent, CABI, and Effluent 
Samples 
COD	  t-­‐test	  p	  value	  
Sample	   Test	   Trial	  A	   Trial	  B	  
Influent	  
Day	  1	  vs	  Day	  2	  full	  bottle	   0.2253	   0.4531	  
Day	  1	  vs	  Day	  2	  partially	  full	  	   0.0243	   0.4041	  
Day	  2	  full	  vs	  Day	  2	  partially	  full	   0.0041	   0.8531	  
	  	  
CABI	  
Day	  1	  vs	  Day	  2	  full	  bottle	   0.2632	   0.1633	  
Day	  1	  vs	  Day	  2	  partially	  full	  	   0.0258	   0.7301	  
Day	  2	  full	  bottle	  vs	  Day	  2	  partially	  full	   0.0098	   0.3423	  
	  	  
Effluent	   Day	  1	  vs	  Day	  2	  partially	  full	  bottle	   0.2381	   0.1346	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4.14.3 Absorbance Holding Test 
Samples (influent, CABI, and effluent) were analyzed and compared similar to the 
BOD5 and COD holding tests.  Samples were analyzed the same day that they were collected 
and then reanalyzed the following day.  The results from the two analyses were compared 
using the two-sample t-test.   
 The wavelengths analyzed for the absorbance test ranged from 240 to 470 nm. The 
absorbance is summarized in Figures 4.52 (Trial A) and 4.53 (Trial B) for each sample that 
was analyzed in the trial.  As expected, the absorbance decreases as the treatment progresses, 
with the most considerable change in absorbance from CABI to effluent. The t-test was 
conducted for each wavelength spectrum (λ = 240 to 470 nm in 1 nm increments) measured 
in the experiment, as summarized in Table 4.18.  Overall, the samples were either statistically 
different or plausibly the same across the entire wavelength spectrum.  The only exception to 
this was the CABI sample, which was plausibly the same for part of the spectrum and 
different for the other part of the spectrum.   
 It appears that the influent sample did not degrade significantly when it was held 
overnight with and without headspace.  Variable results were observed in the CABI and 
effluent samples.  The absorbance tends not to change overnight for more polluted samples 
and becomes more variable as the sample progresses through treatment.  This is contradictory 
to the previous holding experiments.  Table 4.18 also reports the overall trend of the sample.  
The sample is undergoing different processes during the holding time, which can 
impact the sample in a variety of ways and thus create inconsistent and unpredictable results, 
as observed in these trials.  Biological activity is occurring that is oxidizing the organic 
substrate, which will bias the results low.  Also, some of the soluble colloidal matter is 
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becoming dissolved into the sample, which will bias the results high.  The rate that these 
mechanisms change the sample will vary depending on the sample, thus creating a situation 
where it is difficult to predict if and how the absorbance parameters will change.   
 
Table 4.18: Results of the Absorbance (λ = 240 to 470 nm) Holding Test Trials for Influent, 
CABI, and Effluent Samples 
Absorbance t-test results (comparison of mean) 
Sample Comparison Trial A Trial B 
Influent  
Day 1 vs Day 2 full Plausible for all λ Plausible for all λ 
Day 1 vs Day 2 partial Plausible for all λ Plausible for all λ 
Day 2 full vs Day 2 partial Plausible for all λ Plausible for all λ 
Trend in absorbance Increase all λ Decrease all λ 
  
CABI 
Day 1 vs Day 2 full Different for all λ Plausible for all λ 
Day 1 vs Day 2 partial Different for all λ Plausible for λ 470-313 nm Different for λ 314-240 nm 
Day 2 full vs Day 2 partial Plausible for all λ Plausible for λ 470-323 nm Different for λ 324-240 nm 
Trend in absorbance Increase all λ General decrease 
  
Effluent 
Day 1 vs Day 2 full Different for all λ Plausible for all λ 
Trend in absorbance Increase all λ Variable increase/decrease  
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Figure 4.52: Absorbance (λ = 240 to 470 nm) results for holding test trial A.  
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Figure 4.53: Absorbance (λ = 240 to 470 nm) results for holding test trial B.  
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4.14.4 Fluorescence Holding Test 
Samples (influent, CABI, and effluent) were analyzed and compared similar to the 
BOD5 and COD holding tests.  Samples were analyzed the same day that they were collected 
and then reanalyzed the following day.  The results from the two analyses were compared 
using the two-sample t-test.  It should be mentioned that samples were not diluted for this 
experiment; therefore, fluorescence quenching likely occurred with CABI and influent 
samples.  It is impossible to know how quenching impacted the results of day 1 and day 2, 
and if the degree of quenching was the same.  For simplicity, the following discussion 
assumes that quenching was the same for both days.  In actuality, quenching likely had more 
impact on samples analyzed the same day that they were collected, because the sample had 
more organic matter than when it was held overnight (i.e., biological degradation) and 
analyzed the following day. 
Tables 4.19 to 4.23 summarize the fluorescence results and the t-test p values. 
Interestingly, the influent trial A sample did not significantly degrade overnight when it was 
held both with and without headspace. The results from the overnight samples were also 
compared and it can be concluded that it is plausible that the overnight sample stored with 
headspace is the same as the overnight sample stored without headspace.  This was not true 
in the other trial conducted. There was degradation observed in the second influent trial, 
specifically for the parameters of region II, the humic-like peak, and peak A.  Recall that 
peak A is located in region II and the humic-like peak is located in region III; therefore, there 
are some inconsistencies with the results in terms of degradation over fluorescence areas.   
 The CABI sample degraded significantly when it was held overnight without 
headspace, and even more with headspace.  When the sample was held with headspace nearly 
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all of the fluorescence regions and peaks were lower than the previous day.  For samples held 
without headspace, degradation was inhibited by the lack of oxygen, but it affected region III 
in trial A (including the humic-like peak and peak C).  In trial B, sample degradation was 
observed in region I, region II, region III, the total of the regions, and peak A. The t-test also 
indicates that the overnight sample stored with headspace is not the same as the overnight 
sample without headspace in either of the trials. 
 The effluent samples were stored overnight without headspace for the fluorescence 
holding time tests. The results of the two trials indicate that the sample analyzed the first day 
was plausibly similar to the sample analyzed the following day. In both of the trials, region 
III was statistically different, indicating that it may be the most prone to degradation in 
effluent samples stored overnight.   
 The findings of the fluorescence holding tests were consistent with the previous COD 
and BOD5 holding tests.  This is an indication that all of the organic quantification methods 
are sensitive to the holding time and headspace.  The changes in fluorescence were 
inconsistent among the samples; therefore, it can be concluded that samples degrade 
overnight when stored, but it is not possible to make inferences about the type (e.g., specific 
peaks or regions) of degradation.    
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Table 4.19: Fluorescence Holding Test for Influent Trial A 
Influent - Trial A Hold Test (Fluorescence units in AFU) 
 Total 
Region 
I 
Region 
II 
Region 
III 
Proteins 
(280/331) 
Humic 
(342/436) 
A 
(260/450) 
C 
(330/450) 
T 
(275/340) 
Day 1 test run A 168,567 96,162 50,740 21,665 8.653 3.237 3.222 3.428 9.070 
Day 1 test run B 167,580 95,822 50,135 21,624 8.672 3.217 3.183 3.408 9.067 
Day 1 test run C 173,948 100,332 51,410 22,206 9.264 3.277 3.282 3.473 9.524 
  
Day 2 full bottle test run A 168,570 98,146 49,786 20,638 8.966 3.200 3.159 3.355 9.318 
Day 2 full bottle test run B 173,163 100,804 50,916 21,443 9.324 3.253 3.237 3.449 9.634 
Day 2 full bottle test run C 165,695 95,080 49,503 21,112 8.642 3.171 3.162 3.361 9.029 
  
Day 2 partially full test A 163,622 93,292 49,273 21,057 8.545 3.174 3.125 3.362 8.870 
Day 2 partially full test B 170,395 97,987 50,675 21,734 9.133 3.224 3.244 3.420 9.389 
Day 2 partially full test C 165,306 94,078 49,726 21,503 8.620 3.182 3.184 3.374 8.974 
  
T-test results for Day 1 vs 
Day 2 full bottle *0.778 *0.808 *0.290 *0.065 *0.704 *0.301 *0.324 *0.269 *0.669 
T-test results for Day 1 vs 
Day 2 partially full bottle *0.275 *0.321 *0.192 *0.217 *0.739 *0.101 *0.377 *0.124 *0.552 
T-test results Day 2 full 
bottle vs Day 2 partially 
full bottle 
*0.416 *0.260 *0.781 *0.297 *0.477 *0.636 *0.973 *0.933 *0.351 
* When p>0.05 accept the null hypothesis that the means are different. 
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Table 4.20: Fluorescence Holding Test for Influent Trial B 
Influent - Trial B Hold Test (Fluorescence units in AFU) 
 Total 
Region 
I 
Region 
II 
Region 
III 
Proteins 
(280/331) 
Humic 
(342/436) 
A 
(260/450) 
C 
(330/450) 
T 
(275/340) 
Day 1 test run A 158,088 89,819 49,026 19,243 7.913 3.035 3.184 3.005 8.441 
Day 1 test run B 158,575 90,149 49,031 19,394 7.932 3.021 3.171 3.031 8.465 
Day 1 test run C 165,943 95,374 50,472 20,096 8.648 3.079 3.263 3.146 9.061 
  
Day 2 full bottle test run A 152,702 87,652 46,399 18,651 7.941 2.944 2.974 2.895 8.375 
Day 2 full bottle test run B 152,198 87,118 46,365 18,715 7.886 2.945 3.004 2.912 8.340 
Day 2 full bottle test run C 155,362 89,445 46,877 19,040 8.204 2.970 3.036 2.946 8.585 
  
Day 2 partially full test A 149,550 84,754 45,991 18,805 7.651 2.957 3.035 2.955 8.142 
Day 2 partially full test B 147,902 83,597 45,548 18,757 7.553 2.943 3.050 2.941 8.026 
Day 2 partially full test C 150,452 85,252 46,082 19,118 7.777 2.963 3.085 3.023 8.214 
  
T-test results for Day 1 vs 
Day 2 full bottle *0.085 *0.165 0.017 *0.081 *0.603 0.019 0.007 *0.069 *0.392 
T-test results Day 1 vs Day 
2 partially full bottle 0.036 0.048 0.011 *0.106 *0.166 0.025 0.020 *0.175 *0.112 
T-test results Day 2 full 
bottle vs Day 2 partially 
full bottle 
0.032 0.018 0.045 *0.609 0.049 *0.938 *0.089 *0.148 0.036 
*When p>0.05 accept the null hypothesis that the means are different. 
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Table 4.21: Fluorescence Holding Test for CABI Trial A 
CABI - Trial A Hold Test (Fluorescence units in AFU) 
 Total 
Region 
I 
Region 
II 
Region 
III 
Proteins 
(280/331) 
Humic 
(342/436) 
A 
(260/450) 
C 
(330/450) 
T 
(275/340) 
Day 1 test run A 149,095 85,585 48,096 15,414 7.100 2.125 3.034 2.206 7.756 
Day 1 test run B 148,486 84,794 48,098 15,595 7.009 2.186 2.991 2.257 7.625 
Day 1 test run C 148,920 84,901 48,361 15,658 7.038 2.190 3.054 2.271 7.634 
  
Day 2 full bottle test run A 146,668 83,131 47,820 15,717 6.924 2.271 3.039 2.326 7.509 
Day 2 full bottle test run B 148,906 84,832 48,151 15,923 7.122 2.314 3.067 2.367 7.716 
Day 2 full bottle test run C 147,000 83,469 47,620 15,911 7.026 2.328 3.074 2.363 7.590 
  
Day 2 partially full test A 146,166 81,078 48,443 16,646 6.652 2.495 3.157 2.481 7.355 
Day 2 partially full test B 147,073 81,732 48,648 16,693 6.747 2.515 3.173 2.490 7.427 
Day 2 partially full test C 147,858 82,568 48,596 16,695 6.856 2.500 3.156 2.483 7.602 
  
T-test results for full bottle *0.196 *0.117 *0.164 0.041 *0.719 0.008 *0.207 0.015 *0.425 
T-test results for partially 
full bottle *0.053 0.006 0.030 0.003 0.023 0.002 0.013 0.006 *0.084 
T-test results Day 2 full 
bottle vs Day 2 partially 
full bottle 
*0.598 0.042 0.032 0.005 0.030 0.004 0.004 0.001 *0.208 
* When p>0.05 accept the null hypothesis that the means are different. 
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Table 4.22: Fluorescence Holding Test for CABI Trial B 
CABI - Trial B Hold Test (Fluorescence units in AFU) 
 Total 
Region 
I 
Region 
II 
Region 
III 
Proteins 
(280/331) 
Humic 
(342/436) 
A 
(260/450) 
C 
(330/450) 
T 
(275/340) 
Day 1 test run A 136,955 77,873 44,389 14,693 6.412 1.990 2.828 2.086 6.930 
Day 1 test run B 138,621 78,800 44,834 14,987 6.564 2.074 2.868 2.145 7.079 
Day 1 test run C 139,268 78,584 45,378 15,306 6.498 2.151 2.949 2.202 7.007 
  
Day 2 full bottle test run A 132,758 76,216 42,572 13,970 6.376 1.882 2.685 1.995 6.829 
Day 2 full bottle test run B 133,428 76,412 42,752 14,265 6.450 1.955 2.723 2.050 6.838 
Day 2 full bottle test run C 133,387 76,152 42,922 14,312 6.419 1.989 2.708 2.072 6.838 
  
Day 2 partially full test A 131,819 73,208 43,460 15,151 6.032 2.180 2.828 2.206 6.593 
Day 2 partially full test B 132,748 73,548 43,813 15,387 6.078 2.250 2.835 2.253 6.637 
Day 2 partially full test C 131,771 72,485 43,837 15,449 5.964 2.265 2.868 2.270 6.500 
  
T-test results for full bottle 0.012 0.012 0.011 0.025 *0.221 *0.091 0.030 *0.069 *0.058 
T-test results for partially 
full bottle 0.005 0.000 0.040 *0.193 0.002 *0.054 *0.403 *0.079 0.002 
T-test results Day 2 full 
bottle vs Day 2 partially 
full bottle 
*0.056 0.007 0.004 0.001 0.001 0.002 0.001 0.003 0.023 
* When p>0.05 accept the null hypothesis that the means are different. 
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Table 4.23: Fluorescence Holding Test for Effluent Trial A and Trial B 
Effluent - Trial A Hold Test (Fluorescence units in AFU) 
 Total 
Region 
I 
Region 
II 
Region 
III 
Proteins 
(280/331) 
Humic 
(342/436) 
A 
(260/450) 
C 
(330/450) 
T 
(275/340) 
Day 1 test run A 43,605 14,683 20,217 8,705 0.976 1.391 1.607 1.194 1.042 
Day 1 test run B 43,102 14,524 19,928 8,650 0.971 1.363 1.578 1.168 1.012 
Day 1 test run C 42,597 14,241 19,765 8,590 0.921 1.335 1.555 1.145 0.962 
  
Day 2 full bottle test A 42,686 14,456 19,721 8,509 0.930 1.360 1.561 1.162 0.974 
Day 2 full bottle test B 42,168 14,439 19,340 8,389 0.947 1.317 1.538 1.130 0.982 
Day 2 full bottle test C 41,907 14,279 19,268 8,360 0.923 1.311 1.516 1.114 0.949 
  
T-test results  *0.088 *0.568 *0.052 0.018 *0.332 *0.208 *0.106 *0.170 *0.257 
*Statistically significant at 95% 
          Effluent- Trial B Hold Test  
 Total 
Region 
I 
Region 
II 
Region 
III 
Proteins 
(280/331) 
Humic 
(342/436) 
A 
(260/450) 
C 
(330/450) 
T 
(275/340) 
Day 1 test run A 39,481 12,899 18,444 8,138 0.822 1.273 1.452 1.082 0.864 
Day 1 test run B 39,181 12,757 18,333 8,091 0.809 1.256 1.439 1.066 0.851 
Day 1 test run C 39,784 13,141 18,513 8,130 0.850 1.260 1.481 1.071 0.898 
  
Day 2 full bottle test A 38,180 12,435 17,873 7,873 0.801 1.234 1.429 1.042 0.831 
Day 2 full bottle test B 36,335 11,814 16,923 7,598 0.758 1.177 1.329 0.996 0.789 
Day 2 full bottle test C 38,304 12,752 17,729 7,824 0.872 1.205 1.420 1.021 0.890 
  
T-test results  *0.089 *0.149 *0.084 0.049 *0.676 *0.060 *0.170 0.046 *0.376 
* When p>0.05 accept the null hypothesis that the means are different. 
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4.14.5 Implications of the Holding Tests 
 The results of the holding tests show a systematic pattern.  Influent samples tend to be 
the most prone to degradation, but this is accelerated when the sample is stored with 
headspace.  CABI samples are also prone to degradation, but to a lesser degree than influent.  
The effluent tends to be the most consistent when held overnight.  Influent and CABI 
samples contain microorganisms and organic matter; therefore, they degrade more quickly 
than effluent, which has minimal microorganisms (due to the WWTP filtration process) and 
biodegradable organic matter (due to the WWTP biological treatment). 
As shown in the previous results sections, headspace impacts the quality of the results 
for samples held overnight.  There is more oxygen available to microbes to consume the 
substrate, thus decreasing the organics quantified during the experiments.  Despite the logic 
behind this, samples may be held with headspace for two reasons.  First, lab personal often 
ask that samples to be brought into the laboratory with headspace.  This headspace gives the 
analyst adequate room in the bottle to shake the sample and properly homogenize it to 
conduct their experiments.  Despite this request, it would be recommended that the samples 
be collected and transported to the lab without headspace.  Prior to analysis, the analyst 
should transfer the sample to a larger container.  The larger container can be used to 
homogenize the sample and partition it for different testing procedures.   
The second reason that an analyst may leave headspace in their sample container is 
because they do not fully understand the method and the sensitivity to experimental 
conditions.  Many people refer to various versions of the Standard Methods to obtain 
information to conduct their respective tests; the 21st edition (2005) was referenced for this 
research.  The organic quantification methods are in part 5000, and broken into the respective 
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subsections (i.e., COD, BOD, and TOC). A small part of the introduction of part 5000 refers 
the reader to part 1000, which addresses quality control and assurance measures.  A single 
paragraph in sample storage and preservation subsection of part 1000 addresses headspace, 
which the methods say is “important in preservation of samples with volatile organic 
compounds and radon” (Standard Methods, 2005).  An analyst that is performing a method 
that quantifies the aggregate organic matter can easily overlook this obscure reference to 
headspace.  Furthermore, the Standard Methods specifies volatile organic matter, which is 
not quantified in the BOD5 test.  These experiments have clearly demonstrated that 
headspace will accelerate the rate of biodegradable decomposition in the sample, which will 
bias the test results low.  Therefore, it would be highly recommended that the Standard 
Methods more directly address the issue of headspace in the context of each method.  The 
analyst will be far less likely to overlook the importance of the issue and it will provide for 
better quality control and assurance.   
Sample headspace brings up another issue that is related to the traditional composite 
process.  Samples are typically collected over a 24-hour period using a refrigerated 
compositor with a pump assembly that draws the water sample and then transfers it to a 
cubitainer via tubing.  The cubitainer is open to the atmosphere and it is full of air while the 
sample is being collected, slowly filling during each composite event.  Early event 
composites are prone to the most degradation, whereas composites that are collected later in 
the composite period are less prone to degradation due to time and air.  The degree of 
degradation is influenced by many factors including time, available oxygen, and temperature 
each of which are changing during the composite period (Tchobanoglous et al., 2003).  It can 
be concluded that the sample collection method is not ideal and a more proper method would 
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include collection containers that minimize air space, minimize exposure to the atmosphere, 
and expand as the sample fills the container.   
4.15 Fluorescence Integration Times 
 The integration time (i.e., amount of time that the detector stays open to capture light) 
of the fluorescence test will impact how long it takes to analyze the sample and also the 
quality of the results.  It was found that the time to analyze a sample was approximately 15 
minutes, 10 minutes, and 5 minutes for integration settings of 3 seconds, 2 seconds, and 1 
second.  Longer integration times will reduce the signal-noise ratio, but there is a point of 
diminishing return after 3 seconds, as discussed in the literature review.  Based on this 
information from the literature review, integration times of 1s, 2s, and 3s were compared. 
Two criteria were identified to compare the test results: the two sample t-test and the 
normalized standard deviation.  For the two-sample t-test, the samples were conservatively 
assumed to have unequal variance.  
Table 4.24 (influent), 4.25 (CABI), and 4.26 (effluent) present the raw data and the 
results of the t-test.  The influent has fewer parameters that are statistically significant 
compared with CABI and influent.  This sample is the most polluted with organic carbon, so 
it tends to be the most variable due to the sample matrix.  It is interesting to note that the 
parameters (total region, region I, A, and M) that were statistically significant for CABI and 
effluent were similar in the 3s and 2s integration comparison.  It is possible that some of the 
organic matter that caused the influent regions to be insignificant were removed or stabilized 
in the primary clarifier.   
Overall, the t-test shows that the results increase with higher integration times, which 
is expected because the detector is exposed to the sample longer.  Incrementally increasing 
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the integration times may have some use when trying to identify pollutants in the water, for 
instance there may be a minimum integration setting to identify particular pollutants.  For 
this research, all three integration settings quantified the peaks.  As such, the t-test was 
determined to be an inferior method to justify the integration setting for this research.   
The alternate method was to normalize the standard deviation to the mean of the 
samples. The literature suggested that protein-like peaks and tryptophan peaks were best to 
correlate to BOD5.  These two peaks and region I (related to protein-like peaks) were 
determined to be the primary baseline for comparison.  The normalized standard deviation 
(NSD) sharply decreased from when the integration time was increased to from 1 to 2 
seconds, but it was similar when the integration time was increase from 2 to 3 seconds.  The 
CABI data also indicated a general decrease from 1 to 2 seconds.  But there was an increase 
in the NSD from 2 to 3 seconds.  Observation of the data indicate that this may be due to 
lower value reported for test run A.  The integration times for 1s and 3s were compared for 
CABI indicate the NSD are similar, verifying the aforementioned observation.  A skewed 
data point was also reported in the effluent sample for the 2s integration. Comparison of the 
1s and 3s effluent integration times indicated a general decrease or similarity for the NSD.   
Excluding the skewed data, there seems to be a downward trend in NSD associated 
with increased integration times.  Therefore, it can be concluded that a 3 second integration 
time is preferred over 1 or 2 seconds for these datasets.  As mentioned, longer integration 
times increase the analysis time and they will not significantly reduce the signal to noise 
interference associated with the equipment, so it is unreasonable to consider longer 
integration times.  Based on this analysis, a 3 second integration time was implemented for 
the three sample sites in this research.  
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Table 4.24: Fluorescence Integration Results for Influent 
 
Influent (Fluorescence units in AFU) 
Setting Run Total Region I 
Region 
II 
Region 
III Proteins Humic A C M T 
3s 
integration 
Test run A 196,527 118,451 57,203 20,872 10.35 2.72 3.60 2.85 9.43 10.85 
Test run B 202,150 121,399 59,150 21,602 10.69 2.77 3.74 2.91 9.72 11.20 
Test run C 202,957 122,820 58,707 21,430 10.81 2.77 3.73 2.92 9.86 11.35 
  
          
  
2s 
integration 
Test run A 188,521 115,714 53,010 19,797 10.61 3.02 3.39 2.92 10.04 11.10 
Test run B 192,758 118,107 54,006 20,644 11.03 3.25 3.46 3.07 10.36 11.49 
Test run C 187,460 114,152 52,936 20,372 10.62 3.20 3.39 3.06 9.96 10.99 
  
          
  
1s 
integration 
Test run A 167,048 100,194 47,546 19,308 9.40 3.14 3.09 2.92 8.78 9.68 
Test run B 157,261 92,837 45,696 18,729 8.44 3.06 3.07 2.85 8.04 8.89 
Test run C 155,073 91,029 45,169 18,874 8.35 3.07 3.10 2.85 7.94 8.81 
  
          
  
2 sample  
t-test 
3s versus 2s 0.015 0.048 0.004 0.037 *0.500 0.022 0.010 *0.121 *0.062 *0.790 
3s versus 1s 0.002 0.004 0.000 0.001 0.019 0.001 0.004 *0.553 0.019 0.008 
2s versus 1s 0.007 0.009 0.003 0.016 0.015 *0.461 0.003 *0.086 0.009 0.008 
* When p>0.05 accept the null hypothesis that the means are different. 
Normalized 
SD 
3s 0.017 0.018 0.017 0.018 0.023 0.011 0.020 0.012 0.023 0.023 
2s 0.015 0.017 0.011 0.021 0.022 0.037 0.012 0.029 0.021 0.023 
1s 0.040 0.051 0.027 0.016 0.067 0.014 0.004 0.015 0.056 0.053 
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Table 4.25: Fluorescence Integration Results for CABI 
 
CABI (Fluorescence units in AFU) 
Setting Run Total Region I 
Region 
II 
Region 
III Proteins Humic A C M T 
3s 
integration 
Test run A 143,364 81,892 46,033 15,440 7.07 2.23 3.08 2.21 6.80 7.48 
Test run B 140,304 80,140 44,889 15,275 6.95 2.24 2.99 2.21 6.67 7.30 
Test run C 146,883 85,048 46,134 15,700 7.56 2.31 3.05 2.27 7.16 7.86 
  
          
  
2s 
integration 
Test run A 137,737 79,908 43,450 14,379 7.04 1.99 2.83 2.02 6.78 7.47 
Test run B 141,805 82,953 44,112 14,739 7.44 2.04 2.93 2.06 7.12 7.80 
Test run C 142,540 83,002 44,448 15,090 7.52 2.13 2.96 2.12 7.14 7.81 
  
          
  
1s 
integration 
Test run A 127,969 74,564 39,412 13,993 6.52 1.99 2.59 1.95 6.43 7.00 
Test run B 124,663 71,180 39,498 13,984 6.43 2.07 2.61 2.02 6.15 6.72 
Test run C  121,407   68,569   39,161   13,677  6.13 1.98 2.64 1.96 5.85 6.48 
  
          
  
2 sample  
t-test 
3s versus 2s *0.311 *0.830 0.031 0.048 *0.590 0.017 *0.050 0.011 *0.500 *0.4914 
3s versus 1s 0.002 0.009 0.002 0.001 0.026 0.003 0.001 0.001 0.030 0.0219 
2s versus 1s 0.003 0.011 0.002 0.035 0.008 *0.434 0.009 *0.065 0.016 0.0084 
 * When p>0.05 accept the null hypothesis that the means are different. 
Normalized 
SD 
3s 0.023 0.030 0.015 0.014 0.045 0.021 0.016 0.016 0.037 0.038 
2s 0.018 0.022 0.012 0.024 0.035 0.033 0.023 0.023 0.029 0.025 
1s 0.026 0.042 0.004 0.013 0.033 0.024 0.011 0.019 0.047 0.039 
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Table 4.26: Fluorescence Integration Results for Effluent 
 
Effluent (Fluorescence units in AFU) 
Setting Run Total  
Region 
I 
Region 
II 
Region 
III Proteins Humic A C M T 
3s 
integration 
Test run A 42,787 14,052 20,149 8,585 0.86 1.33 1.61 1.13 0.91 0.91 
Test run B 43,886 14,630 20,601 8,655 0.93 1.33 1.67 1.13 0.97 0.96 
Test run C 42,349 13,910 19,843 8,596 0.86 1.33 1.58 1.13 0.91 0.90 
  
          
  
2s 
integration 
Test run A 38,114 12,172 18,081 7,860 0.74 1.20 1.48 1.01 0.79 0.79 
Test run B 38,220 12,314 18,035 7,871 0.76 1.19 1.46 1.02 0.81 0.81 
Test run C 44,665 17,503 19,016 8,147 1.27 1.22 1.53 1.04 1.29 1.33 
  
          
  
1s 
integration 
Test run A 34,883 10,365 16,955 7,563 0.59 1.13 1.33 0.97 0.64 0.65 
Test run B 34,770 10,285 16,984 7,502 0.58 1.12 1.37 0.96 0.64 0.63 
Test run C 34,476 10,015 16,916 7,545 0.54 1.14 1.37 0.97 0.61 0.59 
  
          
  
2 sample  
t-test 
3s versus 2s *0.342 *0.920 0.012 0.016 *0.837 0.003 0.017 0.009 *0.856 *0.809 
3s versus 1s 0.002 0.001 0.004 0.000 0.001 0.001 0.002 0.000 0.001 0.000 
2s versus 1s *0.121 *0.164 0.046 0.041 *0.179 0.002 0.009 0.030 *0.177 *0.184 
  * When p>0.05 accept the null hypothesis that the means are different. 
Normalized 
SD 
3s 0.018 0.027 0.019 0.004 0.048 0.001 0.027 0.002 0.038 0.037 
2s 0.093 0.217 0.030 0.020 0.328 0.011 0.024 0.018 0.294 0.314 
1s 0.006 0.018 0.002 0.004 0.048 0.008 0.019 0.002 0.027 0.050 
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CHAPTER 5 
CONCLUSIONS 	  
 NPDES permits are used to regulate the organic pollution, as determined by the 
BOD5 test, discharged into the environment by wastewater treatment plants.  The BOD5 test 
takes five days to obtain the results, which makes it desirable to seek alternate test procedure 
methods.  In fact, treatment plants can seek approval through their NPDES permit-governing 
agency to use alternate test methods in lieu of the BOD5 method.  A review of the literature 
indicated that COD, TOC, fluorescence, and absorbance could be used as a surrogate for 
BOD5.  The primary benefit to these alternate test methods is that the results can be obtained 
quickly, typically within minutes or a few hours as opposed to the five days required for the 
BOD5 method.  In fact, on-line instrumentation is available for some of the alternate test 
procedures, which would allow treatment plants to estimate their BOD5 concentrations in 
real-time.  
 This research explored the use of the alternate methods as a surrogate for BOD5 using 
influent, primary clarifier effluent, and finished effluent samples that were collected from an 
operational wastewater treatment facility located in Nevada.  The uninhibited BOD5, COD, 
and TOC results were determined in accordance with the Standard Methods (2005).  Samples 
for the BOD5 and COD test were not filtered.  Samples that were used for the TOC test were 
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filtered through a 1.2-micron filter, acidified and sparged to remove the inorganics.  
Fluorescence was determined for an excitation range from 240 to 470 nm using 1-nm 
increments and a 3-second integration time.  The samples were filtered through a 0.7-micron 
filter, and they were not diluted.  Equipment corrections were used to correct for IFE and 
Rayleigh interference.  The fluorescence was also normalized to the area of the Raman peak 
at a 350 nm excitation wavelength.     
 Each of the methods quantifies organic matter differently.  BOD5 quantifies the 
biodegradable organic matter. COD quantifies more of the biodegradable organic matter than 
BOD5 as well as some inorganics, which is attributed to the harsh and effective oxidation of 
potassium dichromate.  TOC quantifies the organic carbon after mineralization to CO2.  
Fluorescence is arguably the most versatile method, because it can identify organic 
compounds based on their peaks (e.g., humic-like, fulvic-like, protein-like, etc.).  Absorbance 
is a measure of how much light is absorbed by a sample, which might be related to 
chromophores present in organic matter but can also be related to some inorganics as well.   
 Samples were analyzed the same day that they were collected for correlations 
between BOD5 and the alternate tests.  The correlations developed in this research have 
shown that COD can be correlated to BOD5 and used to predict the BOD5 of influent, 
primary clarifier effluent (i.e., CABI) and finished effluent.  The relationship between TOC 
and BOD5 was strong for the finished effluent, but weak for influent and CABI samples; 
therefore, TOC should not be used as a surrogate for those sample sites. Fluorescence was 
related to BOD5 based on data for region I and peak T using a power function.  Presumably, 
IFE interference quenched some of the fluorescence, particularly for the more concentrated 
samples (i.e., influent and CABI) and created a nonlinear relationship that caused this 
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research to differ from the literature.  It was concluded that humic-like and region III 
fluorescence are poor surrogates for BOD5 because they are not largely linked to 
biodegradable organic matter.   
 Interestingly, when the results of the correlation and the removal efficiencies are 
compared, it is shown that BOD5 correlates the best to alternate test procedures that have 
similar removal efficiencies.  This was true for COD, which had the most similar removal 
throughout the treatment process, and for TOC, which had the most similar removal during 
biological treatment.  Region I and protein/tryptophan-like peaks had similar removals during 
the biological process as well; the literature has suggested that these are the most related to 
the wastewater treatment process. Humic- and fulvic-like fluorescence are most related to 
nonbiodegradable organic matter, and they are not easily removed during treatment, which 
was also observed in this research.   
It was shown that labile and humic fluorescence were removed in the primary 
clarifier.  Protein-like fluorescence was effectively removed during biological treatment.  
Nearly half of the humic- and fulvic-like fluorescence was removed during the treatment 
processes, mostly during biological treatment.  It was observed that TOC, fulvic-like 
fluorescence, and absorbance increased in the primary clarifier, which was most likely due to 
the return flows associated with sludge treatment that are sent to the primary clarifiers.  
Although impossible to say with certainty, it is likely that these parameters are related 
because they exhibited similar increases in the primary clarifier and similar removal 
efficiency trends.   
Experiments were conducted to see if holding a sample overnight would impact the 
quality of the results.  It was determined that influent samples were the most prone to 
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degradation, which was followed by primary clarifier effluent samples.  The effluent sample 
was not as susceptible to degradation as the other samples.  It was also concluded that 
samples stored overnight with headspace degraded more than their counterpart that was not 
stored with headspace.  It can be concluded that the water matrix and the available air in the 
storage container have an impact on the sample when it is held overnight.    
In particular, influent and CABI samples have large concentrations of biodegradable 
organic matter and microorganisms. When these samples are analyzed following a day of 
storage, the results are biased low because the native microorganisms consume the organic 
matter and utilize ambient dissolved oxygen.  These findings are not novel, but they are 
extremely important.  It is not uncommon for lab analysts to ask sample handlers to bring in 
samples with headspace so that they can properly homogenize the sample.  It is 
recommended for the sample to be stored without headspace, and the lab analyst should 
transfer the sample to a larger container to be homogenized.  Additionally, samples are 
typically collected during a 24-hour composite period with a cubitainer.  Samples are 
deposited into the cubitainer through a lid opening, which is exposed to the environment.  
The cubitainer is initially full of air, and fills with each composite event.  A better composite 
method would be one that has a sample container that is not exposed to the environment and 
that is capable of expanding with each sample event.  This type of container would limit the 
excess oxygen in the sample and also prevent contamination from the environment.   
The second part of the method development explored the use of 1-, 2-, and 3-second 
fluorescence integration times.  The signal to noise ratio decreases as the integration time 
increases, but there is a point of diminishing return after 3 seconds.  Furthermore, the time 
that it takes to analyze a sample increases with increased integration times, so this must also 
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be considered.  Comparison of the integration times using the two-sample t-test was not 
practical, because the observed fluorescence will always increase with increased integration 
times.  Instead, the methods were compared using their normalized standard deviations.  It 
was concluded that the 3-second integration was the most practical for this research because 
it had the lowest normalized standard deviation for peaks related to BOD5. 
Future research should look into the changing ratios between BOD5 and the alternate 
test methods.  Previous researchers have identified BOD5/TOC and BOD5/COD ratios and 
discussed that this is a reason not to combine sample sites, but little has been done to 
embrace the change in ratio and consider it as part of a dynamic relationship as treatment 
progresses.  The use of fluorescence to characterize the wastewater may be a useful tool 
when investigating the relationships between BOD5, TOC, and COD.  For instance, this 
research showed that TOC was more related to fulvic-like fluorescence than biodegradable 
fluorescence, which made it a bad surrogate for influent and primary clarifier effluent BOD5 
which is related to biodegradable fluorescence.  TOC and BOD5 had similar removals during 
biological treatment, which may be an explanation as to why finished effluent correlated well 
in this research.   
The negative removals observed in this research were attributed to return flows 
associated with sludge treatment.  It is known that these flows are highly concentrated with 
BOD and TSS, although little is known about the organic characterization of the centrate.  
Future research should determine if centrate is characterized by biodegradable organic matter 
(e.g., COD or BOD5) or organic carbons (e.g., TOC).  The return flows can also be 
characterized as protein-, fulvic-, or humic-like with fluorescence spectroscopy.  A better 
understanding of the return flows can help plant operators understand if the flows are being 
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adequately treated when they are returned to the primary clarifier and if there is a buildup of 
organic matter during the process.  Furthermore, plant designers can determine if side stream 
treatment is a more adequate way to treat these return flows, particularly if the flows are not 
predominantly biodegradable organic matter.  This may also reduce the need for coagulants 
and precipitants in the primary clarifier, which would have an economical benefit.    
Standardized fluorescence methods do not exist, but fluorescence is gaining 
considerable attention for a wide range of uses.  Therefore, it is essential that standardized 
fluorescence settings be developed that address integration times, integration increments, 
how to address interferences, and acceptance of a standard (e.g., quinine sulfate).  This 
research showed that increases in integration time will increase the fluorescence results.   
Raman interference is overcome by normalizing the sample to a Raman peak or a Raman 
area.  IFE interference is overcome by software corrections, dilutions, or normalizing the data 
to a specific absorbance wavelength.  These arbitrary choices make it difficult to reproduce 
the results of other researchers, to decide which approaches to make during analysis, and to 
directly compare the results of different research projects.  For instance, dilution was not 
done in this research, which resulted in a nonlinear model that could not be compared with 
other research due to the IFE quenching interference. 
This research has shown that alternate methods, particularly COD and protein-like 
fluorescence, can be used as surrogate for BOD5.  WWTPs can develop correlations that are 
specific to their treatment plant and submit the information to their NPDES issuer to obtain 
permission to use an alternate test procedure in lieu of BOD5.  When WWTPs are developing 
their correlations, they should keep in mind the change in ratios, the removal efficiency of 
each unit process, and possible designs that can increase the organic loading (e.g., return 
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flows).  If a WWTP can successfully develop correlations, then BOD5 can be estimated 
rapidly, allowing the plant to make changes to the treatment process quickly and efficiently, 
which will save time and money and ultimately protect the environment from organic 
pollution.  	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Table A.1: Benchmark Data Collection Sheet for BOD5 Test 
BOD bottles prepared by:       First sample in:   
Read back completed by:       
First sample read 
back:   
Date sample tested:       Verify chlorine:   
  
Sample name 
(dup=duplicate) 
Volume 
Sample 
mL 
Volume 
Seed  
mL 
Temp 
°C 
Initial 
DO 
mg/L 
Final 
DO 
mg/L 
Initial-
Final DO 
mg/L 
Calculated 
BOD 
mg/L 
Blank dup. A  0 0           
Blank dup. B 0 0           
  
GGA A 6 2           
GGA B 6 2           
  
Seed Blank 1 3 0           
Seed Blank 2 5 0           
Seed Blank 3 7 0           
Seed Blank 4 10 0           
  
Date sample collected:   
 
pH Influent    
Data Set #:   
 
pH CABI     
    
pH Effluent    
                
Influent 1  2 0           
Influent 2  3 0           
Influent 3 5 0           
Influent dup A 3 0           
Influent dup B 3 0           
  
CABI 1 3 0           
CABI 2 5 0           
CABI 3 10 0           
  
Effluent dup 1 100 2           
Effluent dup 2 150 2           
Effluent	  dup	  3	   200	   2	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Table A.2: Sample Calculations for BOD5 Test 
BOD bottles prepared by: Evelyn  
 
First	  sample	  in:	   1030	  AM	  
Read back completed by: Evelyn  First	  sample	  read	  back:	   940	  AM	  
Date sample tested: 7/16/14  
 
Verify	  chlorine:	   0	  
  
Sample name 
Volume 
Sample 
(mL) 
Volume 
Seed 
(mL) 
Temp 
(°C) 
Initial 
DO 
(mg/L) 
Final 
DO 
(mg/L) 
Initial-
Final DO 
(mg/L) 
Calculated 
BOD 
(mg/L) 
Blank Dup A  0 0 18.2 8.78 8.78 0.00 OK water 
Blank Dup B 0 0 18.2 8.82 8.81 0.01 OK water 
*If Initial-final DO>0.2 mg/L, then the dilution water is inadequate for BOD test 
GGA A 6 2 18.3 8.77 3.75 5.02 210 
GGA B 6 2 18.3 8.78 3.66 5.12 215 
Average GGA BOD 212 
Is the GGA within reasonable limits? Yes 
BOD is based on the average for samples that had a minimum uptake of 2 mg/L but did not have a 
final DO<1.0 mg/L.  GGA standard is 198ppm ± 30.5 
Seed Blank 1 3 0 18.3 8.81 7.53 1.28 Unqualified 
Seed Blank 2 5 0 18.3 8.82 6.79 2.03 0.41 
Seed Blank 3 7 0 18.3 8.82 5.92 2.90 0.41 
Seed Blank 4 10 0 18.4 8.81 4.62 4.19 0.42 
Average seed strength 0.41 
Average seed strength is based on the average for samples that had a minimum uptake of 2 mg/L 
but did not have a final DO<1.0 mg/L 
  
pH Influent 7.39 
 Date sample collected 7/15/2014 pH CABI  7.24 
 
  
pH Effluent 7.90 
 
      
    
All of the averages are based on samples that had a minimum uptake of 2 mg/L but did not have a 
final DO<1.0 mg/L. 
Influent 1  2 0 18.4 8.81 6.97 1.84 Unqualified 
Influent 2  3 0 18.4 8.82 6.17 2.65 265 
Influent 3 5 0 18.4 8.80 3.00 5.80 348 
Influent Dup A 3 0 18.4 8.82 5.98 2.84 284 
Influent Dup B 3 0 18.4 8.81 5.61 3.20 320 
Average Influent BOD 304 
Standard deviation Influent BOD 37 
CABI 1 3 0 18.4 8.83 6.81 2.02 202 
CABI 2 5 0 18.5 8.81 5.86 2.95 177 
CABI 3 10 0 18.5 8.78 0.87 7.91 Unqualified 
Average CABI BOD 190 
Standard Deviation CABI BOD N/A 
Effluent dup 1 100 2 18.4 8.90 5.40 3.50 8.02 
Effluent dup 2 150 2 18.5 8.85 4.34 4.51 7.37 
Effluent dup 3 200 2 18.6 8.84 3.16 5.68 7.28 
Average Effluent BOD 7.56 
Standard Deviation Effluent BOD 0.40 
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Table A.3: Quality Control Parameter Check for BOD5 Samples 
Quality Control Parameter Check Pass Fail 
Dilution water blank does not deplete >0.2 mg/L ✔ ✕ 
GGA within 198±30.5 mg/L ✔ ✕ 
Replicates do not differ by >30% for high and low values ✔ ✕ 
Seed controls meet dilution criteria ✔ ✕ 
	  	  
Final DO must be >1 mg/L.  If all samples have a final 
DO<1mg/L, then report value as "greater than." Data 
points marked with "✕" are greater than values.  These 
values were not included in final correlation. 
✔ ✕ 
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Table A.4: Influent BOD5 Results with Quality Control Parameters (see Table A.3) 
BOD	  Results	  for	  Influent	  
Holding	  Time	  	  
(NR=Not	  reported	  due	  
to	  quality	  control	  fail)	  
Da
te
	  (2
01
4)
	  
M
on
th
/D
ay
	  
BO
D	  
(m
g/
L)
	  
St
an
da
rd
	  
De
vi
at
io
n	  
(S
D)
	  	  
N
or
m
al
ize
d	  
	  	  S
D	  
Di
lu
tio
n	  
W
at
er
	  	  
GG
A	  
Sa
m
pl
e	  
Re
pl
ic
at
es
	  
Se
ed
	  
Re
pl
ic
at
es
	  
Fi
na
l	  D
O
>1
	  
m
g/
L	  
NR	   6/5	   412	   N/A	   N/A	   ✕ ✕ ✕ ✕ ✓ 
NR	   6/10	   349	   18	   0.05	   ✕ ✓ ✓ ✓ ✓ 
NR	   6/11	   348	   19	   0.05	   ✕ ✓ ✓ ✓ ✓ 
NR	   6/18	   326	   36	   0.11	   ✕ ✕ ✓ ✓ ✓ 
NR	   6/19	   331	   27	   0.08	   ✕ ✕ ✓ ✓ ✓ 
NR	   6/19	   346	   25	   0.07	   ✕ ✕ ✓ ✓ ✓ 
NR	   6/20	   475	   N/A	   N/A	   ✕ ✕ N/A	   ✓ ✓ 
Overnight	   6/24	   318	   20	   0.06	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   6/25	   348	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   6/26	   384	   50	   0.13	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   6/27	   364	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/1	   227	   7	   0.03	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/2	   364	   42	   0.12	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/3	   355	   25	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/8	   275	   13	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/9	   337	   16	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/10	   289	   22	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/11	   376	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/15	   304	   37	   0.12	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/16	   359	   29	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/17	   321	   30	   0.09	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/18	   378	   22	   0.06	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/22	   281	   29	   0.10	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/23	   433	   30	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/24	   265	   18	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/25	   438	   53	   0.12	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/29	   226	   19	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/30	   549	   N/A	   N/A	   ✓ ✓ N/A	   ✓ ✓ 
Overnight	   7/31	   273	   13	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/1	   454	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/5	   260	   21	   0.08	   ✓ ✕ ✓ ✓ ✓ 
Same	  Day	   8/6	   447	   39	   0.09	   ✓ ✕ ✓ ✓ ✓ 
Overnight	   8/7	   312	   22	   0.07	   ✓ ✓ ✓ ✓ ✓ 
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Same	  Day	   8/6	   447	   39	   0.09	   ✓ ✕ ✓ ✓ ✓ 
Overnight	   8/7	   312	   22	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/8	   417	   8	   0.02	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/12	   245	   17	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/13	   336	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/14	   243	   14	   0.06	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/15	   379	   24	   0.06	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/19	   243	   9	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/20	   420	   36	   0.09	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/21	   250	   22	   0.09	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/22	   356	   14	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/26	   284	   39	   0.14	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/27	   510	   22	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/28	   293	   17	   0.06	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/29	   603	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   9/2	   332	   38	   0.11	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   9/3	   406	   59	   0.15	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   9/4	   225	   17	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   9/5	   359	   62	   0.17	   ✓ ✓ ✓ ✓ ✓ 
	  
Results	  from	  the	  holding	  test	  
Trial	  (not	  reported	  because	  of	  GGA	  failure)	  
Day	  1	   9/9	   457	   50	   0.11	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  with	  headspace	   9/10	   260	   20	   0.08	   ✓ ✕ ✓ ✓ ✓ 
*Day	  2	  influent	  was	  collected	  from	  a	  different	  aliquot	  &	  the	  GGA	  failed,	  so	  this	  was	  
not	  included	  in	  the	  final	  analysis.	  
Trial	  A	  
Day	  1	   9/11	   327	   3	   0.01	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  with	  headspace	   9/12	   226	   12	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  w/out	  
headspace	   9/12	   307	   13	   0.04	  
✓ ✓ ✓ ✓ ✓ 
Trial	  B	  
Day	  1	  (46)	   9/16	   236	   16	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  with	  headspace	   9/17	   188	   7	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  w/out	  
headspace	   9/17	   277	   21	   0.08	  
✓ ✓ ✓ ✓ ✓ 
Results	  from	  the	  solubility	  test	  (not	  reported)	  
Trial	  A	  
Day	  1	  unfiltered	   9/17	   277	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Day	  1	  filtered	   9/17	   63	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  unfiltered	  	   9/18	   231	   19	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  filtered	  	   9/18	   65	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
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Table A.5: CABI BOD5 Results with Quality Control Parameters (see Table A.3) 
BOD	  Results	  for	  CABI	  
Holding	  Time	  
(NR=Not	  reported	  due	  
to	  quality	  control	  fail)	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NR	   6/5	   N/A	   N/A	   N/A	   ✕ ✕ ✕ ✕ ✕ 
NR	   6/10	   242	   N/A	   N/A	   ✕ ✓ N/A	   ✓ ✓ 
NR	   6/11	   233	   N/A	   N/A	   ✕ ✓ N/A	   ✓ ✓ 
NR	   6/17	   217	   N/A	   N/A	   ✕ ✕ ✓ ✓ ✓ 
NR	   6/18	   224	   14	   0.06	   ✕ ✕ ✓ ✓ ✓ 
NR	   6/19	   235	   N/A	   N/A	   ✕ ✕ ✓ ✓ ✓ 
NR	   6/20	   221	   19	   0.09	   ✕ ✕ ✓ ✓ ✓ 
Overnight	   6/24	   199	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   6/25	   201	   16	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   6/26	   209	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   6/27	   206	   9	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/1	   149	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/2	   189	   13	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/3	   147	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/8	   172	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/9	   183	   10	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/10	   189	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/11	   209	   15	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/15	   190	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/16	   230	   19	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/17	   194	   13	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/18	   226	   11	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/22	   196	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/23	   283	   34	   0.12	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/24	   174	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/25	   194	   10	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/29	   183	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/30	   214	   17	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/31	   206	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/1	   196	   21	   0.11	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/5	   199	   N/A	   N/A	   ✓ ✕ ✓ ✓ ✓ 
Same	  Day	   8/6	   219	   4	   0.02	   ✓ ✕ ✓ ✓ ✓ 
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Overnight	   8/7	   197	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/8	   224	   8	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/12	   143	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/13	   158	   11	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/14	   165	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/15	   244	   16	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/19	   201	   0	   0.00	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/20	   206	   14	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/21	   177	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/22	   202	   11	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/26	   181	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
NR	   8/27	   255	   48	   0.19	   ✓ ✓ ✕ ✓ ✓ 
Overnight	   8/28	   179	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/29	   242	   24	   0.10	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   9/2	   174	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   9/3	   200	   13	   0.07	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   9/4	   150	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   9/5	   161	   4	   0.02	   ✓ ✓ ✓ ✓ ✓ 
	  
Results	  from	  the	  holding	  test	  
Trial	  (not	  reported	  because	  of	  GGA	  failure	  on	  day	  2)	  
Day	  1	   9/9	   198	   10	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  with	  headspace	   9/10	   143	   5	   0.03	   ✓ ✕ ✓ ✓ ✓ 
*Day	  2	  the	  GGA	  failed,	  so	  this	  was	  not	  included	  in	  the	  final	  analysis.	  
Trial	  A	  
Day	  1	   9/11	   228	   18	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  with	  headspace	   9/12	   165	   8	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Trial	  B	  
Day	  1	  	   9/16	   185	   4	   0.02	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  with	  headspace	   9/17	   159	   1	   0.01	   ✓ ✓ ✓ ✓ ✓ 	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Table A.6: Effluent BOD5 Results with Quality Control Parameters (see Table A.3) 
BOD	  Results	  for	  Effluent	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NR	   6/5/	   -­‐	   N/A	   N/A	   N/A	   ✕ ✕ ✕ ✕ ✕ 
NR	   6/10	   -­‐	   3.73	   N/A	   N/A	   ✕ ✓ ✓ ✓ ✓ 
NR	   6/11	   -­‐	   3.41	   N/A	   N/A	   ✕ ✓ ✓ ✓ ✓ 
NR	   6/17	   -­‐	   6.17	   N/A	   N/A	   ✕ ✕ ✓ ✓ ✓ 
NR	   6/18	   -­‐	   7.18	   N/A	   N/A	   ✕ ✕ ✓ ✓ ✓ 
NR	   6/19	   >	   8.16	   N/A	   N/A	   ✕ ✕ ✓ ✓ ✕ 
NR	   6/20	   >	   8.11	   N/A	   N/A	   ✕ ✕ ✓ ✓ ✕ 
NR	   6/24	   >	   7.49	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✕ 
NR	   6/25	   >	   7.66	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✕ 
NR	   6/26	   >	   8.07	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✕ 
NR	   6/27	   >	   8.08	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✕ 
Overnight	   7/1	   -­‐	   13.71	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/2	   -­‐	   4.30	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/3	   -­‐	   3.60	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/8	   -­‐	   3.83	   0.93	   0.24	   ✓ ✓ ✕ ✓ ✓ 
Same	  Day	   7/9	   -­‐	   3.28	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/10	   -­‐	   3.01	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/11	   -­‐	   3.33	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/15	   -­‐	   7.56	   0.40	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/16	   -­‐	   8.06	   0.37	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/17	   -­‐	   9.69	   0.39	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/18	   -­‐	   10.41	   0.43	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/22	   -­‐	   9.82	   0.51	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/23	   -­‐	   12.56	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/24	   -­‐	   12.32	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   7/25	   -­‐	   12.85	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   7/29	   -­‐	   17.61	   N/A	   N/A	   ✓ ✓ N/A	   ✓ ✓ 
Same	  Day	   7/30	   -­‐	   20.01	   N/A	   N/A	   ✓ ✓ N/A	   ✓ ✓ 
Overnight	   7/31	   -­‐	   16.61	   N/A	   N/A	   ✓ ✓ N/A	   ✓ ✓ 
Same	  Day	   8/1	   -­‐	   10.50	   0.40	   0.04	   ✓ ✓ ✓ ✓ ✓ 
NR	   8/5	   >	   23	   N/A	   N/A	   ✓ ✕ N/A	   ✓ ✕ 
NR	   8/6	   -­‐	   5.79	   0.28	   0.05	   ✓ ✕ ✓ ✓ ✓ 
Overnight	   8/7	   -­‐	   3.78	   0.41	   0.11	   ✓ ✓ ✓ ✓ ✓ 
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Same	  Day	   8/8	   -­‐	   3.80	   0.14	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/12	   -­‐	   5.77	   0.22	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/13	   -­‐	   6.39	   0.08	   0.01	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/14	   -­‐	   6.46	   0.16	   0.02	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/15	   -­‐	   8.00	   0.30	   0.04	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/19	   -­‐	   10.36	   0.49	   0.05	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/20	   -­‐	   11.72	   1.01	   0.09	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/21	   -­‐	   9.05	   0.69	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/22	   -­‐	   9.17	   1.22	   0.13	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/26	   -­‐	   6.29	   0.53	   0.08	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/27	   -­‐	   6.88	   1.10	   0.16	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   8/28	   -­‐	   6.47	   0.98	   0.15	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   8/29	   -­‐	   6.48	   0.38	   0.06	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   9/2	   -­‐	   6.06	   0.67	   0.11	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   9/3	   -­‐	   8.88	   0.22	   0.02	   ✓ ✓ ✓ ✓ ✓ 
Overnight	   9/4	   -­‐	   6.83	   0.12	   0.02	   ✓ ✓ ✓ ✓ ✓ 
Same	  Day	   9/5	   -­‐	   5.37	   0.12	   0.02	   ✓ ✓ ✓ ✓ ✓ 
Results	  from	  the	  holding	  test	  
Trial	  (not	  reported	  because	  of	  GGA	  failure	  day	  2)	  	  
Day	  1	   9/9	   -­‐	   3.95	   0.35	   0.09	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  with	  
headspace	   9/10	   -­‐	   3.55	   0.06	   0.02	   ✓ ✕ ✓ ✓ ✓ 
*Day	  2	  the	  GGA	  failed,	  so	  this	  was	  not	  included	  in	  the	  final	  analysis.	  
Trial	  A	  
Day	  1	   9/11	   -­‐	   3.95	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  with	  
headspace	   9/12	   -­‐	   3.58	   N/A	   N/A	   ✓ ✓ ✓ ✓ ✓ 
Trial	  B	  
Day	  1	   9/16	   -­‐	   4.92	   0.17	   0.03	   ✓ ✓ ✓ ✓ ✓ 
Day	  2	  with	  
headspace	   9/17	   -­‐	   4.67	   0.38	   0.08	   ✓ ✓ ✓ ✓ ✓ 	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Table B.1: Benchmark Data Collection Sheet for COD Test 
COD test prepared by:   
Read back completed by:   
Date sample collected:   
Date sample tested:   
Data Set #   
 
      
  Test run A Test run B Test run C 
High range blank   - - 
Influent       
CABI       
Control (500 mg/L)   - - 
  
Low range blank   - - 
Effluent       
Control 50 mg/L    - - 
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Table B.2: Sample Calculations for COD Test 	  
COD test prepared by: Evelyn 
  Read back completed 
by: Evelyn 
  Date sample collected: 8/19/14 
  Date sample tested: 8/19/14 
  
 
  
  
  
Test 
run A 
Test 
run B 
Test 
run C 
Average 
(mg/L) 
Standard 
Deviation 
High range blank 0 - - 0 N/A 
Influent 793 714 671 726 62 
CABI 503 431 424 453 44 
Control (500 mg/L) 496 - - 496 Control within reason 
 
Low range blank 0 - - 0 N/A 
Effluent 38 - - 38 N/A 
Control 50 mg/L  48 - - 48 Control within reason 	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Table B.3: Influent COD Results 	  
Compiled	  COD	  results	  for	  Influent	  
Analysis	  Day	  	  
NR=Not	  reported	  	  
(see	  notes)	  
Date	   COD	  (mg/L)	  
Standard	  
Deviation	  
(SD)	  
Normalized	  
SD	   Notes	  
NR	   6/17/14	   974	   157	   0.16	   BOD	  results	  invalid	  
NR	   6/18/14	   720	   122	   0.17	   BOD	  results	  invalid	  
NR	   6/19/14	   694	   92	   0.13	   BOD	  results	  invalid	  
NR	   6/20/14	   798	   52	   0.07	   BOD	  results	  invalid	  
Same	  Day	   6/24/14	   744	   7	   0.01	   	  	  
Same	  Day	   6/25/14	   748	   27	   0.04	   	  	  
Same	  Day	   6/26/14	   829	   71	   0.09	   	  	  
Same	  Day	   6/27/14	   668	   17	   0.03	   	  	  
Same	  Day	   7/1/14	   654	   39	   0.06	   	  	  
Same	  Day	   7/2/14	   674	   6	   0.01	   	  	  
Same	  Day	   7/3/14	   710	   16	   0.02	   	  	  
Same	  Day	   7/8/14	   692	   22	   0.03	   	  	  
Same	  Day	   7/9/14	   727	   29	   0.04	   	  	  
Same	  Day	   7/10/14	   728	   33	   0.05	   	  	  
Same	  Day	   7/11/14	   645	   17	   0.03	   	  	  
Same	  Day	   7/15/14	   646	   15	   0.02	   	  	  
Same	  Day	   7/16/14	   794	   113	   0.14	   	  	  
Same	  Day	   7/17/14	   755	   46	   0.06	   	  	  
Same	  Day	   7/18/14	   790	   78	   0.10	   	  	  
Same	  Day	   7/22/14	   714	   40	   0.06	   	  	  
Same	  Day	   7/23/14	   764	   16	   0.02	   	  	  
Same	  Day	   7/24/14	   737	   136	   0.18	   	  	  
Same	  Day	   7/25/14	   772	   N/A	   N/A	   	  	  
Same	  Day	   7/29/14	   637	   17	   0.03	   	  	  
Same	  Day	   7/30/14	   886	   95	   0.11	   	  	  
Same	  Day	   7/31/14	   621	   14	   0.02	   	  	  
Same	  Day	   8/1/14	   725	   32	   0.04	   	  	  
Same	  Day	   8/5/14	   639	   7	   0.01	   	  	  
Same	  Day	   8/6/14	   627	   12	   0.02	   	  	  
Same	  Day	   8/7/14	   727	   5	   0.01	   	  	  
Same	  Day	   8/8/14	   723	   24	   0.03	   	  	  
Same	  Day	   8/12/14	   657	   13	   0.02	   	  	  
Same	  Day	   8/13/14	   752	   59	   0.08	   	  	  
Same	  Day	   8/14/14	   704	   19	   0.03	   	  	  
Same	  Day	   8/15/14	   766	   41	   0.05	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Same	  Day	   8/19/14	   726	   62	   0.09	   	  	  
Same	  Day	   8/20/14	   779	   82	   0.11	   	  	  
Same	  Day	   8/21/14	   772	   37	   0.05	   	  	  
Same	  Day	   8/22/14	   706	   39	   0.06	   	  	  
Same	  Day	   8/26/14	   722	   49	   0.07	   	  	  
Same	  Day	   8/27/14	   706	   N/A	   N/A	   	  	  
Same	  Day	   8/28/14	   788	   N/A	   N/A	   	  	  
Same	  Day	   8/29/14	   747	   6	   0.01	   	  	  
Same	  Day	   9/2/14	   718	   21	   0.03	   	  	  
Same	  Day	   9/3/14	   772	   7	   0.01	   	  	  
Same	  Day	   9/4/14	   706	   17	   0.02	   	  	  
Same	  Day	   9/5/14	   771	   79	   0.10	   	  	  
Same	  Day	   9/9/14	   581	   19	   0.03	   	  	  
Same	  Day	   9/11/14	   676	   29	   0.04	   	  	  
Same	  Day	   9/16/14	   612	   16	   0.03	   	  	  
Holding	  Test	  results	  
Trial	  A	  
Day	  1	   9/30/14	   691	   22	   0.03	   	  	  
Day	  2	  without	  
headspace	   10/1/14	   669	   10	   0.01	   	  	  
Day	  2	  with	  
headspace	   10/1/14	   617	   5	   0.01	   	  	  
Trial	  B	  
Day	  1	   10/1/14	   683	   14	   0.02	   	  	  
Day	  2	  without	  
headspace	   10/2/14	   668	   26	   0.04	   	  	  
Day	  2	  with	  
headspace	   10/2/14	   663	   32	   0.05	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Table B.4: CABI COD Results 	  
Compiled	  COD	  results	  for	  CABI	  
Analysis	  Day	  	  
NR=Not	  
reported	  	  
(see	  notes)	  
Date	  	  
	  
COD	  
(mg/L)	  
Standard	  
Deviation	  
(SD)	  
Normalized	  
SD	   Notes	  
NR	   6/17/14	   410	   10	   0.02	   BOD	  results	  invalid	  
NR	   6/18/14	   413	   22	   0.05	   BOD	  results	  invalid	  
NR	   6/19/14	   364	   N/A	   N/A	   BOD	  results	  invalid	  
NR	   6/20/14	   431	   37	   0.09	   BOD	  results	  invalid	  
Same	  Day	   6/24/14	   438	   N/A	   N/A	   	  	  
Same	  Day	   6/25/14	   411	   22	   0.05	   	  	  
Same	  Day	   6/26/14	   450	   N/A	   N/A	   	  	  
Same	  Day	   6/27/14	   410	   13	   0.03	   	  	  
Same	  Day	   7/1/14	   382	   N/A	   N/A	   	  	  
Same	  Day	   7/2/14	   404	   N/A	   N/A	   	  	  
Same	  Day	   7/3/14	   343	   N/A	   N/A	   	  	  
Same	  Day	   7/8/14	   371	   5	   0.01	   	  	  
Same	  Day	   7/9/14	   401	   N/A	   N/A	   	  	  
Same	  Day	   7/10/14	   361	   3	   0.01	   	  	  
Same	  Day	   7/11/14	   387	   N/A	   N/A	   	  	  
Same	  Day	   7/15/14	   412	   12	   0.03	   	  	  
Same	  Day	   7/16/14	   424	   N/A	   N/A	   	  	  
Same	  Day	   7/17/14	   470	   61	   0.13	   	  	  
Same	  Day	   7/18/14	   399	   N/A	   N/A	   	  	  
Same	  Day	   7/22/14	   410	   15	   0.04	   	  	  
Same	  Day	   7/23/14	   419	   N/A	   N/A	   	  	  
Same	  Day	   7/24/14	   398	   34	   0.09	   	  	  
Same	  Day	   7/25/14	   374	   N/A	   N/A	   	  	  
Same	  Day	   7/29/14	   335	   9	   0.03	   	  	  
Same	  Day	   7/30/14	   362	   N/A	   N/A	   	  	  
Same	  Day	   7/31/14	   369	   10	   0.03	   	  	  
Same	  Day	   8/1/14	   339	   N/A	   N/A	   	  	  
Same	  Day	   8/5/14	   321	   6	   0.02	   	  	  
Same	  Day	   8/6/14	   355	   N/A	   N/A	   	  	  
Same	  Day	   8/7/14	   374	   8	   0.02	   	  	  
Same	  Day	   8/8/14	   386	   N/A	   N/A	   	  	  
Same	  Day	   8/12/14	   378	   N/A	   N/A	   	  	  
Same	  Day	   8/13/14	   398	   23	   0.06	   	  	  
Same	  Day	   8/14/14	   411	   N/A	   N/A	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Same	  Day	   8/15/14	   461	   17	   0.04	   	  	  
Same	  Day	   8/19/14	   453	   44	   0.10	   	  	  
Same	  Day	   8/20/14	   407	   N/A	   N/A	   	  	  
Same	  Day	   8/21/14	   473	   117	   0.25	   	  	  
Same	  Day	   8/22/14	   389	   N/A	   N/A	   	  	  
Same	  Day	   8/26/14	   431	   34	   0.08	   	  	  
Same	  Day	   8/28/14	   412	   25	   0.06	   	  	  
Same	  Day	   8/29/14	   405	   N/A	   N/A	   	  	  
Same	  Day	   9/2/14	   353	   6	   0.02	   	  	  
Same	  Day	   9/3/14	   370	   N/A	   N/A	   	  	  
Same	  Day	   9/4/14	   401	   30	   0.07	   	  	  
Same	  Day	   9/5/14	   377	   N/A	   N/A	   	  	  
Same	  Day	   9/9/14	   333	   10	   0.03	   	  	  
Same	  Day	   9/11/14	   462	   22	   0.05	   	  	  
Same	  Day	   9/16/14	   411	   13	   0.03	   	  	  
Holding	  Test	  results	  
Trial	  A	  
Day	  1	   9/30/14	   396	   8	   0.02	   	  	  
Day	  2	  without	  
headspace	   10/1/14	   389	   5	   0.01	   	  	  
Day	  2	  with	  
headspace	   10/1/14	   373	   3	   0.01	   	  	  
Trial	  B	  
Day	  1	   10/1/14	   467	   1	   0.00	   	  	  
Day	  2	  without	  
headspace	   10/2/14	   494	   22	   0.04	   	  	  
Day	  2	  with	  
headspace	   10/2/14	   473	   26	   0.05	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Table B.5: Effluent COD Results 
 
Compiled COD results for Effluent 
Analysis	  Day	  	  
NR=Not	  reported	  	  
(see	  notes) 
Date COD	  (mg/L) 
Standard	  
Deviation	  
(SD) 
Normalized	  
SD Notes 
NR 6/17/14 25 2 0.08 BOD results invalid 
NR 6/18/14 30 N/A N/A BOD results invalid 
NR 6/19/14 31 3 0.10 BOD results invalid 
NR 6/20/14 36 N/A N/A BOD results invalid 
NR 6/24/14 43 4 0.09 BOD results invalid 
NR 6/25/14 42 N/A N/A BOD results invalid 
NR 6/26/14 38 2 0.05 BOD results invalid 
NR 6/27/14 31 N/A N/A BOD results invalid 
Same Day 7/1/14 45 12 0.27   
Same Day 7/2/14 30 N/A N/A   
Same Day 7/3/14 26 3 0.12   
Same Day 7/8/14 25 N/A N/A   
Same Day 7/9/14 23 1 0.04   
Same Day 7/10/14 26 N/A N/A   
Same Day 7/11/14 22 0 0.00   
Same Day 7/15/14 36 N/A N/A   
Same Day 7/16/14 30 2 0.07   
Same Day 7/17/14 33 N/A N/A   
Same Day 7/18/14 32 1 0.03   
Same Day 7/22/14 32 N/A N/A   
Same Day 7/23/14 37 1 0.03   
Same Day 7/24/14 37 N/A N/A   
Same Day 7/25/14 44 31 0.70   
Same Day 7/29/14 45 N/A N/A   
Same Day 7/30/14 47 6 0.13   
Same Day 7/31/14 46 N/A N/A   
Same Day 8/1/14 39 3 0.08   
NR 8/5/14 79 N/A N/A BOD results invalid 
NR 8/6/14 28 1 0.04 BOD results invalid 
Same Day 8/7/14 28 N/A N/A   
Same Day 8/8/14 27 8 0.30   
Same Day 8/12/14 31 3 0.10   
Same Day 8/13/14 33 N/A N/A   
Same Day 8/14/14 30 1 0.03   
Same Day 8/15/14 34 N/A N/A   
Same Day 8/19/14 38 N/A N/A   
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Same Day 8/20/14 41 6 0.15   
NR 8/21/14 N/A N/A N/A COD control fail 
NR 8/22/14 N/A N/A N/A COD control fail 
NR 8/26/14 N/A N/A N/A COD control fail 
NR 8/27/14 N/A N/A N/A COD control fail 
Same Day 8/28/14 33 N/A N/A   
Same Day 8/29/14 29 3 0.10   
Same Day 9/2/14 26 N/A N/A   
Same Day 9/3/14 27 2 0.07   
Same Day 9/4/14 28 N/A N/A   
Same Day 9/5/14 23 1 0.04   
Same Day 9/9/14 23 4 0.17   
Same Day 9/11/14 23 2 0.09   
Same Day 9/16/14 26 2 0.08   
Holding Test results 
Trial A 
HT Day 1 9/30/14 32 2 0.06   
HT Day 2 10/1/14 31 1 0.03   
Trial B 
HT Day 1 10/1/14 30 2 0.07   
HT Day 2 10/2/14 32 1 0.03   
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Table C.1: Influent Fluorescence Results for EEM Regions 
Influent Fluorescence for EEM Regions 
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6/17/14 154,014 - - 89,317 - - 45,866 - - 18,831 - - 
6/18/14 158,201 - - 93,455 - - 46,628 - - 18,117 - - 
6/19/14 155,886 1,006 0.01 90,011 734 0.01 47,036 348 0.01 18,839 100 0.01 
6/20/14 151,805 - - 88,771 - - 45,734 - - 17,300 - - 
6/24/14 160,050 - - 93,514 - - 48,543 - - 17,993 - - 
6/25/14 148,609 2,854 0.02 85,366 1,930 0.02 44,713 579 0.01 18,529 348 0.02 
6/26/14 148,383 - - 84,495 - - 45,388 - - 18,500 - - 
6/27/14 154,449 - - 92,292 - - 44,824 - - 17,333 - - 
7/1/14 162,397 6,906 0.04 95,302 5,370 0.06 47,644 1,250 0.03 19,451 405 0.02 
7/2/14 138,287 - - 79,906 - - 41,359 - - 17,023 - - 
7/3/14 133,219 - - 74,931 - - 41,192 - - 17,096 - - 
7/8/14 154,768 - - 87,899 - - 47,758 - - 19,111 - - 
7/9/14 132,789 3,609 0.03 74,844 2,712 0.04 40,844 744 0.02 17,101 216 0.01 
7/10/14 155,388 - - 89,045 - - 47,597 - - 18,746 - - 
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7/11/14 157,035 - - 90,206  -  - 47,425 - - 19,403 - - 
7/15/14 132,394 389 0.00 74,909 186 0.00 40,773 395 0.01 16,713 129 0.01 
7/16/14 160,251 - - 94,085 - - 47,913 - - 18,253 - - 
7/17/14 143,573 - - 81,684 - - 44,250 - - 17,639 - - 
7/18/14 157,090 7,904 0.05 91,851 6,243 0.07 46,864 1,358 0.03 18,374 334 0.02 
7/22/14 168,667 - - 96,319 - - 52,136 - - 20,212 - - 
7/23/14 151,285 - - 85,666 - - 46,939 - - 18,680 - - 
7/24/14 129,777 - - 72,647 - - 40,452 - - 16,678 - - 
7/25/14 138,653 5,023 0.04 78,190 3,739 0.05 42,760 950 0.02 17,702 349 0.02 
7/29/14 163,611 - - 91,922 - - 50,981 - - 20,708 - - 
7/30/14 136,668 - - 76,028 - - 42,517 - - 18,122 - - 
7/31/14 142,652 232 0.00 80,021 640 0.01 44,091 280 0.01 18,539 304 0.02 
8/1/14 150,029 - - 84,071 - - 46,904 - - 19,055 - - 
8/5/14 147,493 - - 81,288 - - 48,572 - - 17,633 - - 
8/6/14 136,987 2,078 0.02 75,029 1,556 0.02 44,709 510 0.01 17,248 98 0.01 
8/7/14 137,214 - - 77,077 - - 42,743 - - 17,394 - - 
8/8/14 152,329 - - 87,389 - - 46,771 - - 18,169 - - 
8/12/14 138,227 - - 78,315 - - 42,064 - - 17,847 - - 
8/13/14 142,658 2,124 0.01 80,538 1,439 0.02 44,120 544 0.01 18,000 146 0.01 
8/14/14 141,729 - - 79,583 - - 44,122 - - 18,025 - - 
8/15/14 135,211 - - 77,032 - - 41,003 - - 17,176 - - 
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8/19/14 156,279 5,078 0.03 88,182 3,548 0.04 48,221 1,208 0.03 19,876 331 0.02 
8/20/14 152,895 - - 87,240 - - 46,871 - - 18,784 - - 
8/21/14 139,229 - - 77,936 - - 43,800 - - 17,492 - - 
8/22/14 163,934 4,492 0.03 94,464 3,347 0.04 49,436 995 0.02 20,034 194 0.01 
8/26/14 150,008 - - 85,531 - - 46,269 - - 18,208 - - 
8/27/14 149,008 - - 85,671 - - 44,644 - - 18,692 - - 
8/28/14 141,271 3,590 0.03 81,157 2,363 0.03 43,152 849 0.02 16,962 383 0.02 
8/29/14 139,583 - - 78,818 - - 43,208 - - 17,557 - - 
9/2/14 141,100 - - 79,505 - - 42,926 - - 18,669 - - 
9/3/14 142,990 4,674 0.03 82,060 3,417 0.04 42,930 864 0.02 18,000 468 0.03 
9/4/14 140,746 - - 79,563 - - 43,334 - - 17,850 - - 
9/5/14 140,398 - - 78,503 - - 43,963 - - 17,931 - - 
9/9/14 162,796 6,427 0.04 91,754 4,390 0.05 51,418 1,322 0.03 19,624 825 0.04 
9/11/14 168,182 - - 96,787 - - 51,881 - - 19,514 - - 
9/16/14 152,522 - - 84,233 - - 47,990 - - 20,300 - - 	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Table C.2: Influent Fluorescence Results for EEM Peaks 
Influent Fluorescence for EEM Peaks 
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6/17/14 8.026 - - 2.792 - - 3.143 - - 2.858 - - 8.534 - - 
6/18/14 8.697 - - 2.748 - - 3.048 - - 2.714 - - 9.129 - - 
6/19/14 8.266 0.065 0.01 2.849 0.011 0.00 3.173 0.019 0.01 2.850 0.037 0.01 8.795 0.041 0.00 
6/20/14 8.252 - - 2.722 - - 2.982 - - 2.591 - - 8.669 - - 
6/24/14 8.604 - - 2.785 - - 3.190 - - 2.692 - - 9.003 - - 
6/25/14 7.895 0.227 0.03 2.787 0.021 0.01 2.952 0.051 0.02 2.894 0.041 0.01 8.280 0.211 0.03 
6/26/14 7.892 - - 2.857 - - 3.173 - - 2.744 - - 8.377 - - 
6/27/14 8.638 - - 2.667 - - 2.913 - - 2.530 - - 9.120 - - 
7/1/14 8.635 0.680 0.08 2.984 0.058 0.02 3.154 0.053 0.02 2.917 0.076 0.03 9.197 0.600 0.07 
7/2/14 7.444 - - 2.648 - - 2.698 - - 2.578 - - 7.784 - - 
7/3/14 6.721 - - 2.672 - - 2.852 - - 2.658 - - 7.390 - - 
7/8/14 7.786 - - 3.002 - - 3.128 - - 2.927 - - 8.329 - - 
7/9/14 6.959 0.318 0.05 2.702 0.034 0.01 2.744 0.051 0.02 2.687 0.042 0.02 7.339 0.293 0.04 
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7/10/14 7.867 - - 3.008 - - 3.270 - - 2.752 - - 8.542 - - 
7/11/14 8.195 - - 3.088 - - 3.059 - - 3.009 - - 8.550 - - 
7/15/14 6.660 0.036 0.01 2.684 0.001 0.00 2.713 0.039 0.01 2.589 0.019 0.01 7.046 0.044 0.01 
7/16/14 8.764 - - 2.890 - - 3.160 - - 2.730 - - 9.177 - - 
7/17/14 7.537 - - 2.809 - - 3.082 - - 2.598 - - 8.064 - - 
7/18/14 8.466 0.798 0.09 2.898 0.081 0.03 2.995 0.095 0.03 2.777 0.055 0.02 8.907 0.703 0.08 
7/22/14 8.524 - - 3.181 - - 3.409 - - 3.182 - - 9.137 - - 
7/23/14 7.603 - - 2.939 - - 3.071 - - 2.877 - - 8.221 - - 
7/24/14 6.339 - - 2.645 - - 2.665 - - 2.625 - - 6.857 - - 
7/25/14 7.028 0.468 0.07 2.835 0.055 0.02 2.763 0.057 0.02 2.690 0.058 0.02 7.496 0.405 0.05 
7/29/14	   7.991 - - 3.323 - - 3.366 - - 3.260 - - 8.749 - - 
7/30/14	   6.723 - - 2.974 - - 2.787 - - 2.810 - - 7.217 - - 
7/31/14	   7.161 0.109 0.02 3.082 0.025 0.01 2.963 0.030 0.01 2.914 0.063 0.02 7.755 0.055 0.01 
8/1/14	   7.503 - - 3.143 - - 3.114 - - 2.906 - - 8.072 - - 
8/5/14	   6.753 - - 2.802 - - 3.301 - - 2.633 - - 7.264 - - 
8/6/14	   6.400 0.202 0.03 2.853 0.029 0.01 3.064 0.049 0.02 2.666 0.019 0.01 6.816 0.161 0.02 
8/7/14	   6.706 - - 2.935 - - 2.916 - - 2.677 - - 7.259 - - 
8/8/14	   7.860 - - 2.917 - - 3.056 - - 2.737 - - 8.353 - - 
8/12/14	   7.255 - - 2.993 - - 2.952 - - 2.705 - - 7.816 - - 
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8/13/14	   7.208 0.165 0.02 3.017 0.040 0.01 2.963 0.064 0.02 2.789 0.031 0.01 7.769 0.163 0.02 
8/14/14	   6.898 - - 3.057 - - 2.920 - - 2.790 - - 7.573 - - 
8/15/14	   6.800 - - 2.863 - - 2.689 - - 2.643 - - 7.474 - - 
8/19/14	   8.072 0.478 0.06 3.209 0.052 0.02 3.247 0.086 0.03 3.130 0.063 0.02 8.543 0.448 0.05 
8/20/14	   7.995 - - 3.124 - - 3.171 - - 2.890 - - 8.506 - - 
8/21/14	   6.955 - - 2.884 - - 3.019 - - 2.657 - - 7.404 - - 
8/22/14	   8.646 0.387 0.04 3.282 0.038 0.01 3.340 0.067 0.02 3.101 0.029 0.01 9.250 0.375 0.04 
8/26/14	   7.756 - - 2.987 - - 3.147 - - 2.725 - - 8.252 - - 
8/27/14	   7.948 - - 3.155 - - 3.059 - - 2.865 - - 8.558 - - 
8/28/14	   7.663 0.319 0.04 2.722 0.094 0.03 2.899 0.053 0.02 2.497 0.078 0.03 7.977 0.253 0.03 
8/29/14	   7.213 - - 2.845 - - 2.902 - - 2.652 - - 7.623 - - 
9/2/14	   7.304 - - 2.935 - - 2.884 - - 2.993 - - 7.765 - - 
9/3/14	   7.606 0.440 0.06 2.979 0.095 0.03 2.872 0.083 0.03 2.716 0.092 0.03 8.093 0.387 0.05 
9/4/14	   7.002 - - 2.883 - - 2.813 - - 2.763 - - 7.570 - - 
9/5/14	   7.029 - - 2.905 - - 2.893 - - 2.757 - - 7.703 - - 
9/9/14	   8.148 0.599 0.07 3.162 0.186 0.06 3.522 0.069 0.02 2.969 0.149 0.05 8.917 0.513 0.06 
9/11/14	   8.577 - - 3.219 - - 3.366 - - 3.025 - - 9.230 - - 
9/16/14	   7.470 - - 3.114 - - 3.139 - - 3.145 - - 7.899 - - 	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Table C.3: CABI Fluorescence Results for EEM Regions 
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6/17/14 137,527 - - 76,779 - - 45,027 - - 15,721 - - 
6/18/14 130,453 891 0.01 71,914 761 0.01 43,431 162 0.00 15,108 106 0.01 
6/19/14 134,736 - - 75,298 - - 44,601 - - 14,837 - - 
6/20/14 139,907 - - 77,718 - - 46,708 - - 15,481 - - 
6/24/14 130,773 1,946 0.01 72,811 1,535 0.02 43,110 393 0.01 14,852 54 0.00 
6/25/14 124,425 - - 67,812 - - 42,086 - - 14,527 - - 
6/26/14 125,034 - - 68,784 - - 41,475 - - 14,775 - - 
6/27/14 124,477 4,784 0.04 69,242 4,210 0.06 40,721 459 0.01 14,514 170 0.01 
7/1/14 136,143 - - 76,105 - - 44,882 - - 15,156 - - 
7/2/14 126,038 - - 68,737 - - 42,485 - - 14,815 - - 
7/3/14 118,053 - - 64,052 - - 39,680 - - 14,321 - - 
7/8/14 143,299 4,580 0.03 79,854 3,436 0.04 47,472 898 0.02 15,973 323 0.02 
7/9/14 121,258 - - 66,498 - - 40,920 - - 13,840 - - 
7/10/14 142,101 978 0.01 78,592 806 0.01 47,138 196 0.00 16,371 143 0.01 
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7/11/14 141,137 - - 79,766 - - 45,777 - - 15,594 - - 
7/15/14 121,297 - - 68,179 - - 39,384 - - 13,733 - - 
7/16/14 137,438 2,317 0.02 77,475 2,010 0.03 44,718 279 0.01 15,246 172 0.01 
7/17/14 127,718 - - 71,154 - - 41,918 - - 14,646 - - 
7/18/14 124,474 - - 68,881 - - 41,409 - - 14,183 - - 
7/22/14 144,556 4,026 0.03 81,563 3,143 0.04 47,162 809 0.02 15,830 195 0.01 
7/23/14 135,883 - - 74,627 - - 45,472 - - 15,785 - - 
7/24/14 112,766 1,682 0.01 61,091 1,419 0.02 38,059 261 0.01 13,616 129 0.01 
7/25/14 121,237 - - 66,250 - - 40,464 - - 14,523 - - 
7/29/14 141,369 - - 78,178 - - 47,142 - - 16,050 - - 
7/30/14 117,008 2,602 0.02 63,194 1,969 0.03 39,526 494 0.01 14,288 168 0.01 
7/31/14 127,629 - - 70,389 - - 42,451 - - 14,789 - - 
8/1/14 127,832 - - 69,863 - - 42,937 - - 15,032 - - 
8/5/14 133,961 3,242 0.02 72,532 3,192 0.04 46,052 223 0.00 15,377 192 0.01 
8/6/14 127,896 - - 68,386 - - 45,315 - - 14,195 - - 
8/7/14 137,372 - - 76,540 - - 45,873 - - 14,960 - - 
8/8/14 135,511 1,313 0.01 74,966 1,017 0.01 45,324 236 0.01 15,221 96 0.01 
8/12/14 136,109 - - 74,857 - - 45,719 - - 15,533 - - 
8/13/14 137,582 - - 75,614 - - 46,029 - - 15,938 - - 
8/14/14 136,119 1,319 0.01 76,824 1,355 0.02 44,492 211 0.00 14,804 233 0.02 
8/15/14 124,762 - - 68,498 - - 41,317 - - 14,946   0.00 
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8/19/14 143,132 - - 82,066 - - 46,062 - - 15,005 - - 
8/20/14 135,746 1,533 0.01 74,691 1,343 0.02 45,565 194 0.00 15,490 150 0.01 
8/21/14 122,801 - - 68,202 - - 40,661 - - 13,938 - - 
8/22/14 138,748 - - 78,313 - - 45,355 - - 15,080 - - 
8/26/14 132,301 1,454 0.01 73,905 1,266 0.02 43,566 249 0.01 14,830 116 0.01 
8/27/14 137,808 - - 77,625 - - 44,986 - - 15,196 - - 
8/28/14 127,180 - - 70,789 - - 42,051 - - 14,340 - - 
8/29/14 123,701 1,401 0.01 69,092 814 0.01 40,595 417 0.01 14,013 241 0.02 
9/2/14 132,810 - - 74,633 - - 43,552 - - 14,625 - - 
9/3/14 134,248 - - 75,624 - - 43,967 - - 14,658 - - 
9/4/14 126,105 - - 69,819 - - 42,055 - - 14,231 - - 
9/5/14 125,865 542 0.00 68,985 350 0.01 42,446 170 0.00 14,435 96 0.01 
9/9/14 151,819 - - 82,375 - - 51,727 - - 17,717 - - 
9/11/14 154,048 - - 90,098 - - 48,311 - - 15,639 - - 
9/16/14 139,556 - - 78,700 - - 45,246 - - 15,610 - - 	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Table C.4: CABI Fluorescence Results for EEM Peaks 
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6/17/14 6.560 - - 2.252 - - 3.195 - - 2.197 - - 7.000 - - 
6/18/14 6.151 0.086 0.01 2.192 0.028 0.01 3.081 0.026 0.01 2.141 0.029 0.01 6.638 0.080 0.01 
6/19/14 6.415 - - 2.085 - - 3.087 - - 2.084 - - 6.901 - - 
6/20/14 6.717 - - 2.236 - - 3.257 - - 2.228 - - 7.235 - - 
6/24/14 6.324 0.138 0.02 2.140 0.013 0.01 2.999 0.024 0.01 2.145 0.034 0.02 6.741 0.150 0.02 
6/25/14 5.764 - - 2.043 - - 3.020 - - 2.014 - - 6.319 - - 
6/26/14 5.866 - - 2.116 - - 2.972 - - 2.051 - - 6.383 - - 
6/27/14 5.795 0.334 0.06 2.020 0.043 0.02 2.852 0.042 0.01 1.981 0.029 0.01 6.361 0.364 0.06 
7/1/14 6.529 - - 2.191 - - 3.083 - - 2.141 - - 7.072 - - 
7/2/14 5.808 - - 2.116 - - 2.889 - - 2.089 - - 6.309 - - 
7/3/14 5.391 - - 2.141 - - 2.761 - - 2.070 - - 5.951 - - 
7/8/14 6.674 0.371 0.06 2.296 0.051 0.02 3.162 0.058 0.02 2.271 0.039 0.02 7.220 0.341 0.05 
7/9/14 5.697 - - 1.964 - - 2.714 - - 1.961 - - 6.059 - - 
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7/10/14 6.562 0.092 0.01 2.300 0.052 0.02 3.213 0.010 0.00 2.237 0.034 0.02 7.115 0.077 0.01 
7/11/14 6.792 - - 2.189 - - 3.045 - - 2.188 - - 7.266 - - 
7/15/14 5.829 - - 1.931 - - 2.641 - - 1.895 - - 6.290 - - 
7/16/14 6.770 0.281 0.04 2.168 0.049 0.02 2.984 0.011 0.00 2.140 0.035 0.02 7.195 0.257 0.04 
7/17/14 6.197 - - 2.154 - - 2.842 - - 2.062 - - 6.591 - - 
7/18/14 5.852 - - 2.003 - - 2.775 - - 1.980 - - 6.324 - - 
7/22/14 7.076 0.437 0.06 2.263 0.046 0.02 3.185 0.057 0.02 2.217 0.034 0.02 7.683 4.451 0.58 
7/23/14 6.317 - - 2.383 - - 3.108 - - 2.261 - - 6.853 - - 
7/24/14 5.224 0.206 0.04 2.006 0.043 0.02 2.657 0.017 0.01 1.921 0.035 0.02 5.683 0.157 0.03 
7/25/14 5.586 - - 2.132 - - 2.732 - - 2.082 - - 6.099 - - 
7/29/14	   6.622 - - 2.336 - - 3.230 - - 2.277 - - 7.217 - - 
7/30/14	   5.411 0.249 0.05 2.056 0.047 0.02 2.716 0.036 0.01 1.991 0.039 0.02 5.875 0.215 0.04 
7/31/14	   6.083 - - 2.150 - - 2.940 - - 2.070 - - 6.641 - - 
8/1/14	   5.994 - - 2.198 - - 3.020 - - 2.130 - - 6.576 - - 
8/5/14	   5.989 0.409 0.07 2.204 0.076 0.03 3.222 0.004 0.00 2.159 0.054 0.03 6.265 0.501 0.08 
8/6/14	   5.230 - - 2.019 - - 2.997 - - 2.052 - - 5.623 - - 
8/7/14	   6.128 - - 2.133 - - 2.963 - - 2.138 - - 6.650 - - 
8/8/14	   6.135 0.119 0.02 2.196 0.023 0.01 3.006 0.008 0.00 2.191 0.018 0.01 6.714 0.115 0.02 
8/12/14	   6.227 - - 2.233 - - 3.049 - - 2.223 - - 6.929 - - 
8/13/14	   6.342 - - 2.405 - - 3.103 - - 2.355 - - 6.918 - - 
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8/14/14	   6.641 0.182 0.03 2.098 0.071 0.03 3.047 0.035 0.01 2.070 0.054 0.03 7.137 0.161 0.02 
8/15/14	   5.998 - - 2.218 - - 2.992 - - 2.113 - - 6.555 - - 
8/19/14	   7.028 - - 2.109 - - 2.998 - - 2.127 - - 7.544 - - 
8/20/14	   6.287 0.150 0.02 2.271 0.036 0.02 3.100 0.017 0.01 2.248 0.026 0.01 6.756 0.174 0.03 
8/21/14	   5.781 - - 1.997 - - 2.721 - - 2.012 - - 6.159 - - 
8/22/14	   6.666 - - 2.148 - - 3.053 - - 2.148 - - 7.224 - - 
8/26/14	   6.292 0.175 0.03 2.146 0.034 0.02 2.940 0.017 0.01 2.133 0.027 0.01 6.817 0.200 0.03 
8/27/14	   6.669 - - 2.191 - - 3.053 - - 2.172 - - 7.246 - - 
8/28/14	   6.027 - - 2.057 - - 2.883 - - 2.049 - - 6.408 - - 
8/29/14	   5.881 0.092 0.02 1.976 0.067 0.03 2.741 0.041 0.01 1.973 0.051 0.03 6.258 0.094 0.01 
9/2/14	   6.172 - - 2.098 - - 2.769 - - 2.126 - - 6.637 - - 
9/3/14	   6.252 - - 2.044 - - 2.857 - - 2.076 - - 6.757 - - 
9/4/14	   5.671 - - 1.962 - - 2.710 - - 2.010 - - 6.156 - - 
9/5/14	   5.747 0.061 0.01 2.040 0.032 0.02 2.789 0.047 0.02 2.063 0.025 0.01 6.275 0.071 0.01 
9/9/14	   6.858 - - 2.539 - - 3.586 - - 2.517 - - 7.497 - - 
9/11/14	   7.901 - - 2.149 - - 3.108 - - 2.225 - - 8.388 - - 
9/16/14	   6.562 - - 2.147 - - 2.883 - - 2.180 - - 7.022 - - 
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  C.5:	  Effluent	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  Results	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6/17/14 55,353 3,622 0.07 24,500 3,293 0.13 21,457 226 0.01 9,397 204 0.02 
6/18/14 42,369 - - 13,970 - - 19,963 - - 8,436 - - 
6/19/14 44,655 - - 15,275 - - 20,594 - - 8,786 - - 
6/20/14 41,647 1,049 0.03 13,556 623 0.05 19,638 316 0.02 8,453 116 0.01 
6/24/14 44,670 - - 14,481 - - 20,794 - - 9,395 - - 
6/25/14 44,012 - - 15,274 - - 20,370 - - 8,368 - - 
6/26/14 44,893 312 0.01 15,336 257 0.02 20,879 245 0.01 8,677 76 0.01 
6/27/14 43,309 - - 15,042 - - 19,856 - - 8,410 - - 
7/1/14 47,276 - - 16,243 - - 22,175 - - 8,858 - - 
7/2/14 41,689 - - 13,938 - - 19,530 - - 8,222 - - 
7/3/14 41,647 1,049 0.03 13,556 623 0.05 19,638 316 0.02 8,453 116 0.01 
7/8/14 43,067 - - 14,312 - - 20,373 - - 8,382 - - 
7/9/14 34,236 - - 9,235 - - 17,455 - - 7,545 - - 
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7/10/14 43,170 - - 14,377 - - 20,215 - - 8,578 - - 
7/11/14 40,734 157 0.00 13,233 55 0.00 19,539 103 0.01 7,962 30 0.00 
7/15/14 35,750 - - 11,842 - - 16,830 - - 7,077 - - 
7/16/14 42,951 - - 14,290 - - 20,338 - - 8,322 - - 
7/17/14 38,713 174 0.00 12,690 77 0.01 18,345 72 0.00 7,678 26 0.00 
7/18/14 39,929 - - 13,143 - - 18,878 - - 7,909 - - 
7/22/14 43,802 - - 14,575 - - 20,808 - - 8,419 - - 
7/23/14 45,137 83 0.00 14,956 75 0.01 21,560 166 0.01 8,620 37 0.00 
7/24/14 39,126 - - 12,833 - - 18,613 - - 7,680 - - 
7/25/14 43,375 - - 14,499 - - 20,489 - - 8,387 - - 
7/29/14 49,998 790 0.02 16,960 174 0.01 23,937 434 0.02 9,102 193 0.02 
7/30/14 43,239 - - 14,632 - - 20,423 - - 8,184 - - 
7/31/14 48,163 - - 16,784 - - 22,680 - - 8,699 - - 
8/1/14 46,361 1,114 0.02 16,918 899 0.05 20,851 207 0.01 8,592 18 0.00 
8/5/14 51,888 - - 15,448 - - 25,597 - - 10,843 - - 
8/6/14 35,767 - - 7,672 - - 20,106 - - 7,990 - - 
8/7/14 39,750 415 0.01 13,021 161 0.01 18,955 222 0.01 7,775 62 0.01 
8/8/14 39,853 - - 13,008 - - 19,014 - - 7,831 - - 
8/12/14 40,383 125 0.00 13,495 67 0.01 19,045 77 0.00 7,843 22 0.00 
8/13/14 42,279 - - 14,018 - - 20,005 - - 8,256 - - 
8/14/14 41,875 - - 13,717 - - 19,982 - - 8,176 - - 
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8/15/14 40,244 326 0.01 13,399 335 0.03 18,984 20 0.00 7,860 11 0.00 
8/19/14 46,869 - - 16,727 - - 21,288 - - 8,854 - - 
8/20/14 45,235 - - 14,223 - - 22,225 - - 8,787 - - 
8/21/14 45,665 978 0.02 17,002 885 0.05 20,203 97 0.00 8,460 15 0.00 
8/22/14 50,373 - - 19,097 - - 22,338 - - 8,939 - - 
8/26/14 45,327 - - 16,528 - - 20,464 - - 8,335 - - 
8/27/14 48,215 569 0.01 18,220 445 0.02 21,426 78 0.00 8,569 49 0.01 
8/28/14 44,676 - - 16,774 - - 19,669 - - 8,234 - - 
8/29/14 43,303 - - 15,705 - - 19,448 - - 8,151 - - 
9/2/14 41,902 747 0.02 15,244 510 0.03 18,722 174 0.01 7,936 75 0.01 
9/3/14 40,151 - - 13,535 - - 18,719 - - 7,897 - - 
9/4/14 40,664 387 0.01 13,821 377 0.03 18,861 61 0.00 7,982 59 0.01 
9/5/14 39,263 - - 12,611 - - 18,754 - - 7,899 - - 
9/9/14 47,410 - - 15,830 - - 22,470 - - 9,110 - - 
9/11/14 45,064 - - 15,009 - - 21,431 - - 8,625 - - 
9/16/14 38,242 - - 13,087 - - 17,556 - - 7,599 - - 	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6/17/14 1.672 0.254 0.15 1.326 0.012 0.01 1.681 0.025 0.01 1.133 0.013 0.01 1.789 0.283 0.16 
6/18/14 0.889 - - 1.297 - - 1.603 - - 1.104 - - 0.925 - - 
6/19/14 1.001 - - 1.359 - - 1.627 - - 1.174 - - 1.064 - - 
6/20/14 0.850 0.055 0.06 1.306 0.027 0.02 1.564 0.035 0.02 1.111 0.021 0.02 0.885 0.052 0.06 
6/24/14 0.981 - - 1.541 - - 1.565 - - 1.707 - - 0.978 - - 
6/25/14 1.007 - - 1.298 - - 1.633 - - 1.115 - - 1.036 - - 
6/26/14 1.008 0.019 0.02 1.330 0.011 0.01 1.653 0.034 0.02 1.136 0.008 0.01 1.039 0.025 0.02 
6/27/14 0.970 - - 1.298 - - 1.551 - - 1.107 - - 1.011 - - 
7/1/14 1.069 - - 1.398 - - 1.744 - - 1.205 - - 1.098 - - 
7/2/14 0.854 - - 1.275 - - 1.565 - - 1.080 - - 0.897 - - 
7/3/14 0.850 0.055 0.06 1.306 0.027 0.02 1.564 0.035 0.02 1.111 0.021 0.02 0.885 0.052 0.06 
7/8/14 0.875 - - 1.308 - - 1.621 - - 1.118 - - 0.935 - - 
7/9/14 0.568 - - 1.200 - - 1.427 - - 1.014 - - 0.535 - - 
	  274	  
7/10/14 0.869 - - 1.306 - - 1.624 - - 1.117 - - 0.919 - - 
7/11/14 0.785 0.004 0.01 1.227 0.006 0.00 1.565 0.023 0.01 1.054 0.010 0.01 0.829 0.003 0.00 
7/15/14 0.722 - - 1.078 - - 1.333 - - 0.920 - - 0.773 - - 
7/16/14 0.863 - - 1.294 - - 1.632 - - 1.103 - - 0.922 - - 
7/17/14 0.772 0.004 0.00 1.178 0.008 0.01 1.457 0.005 0.00 1.007 0.002 0.00 0.807 0.004 0.01 
7/18/14 0.807 - - 1.222 - - 1.474 - - 1.036 - - 0.850 - - 
7/22/14 0.909 - - 1.325 - - 1.630 - - 1.143 - - 0.964 - - 
7/23/14 0.926 0.006 0.01 1.326 0.002 0.00 1.695 0.016 0.01 1.142 0.006 0.01 0.958 0.005 0.01 
7/24/14 0.814 - - 1.179 - - 1.414 - - 1.009 - - 0.819 - - 
7/25/14 0.899 - - 1.275 - - 1.563 - - 1.099 - - 0.920 - - 
7/29/14 1.040 0.007 0.01 1.405 0.029 0.02 1.821 0.044 0.02 1.235 0.024 0.02 1.070 0.011 0.01 
7/30/14 0.885 - - 1.250 - - 1.552 - - 1.090 - - 0.919 - - 
7/31/14 1.086 - - 1.333 - - 1.715 - - 1.170 - - 1.105 - - 
8/1/14 1.112 0.130 0.12 1.289 0.008 0.01 1.655 0.014 0.01 1.104 0.012 0.01 1.202 0.157 0.13 
8/5/14 0.760 - - 1.895 - - 2.053 - - 1.583 - - 0.588 - - 
8/6/14 0.040 - - 1.275 - - 1.656 - - 1.103 - - 0.000 - - 
8/7/14 0.787 0.014 0.02 1.204 0.005 0.00 1.500 0.027 0.02 1.032 0.007 0.01 0.830 0.015 0.02 
8/8/14 0.800 - - 1.205 - - 1.526 - - 1.027 - - 0.836 - - 
8/12/14 0.859 0.012 0.01 1.210 0.009 0.01 1.527 0.017 0.01 1.036 0.010 0.01 0.909 0.010 0.01 
8/13/14 0.894 - - 1.258 - - 1.587 - - 1.081 - - 0.950 - - 
8/14/14 0.845 - - 1.252 - - 1.571 - - 1.074 - - 0.890 - - 
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8/15/14 0.827 0.051 0.06 1.203 0.002 0.00 1.486 0.013 0.01 1.029 0.003 0.00 0.852 0.063 0.07 
8/19/14 1.216 - - 1.377 - - 1.640 - - 1.173 - - 1.189 - - 
8/20/14 0.900 - - 1.402 - - 1.745 - - 1.202 - - 0.750 - - 
8/21/14 1.296 0.108 0.08 1.329 0.007 0.01 1.563 0.009 0.01 1.131 0.007 0.01 1.301 0.178 0.14 
8/22/14 1.429 - - 1.392 - - 1.714 - - 1.200 - - 1.418 - - 
8/26/14 1.259 - - 1.304 - - 1.566 - - 1.100 - - 1.206 - - 
8/27/14 1.425 0.073 0.05 1.329 0.011 0.01 1.672 0.003 0.00 1.139 0.007 0.01 1.378 0.067 0.05 
8/28/14 1.368 - - 1.282 - - 1.523 - - 1.073 - - 1.261 - - 
8/29/14 1.237 - - 1.252 - - 1.539 - - 1.064 - - 1.124 - - 
9/2/14 1.195 0.071 0.06 1.240 0.015 0.01 1.472 0.021 0.01 1.039 0.010 0.01 1.137 0.070 0.06 
9/3/14 0.864 - - 1.204 - - 1.477 - - 1.022 - - 0.918 - - 
9/4/14 0.872 0.023 0.03 1.216 0.014 0.01 1.481 0.010 0.01 1.030 0.012 0.01 0.932 0.033 0.04 
9/5/14 0.815 - - 1.210 - - 1.489 - - 1.032 - - 0.868 - - 
9/9/14 0.965 - - 1.365 - - 1.805 - - 1.181 - - 1.027 - - 
9/11/14 0.952 - - 1.341 - - 1.721 - - 1.153 - - 1.020 - - 
9/16/14 0.867 - - 1.196 - - 1.389 - - 1.008 - - 0.903 - - 	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Table D.1: TOC Results for Influent, CABI, and Effluent 
TOC Data 
Date Influent CABI Effluent 
6/17/14 68.7 59.4 8.2 
6/18/14 61 74 8.8 
6/19/14 64.5 56.5 9.1 
6/20/14 76.8 62 10 
6/24/14 77.6 58.8 11.2 
6/25/14 72.8 57.1 11.2 
6/26/14 67.5 54.5 10.8 
6/27/14 64.6 57.5 9.5 
7/1/14 63.9 62.2 10.4 
7/2/14 62 62.6 7.7 
7/3/14 88.7 62.8 7 
7/8/14 90.5 64.6 6.9 
7/9/14 90.2 65.6 6.7 
7/10/14 65.7 59.6 6.8 
7/11/14 78.3 74.2 6.7 
7/15/14 69.2 60.9 8.9 
7/16/14 73.1 62.6 9.2 
7/17/14 64 63.2 10 
7/18/14 75.3 59.7 10 
7/22/14 86.3 70.5 9.3 
7/23/14 78.2 66.3 10.1 
7/24/14 72.4 61 10.6 
7/25/14 74.9 57.5 10.3 
7/29/14 67.5 56.5 10.6 
7/30/14 73.4 59.7 11.4 
7/31/14 65 58.2 11.9 
8/1/14 66.9 53.5 9.7 
8/5/14 57.1 53.9 7.6 
8/6/14 60.6 62 7.4 
8/7/14 62.6 68.5 6.8 
8/8/14 59.6 65.4 6.8 
8/12/14 56 59 8 
8/13/14 60 57.4 8.6 
8/14/14 61 58.1 8.7 
8/15/14 58 63.8 9.2 
8/19/14 58.6 62.4 10.4 
8/20/14 54.2 56.5 10.2 
8/21/14 65.3 58.3 9.6 
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8/22/14 75.8 58.7 9.4 
8/26/14 69.4 64.9 8.3 
8/27/14 62.8 63.7 8.7 
8/28/14 59.8 59 8.8 
8/29/14 64.6 58.6 8.9 
9/2/14 76.9 66 8.4 
9/3/14 66.3 67.1 9.2 
9/4/14 68.5 62.1 8.6 
9/5/14 81.9 54.6 7.7 
9/9/14 59.2 59.9 6.8 
9/11/14 64.6 64.1 6.8 
9/16/14 67.7 69.9 7.3 
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Table E.1: Influent Absorbance at 254 nm and 340 nm Results  	  
Absorbance Results for Influent 
Date 254 nm 340 nm 
6/25/14 0.299 0.073 
6/27/14 0.326 0.083 
7/2/14 0.291 0.067 
7/3/14 0.286 0.067 
7/9/14 0.303 0.073 
7/11/14 0.295 0.070 
7/16/14 0.322 0.080 
7/18/14 0.340 0.084 
7/23/14 0.293 0.067 
7/25/14 0.298 0.071 
7/30/14 0.308 0.077 
8/1/14 0.291 0.068 
8/6/14 0.290 0.070 
8/8/14 0.300 0.070 
8/13/14 0.292 0.145 
8/15/14 0.282 0.066 
8/20/14 0.302 0.075 
8/22/14 0.317 0.078 
8/27/14 0.289 0.071 
8/29/14 0.302 0.072 
9/3/14 0.297 0.074 
9/5/14 0.303 0.072 
9/9/14 0.314 0.077 
9/11/14 0.327 0.081 
9/16/14 0.345 0.090 	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Table E.2: CABI Absorbance at 254 nm and 340 nm Results 
Absorbance Results for CABI 
Date 254 nm 340 nm 
6/25/14 0.259 0.061 
6/27/14 0.266 0.061 
7/2/14 0.279 0.066 
7/3/14 0.267 0.062 
7/9/14 0.279 0.063 
7/11/14 0.294 0.067 
7/16/14 0.296 0.071 
7/18/14 0.272 0.062 
7/23/14 0.282 0.065 
7/25/14 0.273 0.064 
7/30/14 0.253 0.056 
8/1/14 0.251 0.057 
8/6/14 0.259 0.054 
8/8/14 0.278 0.061 
8/13/14 0.301 0.072 
8/15/14 0.276 0.065 
8/20/14 0.281 0.066 
8/22/14 0.263 0.060 
8/29/14 0.273 0.063 
9/3/14 0.265 0.056 
9/5/14 0.275 0.062 
9/9/14 0.292 0.065 
9/11/14 0.318 0.078 
9/16/14 0.305 0.068 	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Table E.3: Effluent Absorbance at 254 nm and 340 nm Results 
Absorbance Results for Effluent 
Date 254 nm 340 nm 
7/1/14 0.105 0.029 
7/2/14 0.111 0.032 
7/3/14 0.106 0.029 
7/8/14 0.106 0.030 
7/9/14 0.103 0.028 
7/10/14 0.116 0.034 
7/11/14 0.109 0.031 
7/15/14 0.106 0.030 
7/16/14 0.111 0.031 
7/17/14 0.110 0.032 
7/18/14 0.112 0.033 
7/22/14 0.108 0.030 
7/23/14 0.111 0.031 
7/24/14 0.108 0.030 
7/25/14 0.111 0.031 
7/30/14 0.083 0.017 
7/31/14 0.133 0.042 
8/1/14 0.111 0.030 
8/7/14 0.111 0.032 
8/8/14 0.113 0.032 
8/12/14 0.106 0.031 
8/13/14 0.111 0.032 
8/14/14 0.109 0.029 
8/15/14 0.108 0.030 
8/19/14 0.112 0.032 
8/20/14 0.111 0.031 
8/21/14 0.116 0.033 
8/22/14 0.113 0.031 
8/26/14 0.109 0.031 
8/27/14 0.111 0.030 
8/28/14 0.114 0.032 
8/29/14 0.112 0.031 
9/2/14 0.107 0.029 
9/3/14 0.104 0.029 
9/4/14 0.113 0.032 
9/5/14 0.111 0.031 
9/9/14 0.111 0.029 
9/11/14 0.114 0.034 
9/16/14 0.110 0.034 	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Table F.1: Influent Results for BOD5, COD, TOC, and Fluorescence 	  
Influent Results for Each Method 
Date BOD Hold time 
Sample 
use1&2 BOD COD TOC Total 
Region 
I 
Regio
n II 
Region 
III 
Prot
ein 
Hu
mic A C T 
1Comparative (Comp)- Overnight BOD samples were compared with the same day samples used for correlations.  The results 
from the other methods were used to calculate removal efficiency.  None of these samples were used for correlation models.   
2Correlation (Corr)- Samples were analyzed the same day that they were collected.  These were used for the final correlations 
and also included in the removal efficiency analysis. 
6/24/14 Overnight Comp 318 744 77.6 160,050 93,514 48,543 17,993 8.60 2.78 3.19 2.69 9.00 
6/25/14 Same Day Corr 348 748 72.8 148,609 85,366 44,713 18,529 7.90 2.79 2.95 2.89 8.28 
6/26/14 Overnight Comp 384 829 67.5 148,383 84,495 45,388 18,500 7.89 2.86 3.17 2.74 8.38 
6/27/14 Same Day Corr 364 668 64.6 154,449 92,292 44,824 17,333 8.64 2.67 2.91 2.53 9.12 
7/1/14 Overnight Comp 227 654 63.9 162,397 95,302 47,644 19,451 8.63 2.98 3.15 2.92 9.20 
7/2/14 Same Day Corr 364 674 62 138,287 79,906 41,359 17,023 7.44 2.65 2.70 2.58 7.78 
7/3/14 Same Day Corr 355 710 88.7 133,219 74,931 41,192 17,096 6.72 2.67 2.85 2.66 7.39 
7/8/14 Overnight Comp 275 692 90.5 154,768 87,899 47,758 19,111 7.79 3.00 3.13 2.93 8.33 
7/9/14 Same Day Corr 337 727 90.2 132,789 74,844 40,844 17,101 6.96 2.70 2.74 2.69 7.34 
7/10/14 Overnight Comp 289 728 65.7 155,388 89,045 47,597 18,746 7.87 3.01 3.27 2.75 8.54 
7/11/14 Same Day Corr 376 645 78.3 157,035 90,206 47,425 19,403 8.19 3.09 3.06 3.01 8.55 
7/15/14 Overnight Comp 304 646 69.2 132,394 74,909 40,773 16,713 6.66 2.68 2.71 2.59 7.05 
7/16/14 Same Day Corr 359 794 73.1 160,251 94,085 47,913 18,253 8.76 2.89 3.16 2.73 9.18 
7/17/14 Overnight Comp 321 755 64 143,573 81,684 44,250 17,639 7.54 2.81 3.08 2.60 8.06 
7/18/14 Same Day Corr 378 790 75.3 157,090 91,851 46,864 18,374 8.47 2.90 3.00 2.78 8.91 
7/22/14 Overnight Comp 281 714 86.3 168,667 96,319 52,136 20,212 8.52 3.18 3.41 3.18 9.14 
7/23/14 Same Day Corr 433 764 78.2 151,285 85,666 46,939 18,680 7.60 2.94 3.07 2.88 8.22 
7/24/14 Overnight Comp 265 737 72.4 129,777 72,647 40,452 16,678 6.34 2.64 2.66 2.62 6.86 
7/25/14 Same Day Corr 438 772 74.9 138,653 78,190 42,760 17,702 7.03 2.83 2.76 2.69 7.50 
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7/29/14 Overnight Comp 226 637 67.5 163,611 91,922 50,981 20,708 7.99 3.32 3.37 3.26 8.75 
7/30/14 Same Day Corr 549 886 73.4 136,668 76,028 42,517 18,122 6.72 2.97 2.79 2.81 7.22 
7/31/14 Overnight Comp 273 621 65 142,652 80,021 44,091 18,539 7.16 3.08 2.96 2.91 7.76 
8/1/14 Same Day Corr 454 725 66.9 150,029 84,071 46,904 19,055 7.50 3.14 3.11 2.91 8.07 
8/5/14 Overnight Comp 260 639 57.1 147,493 81,288 48,572 17,633 6.75 2.80 3.30 2.63 7.26 
8/6/14 Same Day Corr 447 627 60.6 136,987 75,029 44,709 17,248 6.40 2.85 3.06 2.67 6.82 
8/7/14 Overnight Comp 312 727 62.6 137,214 77,077 42,743 17,394 6.71 2.93 2.92 2.68 7.26 
8/8/14 Same Day Corr 417 723 59.6 152,329 87,389 46,771 18,169 7.86 2.92 3.06 2.74 8.35 
8/12/14 Overnight Comp 245 657 56 138,227 78,315 42,064 17,847 7.26 2.99 2.95 2.70 7.82 
8/13/14 Same Day Corr 336 752 60 142,658 80,538 44,120 18,000 7.21 3.02 2.96 2.79 7.77 
8/14/14 Overnight Comp 243 704 61 141,729 79,583 44,122 18,025 6.90 3.06 2.92 2.79 7.57 
8/15/14 Same Day Corr 379 766 58 135,211 77,032 41,003 17,176 6.80 2.86 2.69 2.64 7.47 
8/19/14 Overnight Comp 243 726 58.6 156,279 88,182 48,221 19,876 8.07 3.21 3.25 3.13 8.54 
8/20/14 Same Day Corr 420 779 54.2 152,895 87,240 46,871 18,784 8.00 3.12 3.17 2.89 8.51 
8/21/14 Overnight Comp 250 772 65.3 139,229 77,936 43,800 17,492 6.95 2.88 3.02 2.66 7.40 
8/22/14 Same Day Corr 356 706 75.8 163,934 94,464 49,436 20,034 8.65 3.28 3.34 3.10 9.25 
8/26/14 Overnight Comp 284 722 69.4 150,008 85,531 46,269 18,208 7.76 2.99 3.15 2.72 8.25 
8/27/14 Same Day Corr 510 706 62.8 149,008 85,671 44,644 18,692 7.95 3.15 3.06 2.87 8.56 
8/28/14 Overnight Comp 293 788 59.8 141,271 81,157 43,152 16,962 7.66 2.72 2.90 2.50 7.98 
8/29/14 Same Day Corr 603 747 64.6 139,583 78,818 43,208 17,557 7.21 2.85 2.90 2.65 7.62 
9/2/14 Overnight Comp 332 718 76.9 141,100 79,505 42,926 18,669 7.30 2.94 2.88 2.99 7.76 
9/3/14 Same Day Corr 406 772 66.3 142,990 82,060 42,930 18,000 7.61 2.98 2.87 2.72 8.09 
9/4/14 Overnight Comp 225 706 68.5 140,746 79,563 43,334 17,850 7.00 2.88 2.81 2.76 7.57 
9/5/14 Same Day Corr 359 771 81.9 140,398 78,503 43,963 17,931 7.03 2.90 2.89 2.76 7.70 
9/9/14 Same Day Corr 457 581 59.2 162,796 91,754 51,418 19,624 8.15 3.16 3.52 2.97 8.92 
9/11/14 Same Day Corr 327 676 64.6 168,182 96,787 51,881 19,514 8.58 3.22 3.37 3.02 9.23 
9/16/14 Same Day Corr 236 612 67.7 152,522 84,233 47,990 20,300 7.47 3.11 3.14 3.15 7.90 
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Table F.2: CABI Results for BOD5, COD, TOC, and Fluorescence 	  
CABI Results for Each Method 
Date BOD Hold time 
Sampl
e 
use1&2 
BOD COD 
TO
C Total Reg. I Reg. II 
Reg. 
III 
Pr
ote
in 
Hum
ic A C T 
1Comparative- Overnight BOD samples were compared with the same day samples used for correlations.  The results from 
the other methods were used to calculate removal efficiency.  None of these samples were used for correlation models.   
2Correlation - Samples were analyzed the same day that they were collected.  These were used for the final correlations and 
also included in the removal efficiency analysis. 
6/24/14 Overnight	   Comp	   199 438 58.8 130,773 72,811 43,110 14,852 6.32 2.14 3.00 2.14 6.74 
6/25/14 Same	  Day	   Corr	   201 411 57.1 124,425 67,812 42,086 14,527 5.76 2.04 3.02 2.01 6.32 
6/26/14 Overnight	   Comp	   209 450 54.5 125,034 68,784 41,475 14,775 5.87 2.12 2.97 2.05 6.38 
6/27/14 Same	  Day	   Corr	   206 410 57.5 124,477 69,242 40,721 14,514 5.80 2.02 2.85 1.98 6.36 
7/1/14 Overnight	   Comp	   149 382 62.2 136,143 76,105 44,882 15,156 6.53 2.19 3.08 2.14 7.07 
7/2/14 Same	  Day	   Corr	   189 404 62.6 126,038 68,737 42,485 14,815 5.81 2.12 2.89 2.09 6.32 
7/3/14 Same	  Day	   Corr	   147 343 62.8 118,053 64,052 39,680 14,321 5.39 2.14 2.76 2.07 5.95 
7/8/14 Overnight	   Comp	   172 371 64.6 143,299 79,854 47,472 15,973 6.67 2.30 3.16 2.27 7.22 
7/9/14 Same	  Day	   Corr	   183 401 65.6 121,258 66,498 40,920 13,840 5.70 1.96 2.71 1.96 6.06 
7/10/14 Overnight	   Comp	   189 361 59.6 142,101 78,592 47,138 16,371 6.56 2.30 3.21 2.24 7.12 
7/11/14 Same	  Day	   Corr	   209 387 74.2 141,137 79,766 45,777 15,594 6.79 2.19 3.04 2.19 7.27 
7/15/14 Overnight	   Comp	   190 412 60.9 121,297 68,179 39,384 13,733 5.83 1.93 2.64 1.89 6.29 
7/16/14 Same	  Day	   Corr	   230 424 62.6 137,438 77,475 44,718 15,246 6.77 2.17 2.98 2.14 7.20 
7/17/14 Overnight	   Comp	   194 470 63.2 127,718 71,154 41,918 14,646 6.20 2.15 2.84 2.06 6.59 
7/18/14 Same	  Day	   Corr	   226 399 59.7 124,474 68,881 41,409 14,183 5.85 2.00 2.78 1.98 6.32 
7/22/14 Overnight	   Comp	   196 410 70.5 144,556 81,563 47,162 15,830 7.08 2.26 3.19 2.22 7.68 
7/23/14 Same	  Day	   Corr	   283 419 66.3 135,883 74,627 45,472 15,785 6.32 2.38 3.11 2.26 6.85 
7/24/14 Overnight	   Comp	   174 398 61 112,766 61,091 38,059 13,616 5.22 2.01 2.66 1.92 5.68 
7/25/14 Same	  Day	   Corr	   194 374 57.5 121,237 66,250 40,464 14,523 5.59 2.13 2.73 2.08 6.10 
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7/29/14 Overnight	   Comp	   183 335 56.5 141,369 78,178 47,142 16,050 6.62 2.34 3.23 2.28 7.22 
7/30/14 Same	  Day	   Corr	   214 362 59.7 117,008 63,194 39,526 14,288 5.41 2.06 2.72 1.99 5.88 
7/31/14 Overnight	   Comp	   206 369 58.2 127,629 70,389 42,451 14,789 6.08 2.15 2.94 2.07 6.64 
8/1/14 Same	  Day	   Corr	   196 339 53.5 127,832 69,863 42,937 15,032 5.99 2.20 3.02 2.13 6.58 
8/5/14 Overnight	   Comp	   199 321 53.9 133,961 72,532 46,052 15,377 5.99 2.20 3.22 2.16 6.27 
8/6/14 Same	  Day	   Corr	   219 355 62 127,896 68,386 45,315 14,195 5.23 2.02 3.00 2.05 5.62 
8/7/14 Overnight	   Comp	   197 374 68.5 137,372 76,540 45,873 14,960 6.13 2.13 2.96 2.14 6.65 
8/8/14 Same	  Day	   Corr	   224 386 65.4 135,511 74,966 45,324 15,221 6.14 2.20 3.01 2.19 6.71 
8/12/14 Overnight	   Comp	   143 378 59 136,109 74,857 45,719 15,533 6.23 2.23 3.05 2.22 6.93 
8/13/14 Same	  Day	   Corr	   158 398 57.4 137,582 75,614 46,029 15,938 6.34 2.40 3.10 2.36 6.92 
8/14/14 Overnight	   Comp	   165 411 58.1 136,119 76,824 44,492 14,804 6.64 2.10 3.05 2.07 7.14 
8/15/14 Same	  Day	   Corr	   244 461 63.8 124,762 68,498 41,317 14,946 6.00 2.22 2.99 2.11 6.56 
8/19/14 Overnight	   Comp	   201 453 62.4 143,132 82,066 46,062 15,005 7.03 2.11 3.00 2.13 7.54 
8/20/14 Same	  Day	   Corr	   206 407 56.5 135,746 74,691 45,565 15,490 6.29 2.27 3.10 2.25 6.76 
8/21/14 Overnight	   Comp	   177 473 58.3 122,801 68,202 40,661 13,938 5.78 2.00 2.72 2.01 6.16 
8/22/14 Same	  Day	   Corr	   202 389 58.7 138,748 78,313 45,355 15,080 6.67 2.15 3.05 2.15 7.22 
8/26/14 Overnight	   Comp	   181 431 64.9 132,301 73,905 43,566 14,830 6.29 2.15 2.94 2.13 6.82 
8/28/14 Overnight	   Comp	   179 412 59 127,180 70,789 42,051 14,340 6.03 2.06 2.88 2.05 6.41 
8/29/14 Same	  Day	   Corr	   242 405 58.6 123,701 69,092 40,595 14,013 5.88 1.98 2.74 1.97 6.26 
9/2/14 Overnight	   Comp	   174 353 66 132,810 74,633 43,552 14,625 6.17 2.10 2.77 2.13 6.64 
9/3/14 Same	  Day	   Corr	   200 370 67.1 134,248 75,624 43,967 14,658 6.25 2.04 2.86 2.08 6.76 
9/4/14 Overnight	   Comp	   150 401 62.1 126,105 69,819 42,055 14,231 5.67 1.96 2.71 2.01 6.16 
9/5/14 Same	  Day	   Corr	   161 377 54.6 125,865 68,985 42,446 14,435 5.75 2.04 2.79 2.06 6.28 
9/9/14 Same	  Day	   Corr	   198 333 59.9 151,819 82,375 51,727 17,717 6.86 2.54 3.59 2.52 7.50 
9/11/14 Same	  Day	   Corr	   223 462 64.1 154,048 90,098 48,311 15,639 7.90 2.15 3.11 2.23 8.39 
9/16/14 Same	  Day	   Corr	   185 411 69.9 139,556 78,700 45,246 15,610 6.56 2.15 2.88 2.18 7.02 	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Table F.3: Effluent Results for BOD5, COD, TOC, and Fluorescence 	  
Effluent Results for Each Method  
Date BOD	  Hold	  time	  
Sampl
e	  
use1&2	  
BOD COD TOC Total Reg. I Reg. II Reg. III 
Prote
in 
Hu
mic A C T 
1Comparative- Overnight BOD samples were compared with the same day samples used for correlations.  The results from 
the other methods were used to calculate removal efficiency.  None of these samples were used for correlation models.   
2Correlation - Samples were analyzed the same day that they were collected.  These were used for the final correlations and 
also included in the removal efficiency analysis. 
7/1/14 Overnight	   Comp	   13.71 45 10.4 47,276 16,243 22,175 8,858 1.07 1.40 1.74 1.20 1.10 
7/2/14 Same	  Day	   Corr	   4.30 30 7.7 41,689 13,938 19,530 8,222 0.85 1.28 1.56 1.08 0.90 
7/3/14 Same	  Day	   Corr	   3.60 26 7 41,647 13,556 19,638 8,453 0.85 1.31 1.56 1.11 0.89 
7/8/14 Overnight	   Comp	   3.83 25 6.9 43,067 14,312 20,373 8,382 0.88 1.31 1.62 1.12 0.94 
7/9/14 Same	  Day	   Corr	   3.28 23 6.7 34,236 9,235 17,455 7,545 0.57 1.20 1.43 1.01 0.53 
7/10/14 Overnight	   Comp	   3.01 26 6.8 43,170 14,377 20,215 8,578 0.87 1.31 1.62 1.12 0.92 
7/11/14 Same	  Day	   Corr	   3.33 22 6.7 40,734 13,233 19,539 7,962 0.78 1.23 1.56 1.05 0.83 
7/15/14 Overnight	   Comp	   7.56 36 8.9 35,750 11,842 16,830 7,077 0.72 1.08 1.33 0.92 0.77 
7/16/14 Same	  Day	   Corr	   8.06 30 9.2 42,951 14,290 20,338 8,322 0.86 1.29 1.63 1.10 0.92 
7/17/14 Overnight	   Comp	   9.69 33 10 38,713 12,690 18,345 7,678 0.77 1.18 1.46 1.01 0.81 
7/18/14 Same	  Day	   Corr	   10.41 32 10 39,929 13,143 18,878 7,909 0.81 1.22 1.47 1.04 0.85 
7/22/14 Overnight	   Comp	   9.82 32 9.3 43,802 14,575 20,808 8,419 0.91 1.33 1.63 1.14 0.96 
7/23/14 Same	  Day	   Corr	   12.56 37 10.1 45,137 14,956 21,560 8,620 0.93 1.33 1.69 1.14 0.96 
7/24/14 Overnight	   Comp	   12.32 37 10.6 39,126 12,833 18,613 7,680 0.81 1.18 1.41 1.01 0.82 
7/25/14 Same	  Day	   Corr	   12.85 44 10.3 43,375 14,499 20,489 8,387 0.90 1.27 1.56 1.10 0.92 
7/29/14 Overnight	   Comp	   17.61 45 10.6 49,998 16,960 23,937 9,102 1.04 1.41 1.82 1.24 1.07 
7/30/14 Same	  Day	   Corr	   20.01 47 11.4 43,239 14,632 20,423 8,184 0.88 1.25 1.55 1.09 0.92 
7/31/14 Overnight	   Comp	   16.61 46 11.9 48,163 16,784 22,680 8,699 1.09 1.33 1.71 1.17 1.11 
8/1/14 Same	  Day	   Corr	   10.50 39 9.7 46,361 16,918 20,851 8,592 1.11 1.29 1.65 1.10 1.20 
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8/7/14 Overnight	   Comp	   3.78 28 6.8 39,750 13,021 18,955 7,775 0.79 1.20 1.50 1.03 0.83 
8/8/14 Same	  Day	   Corr	   3.80 27 6.8 39,853 13,008 19,014 7,831 0.80 1.20 1.53 1.03 0.84 
8/12/14 Overnight	   Comp	   5.77 31 8 40,383 13,495 19,045 7,843 0.86 1.21 1.53 1.04 0.91 
8/13/14 Same	  Day	   Corr	   6.39 33 8.6 42,279 14,018 20,005 8,256 0.89 1.26 1.59 1.08 0.95 
8/14/14 Overnight	   Comp	   6.46 30 8.7 41,875 13,717 19,982 8,176 0.85 1.25 1.57 1.07 0.89 
8/15/14 Same	  Day	   Corr	   8.00 34 9.2 40,244 13,399 18,984 7,860 0.83 1.20 1.49 1.03 0.85 
8/19/14 Overnight	   Comp	   10.36 38 10.4 46,869 16,727 21,288 8,854 1.22 1.38 1.64 1.17 1.19 
8/20/14 Same	  Day	   Corr	   11.72 41 10.2 45,235 14,223 22,225 8,787 0.90 1.40 1.75 1.20 0.75 
8/21/14 Overnight	   Comp	   9.05 N/A 9.6 45,665 17,002 20,203 8,460 1.30 1.33 1.56 1.13 1.30 
8/22/14 Same	  Day	   Corr	   9.17 N/A 9.4 50,373 19,097 22,338 8,939 1.43 1.39 1.71 1.20 1.42 
8/26/14 Overnight	   Comp	   6.29 N/A 8.3 45,327 16,528 20,464 8,335 1.26 1.30 1.57 1.10 1.21 
8/27/14 Same	  Day	   Corr	   6.88 N/A 8.7 48,215 18,220 21,426 8,569 1.42 1.33 1.67 1.14 1.38 
8/28/14 Overnight	   Comp	   6.47 33 8.8 44,676 16,774 19,669 8,234 1.37 1.28 1.52 1.07 1.26 
8/29/14 Same	  Day	   Corr	   6.48 29 8.9 43,303 15,705 19,448 8,151 1.24 1.25 1.54 1.06 1.12 
9/2/14 Overnight	   Comp	   6.06 26 8.4 41,902 15,244 18,722 7,936 1.19 1.24 1.47 1.04 1.14 
9/3/14 Same	  Day	   Corr	   8.88 27 9.2 40,151 13,535 18,719 7,897 0.86 1.20 1.48 1.02 0.92 
9/4/14 Overnight	   Comp	   6.83 28 8.6 40,664 13,821 18,861 7,982 0.87 1.22 1.48 1.03 0.93 
9/5/14 Same	  Day	   Corr	   5.37 23 7.7 39,263 12,611 18,754 7,899 0.82 1.21 1.49 1.03 0.87 
9/9/14 Same	  Day	   Corr	   3.95 23 6.8 47,410 15,830 22,470 9,110 0.96 1.36 1.80 1.18 1.03 
9/11/14 Same	  Day	   Corr	   3.77 23 6.8 45,064 15,009 21,431 8,625 0.95 1.34 1.72 1.15 1.02 
9/16/14 Same	  Day	   Corr	   4.92 26 7.3 38,242 13,087 17,556 7,599 0.87 1.20 1.39 1.01 0.90 	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APPENDIX G 
R CODES 
The corresponding Excel files are available upon request.  All referenced data files were 
developed from data reported in the previous appendices.   
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G.1 R Code for BOD and COD Regression Models and Summary Statistics 
 
#-------Import BOD and COD Data-------------------------------------------------------------- 
library(XLConnect) 
CODBOD=loadWorkbook("BODCOD.xlsx") 
effluent=readWorksheet(CODBOD, sheet="effluent") 
all=readWorksheet(CODBOD, sheet="All") 
 
#-------Summary Statistics-------------------------------------------------------------- 
 
#Determine summary statistics 
library(boot) 
library(pastecs) 
summary(influent)  
stat.desc(influent)  
summary(cabi) 
stat.desc(cabi) 
stat.desc(effluent)  
summary(effluent)  
 
#Determine ratios 
y1<-influent$COD/influent$BOD 
summary(y1) 
y2<-cabi$COD/cabi$BOD 
summary(y2) 
y3<-effluent$COD/effluent$BOD 
summary(y3) 
 
#--------Linear Models----------------------------------------------------------------------- 
 
#influent 
lminfluent=lm(BOD~COD, influent) 
summary(lminfluent) 
#r2=0.02763 --> bad model 
 
#CABI 
lmcabi=lm(BOD~COD, cabi) 
summary(lmcabi) 
#r2=0.1453 --> bad model 
 
#effluent 
lmeffluent=lm(BOD~COD, effluent) 
summary(lmeffluent) 
#r2=0.7682 
#Residual SE 1.713 
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qqnorm(lmeffluent$residuals) 
shapiro.test(lmeffluent$residuals) 
#Errors are non normal p=0.02408 
 
#influent and cabi combined 
lminfluentcabi=lm(BOD~COD, influentcabi) 
summary(lminfluentcabi) 
#r2=0.7274 
#Residual SE 55.75 
#Check residuals for error assumption 
qqnorm(lminfluentcabi$residuals) 
shapiro.test(lminfluentcabi$residuals) 
#Errors are non normal p=1.012e-08 
 
#all data combined 
lmalldata=lm(BOD~COD, all) 
summary(lmalldata) 
#r2=0.9189 
qqnorm(lmalldata$residuals) 
shapiro.test(lmalldata$residuals) 
#Errors are non normal p=2.734e-16 
 
#Errors are not normally distributed; therefore, use robust regression. 
 
#------Robust Linear Regression ---------------------------------- 
 
# Errors are non-normal, use Robust Regression 
library(MASS) 
library(sandwich) 
library(lmtest)  
 
#Try robust linear model for all data combined 
rlmall <- rlm(BOD~COD,data=all) 
summary(rlmall) 
#BOD=0.5389*COD-9.7876 
#Residual SE 20.16 
r2all<-lm(all$BOD~ rlmall $fitted.values) 
summary(r2all) 
#Psuedo r2 = 0.9189 
 
#Try robust linear model for all data combined by location 
rlmall2 <- rlm(BOD~COD+factor(Location),data=all) 
summary(rlmall2) 
#BOD=0.1996*COD+110.8749*Influent-127.7315*Effluent+129.0188 
#Residual SE 16.21 
r2infcabi0<-lm(all$BOD~ rlmall2 $fitted.values) 
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summary(r2infcabi0) 
#Psuedo r2 = 0.9252 
#Check the coefficients 
coeftest(rlmall2, df = Inf, vcov = vcovHC(rlmall2, type = "const")) 
coeftest(rlmall2, df = Inf, vcov = vcovHC(rlmall2, type = "HC")) 
coeftest(rlmall2, df = Inf, vcov = vcovHC(rlmall2, type = "HC0")) 
coeftest(rlmall2, df = Inf, vcov = vcovHC(rlmall2, type = "HC3")) 
coeftest(rlmall2, df = Inf, vcov = vcovHC(rlmall2, type = "HC4")) 
 
#Robust linear model for influent/cabi combined 
rlminfcab0 <- rlm(BOD~COD,data=influentcabi) 
summary(rlminfcab0) 
#BOD=0.5176*COD+5.0854 
#Residual SE 41.17 
r2infcabi0<-lm(influentcabi$BOD~ rlminfcab0 $fitted.values) 
summary(r2infcabi0) 
#Psuedo r2 = 0.7274 
 
#Robust linear model for influent/cabi combined by location 
rlminfcab <- rlm(BOD~COD+factor(Location),data=influentcabi) 
summary(rlminfcab) 
#BOD=0.1792*COD+119.8388*Influent+136.0053 
#Residual SE 35.87 
r2infcabi<-lm(influentcabi$BOD~rlminfcab $fitted.values) 
summary(r2infcabi) 
#Psuedo r2 = 0.7586 
#Check the coefficients 
coeftest(rlminfcab, df = Inf, vcov = vcovHC(rlminfcab, type = "const")) 
coeftest(rlminfcab, df = Inf, vcov = vcovHC(rlminfcab, type = "HC")) 
coeftest(rlminfcab, df = Inf, vcov = vcovHC(rlminfcab, type = "HC0")) 
coeftest(rlminfcab, df = Inf, vcov = vcovHC(rlminfcab, type = "HC3")) 
coeftest(rlminfcab, df = Inf, vcov = vcovHC(rlminfcab, type = "HC4")) 
 
#Robust linear model for effluent 
rlmeffluent <- rlm(BOD~COD,data=effluent) 
summary(rlmeffluent) 
#BOD=0.4876*COD-7.7833 
#Residual SE 1.931 
effr2<-lm(effluent$BOD~rlmeffluent$fitted.value) 
summary(effr2) 
#r2=0.7682 
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G.2 R Code for BOD and TOC Regression Models and Summary Statistics 
 
 
#-------Import data-------------------------------------------------------------- 
library(XLConnect) 
TOCBOD=loadWorkbook("BODTOC.xlsx") 
influent=readWorksheet(TOCBOD, sheet="influent") 
cabi=readWorksheet(TOCBOD, sheet="cabi") 
influentcabi=readWorksheet(TOCBOD, sheet="influentcabi") 
effluent=readWorksheet(TOCBOD, sheet="effluent") 
all=readWorksheet(TOCBOD, sheet="all") 
cabieff=readWorksheet(TOCBOD, sheet="cabieffluent") 
 
#-------Summary Statistics-------------------------------------------------------------- 
#Determine summary statistics 
library(boot) 
library(pastecs) 
summary(influent)  
stat.desc(influent)  
summary(cabi) 
stat.desc(cabi) 
stat.desc(effluent)  
summary(effluent)  
 
#Determine BOD/TOC ratios 
y1<-influent$BOD/influent$TOC 
y2<-cabi$BOD/cabi$TOC 
y3<-effluent$BOD/effluent$TOC 
summary(y1) 
summary(y2) 
summary(y3) 
 
#--------Linear Models----------------------------------------------------------------------- 
 
#build linear models 
lminfluent=lm(BOD~TOC, influent) 
summary(lminfluent) 
#r2=0.06485 -> bad model 
 
lmcabi=lm(BOD~TOC, cabi) 
summary(lmcabi) 
#r2=0.0361 -> bad model 
 
#influent and cabi combined 
lminfluentcabi=lm(BOD~TOC, influentcabi) 
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summary(lminfluentcabi) 
#r2=0.111-> bad model 
 
#effluent 
lmeffluent=lm(BOD~TOC, effluent) 
summary(lmeffluent) 
#r2=0.8663 -> ok model 
#Residual SE 1.237 
qqnorm(lmeffluent$residuals) 
shapiro.test(lmeffluent$residuals) 
#Data are not normally distributed =5.9e-08 
 
#all data combined 
lmalldata=lm(BOD~TOC, all) 
summary(lmalldata) 
#r2=0.7493 
#Residual SE 79.54 
#combined data appear to be the best fit 
qqnorm(lmalldata$residuals) 
shapiro.test(lmalldata$residuals) 
#Data are not normally distributed p=2.845e-15 
 
#Errors are not normally distributed; therefore, use robust regression. 
 
#------Robust Regression ------------------------------------------------- 
 
#Perform robust regression on effluent and all data point 
library(MASS) 
library(sandwich) 
library(lmtest)  
 
#Robust linear model for all sites combined 
rlmall <- rlm(BOD~TOC,data=all) 
summary(rlmall) 
#Residual SE 27.92 
#BOD=4.4126*TOC-31.7059 
#Residual SE 20.16 
r2all<-lm(all$BOD~ rlmall $fitted.values) 
summary(r2all) 
#Psuedo r2 = 0.7493 
 
#Robust linear model for all sites combined by location 
rlmall2 <- rlm(BOD~TOC +factor(Location),data=all) 
summary(rlmall2) 
#Residual SE 14.87 
#BOD=-0.9427*TOC+184.4776*Inf-249.2292*Effluent+264.9775 
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r2all2<-lm(all$BOD~ rlmall2 $fitted.values) 
summary(r2all2) 
#Psuedo r2 = 0.9277 
#Check coefficients 
coeftest(rlmall2, df = Inf, vcov = vcovHC(rlmall2, type = "const")) 
coeftest(rlmall2, df = Inf, vcov = vcovHC(rlmall2, type = "HC")) 
coeftest(rlmall2, df = Inf, vcov = vcovHC(rlmall2, type = "HC0")) 
coeftest(rlmall2, df = Inf, vcov = vcovHC(rlmall2, type = "HC3")) 
coeftest(rlmall2, df = Inf, vcov = vcovHC(rlmall2, type = "HC4")) 
 
#Robust linear model for influent/cabi combined 
rlminfcab0 <- rlm(BOD~TOC,data=influentcabi) 
summary(rlminfcab0) 
#BOD=4.8462*TOC-44.1455 
#Residual SE 80.83 
r2infcabi0<-lm(influentcabi$BOD~ rlminfcab0 $fitted.values) 
summary(r2infcabi0) 
#Psuedo r2 = 0.111 
 
#Robust linear model for influent/cabi combined by location 
rlminfcab <- rlm(BOD~TOC+factor(Location.),data=influentcabi) 
summary(rlminfcab) 
#BOD=-1.0708*TOC+188.9198*Influent+272.4721 
#Residual SE 33.82 
r2infcabi<-lm(influentcabi$BOD~rlminfcab $fitted.values) 
summary(r2infcabi) 
#Psuedo r2 = 0.7445 
#okay fit, but the slope is not representative of the data 
#Check the coefficients 
coeftest(rlminfcab, df = Inf, vcov = vcovHC(rlminfcab, type = "const")) 
coeftest(rlminfcab, df = Inf, vcov = vcovHC(rlminfcab, type = "HC")) 
coeftest(rlminfcab, df = Inf, vcov = vcovHC(rlminfcab, type = "HC0")) 
coeftest(rlminfcab, df = Inf, vcov = vcovHC(rlminfcab, type = "HC3")) 
coeftest(rlminfcab, df = Inf, vcov = vcovHC(rlminfcab, type = "HC4")) 
 
#Robust linear model for effluent 
rlmeffluent <- rlm(BOD~TOC,data=effluent) 
summary(rlmeffluent) 
#Residual SE 0.8721 
#BOD=2.2456*TOC-12.0691 
r2eff<-lm(effluent$BOD~rlmeffluent$fitted.value) 
summary(r2eff) 
#r2=0.8663  
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G.3 BOD and Fluorescence Models 
 
library(XLConnect) 
fl=loadWorkbook("Fluorescence.xlsx") 
influent=readWorksheet(fl, sheet="influent") 
cabi=readWorksheet(fl, sheet="cabi") 
influentcabi=readWorksheet(fl, sheet="influentcabi") 
effluent=readWorksheet(fl, sheet="effluent") 
all=readWorksheet(fl, sheet="all") 
 
 
#----Linear influent correlations---------------------------------------------------------------- 
#build linear models for influent 
lmtotalinf=lm(BOD~Total, influent) 
summary(lmtotalinf) 
#r2=0.0139 
 
lmregionIinf=lm(BOD~RegionI, influent) 
summary(lmregionIinf) 
#r2=0.01319 
 
lmregionIIinf=lm(BOD~RegionII, influent) 
summary(lmregionIIinf) 
#r2=0.007189 
 
lmregionIIIinf=lm(BOD~RegionIII, influent) 
summary(lmregionIIIinf) 
#r2=0.0354 
 
lmProteinsinf=lm(BOD~Proteins, influent) 
summary(lmProteinsinf) 
#r2=0.01184 
 
lmHumicsinf=lm(BOD~Humics, influent) 
summary(lmHumicsinf) 
#r2=0.0014 
 
lmAinf=lm(BOD~A, influent) 
summary(lmAinf) 
#r2=0.0002 
 
lmCinf=lm(BOD~C, influent) 
summary(lmCinf) 
#r2=0.0642 
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lmMinf=lm(BOD~M, influent) 
summary(lmMinf) 
#r2=0.0056 
 
lmTinf=lm(BOD~T, influent) 
summary(lmTinf) 
#r2=0.0068 
 
#No significant correlation coefficients 
 
#----Linear CABI correlations------------------------------------------------------------------- 
 
lmtotalcabi=lm(BOD~Total, cabi) 
summary(lmtotalcabi) 
#r2=0.0069 
 
lmregionIcabi=lm(BOD~RegionI, cabi) 
summary(lmregionIcabi) 
#r2=0.0113 
 
lmregionIIcabi=lm(BOD~RegionII, cabi) 
summary(lmregionIIcabi) 
#r2=0.0016 
 
lmregionIIIcabi=lm(BOD~RegionIII, cabi) 
summary(lmregionIIIcabi) 
#r2=0.0024 
 
lmProteinscabi=lm(BOD~Proteins, cabi) 
summary(lmProteinscabi) 
#r2=0.0209 
 
lmHumicscabi=lm(BOD~Humics, cabi) 
summary(lmHumicscabi) 
#r2=0.0015 
 
lmAcabi=lm(BOD~A, cabi) 
summary(lmAcabi) 
#r2=0.0097 
 
lmCcabi=lm(BOD~C, cabi) 
summary(lmCcabi) 
#r2=0.0015 
 
lmMcabi=lm(BOD~M, cabi) 
summary(lmMcabi) 
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#r2=0.0170 
 
lmTcabi=lm(BOD~T, cabi) 
summary(lmTcabi) 
#r2=0.0144 
#No significant correlation coefficients 
 
#----Linear effluent correlations--------------------------------------------------------------- 
 
lmtotaleff=lm(BOD~Total, effluent) 
summary(lmtotaleff) 
#r2=0.1111 
 
lmregionIeff=lm(BOD~RegionI, effluent) 
summary(lmregionIeff) 
#r2=0.0758 
 
lmregionIIeff=lm(BOD~RegionII, effluent) 
summary(lmregionIIeff) 
#r2=0.1354 
 
lmregionIIIeff=lm(BOD~RegionIII, effluent) 
summary(lmregionIIIeff) 
#r2=0.0680 
 
lmProteinseff=lm(BOD~Proteins, effluent) 
summary(lmProteinseff) 
#r2=0.0262 
 
lmHumicseff=lm(BOD~Humics, effluent) 
summary(lmHumicseff) 
#r2=0.0655 
 
lmAeff=lm(BOD~A, effluent) 
summary(lmAeff) 
#r2=0.0492 
 
lmCeff=lm(BOD~C, effluent) 
summary(lmCeff) 
#r2=0.0920 
 
lmMeff=lm(BOD~M, effluent) 
summary(lmMeff) 
#r2=0.0287 
 
lmTeff=lm(BOD~T, effluent) 
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summary(lmTeff) 
#r2=0.0192 
#No significant correlation coefficients 
 
#----Linear Influent/CABI correlations---------------------------------------------------------- 
#build linear models for CABI and Influent 
lmtotalc=lm(BOD~Total, influentcabi) 
summary(lmtotalc) 
#r2=0.2953 
 
lmregionIc=lm(BOD~RegionI, influentcabi) 
summary(lmregionIc) 
#r2=0.3208 
 
lmregionIIc=lm(BOD~RegionII, influentcabi) 
summary(lmregionIIc) 
#r2=0.0677 
 
lmregionIIIc=lm(BOD~RegionIII, influentcabi) 
summary(lmregionIIIc) 
#r2=0.5331 
 
lmProteinsc=lm(BOD~Proteins, influentcabi) 
summary(lmProteinsc) 
#r2=0.4314 
 
lmHumicsc=lm(BOD~Humics,influentcabi) 
summary(lmHumicsc) 
#r2=0.6489 
shapiro.test(lmHumicsc$residuals) 
#nonnormal p=5.261e-6 
rlmHumicsc=rlm(BOD~Humics,influentcabi) 
summary(rlmHumicsc) 
#model 205*Humic peak - 222.81 
#Visually inspect model    
 plot(influentcabi $BOD~ influentcabi $Humics, xlim=range(influentcabi $Humics), 
ylim=range(influentcabi$BOD) )                                                        
 par(new=T) 
 curve(205*x-222, from=min(influentcabi $Humics), to=max(influentcabi$Humics), 
ylim=range(influentcabi $BOD),col="red")    
 #Conclude that it is not a goof fit for the data 
                           
lmAc=lm(BOD~A, influentcabi) 
summary(lmAc) 
#r2=0.0355 
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lmCc=lm(BOD~C, influentcabi) 
summary(lmCc) 
#r2=0.5699 
 
lmMc=lm(BOD~M, influentcabi) 
summary(lmMc) 
#r2=0.4407 
 
lmTc=lm(BOD~T, influentcabi) 
summary(lmTc) 
#r2=0.4322 
 
 
#----Linear Influent/CABI/effluent correlations-------------------------------------------------- 
 
#Total of the regions 
lmtotalall=lm(BOD~Total, all) 
summary(lmtotalall) 
#r2= 0.7915 and residual SE 72.55 
shapiro.test(lmtotalall$residuals) 
#non normal 
rlmtotalall=rlm(BOD~Total+factor(Location), all) 
summary(rlmtotalall) 
#The Total fl. factor drops out, bad model 
rlmtotalallb=rlm(BOD~Total, all) 
summary(rlmtotalallb) 
#y=0.0027*Total-111.0774 
#Visually inspect model    
 plot(all $BOD~ all $Humics, xlim=range(all $Humics), ylim=range(all$BOD) )                                                        
 par(new=T) 
 curve(0.0027*x-111, from=min(all $Total), to=max(all$Total), ylim=range(all 
$BOD),col="red")    
#Not a good model 
 
lmregionI=lm(BOD~RegionI, all) 
summary(lmregionI) 
#r2= 0.7971 
#residual SE 71.55 
qqnorm(lmregionI$residuals) 
shapiro.test(lmregionI$residuals) 
#non normal 
 
lmregionII=lm(BOD~RegionII, all) 
summary(lmregionII) 
#r2=0.7303 
#residual SE 82.5 
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qqnorm(lmregionII$residuals) 
shapiro.test(lmregionII$residuals) 
#non normal 
 
lmregionIII=lm(BOD~RegionIII, all) 
summary(lmregionIII) 
#r2=0.8618 
#residual SE 59.07 
qqnorm(lmregionIII$residuals) 
shapiro.test(lmregionIII$residuals) 
#non normal 
 
lmProteins=lm(BOD~Proteins, all) 
summary(lmProteins) 
#r2=0.8261 
#residual SE 66.26 
qqnorm(lmregionIII$residuals) 
shapiro.test(lmregionIII$residuals) 
#non normal 
 
lmHumics=lm(BOD~Humics,all) 
summary(lmHumics) 
#r2=0.8946 
#residual SE 51.58 
qqnorm(lmHumics$residuals) 
shapiro.test(lmHumics$residuals) 
#non normal 
 
lmA=lm(BOD~A, all) 
summary(lmA) 
#r2=0.7128 
#residual SE 85.13 
qqnorm(lmA$residuals) 
shapiro.test(lmA$residuals) 
#non normal 
 
lmC=lm(BOD~C, all) 
summary(lmC) 
#r2=0.8764 
#residual SE 55.86 
qqnorm(lmC$residuals) 
shapiro.test(lmC$residuals) 
#non normal 
 
lmM=lm(BOD~M, all) 
summary(lmM) 
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#r2= 0.8244 
#residual SE 66.57 
qqnorm(lmM$residuals) 
shapiro.test(lmM$residuals) 
#non normal 
 
lmT=lm(BOD~T, all) 
summary(lmT) 
#r2= 0.8234 
#residual SE 66.76 
qqnorm(lmT$residuals) 
shapiro.test(lmT$residuals) 
#non normal 
 
#----Robust regressions Humic peak-------------------------------------------------------------- 
 
#Humic peak 
rlmhumic <- rlm(BOD~Humics,data=all) 
summary(rlmhumic) 
#Residual 29.26 
#Model a=227.6772 and b=-277.7612 
r2humica<-lm(all$BOD~ rlmhumic $fitted.value) 
summary(r2humica) 
#r2=0.89463 
 
 
rlmhumicb <- rlm(BOD~Humics +factor(Location),data=all) 
summary(rlmhumicb) 
#Model 14.65*Humic+166.75*Inf -187.3350*Effluent +176.2195 
r2humicb<-lm(all$BOD~ rlmhumicb $fitted.value) 
summary(r2humicb) 
#R2=0.9295 
coeftest(rlmhumicb, df = Inf, vcov = vcovHC(rlmhumicb, type = "const")) 
coeftest(rlmhumicb, df = Inf, vcov = vcovHC(rlmhumicb, type = "HC")) 
coeftest(rlmhumicb, df = Inf, vcov = vcovHC(rlmhumicb, type = "HC0")) 
coeftest(rlmhumicb, df = Inf, vcov = vcovHC(rlmhumicb, type = "HC3")) 
coeftest(rlmhumicb, df = Inf, vcov = vcovHC(rlmhumicb, type = "HC4")) 
 
plot(all$BOD~all$Humics, xlim=range(all$Humics), ylim=range(all$BOD),  main="Linear 
Fit for Humic Peak", xlab="Humic Peak Fluorescence (AFU)", ylab="BOD5 (mg/L)"  )    
 
legend('topleft', c("Influent Regression Line (as a function of sample point)", "CABI 
Regression Line (as a function of sample point)", "Effluent (as a function of sample point)", 
"Regression model(sample site not considered) "), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), 
col=c('black', 'orange', 'green', 'red'), inset=0.02, cex=0.8)   
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#Sample sites not included                                                       
 par(new=T) 
 curve(227.68*x-277.76, from=min(all$Humics),  
                          to=max(all$Humics),  
                          ylim=range(all$BOD),col="red" , xlab="Humic Peak Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
 
#Samples sites as part of linear function 
#effluent 
 par(new=T) 
 curve(14.65*x-11.12, from=min(all$Humics),  
                          to=max(all$Humics),  
                          ylim=range(all$BOD),col="green" , xlab="Humic Peak Fluorescence 
(AFU)", ylab="BOD5 (mg/L)")  
 
#CABI 
 par(new=T) 
 curve(14.65*x+176.22, from=min(all$Humics),  
                          to=max(all$Humics),  
                          ylim=range(all$BOD),col="orange" , xlab="Humic Peak Fluorescence 
(AFU)", ylab="BOD5 (mg/L)")  
 
 
#influent 
 par(new=T) 
 curve(14.65*x+342.97, from=min(all$Humics),  
                          to=max(all$Humics),  
                          ylim=range(all$BOD),col="black" , xlab="Humic Peak Fluorescence 
(AFU)", ylab="BOD5 (mg/L)")  
 
 
#Try a nonlinear power model ax^b 
nlhumic<-nlrob((BOD~a*Humics^b), data=all, start=list(a=4e7, b=3)) 
summary(nlhumic) 
#residual error 64.81 
#model is a=29.6989 b=2.3878 
r2humicc<-lm(all$BOD~fitted.values(nlhumic)) 
summary(r2humicc) 
#r2=0.847 
 
#Try a nonlinear power model ax^b+c 
nlhumicb<-nlrob((BOD~a*Humics^b+c), data=all, start=list(a=1, b=1.494, c=-15)) 
summary(nlhumicb) 
#residual error 31.97 
#model is a=297.2757, b=0.8460, and c=-353.3478 
r2humicd<-lm(all$BOD~fitted.values(nlhumicb)) 
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summary(r2humicd) 
#r2=0.90 
 
#Exponential model without c 
exphumic<-nlrob((BOD~a*exp(Humics*b)), data=all, start=list(a=1, b=1.494)) 
summary(exphumic) 
#Residuals 90.8 
#Model is a=19.96 and b=1.00 
r2humice<-lm(all$BOD~fitted.values(exphumic)) 
summary(r2humice)                                                      
 
#Exponential model with c intercept 
exphumicb<-nlrob((BOD~a*exp(Humics*b)+c), data=all, start=list(a=4e3, b=2e-2, c=-
2.69e5), trace=T) 
summary(exphumicb)           
#Model a=-2.90e3, b=-9.443e-2, c=2.585e3                                                        
r2humicf<-lm(all$BOD~fitted.values(exphumicb)) 
summary(r2humicf) 
#r2-0.90 
 
 plot(all$BOD~all$Humics, xlim=range(all$Humics), ylim=range(all$BOD) , 
main="Nonlinear Fit for Humic Peak", xlab="Humic Peak Fluorescence (AFU)", 
ylab="BOD5 (mg/L)" )             
  
 legend('topleft', c("Power model", "Power model with a constant ", "Exponential model", 
"Exponential model with a constant"), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), col=c('black', 
'orange', 'red', 'green'), inset=0.02, cex=0.8)   
                                                
 par(new=T) 
 curve(29.6989*x^2.3878, from=min(all$Humics),  
                          to=max(all$Humics),  
                          ylim=range(all$BOD),col="black", xlab="Humic Peak Fluorescence 
(AFU)", ylab="BOD5 (mg/L)" )   
                                                         
 par(new=T) 
 curve(297.2757*x^0.8460-353.3478, from=min(all$Humics),  
                          to=max(all$Humics),  
                          ylim=range(all$BOD),col="orange", xlab="Humic Peak Fluorescence 
(AFU)", ylab="BOD5 (mg/L)" )  
 
 par(new=T) 
 curve(19.96*exp(x*1.00), from=min(all$Humics),  
                          to=max(all$Humics),  
                          ylim=range(all$BOD),col="red", xlab="Humic Peak Fluorescence (AFU)", 
ylab="BOD5 (mg/L)" )  
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par(new=T) 
 curve(-2903*exp(x*-9.443e-2)+2.585e3, from=min(all$Humics),  
                          to=max(all$Humics),  
                          ylim=range(all$BOD),col="green", xlab="Humic Peak Fluorescence 
(AFU)", ylab="BOD5 (mg/L)" )                      
 
 
#----Robust regressions Region III------------------------------------------------------------------ 
 
#All of the data is non normal 
#Perform a robust regression  
 
#Region III 
rlmregionIII <- rlm(BOD~RegionIII,data=all) 
summary(rlmregionIII) 
#Residual 30.89 
#model a=0.0337 b=-271.96 
r2region3a<-lm(all$BOD~rlmregionIII$fitted.value) 
summary(r2region3a) 
#r2=0.8613 
coeftest(rlmregionIII, df = Inf, vcov = vcovHC(rlmregionIII, type = "const")) 
coeftest(rlmregionIII, df = Inf, vcov = vcovHC(rlmregionIII, type = "HC")) 
coeftest(rlmregionIII, df = Inf, vcov = vcovHC(rlmregionIII, type = "HC0")) 
coeftest(rlmregionIII, df = Inf, vcov = vcovHC(rlmregionIII, type = "HC3")) 
coeftest(rlmregionIII, df = Inf, vcov = vcovHC(rlmregionIII, type = "HC4")) 
 
#Region III with sample sites as factor 
rlmregionIIIb <- rlm(BOD~RegionIII +factor(Location),data=all) 
summary(rlmregionIIIb) 
#Residual 14.21 
#model a=-0.0006, effluent=-204.1823, influent=179.8176, intercept=216.7640 
r2reg3b<-lm(all$BOD~rlmregionIIIb$fitted.value) 
summary(r2reg3b) 
#r2=0.9292 
coeftest(rlmregionIIIb, df = Inf, vcov = vcovHC(rlmregionIIIb, type = "const")) 
coeftest(rlmregionIIIb, df = Inf, vcov = vcovHC(rlmregionIIIb, type = "HC")) 
coeftest(rlmregionIIIb, df = Inf, vcov = vcovHC(rlmregionIIIb, type = "HC0")) 
coeftest(rlmregionIIIb, df = Inf, vcov = vcovHC(rlmregionIIIb, type = "HC3")) 
coeftest(rlmregionIIIb, df = Inf, vcov = vcovHC(rlmregionIIIb, type = "HC4")) 
 
 
plot(all$BOD~all$RegionIII, xlim=range(all$RegionIII), ylim=range(all$BOD),  
main="Linear Fit for Region III", xlab="Region III Fluorescence (AFU)", ylab="BOD5 
(mg/L)"  )   
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legend('topleft', c("Influent Regression Line (as a function of sample point)", "CABI 
Regression Line (as a function of sample point)", "Effluent (as a function of sample point)", 
"Regression model(sample site not considered) "), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), 
col=c('black', 'orange', 'green', 'red'), inset=0.02, cex=0.8)   
 
 
par(new=T) 
 curve(0.037*x-271.96, from=min(all$RegionIII),  
                          to=max(all$RegionIII),  
                          ylim=range(all$BOD),col="red" , xlab="Region III Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
 
par(new=T) 
 curve(-0.0006*x+12.56, from=min(all$RegionIII),  
                          to=max(all$RegionIII),  
                          ylim=range(all$BOD),col="green" , xlab="Region III Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
 
par(new=T) 
 curve(-0.0006*x+216.76, from=min(all$RegionIII),  
                          to=max(all$RegionIII),  
                          ylim=range(all$BOD),col="orange" , xlab="Region III Fluorescence 
(AFU)", ylab="BOD5 (mg/L)")  
 
 
par(new=T) 
 curve(-0.0006*x+396.58, from=min(all$RegionIII),  
                          to=max(all$RegionIII),  
                          ylim=range(all$BOD),col="black" , xlab="Region III Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
 
#Try a nonlinear power model ax^b 
nlabsreg3<-nlrob((BOD~a*RegionIII^b), data=all, start=list(a=4e7, b=3)) 
summary(nlabsreg3) 
#residual error 40.63 
#model is a=3.987e-11 b=3.045 
r2reg3<-lm(all$BOD~fitted.values(nlabsreg3)) 
summary(r2reg3) 
#r2=0.833 
 
#Try a nonlinear power model ax^b+c 
nlabsreg3bb<-nlrob((BOD~a*RegionIII^b+c), data=all, start=list(a=9e-8, b=2.274, c=-9.54)) 
summary(nlabsreg3bb) 
#Residuals 24.53 
#Model a=1.502e-6, b=1.99, c=-8.470e1 
r2reg3b<-lm(all$BOD~fitted.values(nlabsreg3bb)) 
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summary(r2reg3b) 
#r2=0.86 
                      
#Try an exponential model 
expreg3a<-nlrob((BOD~a*exp(RegionIII*b)), data=all, start=list(a=1, b=4e-7)) 
summary(expreg3a) 
#Residuals 65.86 
#Model a=1.052e+1, b=1.951e-4 
r2exp3<-lm(all$BOD~fitted.values(expreg3a)) 
summary(r2exp3) 
#r2=0.79 
 
#Try an exponential model with c  
expreg3b<-nlrob((BOD~a*exp(RegionIII*b)+c), data=all, start=list(a=2.1e2, b=6.9e-5, c=-
3.56e2)) 
summary(expreg3b) 
#Residuals 25 
#Model a=2.072e2, b=6.85e-5, c=-3.556+2 
r2exp3b<-lm(all$BOD~fitted.values(expreg3b)) 
summary(r2exp3b) 
#r2=0.86 
 
 plot(all$BOD~all$RegionIII, xlim=range(all$RegionIII), ylim=range(all$BOD), 
main="Nonlinear Fit for Region III", xlab="Region III Fluorescence (AFU)", ylab="BOD5 
(mg/L)"   )     
      
  legend('topleft', c("Power model", "Power model with a constant ", "Exponential model", 
"Exponential model with a constant"), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), col=c('black', 
'orange', 'red', 'green'), inset=0.02, cex=0.8)                          
                              
 par(new=T) 
 curve(3.987e-11*x^3.045, from=min(all$RegionIII),  
                          to=max(all$RegionIII),  
                          ylim=range(all$BOD),col="black", xlab="Region III Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")   
 par(new=T) 
 curve(1.502e-6*x^1.99-8.470e1, from=min(all$RegionIII),  
                          to=max(all$RegionIII),  
                          ylim=range(all$BOD),col="orange", xlab="Region III Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")                            
 par(new=T) 
 curve(1.052e1*exp(x*1.951e-4), from=min(all$RegionIII),  
                          to=max(all$RegionIII),  
                          ylim=range(all$BOD),col="red", xlab="Region III Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")                            
par(new=T) 
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 curve(2.072e2*exp(x*6.85e-5)-3.556e+2, from=min(all$RegionIII),  
                          to=max(all$RegionIII),  
                          ylim=range(all$BOD),col="green", xlab="Region III Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
                           
                           
                                           
 
#----Robust linear regressions Peak T ---------------------------------------------------- 
 
rlmT<- rlm(BOD~T,data=all) 
summary(rlmT) 
#Residual 29.42 
#Model a=42.0179 and b=-36.9042 
r2Ta<-lm(all$BOD~ rlmT $fitted.value) 
summary(r2Ta) 
#r2=0.83 
coeftest(rlmT, df = Inf, vcov = vcovHC(rlmT, type = "const")) 
coeftest(rlmT, df = Inf, vcov = vcovHC(rlmT, type = "HC")) 
coeftest(rlmT, df = Inf, vcov = vcovHC(rlmT, type = "HC0")) 
coeftest(rlmT, df = Inf, vcov = vcovHC(rlmT, type = "HC3")) 
coeftest(rlmT, df = Inf, vcov = vcovHC(rlmT, type = "HC4")) 
 
 
rlmTb <- rlm(BOD~ T +factor(Location),data=all) 
summary(rlmTb) 
#Model -1.0621*T+179.5924*Influent -205.9731*Effluent +214.4779 
r2Tb<-lm(all$BOD~ rlmTb $fitted.value) 
summary(r2Tb) 
#R2=0.9292 residual  
coeftest(rlmTb, df = Inf, vcov = vcovHC(rlmTb, type = "const")) 
coeftest(rlmTb, df = Inf, vcov = vcovHC(rlmTb, type = "HC")) 
coeftest(rlmTb, df = Inf, vcov = vcovHC(rlmTb, type = "HC0")) 
coeftest(rlmTb, df = Inf, vcov = vcovHC(rlmTb, type = "HC3")) 
coeftest(rlmTb, df = Inf, vcov = vcovHC(rlmTb, type = "HC4")) 
 
plot(all$BOD~all$Proteins, xlim=range(all$T), ylim=range(all$BOD),  main="Linear Fit for 
Peak T", xlab="Peak T Fluorescence (AFU)", ylab="BOD5 (mg/L)"  )      
 
legend('topleft', c("Influent Regression Line (as a function of sample point)", "CABI 
Regression Line (as a function of sample point)", "Effluent (as a function of sample point)", 
"Regression model(sample site not considered) "), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), 
col=c('black', 'orange', 'green', 'red'), inset=0.02, cex=0.8)   
                                                      
 par(new=T) 
 curve(-1.06*x+394.07, from=min(all$T),  
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                          to=max(all$T),  
                          ylim=range(all$BOD),col="black" , xlab="Peak T Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
 par(new=T) 
 curve(-1.06*x+ 214.48, from=min(all$T),  
                          to=max(all$T),  
                          ylim=range(all$BOD),col="orange" , xlab="Peak T Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")                            
 par(new=T) 
 curve(-1.06*x+8.51, from=min(all$T),  
                          to=max(all$T),  
                          ylim=range(all$BOD),col="green" , xlab="Peak T Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
 par(new=T) 
 curve(42.02*x-36.09, from=min(all$T),  
                          to=max(all$T),  
                          ylim=range(all$BOD),col="red" , xlab="Peak T Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
 
 
#Try a nonlinear power model ax^b 
nlTpeak<-nlrob((BOD~a*T^b), data=all, start=list(a=4e7, b=3)) 
summary(nlTpeak) 
#residual error 23.19 
#model is a=7.85 b=1.78 
r2T<-lm(all$BOD~fitted.values(nlTpeak)) 
summary(r2T) 
#r2=0.8378 
 
 
#Try a nonlinear power model ax^b+c 
nlTpeakb<-nlrob((BOD~a*T^b+c), data=all, start=list(a=1, b=1.494, c=-15)) 
summary(nlTpeakb) 
#residual error 23.06 
#model is a=7.95, b=1.77, and c=-0.36266 
r2Tb<-lm(all$BOD~fitted.values(nlTpeakb)) 
summary(r2Tb) 
#r2=0.84 
 
 
#Exponential model without c 
expTa<-nlrob((BOD~a*exp(T*b)), data=all, start=list(a=1, b=1.494)) 
summary(expTa) 
#Residuals 45.66 
#Model is a=26.05 and b=0.31 
r2Tc<-lm(all$BOD~fitted.values(expTa)) 
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summary(r2Tc) 
#r2=0.80 
 
#Exponential model with c intercept 
expTb <-nlrob((BOD~a*exp(T*b)+c), data=all, start=list(a=4e3, b=2e-2, c=-2.69e5)) 
summary(expTb)  
#Residuals 24.46          
#Model a=143.25, b=-0.149, c=-158.39 
r2Td<-lm(all$BOD~fitted.values(expTb)) 
summary(r2Td) 
#r2=0.84 
  
 plot(all$BOD~all$T, xlim=range(all$T), ylim=range(all$BOD), main="Nonlinear Fit for 
Peak T", xlab="Peak T Fluorescence (AFU)", ylab="BOD5 (mg/L)"   )    
  
   legend('topleft', c("Power model", "Power model with a constant ", "Exponential model", 
"Exponential model with a constant"), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), col=c('black', 
'orange', 'red', 'green'), inset=0.02, cex=0.8)     
  
  par(new=T) 
 curve(7.85*x^1.79, from=min(all$T),  
                          to=max(all$T),  
                          ylim=range(all$BOD),col="black", xlab="Peak T Fluorescence (AFU)", 
ylab="BOD5 (mg/L)"  )   
 par(new=T) 
 curve(7.95*x^ 1.77-0.36266, from=min(all$T),  
                          to=max(all$T),  
                          ylim=range(all$BOD),col="orange", xlab="Peak T Fluorescence (AFU)", 
ylab="BOD5 (mg/L)"  )                                                     
 par(new=T) 
 curve(26.05*exp(x*0.31), from=min(all$T),  
                          to=max(all$T),  
                          ylim=range(all$BOD),col="red", xlab="Peak T Fluorescence (AFU)", 
ylab="BOD5 (mg/L)"  )                                                     
 par(new=T) 
 curve(143.25*exp(x*0.149)-158.39, from=min(all$T),  
                          to=max(all$T),  
                          ylim=range(all$BOD),col="green", xlab="Peak T Fluorescence (AFU)", 
ylab="BOD5 (mg/L)"  )  
 
 
#----Robust regressions Region I----------------------------------------------------- 
 
#Region I 
rlmregionI <- rlm(BOD~RegionI,data=all) 
summary(rlmregionI) 
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#Residual 33.79 
#model a=0.0042 b=-55.6370 
r2region1a<-lm(all$BOD~rlmregionI$fitted.value) 
summary(r2region1a) 
#r2=0.7964 
coeftest(rlmregionI, df = Inf, vcov = vcovHC(rlmregionI, type = "const")) 
coeftest(rlmregionI, df = Inf, vcov = vcovHC(rlmregionI, type = "HC")) 
coeftest(rlmregionI, df = Inf, vcov = vcovHC(rlmregionI, type = "HC0")) 
coeftest(rlmregionI, df = Inf, vcov = vcovHC(rlmregionI, type = "HC3")) 
coeftest(rlmregionI, df = Inf, vcov = vcovHC(rlmregionI, type = "HC4")) 
 
#Region III with sample sites as factor 
rlmregionIb <- rlm(BOD~RegionI +factor(Location),data=all) 
summary(rlmregionIb) 
#Residual 14.16 
#model a=0, effluent=-202.0265, influent=178.2512, intercept=210.0014 
r2reg1b<-lm(all$BOD~rlmregionIb$fitted.value) 
summary(r2reg1b) 
#r2=0.9292 
coeftest(rlmregionIb, df = Inf, vcov = vcovHC(rlmregionIb, type = "const")) 
coeftest(rlmregionIb, df = Inf, vcov = vcovHC(rlmregionIb, type = "HC")) 
coeftest(rlmregionIb, df = Inf, vcov = vcovHC(rlmregionIb, type = "HC0")) 
coeftest(rlmregionIb, df = Inf, vcov = vcovHC(rlmregionIb, type = "HC3")) 
coeftest(rlmregionIb, df = Inf, vcov = vcovHC(rlmregionIb, type = "HC4")) 
 
 
plot(all$BOD~all$RegionI, xlim=range(all$RegionI), ylim=range(all$BOD),  main="Linear 
Fit for Region I", xlab="Region I Fluorescence (AFU)", ylab="BOD5 (mg/L)"  )      
 
legend('topleft', c("Influent Regression Line (as a function of sample point)", "CABI 
Regression Line (as a function of sample point)", "Effluent (as a function of sample point)", 
"Regression model(sample site not considered) "), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), 
col=c('black', 'orange', 'green', 'red'), inset=0.02, cex=0.8)   
 
 
 par(new=T) 
 curve(0*x+388.25, from=min(all$RegionI),  
                          to=max(all$RegionI),  
                          ylim=range(all$BOD),col="black" , xlab="Region I Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
 par(new=T) 
 curve(0*x+210.0014, from=min(all$RegionI),  
                          to=max(all$RegionI),  
                          ylim=range(all$BOD),col="orange" , xlab="Region I Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
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 par(new=T) 
 curve(0*x+7.9749, from=min(all$RegionI),  
                          to=max(all$RegionI),  
                          ylim=range(all$BOD),col="green" , xlab="Region I Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
 par(new=T) 
 curve(0.0042*x-55.6370, from=min(all$RegionI),  
                          to=max(all$RegionI),  
                          ylim=range(all$BOD),col="red" , xlab="Region I Fluorescence (AFU)", 
ylab="BOD5 (mg/L)") 
 
library(robustbase) 
 
#Try a nonlinear power model ax^b 
nlreg2<-nlrob((BOD~a*RegionI^b), data=all, start=list(a=6.78e-09, b=2.2), trace=T) 
summary(nlreg2) 
#residual error 22.22 
#model is a=7.41e-8 b=1.95 
r2reg2<-lm(all$BOD~fitted.values(nlreg2)) 
summary(r2reg2) 
#r2=0.81 
 
#Try a nonlinear power model ax^b+c 
nlregIb<-nlrob((BOD~a*RegionI^b+c), data=all, start=list(a=4.38e-5, b=1.38, c=-92), 
trace=T) 
summary(nlregIb) 
#Residuals 25.42 
#Model a=2.28e-7, b=1.856, c=-4.79 
r2reg2b<-lm(all$BOD~fitted.values(nlregIb)) 
summary(r2reg2b) 
#r2=0.81 
 
#Try an exponential model 
expreg2a<-nlrob((BOD~a*exp(RegionI*b)), data=all, start=list(a=4, b=3e-6), trace=T) 
summary(expreg2a) 
#Residuals 44.56 
#Model a=21.28, b=3.198e-5 
r2reg2c<-lm(all$BOD~fitted.values(expreg2a)) 
summary(r2reg2c) 
         
 #Try an exponential model with c 
expreg2b<-nlrob((BOD~a*exp(RegionI*b)+c), data=all, start=list(a=2.3e3, b=4.4e-6, c=-
2.5e3), trace=T) 
summary(expreg2b) 
#Residuals 43.53 
#Model a=129.6, b=1.511e-5, c=-154.0 
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r2reg2d<-lm(all$BOD~fitted.values(expreg2b)) 
summary(r2reg2d) 
#r2=0.80 
 
 
 
plot(all$BOD~all$RegionI, xlim=range(all$RegionI), ylim=range(all$BOD) , 
main="Nonlinear Fit for Region I", xlab="Region I Fluorescence (AFU)", ylab="BOD5 
(mg/L)"   )    
  
   legend('topleft', c("Power model", "Power model with a constant ", "Exponential model", 
"Exponential model with a constant"), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), col=c('black', 
'orange', 'red', 'green'), inset=0.02, cex=0.8)       
 
 
  par(new=T) 
 curve(7.41e-8*x^1.95, from=min(all$RegionI),  
                          to=max(all$RegionI),  
                          ylim=range(all$BOD),col="black", xlab="Region I Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")    
  par(new=T) 
 curve(2.28e-7*x^1.856-4.79, from=min(all$RegionI),  
                          to=max(all$RegionI),  
                          ylim=range(all$BOD),col="orange", xlab="Region I Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")                                                                                   
 par(new=T) 
 curve(21.28*exp(x*3.198e-5), from=min(all$RegionI),  
                          to=max(all$RegionI),  
                          ylim=range(all$BOD),col="red", xlab="Region I Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
 par(new=T) 
 curve(1.296e2*exp(x*1.511e-5)-1.540e2, from=min(all$RegionI),  
                          to=max(all$RegionI),  
                          ylim=range(all$BOD),col="green", xlab="Region I Fluorescence (AFU)", 
ylab="BOD5 (mg/L)")  
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G.4 BOD and Absorbance Models 
 
#importdata 
library(XLConnect) 
abs=loadWorkbook("absorbancedata.xlsx") 
influent=readWorksheet(abs, sheet="influent") 
cabi=readWorksheet(abs, sheet="cabi") 
influentcabi=readWorksheet(abs, sheet="influentcabi") 
effluent=readWorksheet(abs, sheet="effluent") 
all=readWorksheet(abs, sheet="all") 
 
 
#Plot data 
library(ggplot2) 
qplot(Abs254,BOD, main= "BOD and Absorbance (254 nm) data for all sample sites", 
ylab="BOD5 (mg/L)", xlab="Absorbance at 254 nm (AU)", colour = Location, shape = 
Location, data = all) 
    
qplot(Abs254,BOD, main= "BOD and Absorbance (254 nm) data for Effluent", colour = 
Location, shape = Location, data = effluent) 
 
 
#-----BOD vs 254 nm linear--------------------------------------------------------------------- 
#First correlation is for BOD vs 254nm absorbance 
 
lm254<-lm(BOD~Abs254, data=all) 
shapiro.test(lm254$residuals) 
#p=1.713e-11, data non normal use robust regression 
 
library(robustbase) 
 
rlm254a <- rlm(BOD~Abs254,data=all) 
summary(rlm254a) 
#SE=31.93 
#Model a=1458.7 and b=-155.07 
lm254r2a<-lm(all$BOD~ rlm254a $fitted.values) 
summary(lm254r2a) 
#R2=0.77 
 
#Try a robust linear model 
rlm254b <- rlm(BOD~Abs254 + factor(Location),data=all) 
summary(rlm254b) 
#Residual SE 13.18 
#Model is BOD=-377.8830+188.2781*Inf-261.76*Eff+310.7882 
lm254r2<-lm(all$BOD~rlm254b$fitted.values) 
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summary(lm254r2) 
#r2=0.9292 
 
#Plot the lines for each regression model 
 plot(all$BOD~all$Abs254, xlim=range(all$Abs254), ylim=range(all$BOD),  main="Linear 
Fit for Absorbance at 254 nm", xlab="Absorbance at 254 nm (AU)", ylab="BOD5 (mg/L)" )  
 legend('topleft', c("Influent Regression Line (as a function of sample point)", "CABI 
Regression Line (as a function of sample point)", "Effluent (as a function of sample point)", 
"Regression model(sample site not considered) "), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), 
col=c('black', 'orange', 'green', 'red'), inset=0.02, cex=0.8)   
  par(new=T) 
 curve(-377.8830*x+499.07, from=min(all$Abs254), to=max(all$Abs254), ylim= 
range(all$BOD),col="black", xlab="Absorbance at 254 nm (AU)", ylab="BOD5 (mg/L)"  )                          
 par(new=T) 
 curve(-377.8830*x+310.7882, from=min(all$Abs254), to=max(all$Abs254),ylim= 
range(all$BOD), col="orange", xlab="Absorbance at 254 nm (AU)", ylab="BOD5 (mg/L)"  
) 
 
par(new=T)                       
curve(-377.8830*x+49.03, from=min(all$Abs254), to=max(all$Abs254), ylim= 
range(all$BOD), col="green", xlab="Absorbance at 254 nm (AU)", ylab="BOD5 (mg/L)"  )  
                          
  par(new=T) 
 curve(1458.67*x-155.07, from=min(all$Abs254),  to=max(all$Abs254), ylim= 
range(all$BOD), col="red", xlab="Absorbance at 254 nm (AU)", ylab="BOD5 (mg/L)"  )  
 
#Try a nonlinear power model ax^b 
nlabs254<-nlrob((BOD~a*Abs254^b), data=all, start=list(a=4e7, b=3)) 
summary(nlabs254) 
#residual error 26.14 
#model is a=8533.16 b=2.80 
r2nl254<-lm(all$BOD~fitted.values(nlabs254)) 
summary(r2nl254) 
#r2=0.7624 
 
#Try a nonlinear power model ax^b+c 
nlabs254b<-nlrob((BOD~a*Abs254^b+c), data=all, start=list(a=4000, b=3, c=100)) 
summary(nlabs254b) 
#residual error 22.07 
#model is a=4090.4313 b=2.1087 c=-31.6428 
r2nl254b<-lm(all$BOD~fitted.values(nlabs254b)) 
summary(r2nl254b) 
 
#Try an exponential regression model ae^xb 
nlabs254exp<-nlrob((BOD~a*exp(Abs254*b)), data=all, start=list(a=0.8, b=20)) 
summary(nlabs254exp) 
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#Residual error 44.02 
#Model is a=11.34 and b=9.73 
r2exp254<-lm(all$BOD~fitted.values(nlabs254exp)) 
summary(r2exp254) 
#r2=0.7289 
 
#Try an exponential regression model ae^xb+c 
nlabs254expb<-nlrob((BOD~a*exp(Abs254*b)+c ), data=all, start=list(a=0.8, b=20, c=10)) 
summary(nlabs254expb) 
#Residual error 22.33 
#Model is a=120.41 and b=4.63 and c=-193.20 
r2exp254b<-lm(all$BOD~fitted.values(nlabs254expb)) 
summary(r2exp254b) 
#r2=0.771 
 
#Plot the lines for each regression model 
 plot(all$BOD~all$Abs254, xlim=range(all$Abs254), ylim=range(all$BOD) ,  
main="Nonlinear Fit for Absorbance at 254 nm", xlab="Absorbance at 254 nm (AU)", 
ylab="BOD5 (mg/L)" ) 
    legend('topleft', c("Power model", "Power model with a constant ", "Exponential model", 
"Exponential model with a constant"), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), col=c('black', 
'orange', 'red', 'green'), inset=0.02, cex=0.8)       
 par(new=T) 
 curve(8533*x^2.80, from=min(all$Abs254), to=max(all$Abs254), 
ylim=range(all$BOD),col="black", xlab="Absorbance at 254 nm (AU)", ylab="BOD5 
(mg/L)")                          
 par(new=T) 
 curve(4090*x^2.11-31.64, from=min(all$Abs254), to=max(all$Abs254), 
ylim=range(all$BOD), col="orange", xlab="Absorbance at 254 nm (AU)", ylab="BOD5 
(mg/L)") 
par(new=T)                       
curve(9.73*exp(11.34*x), from=min(all$Abs254), to=max(all$Abs254), 
ylim=range(all$BOD), col="red", xlab="Absorbance at 254 nm (AU)", ylab="BOD5 
(mg/L)")           
par(new=T)                       
curve(120.41*exp(4.63*x)-193.2, from=min(all$Abs254, to=max(all$Abs254), 
ylim=range(all$BOD), col="green", xlab="Absorbance at 254 nm (AU)", ylab="BOD5 
(mg/L 
 
 
 
 
 
 
 
 
	   318	  
#-------BOD Abs340 correlations------------------------------------------------ 
 
 
lm340 <- rlm(BOD~Abs340 + factor(Location),data=all) 
shapiro.test(lm340$residuals) 
#nonnormal data, use robust regression p<2.2e-16 
 
 
#Try a linear model 
rlm340a <- rlm(BOD~Abs340,data=all) 
summary(rlm340a) 
#Residual SE 31.72 
#Model is BOD=7094.19x-211.3323 
lm340r2a<-lm(all$BOD~ rlm340a $fitted.values) 
summary(lm340r2a) 
#r2=0.78 
 
 
#Try a robust linear model with factor 
rlm340 <- rlm(BOD~Abs340 + factor(Location),data=all) 
summary(rlm340) 
#Residual SE 14.35 
#Model is BOD=-1124.32*Abs+189.94*Inf-234.56*eff +276.80 
lm340r2<-lm(all$BOD~rlm340$fitted.values) 
summary(lm340r2) 
#r2=0.9292 
 
 
#Plot the lines for each line regression line 
 plot(all$BOD~all$Abs340, xlim=range(all$Abs340), ylim=range(all$BOD),  main="Linear 
Fit for Absorbance at 340 nm", xlab="Absorbance at 340 nm (AU)", ylab="BOD5 (mg/L)"} 
 legend('topleft', c("Influent Regression Line (as a function of sample point)", "CABI 
Regression Line (as a function of sample point)", "Effluent (as a function of sample point)", 
"Regression model(sample site not considered) "), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), 
col=c('black', 'orange', 'green', 'red'), inset=0.02, cex=0.8)  
  par(new=T) 
 curve(-1124*x+466.74, from=min(all$Abs340), to=max(all$Abs340), 
ylim=range(all$BOD), col="black", xlab="Absorbance at 340 nm (AU)", ylab="BOD5 
(mg/L)" )                 
  par(new=T)                       
  curve(-1124*x+276.80, from=min(all$Abs340), to=max(all$Abs340), 
ylim=range(all$BOD), col="orange", xlab="Absorbance at 340 nm (AU)", ylab="BOD5 
(mg/L)" ) 
                         
     par(new=T)                       
 curve(-1124*x+42.24, from=min(all$Abs340), to=max(all$Abs340), ylim=range(all$BOD), 
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col="green", xlab="Absorbance at 340 nm (AU)", ylab="BOD5 (mg/L)" )      
     par(new=T)                       
 curve(7094*x-211, from=min(all$Abs340), to=max(all$Abs340), ylim=range(all$BOD), 
col="red", xlab="Absorbance at 340 nm (AU)", ylab="BOD5 (mg/L)" )   
 
 
#Try a nonlinear power model ax^b 
nlabs340<-nlrob((BOD~a*Abs340^b), data=all, start=list(a=4e6, b=3)) 
summary(nlabs340) 
#residual error 50.23 
#model is a=19550 b=2.46 
r2nl340<-lm(all$BOD~fitted.values(nlabs340)) 
summary(r2nl340) 
#r2=0.7321 
 
#Try a nonlinear power model ax^b+c 
nlabs340b<-nlrob((BOD~a*Abs340^b+c), data=all, start=list(a=400000, b=3, c=1)) 
summary(nlabs340b) 
#residual error 31.25 
#model is a=7641.95 b=1.04 c=-199.61 
r2nl340b<-lm(all$BOD~fitted.values(nlabs340b)) 
summary(r2nl340b) 
#r2=0.7786 
 
#Try an exponential regression model ae^xb 
nlabs340exp<-nlrob((BOD~a*exp(Abs340*b)), data=all, start=list(a=0.8, b=20)) 
summary(nlabs340exp) 
#Residual error 76.89 
#Model is a=17.66 and b=39.14 
r2exp340<-lm(all$BOD~fitted.values(nlabs340exp)) 
summary(r2exp340) 
#r2=0.662 
 
#Try an exponential regression model ae^xb+c 
nlabs340exp<-nlrob((BOD~a*exp(Abs340*b)+c), data=all, start=list(a=-6442, b=-1.17, 
c=6220), trace=T) 
summary(nlabs340exp) 
#Residual 32.25 
#Model a=-8870.5, b=-0.835, c=8652.3     
r2exp340b<-lm(all$BOD~fitted.values(nlabs340exp)) 
summary(r2exp340b) 
 
#Plot the lines for each regression model 
 plot(all$BOD~all$Abs340, xlim=range(all$Abs340), ylim=range(all$BOD) ,  
main="Nonlinear Fit for Absorbance at 340 nm", xlab="Absorbance at 340 nm (AU)", 
ylab="BOD5 (mg/L)" ) 
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    legend('topleft', c("Power model", "Power model with a constant ", "Exponential model", 
"Exponential model with a constant"), lty=c(1,1,1,1), lwd=c(1, 1, 1,1), col=c('black', 
'orange', 'red', 'green'), inset=0.02, cex=0.8)       
 par(new=T) 
 curve(19550*x^2.46, from=min(all$Abs340),  to=max(all$Abs340), ylim= range(all$BOD), 
col="black", xlab="Absorbance at 340 nm (AU)", ylab="BOD5 (mg/L)" )                
 par(new=T) 
 curve(7641*x^1.04-199.61, from=min(all$Abs340), to=max(all$Abs340), ylim= 
range(all$BOD), col="orange", xlab="Absorbance at 340 nm (AU)", ylab="BOD5 (mg/L)") 
par(new=T)                       
curve(17.66*exp(39.14*x), from=min(all$Abs340),   to=max(all$Abs340), ylim= 
range(all$BOD), col="red", xlab="Absorbance at 340 nm (AU)", ylab="BOD5 (mg/L)")        
par(new=T)                       
curve(-8870.5*exp(-0.835*x)+8652.3, from=min(all$Abs340), to=max(all$Abs340), 
ylim=range(all$BOD), col="green", xlab="Absorbance at 340 nm (AU)", ylab="BOD5 
(mg/L)" ) 
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G.5 Removal Efficiency (Example for absorbance at 340 nm) 
#Removal efficiency was calculated in Excel worksheet and R was used to calculate 
bootstrap samples and summary statstics 
library(XLConnect) 
removals=loadWorkbook("difference.xlsx") 
abs340=readWorksheet(removals, sheet="removalAbs340") 
 
primary.mean <- vector() 
basin.mean <- vector() 
plant.mean <- vector() 
x1 <- vector() 
x2 <- vector() 
x3 <- vector() 
 
B <- 1000  # number of bootstrap runs 
for (i in 1:B) 
{ 
x1 <- sample(abs340 $abs340primary,replace=TRUE) 
x2 <- sample(abs340 $abs340basin,replace=TRUE) 
x3 <- sample(abs340 $abs340plant,replace=TRUE) 
primary.mean[i] <- mean(x1) 
basin.mean[i] <- mean(x2) 
plant.mean[i] <- mean(x3) 
} 
Primary.mean <- mean(primary.mean) 
Basin.mean <- mean(basin.mean) 
Plant.mean <- mean(plant.mean) 
 
Primary.sd <- sd(primary.mean) 
Basin.sd <- sd(basin.mean) 
Plant.sd <- sd(plant.mean) 
 
# Approximate 95% CIs 
PrimaryL95 <- Primary.mean - 1.96*Primary.sd 
PrimaryU95 <- Primary.mean + 1.96*Primary.sd 
 
BasinL95 <- Basin.mean - 1.96*Basin.sd 
BasinU95 <- Basin.mean + 1.96*Basin.sd 
 
PlantL95 <- Plant.mean - 1.96*Plant.sd 
PlantU95<- Plant.mean + 1.96*Plant.sd 
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